
<html lang="en"     class="pb-page"  data-request-id="babb7fe5-82a9-4041-a6db-53504712839e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c02022;issue:issue:10.1021/jmcmar.2021.64.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum" /></meta><meta name="dc.Creator" content="Aloysus  Lawong" /></meta><meta name="dc.Creator" content="Suraksha  Gahalawat" /></meta><meta name="dc.Creator" content="John  Okombo" /></meta><meta name="dc.Creator" content="Josefine  Striepen" /></meta><meta name="dc.Creator" content="Tomas  Yeo" /></meta><meta name="dc.Creator" content="Sachel  Mok" /></meta><meta name="dc.Creator" content="Ioanna  Deni" /></meta><meta name="dc.Creator" content="Jessica L.  Bridgford" /></meta><meta name="dc.Creator" content="Hanspeter  Niederstrasser" /></meta><meta name="dc.Creator" content="Anwu  Zhou" /></meta><meta name="dc.Creator" content="Bruce  Posner" /></meta><meta name="dc.Creator" content="Sergio  Wittlin" /></meta><meta name="dc.Creator" content="Francisco Javier  Gamo" /></meta><meta name="dc.Creator" content="Benigno  Crespo" /></meta><meta name="dc.Creator" content="Alisje  Churchyard" /></meta><meta name="dc.Creator" content="Jake  Baum" /></meta><meta name="dc.Creator" content="Nimisha  Mittal" /></meta><meta name="dc.Creator" content="Elizabeth  Winzeler" /></meta><meta name="dc.Creator" content="Benoît  Laleu" /></meta><meta name="dc.Creator" content="Michael J.  Palmer" /></meta><meta name="dc.Creator" content="Susan A.  Charman" /></meta><meta name="dc.Creator" content="David A.  Fidock" /></meta><meta name="dc.Creator" content="Joseph M.  Ready" /></meta><meta name="dc.Creator" content="Margaret A.  Phillips" /></meta><meta name="dc.Description" content="Malaria control programs continue to be threatened by drug resistance. To identify new antimalarials, we conducted a phenotypic screen and identified a novel tetrazole-based series that shows fast-..." /></meta><meta name="Description" content="Malaria control programs continue to be threatened by drug resistance. To identify new antimalarials, we conducted a phenotypic screen and identified a novel tetrazole-based series that shows fast-..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 23, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02022" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02022" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02022" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02022" /></link>
        
    
    

<title>Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02022" /></meta><meta property="og:title" content="Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0015.jpeg" /></meta><meta property="og:description" content="Malaria control programs continue to be threatened by drug resistance. To identify new antimalarials, we conducted a phenotypic screen and identified a novel tetrazole-based series that shows fast-kill kinetics and a relatively low propensity to develop high-level resistance. Preliminary structure–activity relationships were established including identification of a subseries of related amides with antiplasmodial activity. Assaying parasites with resistance to antimalarials led us to test whether the series had a similar mechanism of action to chloroquine (CQ). Treatment of synchronized Plasmodium falciparum parasites with active analogues revealed a pattern of intracellular inhibition of hemozoin (Hz) formation reminiscent of CQ’s action. Drug selections yielded only modest resistance that was associated with amplification of the multidrug resistance gene 1 (pfmdr1). Thus, we have identified a novel chemical series that targets the historically druggable heme polymerization pathway and that can form the basis of future optimization efforts to develop a new malaria treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02022"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02022">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02022&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02022&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02022&amp;href=/doi/10.1021/acs.jmedchem.0c02022" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2739-2761</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02011" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02047" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in <i>Plasmodium falciparum</i></span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Aloysus Lawong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aloysus Lawong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aloysus++Lawong">Aloysus Lawong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Suraksha Gahalawat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Suraksha Gahalawat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Suraksha++Gahalawat">Suraksha Gahalawat</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Okombo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Okombo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Okombo">John Okombo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Josefine Striepen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Josefine Striepen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Josefine++Striepen">Josefine Striepen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomas Yeo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomas Yeo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomas++Yeo">Tomas Yeo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sachel Mok</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sachel Mok</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sachel++Mok">Sachel Mok</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ioanna Deni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ioanna Deni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ioanna++Deni">Ioanna Deni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessica L. Bridgford</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica L. Bridgford</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica+L.++Bridgford">Jessica L. Bridgford</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hanspeter Niederstrasser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanspeter Niederstrasser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanspeter++Niederstrasser">Hanspeter Niederstrasser</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anwu Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anwu Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anwu++Zhou">Anwu Zhou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruce Posner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruce Posner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruce++Posner">Bruce Posner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sergio Wittlin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sergio Wittlin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland</div><div class="loa-info-affiliations-info">University of Basel, 4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sergio++Wittlin">Sergio Wittlin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francisco Javier Gamo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francisco Javier Gamo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicines Development Campus, GlaxoSmithKline, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francisco+Javier++Gamo">Francisco Javier Gamo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1854-2882" title="Orcid link">http://orcid.org/0000-0002-1854-2882</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benigno Crespo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benigno Crespo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicines Development Campus, GlaxoSmithKline, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benigno++Crespo">Benigno Crespo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alisje Churchyard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alisje Churchyard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life Sciences, Imperial College London, SW7 2AZ South Kensington, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alisje++Churchyard">Alisje Churchyard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jake Baum</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jake Baum</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life Sciences, Imperial College London, SW7 2AZ South Kensington, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jake++Baum">Jake Baum</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nimisha Mittal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nimisha Mittal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nimisha++Mittal">Nimisha Mittal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elizabeth Winzeler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elizabeth Winzeler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Winzeler">Elizabeth Winzeler</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4049-2113" title="Orcid link">http://orcid.org/0000-0002-4049-2113</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benoît Laleu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benoît Laleu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicines for Malaria Venture, 1215 Geneva, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Beno%C3%AEt++Laleu">Benoît Laleu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7530-2113" title="Orcid link">http://orcid.org/0000-0002-7530-2113</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael J. Palmer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael J. Palmer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicines for Malaria Venture, 1215 Geneva, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Palmer">Michael J. Palmer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susan A. Charman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susan A. Charman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susan+A.++Charman">Susan A. Charman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David A. Fidock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David A. Fidock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div><div class="loa-info-affiliations-info">Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Fidock">David A. Fidock</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph M. Ready</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph M. Ready</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7f15100c1a0f17510d1a1e1b063f0a0b0c100a0b17081a0c0b1a0d11511a1b0a"><span class="__cf_email__" data-cfemail="254f4a5640554d0b574044415c655051564a50514d5240565140574b0b404150">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+M.++Ready">Joseph M. Ready</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1305-9581" title="Orcid link">http://orcid.org/0000-0003-1305-9581</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Margaret A. Phillips</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Margaret A. Phillips</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3558544752544750411b455d5c59595c4546754041465a40415d4250464150475b1b505140"><span class="__cf_email__" data-cfemail="5538342732342730217b253d3c39393c2526152021263a20213d2230262130273b7b303120">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Margaret+A.++Phillips">Margaret A. Phillips</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5250-5578" title="Orcid link">http://orcid.org/0000-0001-5250-5578</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02022&amp;href=/doi/10.1021%2Facs.jmedchem.0c02022" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2739–2761</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 23, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 November 2020</li><li><span class="item_label"><b>Published</b> online</span>23 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 March 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02022" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02022</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2739%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAloysus%2BLawong%252C%2BSuraksha%2BGahalawat%252C%2BJohn%2BOkombo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D5%26contentID%3Dacs.jmedchem.0c02022%26title%3DNovel%2BAntimalarial%2BTetrazoles%2Band%2BAmides%2BActive%2Bagainst%2Bthe%2BHemoglobin%2BDegradation%2BPathway%2Bin%2BPlasmodium%2Bfalciparum%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2761%26publicationDate%3DMarch%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02022"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">900</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02022" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Aloysus&quot;,&quot;last_name&quot;:&quot;Lawong&quot;},{&quot;first_name&quot;:&quot;Suraksha&quot;,&quot;last_name&quot;:&quot;Gahalawat&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Okombo&quot;},{&quot;first_name&quot;:&quot;Josefine&quot;,&quot;last_name&quot;:&quot;Striepen&quot;},{&quot;first_name&quot;:&quot;Tomas&quot;,&quot;last_name&quot;:&quot;Yeo&quot;},{&quot;first_name&quot;:&quot;Sachel&quot;,&quot;last_name&quot;:&quot;Mok&quot;},{&quot;first_name&quot;:&quot;Ioanna&quot;,&quot;last_name&quot;:&quot;Deni&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;L. Bridgford&quot;},{&quot;first_name&quot;:&quot;Hanspeter&quot;,&quot;last_name&quot;:&quot;Niederstrasser&quot;},{&quot;first_name&quot;:&quot;Anwu&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Posner&quot;},{&quot;first_name&quot;:&quot;Sergio&quot;,&quot;last_name&quot;:&quot;Wittlin&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Javier Gamo&quot;},{&quot;first_name&quot;:&quot;Benigno&quot;,&quot;last_name&quot;:&quot;Crespo&quot;},{&quot;first_name&quot;:&quot;Alisje&quot;,&quot;last_name&quot;:&quot;Churchyard&quot;},{&quot;first_name&quot;:&quot;Jake&quot;,&quot;last_name&quot;:&quot;Baum&quot;},{&quot;first_name&quot;:&quot;Nimisha&quot;,&quot;last_name&quot;:&quot;Mittal&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Winzeler&quot;},{&quot;first_name&quot;:&quot;Benoît&quot;,&quot;last_name&quot;:&quot;Laleu&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Palmer&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;A. Charman&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Fidock&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;M. Ready&quot;},{&quot;first_name&quot;:&quot;Margaret&quot;,&quot;last_name&quot;:&quot;A. Phillips&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2739-2761&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02022&quot;},&quot;abstract&quot;:&quot;Malaria control programs continue to be threatened by drug resistance. To identify new antimalarials, we conducted a phenotypic screen and identified a novel tetrazole-based series that shows fast-kill kinetics and a relatively low propensity to develop high-level resistance. Preliminary structure–activity relationships were established including identification of a subseries of related amides with antiplasmodial activity. Assaying parasites with resistance to antimalarials led us to test whether the series had a similar mechanism of action to chloroquine (CQ). Treatment of synchronized Plasmodium falciparum parasites with active analogues revealed a pattern of intracellular inhibition of hemozoin (Hz) formation reminiscent of CQ’s action. Drug selections yielded only modest resistance that was associated with amplification of the multidrug resistance gene 1 (pfmdr1). Thus, we have identified a novel chemical series that targets the historically druggable heme polymerization pathway and that can form the basi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02022&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02022" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02022&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02022" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02022&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02022" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02022&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02022&amp;href=/doi/10.1021/acs.jmedchem.0c02022" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02022" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02022" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02022%26sid%3Dliteratum%253Aachs%26pmid%3D33620219%26genre%3Darticle%26aulast%3DLawong%26date%3D2021%26atitle%3DNovel%2BAntimalarial%2BTetrazoles%2Band%2BAmides%2BActive%2Bagainst%2Bthe%2BHemoglobin%2BDegradation%2BPathway%2Bin%2BPlasmodium%2Bfalciparum%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D5%26spage%3D2739%26epage%3D2761%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/jmcmar.2021.64.issue-5/20210311/jmcmar.2021.64.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Malaria control programs continue to be threatened by drug resistance. To identify new antimalarials, we conducted a phenotypic screen and identified a novel tetrazole-based series that shows fast-kill kinetics and a relatively low propensity to develop high-level resistance. Preliminary structure–activity relationships were established including identification of a subseries of related amides with antiplasmodial activity. Assaying parasites with resistance to antimalarials led us to test whether the series had a similar mechanism of action to chloroquine (CQ). Treatment of synchronized <i>Plasmodium falciparum</i> parasites with active analogues revealed a pattern of intracellular inhibition of hemozoin (Hz) formation reminiscent of CQ’s action. Drug selections yielded only modest resistance that was associated with amplification of the multidrug resistance gene 1 (<i>pfmdr1</i>). Thus, we have identified a novel chemical series that targets the historically druggable heme polymerization pathway and that can form the basis of future optimization efforts to develop a new malaria treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria remains a leading cause of mortality and morbidity worldwide. Global malaria deaths in 2020 were estimated at ∼0.4 million, with African children under the age of 5 representing the most vulnerable demographic and accounting for 272,000 (67%) of all malaria deaths.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> An estimated 228 million cases occurred worldwide in the same period. In high-burden countries, malaria continues to place a significant strain on healthcare systems, while leading to substantial losses in economic output, creating a cycle of poverty. The causative agent of malaria is an obligate intracellular parasite from the <i>Plasmodium</i> genus, of which there are five human infective species. <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i> account for most cases of malaria, with the former responsible for almost all malaria deaths.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">A number of drugs with a range of modes of action (MOA) have been used to treat malaria, including chloroquine (CQ), which became the mainstay of treatment and prevention programs in the late 1940s.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Widespread <i>P. falciparum</i> resistance to CQ led to its loss of efficacy, a fate shared by sulfadoxine + pyrimethamine (which inhibit dihydropteroate synthase and dihydrofolate reductase, respectively) that was introduced in the late 1950s. Parasite resistance extends to nearly every other drug that has been used in malaria treatment programs.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The introduction of artemisinin-based combination therapies (ACTs) as the first-line treatment regimen restored effective malaria control, and their use has led to substantial reductions in malaria disease burden in the last two decades.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, increasing ACT treatment failure rates are being reported, particularly in the Greater Mekong Subregion. <i>P. falciparum</i> resistance to artemisinin (ART) is associated with mutations in Kelch13 and with delayed parasite clearance times.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a> These reductions in ART potency have paralleled the emergence of resistance to partner compounds,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> further jeopardizing the efficacy of first-line antimalarials and foreshadowing a reversal of the gains made in the last decade.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> New challenges in emerging resistance to the current frontline therapies make the discovery of novel antimalarials a critical component to sustaining and improving malaria control programs.</div><div class="NLM_p">Academic and commercial antimalarial high-throughput screening (HTS) campaigns have leveraged whole cell-based approaches to identify novel antimalarial candidates, some currently in clinical development.<a onclick="showRef(event, 'ref2 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref11 ref12">(2,11,12)</a> Early phenotypic screening campaigns focused on targeting asexual blood stage (ABS) parasites, which cause clinical symptoms. This approach led to the identification of several clinical candidates for the treatment of malaria, including the spiroindolone ATP4 inhibitor KAE609 (NITD609),<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> the imidazolopiperazine, KAF156,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> and PI4 kinase inhibitors<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> including KDU691 and MMV390048. More recent approaches have since allowed development of screening platforms targeting multiple stages of the <i>Plasmodium</i> life cycle.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> These phenotypic screening efforts, combined with the use of forward genetics and whole-genome sequencing (WGS), have proven powerful in identifying the protein targets of antimalarial compounds, including for several of these current development candidates.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Target-based screens, including those against dihydroorotate dehydrogenase that led to the identification of DSM265,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> have also been deployed but so far have led to fewer development candidates than the phenotypic approach.</div><div class="NLM_p last">Herein, we describe the identification of a novel tetrazole-based series from a phenotypic screen against <i>P. falciparum</i> ABS parasites (using the 3D7 strain). This series shows a fast kill rate <i>in vitro</i>, and life-cycle profiling reveals it to be ABS-specific. Synthesis and evaluation of additional analogues in the series have established preliminary structure–activity relationships (SARs). MOA studies suggest that parasite killing is mediated by inhibition of hemozoin (Hz) formation and the toxic buildup of free heme in the parasite digestive vacuole (DV), similar to CQ. Selections for resistant parasites have yielded only low-level resistance, and WGS reveals amplification of the multidrug resistance 1 gene (<i>pfmdr1</i>). We have thus identified a novel class of antimalarial compounds with a fast-kill mechanism and low resistance propensity and whose MOA appears to involve inhibition of heme detoxification, a critical pathway in the parasite’s intraerythrocytic development and a well-validated antimalarial target. These compounds also have the advantage of rapid synthesis from readily available starting materials.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Phenotypic Screen to Identify Novel Compounds Active against <i>P. falciparum</i> ABS Parasites</h3><div class="NLM_p">A single-point (5 μM) primary screen of an 8K subset of our larger library was executed in a high-throughput optimized 384-well format against the pan-susceptible <i>P. falciparum</i> 3D7 strain of ABS parasites, using a published SYBR Green assay.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> The assay was highly robust, with an average <i>Z</i>′ of 0.76 ± 0.059 (where >0.5 is considered a robust assay) across all plates (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). We identified a total of 79 hits based on an RZ score cutoff of <−3. The RZ score represents the number of robust standard deviations (RSD) from the corrected median of a measurement for a library compound, as determined after correction for systematic errors (plate, row, and column effects).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Compounds with structural alerts (e.g., PAINS compounds<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>) or poor drug-like properties<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> were removed, and a secondary screen at three concentrations (5, 1.7, and 0.42 μM) was performed, yielding 38 confirmed hits. We prioritized compounds with EC<sub>50</sub> values <3 μM against 3D7 parasites and selected for chemical novelty based on PubChem and SciFinder(R) searches, while deprioritizing hits that have been previously reported in other malaria screening programs. From our initial hits, we selected three chemotypes (<b>1</b>, <b>2</b>, and <b>3</b>) for commercial resupply and evaluated them in 10-point concentration response assays against 3D7 parasites (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). These compounds ranged in potency on 3D7 from 0.31 to 3.5 μM, with <b>1</b> showing the best potency [EC<sub>50</sub> values of 0.31 μM (<b>1</b>), 0.71 μM (<b>2</b>), and 3.5 μM (<b>3</b>)] (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> legend). Cytotoxicity was assessed against HepG2 cells, with all three compounds showing a CC<sub>50</sub> >30 μM in this assay.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HTS-based identification of compounds that inhibit growth of <i>P. falciparum</i> 3D7 ABS parasites. (A) Range of <i>Z</i>′ values observed for 384-well plates covering the 8K screening library. The black bar shows the mean ± standard deviation (std dev). (B) Representative concentration response curves for validated hits vs 3D7 parasites. Data for each drug concentration were collected in triplicate wells, and error bars represent the std dev. Data were fitted to the log(<i>I</i>) vs response—four-parameter variable slope equation in GraphPad Prism. Replicate data were subsequently collected, yielding the following EC<sub>50</sub>’s: <b>1</b>, 0.31 ± 0.10 μM; <b>2</b>, 0.71 ± 0.075 μM; and <b>3</b>, 3.5 ± 0.71 μM, where errors are the std dev for at least three independent biological replicates. (C) BRRoK rate of kill assay. Serial log-fold dilutions of compounds from 30× EC<sub>50</sub> to 0.33× EC<sub>50</sub> were incubated for 6 h with NF54-luc parasites, and viability was assessed by bioluminescence at the end of the incubation. Bioluminescence signals normalized to untreated controls are plotted and represent mean ± std dev from triplicate wells. EC<sub>50</sub> values against 3D7 parasites were determined in standard 72 h SYBR Green assays prior to the start of the study and were used as indicated for compounds <b>1–3</b>. Benchmark compounds included artemisinin, ART (fast-kill) (EC<sub>50</sub> = 0.013 μM), chloroquine, CQ (fast-kill) (EC<sub>50</sub> = 0.014 μM), atovaquone, ATQ (slow-kill) (EC<sub>50</sub> = 0.0013 μM), and DSM265 (slow-kill) (EC<sub>50</sub> = 0.0050 μM), with EC<sub>50</sub> values used to calculate compound concentrations for the study indicated in parenthesis. Similar EC<sub>50</sub> values were obtained versus NF54-luc parasites using bioluminescence as a readout in a 72 h assay (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compounds that show fast kill kinetics are being sought because they provide rapid relief of symptoms, and a more rapid reduction in parasite numbers may also reduce the propensity for resistance to develop.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Kill rates also provide information about the MOA as the kill rate has been shown to be a property of the target.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To this end, compounds were profiled to estimate the rate of kill (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) using a rapid bioluminescence relative rate of kill (BRRoK) assay.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This method follows bioluminescence in a cytocidal 6 h exposure assay over multiple drug concentrations using a <i>P. falciparum</i> strain (<i>Pf</i>NF54<sup>luc</sup>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> that expresses luciferase. We benchmarked the assay against the known fast- (ART and CQ) or slow [DSM265<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and atovaquone (ATQ)]-acting compounds previously characterized using the standard parasite reduction rate (PRR) assay, which measures viability after treatment and regrowth over 28 days.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In the BRRoK assay, both <b>1</b> and <b>2</b> showed slow kill kinetics similar to DSM265 and ATQ, while the profile for <b>3</b> was similar to CQ and thus consistent with a fast kill mechanism. Based on this desirable property, the <b>3</b>-series was selected for more in-depth profiling despite lower potency compared to <b>1</b> and <b>2</b>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">Tetrazoles were synthesized using a one-pot, four-component Ugi coupling in the racemic form<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A). An amine, aldehyde, isocyanate, and trimethylsilyl azide were combined in methanol and stirred for 12–36 h at room temperature (RT) to provide the corresponding coupling product in high yields. In several cases, the enantiomers were separated by preparative high-performance liquid chromatography (HPLC) using a chiral stationary phase. Similarly, most amides were prepared through a three-component Ugi coupling, featuring phenyl phosphinic acid<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B). The resulting secondary amides were alkylated using methyl iodide in the presence of sodium hydride. Finally, amide <b>34</b> was prepared via a Strecker reaction involving 3-pyridine carboxaldehyde and amine <b>35</b>. Nitrile hydrolysis under basic conditions and amide coupling provided product <b>34</b> in high yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Antimalarial Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Medicinal Chemistry to Establish SAR of the <b>3</b>-Series</h3><div class="NLM_p">The <b>3</b>-series is chemically attractive, with a basic amine, a stable heterocycle, and four vectors for optimization. Initial SAR of the <b>3</b>-series was established through the synthesis and testing of 19 tetrazole analogues against two strains of <i>P. falciparum</i>. These included the 3D7 strain that is broadly drug-sensitive and the Dd2 strain that is resistant to chloroquine and partially resistant to mefloquine (MFQ) and quinine.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> Compounds were also tested against human HepG2 cells to evaluate cytotoxicity. This work identified compounds with improved potency versus 3D7 of 10- to 20-fold (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of the Tetrazole Series<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0009.gif" alt="" id="GRAPHIC-d7e877-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>P. falciparum</i> EC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" align="center">cytotox CC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">B-ring</th><th class="colsep0 rowsep0" align="center">C-ring</th><th class="colsep0 rowsep0" align="center"><i>Pf</i>3D7</th><th class="colsep0 rowsep0" align="center"><i>Pf</i>Dd2</th><th class="colsep0 rowsep0" align="center">HepG2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.71 (10)</td><td class="colsep0 rowsep0" align="left">5.4 ± 0.78 (5)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(+)-<b>3</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">1.5, 1.9</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>3</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">4.6, 4.4</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">9.7 ± 3.0 (3)</td><td class="colsep0 rowsep0" align="left">10 ± 1.5 (3)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.67 (4)</td><td class="colsep0 rowsep0" align="left">3.7 ± 0.25 (3)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>c</i>-tol</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.12 (3)</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.40 (3)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(+)-<b>6</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>c</i>-tol</td><td class="colsep0 rowsep0" align="left">1.6, 1.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>6</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">1.2, 1.2</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.49 ± 0.10 (3)</td><td class="colsep0 rowsep0" align="left">0.48 ± 0.029 (3)</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">CF3</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.17 (3)</td><td class="colsep0 rowsep0" align="left">0.67 ± 0.031 (3)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.38 ± 0.071 (5)</td><td class="colsep0 rowsep0" align="left">0.54 ±0.17 (3)</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.40 ± 0.070 (4)</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.34 (4)</td><td class="colsep0 rowsep0" align="left">37, 33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.37 ± 0.041 (4)</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.67 (4)</td><td class="colsep0 rowsep0" align="left">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(+)-<b>11</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-<b>11</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.47 ± 0.11 (3)</td><td class="colsep0 rowsep0" align="left">*EC<sub>50.1</sub>; EC<sub>50.2</sub> 0.68 ± 0.10; 3.6 ± 1.3 (4)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.47 ± 0.18 (3)</td><td class="colsep0 rowsep0" align="left">*EC<sub>50.1</sub>; EC<sub>50.2</sub> 0.71 ± 0.13; 4.8 ± 1.3 (4)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">4.8, 4.7</td><td class="colsep0 rowsep0" align="left">3.2, 4.2</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">15, 15</td><td class="colsep0 rowsep0" align="left">>30, 21</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.14 (3)</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.26 (3)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">cHex</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.56 (3)</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.49 (3)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.29 (3)</td><td class="colsep0 rowsep0" align="left">3.0 ± 0.55 (3)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">2Me-3Pyr</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">>30, 14</td><td class="colsep0 rowsep0" align="left">21, 16</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">nPr</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.056 (3)</td><td class="colsep0 rowsep0" align="left">0.52 ± 0.11 (3)</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">nPr</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left"><i>o</i>-tol</td><td class="colsep0 rowsep0" align="left">0.23 ± 0.025 (3)</td><td class="colsep0 rowsep0" align="left">0.41 ± 0.083 (3)</td><td class="colsep0 rowsep0" align="left">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Concentration response data were collected with technical duplicates or triplicates at each inhibitor concentration. Data were fitted in GraphPad Prism to the inhibitor vs response—variable slope (four parameters) equation to determine the EC<sub>50</sub>, with the exception of *, where biphasic curves were observed and data were fitted to the biphasic equation with constraints (top = 1.0, bottom >0, and hill coefficients <0) to determine EC<sub>50.1</sub> and EC<sub>50.2</sub>. Data are the EC<sub>50</sub> mean ± std dev with the number of independent biological replicates shown in parenthesis. Individual values are shown for studies with less than three biological replicates. Ph, phenyl; Py, pyridyl; Pyr, pyrimidinyl; tol, tolyl. Compounds are racemic, unless otherwise indicated.</p></div></div></div><div class="NLM_p">On the A-ring, the Br could be replaced with CF<sub>3</sub> to give <b>5</b> with a slight improvement in activity, while removing the Br decreased activity by a factor of 3 (<b>4</b>). Removing the A-ring altogether resulted in an inactive analogue (data not shown). Replacing the B-ring phenyl with 3-pyridine (3-Py) further improved activity to ∼1 μM (<b>6</b>), while also improving drug-like properties. The <i>N</i>-methyl at the R2 position could be replaced by cyclopropyl (cPr) (<b>7</b>), yielding an additional threefold improvement in potency against 3D7. The OMe on the A-ring could be replaced by F (<b>8</b>) or H (<b>9</b>) without loss of activity. Further modification of the B-ring showed that the 3-Py of <b>9</b> could be replaced by a 5-substituted pyrimidine (5-Pyr, <b>10</b>) with similar activity against 3D7. Introduction of fluoro on the A-ring was also well tolerated at the 3 (<b>11</b>), 4 (<b>12</b>), and 6 (<b>13</b>) positions on the ring. The B-ring could not be replaced with a small nonaromatic cPr ring (<b>14</b>), and a basic amine appeared important because the R2 alkyl group could not be replaced with COCH<sub>3</sub> (<b>15</b>). In contrast, the C-ring could be replaced by either cyclohexyl (<b>17</b>) or cPr (<b>18</b>) with only a two- or threefold loss of activity against 3D7 compared to compounds with matched R2 and B rings, <b>16</b> or <b>9</b>, respectively. However, within the context of the cPr in the C-ring position, the addition of a 2-Me to the B-ring 3-Py was not tolerated (<b>19</b>). The benzylic carbon between the A ring and the tertiary amine could be substituted with a cPr to block a potential site of metabolism. When combined with a propyl (Pr) at R2, these compounds yielded the most potent of the tetrazole series (<b>20</b> and <b>21</b>) (3D7 EC<sub>50</sub>’s ∼ 0.3 μM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), representing a 10-fold improvement over the initial hit <b>3</b>.</div><div class="NLM_p">Three analogues were selected for separation and evaluation of enantiomer pairs. A small two- to threefold difference in potency was observed between the separated <b>3</b>-enantiomers [(+)-<b>3</b> vs (−)-<b>3</b>], while the enantiomers of <b>6</b> [(+)-<b>6</b> and (−)-<b>6</b>] and <b>11</b> [(+)-<b>11</b> and (−)-<b>11</b>] showed equal potency. Taken together, the data support an absence of enantiomer selectivity for the series.</div><div class="NLM_p">While the initial hit <b>3</b> showed similar activity on both 3D7 and Dd2 parasite lines, a number of subsequent compounds in the series showed reduced activity on Dd2, with differences of up to 5–10-fold observed for the most disparate compounds (e.g., <b>10</b>, <b>12</b>, and <b>13</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). These differences will be discussed in greater detail below. Cytotoxicity was evaluated using human HepG2 cells. While <b>3</b> did not show any activity up to the highest tested concentration of 30 μM, several of the more potent analogues (<b>9</b>, <b>20</b>, and <b>21</b>) displayed cytotoxicity with CC<sub>50</sub> values in the 10–15 μM range, yielding a selectivity window of 40–50-fold in these cases (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Molecular modeling suggested that a <i>cis</i>-amide could orient the A, B, and C rings similarly to the tetrazole. A subseries of amides was synthesized to test this hypothesis (<b>22–34</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Consistently, <b>22</b> and <b>23</b> were equipotent to their tetrazole congeners <b>9</b> and <b>10</b>. The NH amides were fivefold less active, as predicted based on conformational considerations (data not shown). The SAR from the two subseries was found to be similar, consistent with a similar MOA. This includes the finding that for the B-ring, both 3-Py (<b>22</b>, <b>24</b>, <b>26</b>, and <b>28</b>) and 5-Pyr (<b>23</b>, <b>25</b>, <b>27</b>, and <b>29</b>) showed similar activity against 3D7, while similar to the tetrazoles <b>9</b> and <b>10</b>, Dd2 activity on the 5-Pyr tended to be lower than for the 3-Py. The A-ring CF<sub>3</sub> could be replaced with SCF<sub>3</sub> (<b>24</b> and <b>25</b>) or OCF<sub>3</sub> (<b>26</b> and <b>27</b>), yielding similar potency. The methyl on the C-ring could be extended to ethyl to improve activity approximately twofold (<b>22</b> vs <b>28</b>; <b>23</b> vs <b>29</b>), whereas removing the C-ring methyl was associated with an approximately twofold loss in activity (<b>23</b> vs <b>30</b>). The addition of a 2-Me to the 5-Pyr at the B-ring led to a substantial 20-fold loss in potency (<b>31</b> vs <b>23</b>). As observed with the tetrazole series, the addition of 2-F to the A ring was well tolerated (<b>32</b> vs <b>22</b>; compared to <b>16</b> in the tetrazole series), while a benzylic cyclopropyl group again improved activity to give <b>33</b> (vs <b>20</b> and <b>21</b> in the tetrazole series), currently our most potent analogue (EC<sub>50</sub> = 0.21–0.33 μM on 3D7 and Dd2, respectively). Additionally, as with the tetrazoles, replacement of the C-ring with a saturated ring (piperidine <b>34</b>) led to a fivefold reduction in activity but showed some promise. Relative to other compounds in the series, compound <b>30</b> showed the greatest loss of potency against Dd2 parasites, requiring over 20-fold higher concentrations for complete killing (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Cytotoxicity in the amide series was improved over the tetrazoles, with no compounds showing any cytotoxic activity up to the highest tested concentration of 30 μM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the Amide Subseries<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0010.gif" alt="" id="GRAPHIC-d7e2244-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>P. falciparum</i> EC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" align="center">cytotox CC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center">B-ring</th><th class="colsep0 rowsep0" align="center"><i>Pf</i>3D7</th><th class="colsep0 rowsep0" align="center"><i>Pf</i>Dd2</th><th class="colsep0 rowsep0" align="center">HepG2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">0.34 ± 0.044 (3)</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.067 (3)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left">0.40 ± 0.015 (3)</td><td class="colsep0 rowsep0" align="left">0.79 ± 0.19 (3)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">SCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.078 (3)</td><td class="colsep0 rowsep0" align="left">0.39 ± 0.045 (3)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">SCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left">0.26 ± 0.046 (3)</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.55 (5)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.035 (3)</td><td class="colsep0 rowsep0" align="left">0.52 ±0.055 (3)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left">0.24 ± 0.044 (3)</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.17 (5)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">0.19 ± 0.025 (3)</td><td class="colsep0 rowsep0" align="left">0.48 ± 0.084 (3)</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left">0.24 ± 0.042 (3)</td><td class="colsep0 rowsep0" align="left">0.57 ± 0.14 (3)</td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-Pyr</td><td class="colsep0 rowsep0" align="left">0.72 ± 0.021 (3)</td><td class="colsep0 rowsep0" align="left">*EC<sub>50.1</sub>; EC<sub>50.2</sub> 2.0 ± 1.4; 16 ± 5.4 (4)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2-Me, 5-Pyr</td><td class="colsep0 rowsep0" align="left">8.1, 7.5</td><td class="colsep0 rowsep0" align="left">9.8, 7.7</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.026 (3)</td><td class="colsep0 rowsep0" align="left">0.46 ± 0.046 (3)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">nPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">0.21 ± 0.021 (3)</td><td class="colsep0 rowsep0" align="left">0.33 ± 0.035 (3)</td><td class="colsep0 rowsep0" align="left">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">C**</td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.15 (3)</td><td class="colsep0 rowsep0" align="left">4.2 ±0.84 (3)</td><td class="colsep0 rowsep0" align="left">>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Concentration response data were collected with technical triplicates at each inhibitor concentration, and data were fitted in GraphPad Prism to determine the EC<sub>50</sub>, as described in the <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> footnote. Data are the EC<sub>50</sub> mean ± std dev with the number of independent biological replicates shown in parenthesis. **C-ring replaced with piperidine.</p></div></div></div><div class="NLM_p">To confirm that the <b>3</b>-series shows fast kill kinetics, we re-evaluated the kill rate using more potent analogues from both the tetrazole (<b>10</b>) and amide (<b>23</b>) subseries using the BRRoK assay cited above. Like <b>3</b>, both compounds behaved similarly to CQ in this assay, consistent with fast kill kinetics (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">S1</a>). Finally, <b>10</b> was tested in both a flow cytometry (FACS) assay<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> that detects the ability of parasites to invade new RBCs after incubation with drug and in the PRR-based washout assay,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with both assays confirming that <b>10</b> exhibited kill kinetics similar to CQ, although slower than ART (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Relative rate of kill of <b>10</b> vs control antimalarials. (A) BRRoK rate of kill assay. Conditions used were as described in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. The mean EC<sub>50</sub> for <b>10</b> was 0.32 μM, as determined using 72 h SBYR Green assays. DSM265 and ART controls were collected simultaneously to the <b>10</b> data. CQ data were replotted from <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and are provided again in this plot as a reference. (B) Kill rate determination using two-color FACS analysis. Benchmark compounds are described above. Pyrimethamine (PYR) was included as a medium rate of the kill compound. Compounds were plated at 10× EC<sub>50</sub>, where EC<sub>50</sub> values, determined using 48 h hypoxanthine assays, were <b>10</b> (1.7 μM), CQ (0.021 μM), ART (0.03 μM), PYR (0.094 μM), and ATQ (0.001 μM). (C) PRR washout assay. Data show % parasite survival vs h of drug treatment prior to drug washout and replating. PYR data were collected simultaneously to <b>10</b>. CQ and ART data are historical control data collected in a separate study<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and provided as a reference. Triplicate data were collected at each compound concentration, symbols represent the mean, and error bars represent the std dev.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> ADME Assessment of Selected Tetrazole and Amide Compounds</h3><div class="NLM_p">A preliminary assessment of the physicochemical properties and metabolic stability was conducted for several compounds in the tetrazole and amide subseries (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Lipophilicity in the series was high, and this property correlated with the overall poor metabolic stability in human liver microsomes for all tested compounds. Compound <b>7</b> and some with lower cLog <i>D</i> (<b>10</b> and <b>34</b>) performed marginally better than other compounds in the series, and overall, the tetrazoles were slightly better than the amides. Solubility in pH 6.5 phosphate buffered saline (PBS) was poor for the tetrazoles but was substantially better for the amides at both pH 2.0 and 6.5, with <b>34</b> showing the best overall properties in these assays. Overall, these studies identified a significant metabolic liability that would need to be addressed before these series could be expected to show <i>in vivo</i> efficacy.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Physicochemical Properties and <i>In Vitro</i> Metabolism in Human Liver Microsomes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">MW</th><th class="colsep0 rowsep0" align="center" char=".">cLog <i>D</i> pH 7.4</th><th class="colsep0 rowsep0" align="center">predicted p<i>K</i><sub>a</sub> (basic)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> (μL/min/mg protein)</th><th class="colsep0 rowsep0" align="center">kinetic solubility pH 2.0 (μg/mL)</th><th class="colsep0 rowsep0" align="center">kinetic solubility pH 6.5 (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">495</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="left">4.6, 3.3</td><td class="colsep0 rowsep0" align="char" char=".">154</td><td class="colsep0 rowsep0" align="left">12.5–25</td><td class="colsep0 rowsep0" align="left">1.6–3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">465</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="left">5.1, 2.9</td><td class="colsep0 rowsep0" align="char" char=".">360</td><td class="colsep0 rowsep0" align="left">12–23</td><td class="colsep0 rowsep0" align="left">1.5–2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">465</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="char" char=".">261</td><td class="colsep0 rowsep0" align="left">1.5–2.9</td><td class="colsep0 rowsep0" align="left">1.5–2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">454</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="left">6.0, 3.4</td><td class="colsep0 rowsep0" align="char" char=".">781</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">6.3–12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">454</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="char" char=".">531</td><td class="colsep0 rowsep0" align="left">11–23</td><td class="colsep0 rowsep0" align="left">>45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">472</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="left">5.0, 3.4</td><td class="colsep0 rowsep0" align="char" char=".">548</td><td class="colsep0 rowsep0" align="left">>47</td><td class="colsep0 rowsep0" align="left">1.5–2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">418</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="left">6.1, 3.4</td><td class="colsep0 rowsep0" align="char" char=".">244</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">25–50</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Life-Cycle Profiling</h3><div class="NLM_p">Representative compounds, one each from the tetrazole (<b>9</b>) and amide (<b>32</b>) series, were profiled against liver- and sexual-stage parasites to determine if the series would have prophylactic or transmission-blocking activity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Liver-stage activity was assessed against <i>Plasmodium berghei</i> to determine whether compounds could block liver-stage development in HepG2 cells infected by sporozoites.<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19,21)</a> Modest activity was observed in this assay, but the <i>Pb</i> liver-stage EC<sub>50</sub> for both compounds was 20- to 30-fold higher than for <i>P. falciparum</i> blood stages. The dual gamete formation assay (DGFA) was used to assess the ability of compounds to block maturation of both male and female stage V gametocytes, providing a readout of functional viability. The assay identifies compounds that either kill stage V gametocytes or interfere with gamete formation. No activity was observed against female gametocytes for either compound, while modest activity was seen for <b>32</b> against male gametocytes (∼60% inhibition at 25 μM). Thus, the <b>3</b>-series compounds do not have significant liver-stage or transmission-blocking activity, positioning them for use solely for treatment of ABS infections.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Life Cycle Profiling<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center"><i>Pb</i> liver-stage EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">HepG2 CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">DGFA (male/female) gametocytes EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">7.3, 12</td><td class="colsep0 rowsep0" align="left">19, >17</td><td class="colsep0 rowsep0" align="left">>25/>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">7.0, 16</td><td class="colsep0 rowsep0" align="left">24, 24</td><td class="colsep0 rowsep0" align="left">∼60% at 25 μM/>25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are shown for two independent replicates. DGFA, dual gamete formation assay.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Evaluation of Cross Resistance to the Known Drugs Suggests a Common Resistance Mechanism with Hz-Inhibiting Antimalarials</h3><div class="NLM_p">To obtain insight into the potential MOA of the <b>3</b>-series compounds, we evaluated compounds against a selection of drug-sensitive and drug-resistant parasite lines. Initial work focused on comparing the effectiveness against 3D7 and Dd2 parasites. As noted above, while <b>3</b> showed similar activity against these strains (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), a number of analogues in both the tetrazole and amide subseries showed lower activity against Dd2 than 3D7 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The largest differences (three- to fivefold) were observed for compounds with a 5-Pyr in the B-ring (<b>10</b>, <b>26</b>), whereas the matched compounds with 3-Py in this position showed smaller (1.4–3.0-fold) effects (<b>9</b> and <b>27</b>) based on comparisons of matched pairs that contained only variations in this position (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">S2</a>). Additionally, for several analogues (<b>12</b>, <b>13</b>, and <b>30</b>) containing the 5-Pyr in the B-ring, we observed biphasic concentration response curves versus Dd2. In these cases, up to a 20-fold potency difference was observed between 3D7 and the second of the fitted EC<sub>50</sub> values determined for Dd2, whereas the more potent EC<sub>50</sub> values were similar to that observed for 3D7 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These data suggest that a second target might be responsible for the reduced Dd2 efficacy at higher concentrations for these compounds. In contrast, biphasic concentration response curves were never observed versus 3D7 for any compound. Encouragingly, our data show that it is possible to identify compounds with similar potency against 3D7 and Dd2, for example, by avoiding the 5-Pyr that frequently led to biphasic concentration response curves. These results highlight the value of including multiple parasite lines in early-stage compound evaluation.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reduced efficacy of <b>3</b>-analogues containing 5-Pyr against <i>P. falciparum</i> Dd2 compared to 3D7 parasites. Comparison of representative concentration response curves for tetrazoles <b>9</b> (A) and <b>10</b> (B) and for amides <b>26</b> (C) and <b>27</b> (D), tested against 3D7 (green circles) and Dd2 (black squares) parasites. Results showed that compounds containing 5-Pyr have poorer activity against Dd2 than do compounds containing 3-Py in the B-ring. Compound structures are shown above the graphs. Data were fitted to the [<i>I</i>] vs response, variable slope (four parameter) equation in GraphPad Prism to determine the EC<sub>50</sub>. Triplicate data were collected at each concentration, symbols represent the mean, and error bars represent the std dev. EC<sub>50</sub> data are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, which contain average data for at least three biological replicates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Biphasic growth curves were observed for select 5-Pyr <b>3</b>-series compounds assayed against Dd2 parasites. Comparison of representative concentration response curves for tetrazoles <b>12</b> (A) and <b>13</b> (B) and for amide <b>30</b> (C) tested against 3D7 (green circles) and Dd2 (black squares) parasites. Compound structures are displayed above the graphs. Triplicate data were collected at each concentration, symbols represent the mean, and error bars represent the std dev. EC<sub>50</sub> data and curve fitting methods are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further probe the MOA, <b>9</b> and <b>10</b> were evaluated against two panels of resistant parasite lines that were either obtained as clinical isolates<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> or were generated in Dd2 parasites through <i>in vitro</i> selections with various antimalarials. Data were compared to the drug-sensitive 3D7 and NF54 strains (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>; note that 3D7 is a clone of NF54). No cross resistance was observed for <b>9</b> across the two panels. In contrast, <b>10</b> showed reduced potency against the CQ-resistant Dd2 and piperaquine (PPQ)-resistant RF12 strains, although reduced activity was not observed against other tested lines with other drug-resistant phenotypes. Interestingly, both <b>9</b> and <b>10</b> were more effective against 7G8 parasites than any of the other tested lines, even though this line, similar to Dd2, RF12, K1, and TM90C2B, contains point mutations in the <i>P. falciparum</i> CQ resistance transporter (<i>Pf</i>CRT; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Activity of <b>9</b> and <b>10</b> Versus Parasite Strains with Resistance to Compounds from Diverse Structural Classes and Mechanisms of Action</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>9</b></th><th class="colsep0 rowsep0" align="center" char="."><b>9</b></th><th class="colsep0 rowsep0" align="center"><b>10</b></th><th class="colsep0 rowsep0" align="center" char="."><b>10</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><i>Pf</i> parasite line</th><th class="colsep0 rowsep0" align="center">resistance profile</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">fold diff<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">fold diff<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" colspan="5" align="center">Drug-Resistant Field Isolates<a onclick="showRef(event, 'ref42 ref44 ref49'); return false;" href="javascript:void(0);" class="ref ref42 ref44 ref49">(42,44,49)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3D7</td><td class="colsep0 rowsep0" align="left">sensitive</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NF54</td><td class="colsep0 rowsep0" align="left">sensitive</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K1</td><td class="colsep0 rowsep0" align="left">CQ, PYR</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7G8</td><td class="colsep0 rowsep0" align="left">CQ, PYR</td><td class="colsep0 rowsep0" align="left">0.18 ± 0.042 (3)</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="left">0.16 ±0.024 (3)</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TM90C2B</td><td class="colsep0 rowsep0" align="left">CQ, ATQ, PYR</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RF12</td><td class="colsep0 rowsep0" align="left">PPQ, PYR</td><td class="colsep0 rowsep0" align="left">0.61</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dd2</td><td class="colsep0 rowsep0" align="left">CQ, PYR</td><td class="colsep0 rowsep0" align="left">0.54</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" colspan="5" align="center"><i>Pf</i>CRT Gene Edited Isogenic Lines</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dd2-GC03</td><td class="colsep0 rowsep0" align="left">sensitive</td><td class="colsep0 rowsep0" align="left">0.89 ± 0.12 (3)</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dd2-Dd2</td><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">0.45 ± 0.13 (3)</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dd2-M343L</td><td class="colsep0 rowsep0" align="left">PPQ, CQ</td><td class="colsep0 rowsep0" align="left">0.38 ± 0.10 (3)</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" colspan="5" align="center">Lab-Derived Dd2 Lines Resistant to Development Candidates</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PfeEF2</td><td class="colsep0 rowsep0" align="left">DDD107498<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></td><td class="colsep0 rowsep0" align="left">0.92</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pfpi4K</td><td class="colsep0 rowsep0" align="left">MMV390048<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PfDHODH</td><td class="colsep0 rowsep0" align="left">DSM265<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></td><td class="colsep0 rowsep0" align="left">0.80</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pfcarl</td><td class="colsep0 rowsep0" align="left">KAF156<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">0.65</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PfCytB</td><td class="colsep0 rowsep0" align="left">ELQ300<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Fold differences were calculated relative to 3D7 for field isolates, relative to Dd2-GC03 for the isogenic gene-edited lines, or relative to Dd2 for lab-selected Dd2 resistant lines. The GC03 line (which contains the <i>pfcrt</i> wild-type allele, also found in 3D7 or NF54) was previously isolated from the Dd2 × HB3 cross and is CQ-sensitive. The gene-edited lines were constructed using customized zinc-finger nucleases and have been previously reported.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46−48)</a> Dd2-GC03 was derived by introducing the 3D7 <i>pfcrt</i> sequence into Dd2 in place of the endogenous <i>pfcrt</i> Dd2 locus (sequence shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Dd2-Dd2 was engineered using the same method to replace the endogenous <i>pfcrt</i> locus with the recombinant Dd2 sequence, and Dd2-M343L replaced the endogenous <i>pfcrt</i> locus with the recombinant Dd2 sequence and the PPQ resistance-conferring M343L<a onclick="showRef(event, 'ref44 ref49'); return false;" href="javascript:void(0);" class="ref ref44 ref49">(44,49)</a> mutation. Concentration response data were collected with technical duplicates at each inhibitor concentration, and reported data represent the average of two biological replicates, and where additional biological replicates were collected (number in parenthesis), the std dev is provided. Additional replicate data for NF54 can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S2A</a>. Development candidates used for selections are listed, and parasite lines are named based on the protein target of the resistance allele. CQ, chloroquine, ATQ, atovaquone, PYR, pyrimethamine, and PPQ, piperaquine. Data for Dd2 and 3D7 were taken from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Documented Point Mutations in <i>Pf</i>CRT Across the Tested Strains<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0011.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Data were taken from refs <a onclick="showRef(event, 'ref23 ref43 ref44 ref49 ref88'); return false;" href="javascript:void(0);" class="ref ref23 ref43 ref44 ref49 ref88">(23,43,44,49,and88)</a>. Colors highlight residue differences between strains: yellow (3D7 and Dd2), green (3D7 and 7G8), and turquoise (3D7 and RF12). RF12 is also known in the literature as PH1263-C. 3D7 is a clone of NF54.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></p></div></div><div></div></div><div class="NLM_p last"><i>Pf</i>CRT in certain mutant forms mediates CQ efflux from the DV and is causal for CQ resistance.<a onclick="showRef(event, 'ref23 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref23 ref43 ref44 ref45">(23,43−45)</a> While each strain harbors a key set of <i>Pf</i>CRT mutations (including K76T, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) that confer CQ resistance, the specific set of point mutations differs across strains and mediates differences in sensitivity to CQ and other 4-aminoquinolines such as PPQ and amodiaquine.<a onclick="showRef(event, 'ref44 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref46 ref47">(44,46,47)</a> The 7G8 mutational background has also been reported to increase sensitivity to lumefantrine (LUM).<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> Thus, each <i>Pf</i>CRT isoform could display different binding affinities and transport levels of <b>3</b>-series compounds as well and thus modulate parasite susceptibility to these compounds differentially. This hypothesis was investigated by testing gene-edited isogenic lines that allow comparison between different <i>pfcrt</i> alleles with varied sensitivity to CQ in the same genetic background. These lines were generated previously by zinc-finger nuclease-mediated editing of Dd2 parasites to insert (1) the wild-type <i>pfcrt</i> allele (Dd2-GC03); (2) the recombinant Dd2 <i>pfcrt</i> allele (Dd2-Dd2) (differing from wild-type <i>Pf</i>CRT by eight point mutations <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>); or (3) the recombinant Dd2 <i>pfcrt</i> allele and the M343L mutation (Dd2-M343L), resulting in PPQ resistance.<a onclick="showRef(event, 'ref44 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref44 ref46 ref47 ref48 ref49">(44,46−49)</a> We found that either the Dd2 <i>Pf</i>CRT background or the Dd2-M343L background led to a two- to threefold increased sensitivity to both <b>9</b> and <b>10</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) relative to Dd2-GC03. These data suggest that the wild-type <i>Pf</i>CRT transporter might bind better to <b>9</b> and <b>10</b> than do the variant Dd2 or Dd2 + M343L isoforms, leading to lower drug concentrations in the DV. Interestingly, the addition of M343L has also been reported to reduce the degree of CQ resistance by two- to threefold, compared with the Dd2 isoforms.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The finding that the EC<sub>50</sub> for <b>10</b> on Dd2-GC03 is higher than for the Dd2-Dd2 line shows that the poor activity of <b>10</b> on Dd2 relative to 3D7 is not linked to differences in the <i>pfcrt</i> allele.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Heme Polymerization is Inhibited by <b>3</b>-Series Compounds</h3><div class="NLM_p">Similarities between CQ and the <b>3</b>-series compounds suggested to us the potential for a common MOA. CQ functions by interrupting heme detoxification via inhibition of the biomineralization of toxic labile heme into the chemically inert Hz in the DV.<a onclick="showRef(event, 'ref43 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref43 ref50 ref51">(43,50,51)</a> Similarities include the killing kinetics, the life-cycle profile showing activity only on ABS, and the observations that CQ-resistant (7G8 and Dd2) and genetically engineered lines containing <i>Pf</i>CRT mutations showed differential sensitivity to compounds in the <b>3</b>-series, suggesting that like CQ and other quinolines, the <b>3</b>-series compounds targeted a process in the DV. Additionally, the lack of enantiomer selectivity of the <b>3</b>-series supports the hypothesis of a nonprotein target such as heme polymerization.</div><div class="NLM_p">To investigate the activity of <b>3</b>, <b>9</b>, and <b>10</b> against the heme detoxification pathway, we tested the ability of these compounds to inhibit conversion of hematin (Fe(III)PPIX) to the synthetic β-hematin (βH) form of Hz. These experiments used a pyridine-based detergent-mediated colorimetric assay that simulates the physiological microenvironment of the DV.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Standard antimalarials with diverse MOAs were tested in parallel to serve as controls. As expected, CQ, amodiaquine, MFQ, and pyronaridine inhibited βH formation with IC<sub>50</sub> ≤100 μM, while pyrimethamine, dihydroartemisinin, and doxycycline did not inhibit conversion of hematin to βH (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Among the tested compounds, <b>9</b> inhibited βH formation with the same potency as MFQ, while <b>10</b> showed weaker inhibition. Compound <b>3</b> was nearly inactive in the concentration range that could be studied (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The IC<sub>50</sub> values for inhibition of βH formation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) of the <b>3</b>-series compounds correlated loosely with their EC<sub>50</sub> values for inhibiting NF54 proliferation (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">S2</a>). <b>9</b> was the most potent in both assays, supporting the hypothesis that the mechanism of cell killing was related to inhibition of βH formation. The concentration of the compound required to inhibit βH formation was ∼1000-fold higher than the EC<sub>50</sub> for parasite survival not only for the <b>3</b>-series but also for the 4-aminoquinolines. These differences are thought to reflect the fact that drug accumulation in the DV is in a function of pH trapping;<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> hence, the extent of accumulation determines the concentration at the site of action.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. β-Hematin inhibition assay (βHIA) for <b>3</b>-series compounds in comparison to antimalarial control compounds. (A) Representative titration data showing inhibition of β-hematin formation vs concentration profiles for <b>3</b>, <b>9</b>, and <b>10</b> in comparison to known antimalarials, using the β-hematin inhibition assay (βHIA).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Positive (pyronaridine, amodiaquine, CQ, and MFQ) and negative controls were assayed, with the latter representing a diverse set of MOAs (the DHODH inhibitor DSM1,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> artesunate, sulfadoxine, and doxycycline). Data show the mean ± std dev for duplicate data at each compound concentration. Data were fitted to the sigmoidal concentration response (variable slope) equation in GraphPad Prism to determine the IC<sub>50</sub>. (B) Fitted IC<sub>50</sub> values. Data represent the mean ± std dev for four independent studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cellular Heme Fractionation</h3><div class="NLM_p">To mechanistically validate the <i>in vitro</i> heme polymerization results described above, we applied a heme fractionation assay to measure inhibition of Hz formation in NF54 parasites. In this assay, “% free heme”, % Hz (determined as proportions of total heme species extracted), and levels of “free” heme-Fe and Hz-Fe (absolute amounts of each species per cell calculated from the total amount of Fe obtained using a heme standard curve) were quantified from isolated trophozoites after their treatment with compounds. This assay tested a range of compound concentrations at or above their EC<sub>50</sub> for antimalarial activity (0.5× to 3× EC<sub>50</sub>). For the positive CQ control, both the % “free” heme and the levels of “free” heme-Fe showed a significant concentration-dependent increase as the drug concentration was increased above the EC<sub>50</sub> compared to the no-drug control (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A(i)), whereas Hz and Hz-Fe decreased over the same concentration range (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A(ii)). Overlaying the parasite survival curve with the “free” heme-Fe titration curve showed that the concentration of CQ leading to 50% activity (EC<sub>50</sub> for heme-Fe release vs EC<sub>50</sub> for parasite survival) was similar in both assays (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A(iii)), consistent with CQ being a bona fide inhibitor of Hz formation.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This result contrasts with the data for the dihydrofolate reductase inhibitor pyrimethamine (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B), included as a negative control to illustrate the robustness of this protocol in discriminating agents that do not inhibit Hz formation. No significant increase in free heme was observed over the course of the titration, regardless of drug concentration.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular heme fractionation and concentration response versus parasite survival. Data are shown for (A) CQ, the positive control, for (B) PYR, the negative control, and for two <b>3</b>-analogues, (C) compound <b>9</b> and (D) compound <b>10</b>. Panels (i,ii) Heme species present as “free” heme (panel i) and Hz Fe (fg) (panel ii) isolated per cell from drug-treated <i>Pf</i>NF54 parasites. Data represent the mean ± std dev from three biological replicates, each arising from two technical replicates (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S3</a>). Panel (iii) Overlay of parasite survival with the total amount of “free” heme-Fe as a function of drug concentration. Free heme data represent the mean ± std dev from three biological replicates (taken from panels i), while representative parasite survival data from one biological replicate with technical duplicates is displayed (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S2A</a> for average EC<sub>50</sub>’s from three biological replicates). Data were fitted to the sigmoidal concentration response (variable slope) equation in GraphPad Prism. Calculated EC<sub>50</sub> values for the drug concentration giving 50% response are as follows: CQ, 58 nM (heme) and 15 nM (survival); PYR, >100 nM (heme) and 33 nM (survival); cmpd <b>9</b>, 620 nM (heme) and 440 nM (survival); and cmpd <b>10</b>, 1040 nM (heme) and 910 nM (survival). See <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S2A,B</a> for error analysis. Significance was assessed using a two-tailed Welch’s <i>t</i>-test, where * <0.05, ** <0.01, and *** <0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Treatment with <b>9</b> and <b>10</b> led to a robust buildup of free heme (calculated as a percent of total heme species) and the level of heme-Fe, with a corresponding decrease in Hz levels (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D). These compounds led to significantly larger amounts of free heme release (sixfold increase in free heme-Fe for <b>9</b> and <b>10</b> vs only twofold for CQ) and a corresponding reduction in Hz levels at 3× EC<sub>50</sub> compared to CQ (2-fold decrease in Hz heme-Fe for <b>9</b> and <b>10</b> compared to 1.3-fold for CQ), demonstrating a higher amount of free heme at the compound concentrations that disrupt parasite growth. Similar to CQ, overlaying the parasite survival curve with the “free” heme-Fe titration curve showed that the concentrations of <b>9</b> and <b>10</b> at the EC<sub>50</sub> of heme-Fe release versus EC<sub>50</sub> for parasite survival were very similar in both assays. These data suggest that the MOA of the <b>3</b>-series compounds is at least in part due to inhibition of Hz formation.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Selections for <i>P. falciparum</i> 3D7 Parasites Resistant to Compound <b>9</b></h3><div class="NLM_p">To obtain additional insight into the potential mode of resistance to <b>3</b>-series compounds, we performed single-step selection studies to obtain parasites resistant to <b>9</b>. Selections were performed with a starting parasite inocula of 2 × 10<sup>9</sup> 3D7 parasites per flask, and two separate flasks were pressured with <b>9</b> at a concentration of 3× EC<sub>50</sub>. Drug-treated parasites cleared in both flasks by day 5 and recrudesced on day 25. Bulk cultures showed EC<sub>50</sub> shifts of only 2.4- to 3.4-fold compared to the parental line. Three clones were then obtained from each flask by limiting dilution. EC<sub>50</sub> and ED<sub>90</sub> shifts for these six clones were found to be a modest 2.8–2.6-fold (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The high starting inocula and the modest shifts in EC<sub>50</sub> for the selected mutant lines suggest that it is relatively difficult to evolve resistance against <b>9</b>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. <i>In Vitro</i> Selections for <i>Pf</i>3D7 Parasites Resistant to <b>9</b> Showing EC<sub>50</sub>/EC<sub>90</sub> Shifts of Clonal Lines<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">parental</th><th class="rowsep1 colsep0" colspan="6" align="center"><b>9</b> resistant clonal 3D7 lines</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">clone</th><th class="colsep0 rowsep0" align="center">3D7-A10</th><th class="colsep0 rowsep0" align="center">F1-B6</th><th class="colsep0 rowsep0" align="center">F1-C1</th><th class="colsep0 rowsep0" align="center">F1-E4</th><th class="colsep0 rowsep0" align="center">F2-A10</th><th class="colsep0 rowsep0" align="center">F2-A11</th><th class="colsep0 rowsep0" align="center">F2-H12</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> μM</td><td class="colsep0 rowsep0" align="left">0.30 ± 0.033</td><td class="colsep0 rowsep0" align="left">0.55 ± 0.058</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.061</td><td class="colsep0 rowsep0" align="left">0.74 ± 0.12</td><td class="colsep0 rowsep0" align="left">0.83 ± 0.11</td><td class="colsep0 rowsep0" align="left">0.67 ± 0.029</td><td class="colsep0 rowsep0" align="left">0.64 ± 0.055</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>90</sub> μM</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.12</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.16</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.17</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.21</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.10</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.041</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.078</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">2.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean ± standard error of the mean for three independent replicates.</p></div></div></div><div class="NLM_p">WGS performed on two clones per flask found that each clone had a copy number variation (CNV) on chromosome 5, with flask 1 (F1) clones showing three- to fourfold amplification and flask 2 (F2) clones showing fivefold amplification of the region (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Tables S4 and S5 and Figure S3A</a>). Clones from the two flasks differed in the chromosome 5 segment that was amplified. Nonetheless, all clones overlapped in the multidrug resistance gene 1 (<i>pfmdr1</i>, PF3D7_0523000) locus. This gene has previously been shown to be involved in MFQ, LUM, and quinine drug resistance and can also modulate CQ potency.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> This was the only change observed in all four clones, suggesting that it represents the major mechanism of resistance to <b>9</b> in these lines.</div><div class="NLM_p last">In addition to the CNV on chromosome 5, F2 clones A10 and A11 had another set of CNVs on chromosome 12, showing an approximately twofold amplification (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S5 and Figure S3B</a>). It is interesting to note that one of the eight genes in this amplified locus (Pf3D7_1223700) encodes a proposed vacuolar iron transporter, which could potentially be involved in modulating the consequences of disrupting heme polymerization in the DV. Finally, F1 clones F1-B6 and F1-E4 had single nucleotide polymorphisms (SNPs) in two common genes (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S6</a>), an M199I-substitution in PF3D7_0208200 (KRR1 small subunit processome component) and a N353K-substitution in PF3D7_1316700 (unknown function), while F1-B6 also contained a D4190N mutation in PF3D7_1343800 (unknown function). The relevance of these SNPs to the resistance mechanism of <b>9</b> is unknown.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ability of <i>P. falciparum</i> to develop resistance to virtually every drug that has been used clinically exemplifies the importance of working on this pathogen to further elucidate its biology and identify new drugs. Herein, we describe the identification of a novel, fast-acting antimalarial compound series that has efficacy against ABS parasites. In addition to showing fast kill kinetics, selection of resistant parasites toward one of the more potent compounds <b>9</b> generated only modest levels of resistance (two- to threefold) and WGS suggested that resistance was associated with amplification of the <i>pfmdr1</i> gene. We showed that <b>3</b>-series compounds <b>9</b> and <b>10</b> inhibited heme polymerization both <i>in vitro</i> and in <i>P. falciparum</i> cellular assays. Importantly, <b>9</b> showed equal efficacy on both CQ-sensitive and CQ-resistant strains. Thus, the <b>3</b>-series meets the objective of identifying fast kill compounds with a relatively low propensity of resistance for the treatment of malaria, and they provide a new scaffold that targets heme polymerization, a highly successful strategy for killing malaria parasites. Based on their lack of liver-stage or sexual-stage activity, these compounds would be best positioned in the portfolio for treatment, and their fast kill kinetics could allow them to be suitable for development in non-ART-based therapies. Further work to optimize both potency and drug-like properties would however be needed for this series to advance to lead optimization and to <i>in vivo</i> activity.</div><div class="NLM_p">A limited medicinal chemistry effort was undertaken for the <b>3</b>-series to define the structural requirements for activity. We found that parasite killing was not dependent on the stereochemistry and that both enantiomers were equally active for those that were tested. The A- and B-rings could be aryl or heteroaryl, but they could not be removed or replaced with aliphatic rings. Substantial substitution on the A ring was tolerated, which allowed us to replace the original Br/OMe substitution with more drug-like CF<sub>3</sub>/F groups. Similarly, we were able to improve the polarity of the series by replacing the B-ring phenyl group with heteroaryl rings including 3-pyridine (3-Py) and 5-pyrimidine (5-Pyr). This ring showed the steepest SAR profile with substantial loss in activity associated with substitution on various positions or alternative heteroaryl rings. Activity was improved by replacing the <i>N</i>-methyl group with larger <i>N</i>-alkyl groups, and the benzylic CH<sub>2</sub> could be replaced with a cyclopropyl group, blocking a potential metabolic liability. The tetrazole could be replaced with a conformationally restricted amide bond, and both series showed similar SAR. Overall, potency improvements of 10–20-fold were obtained relative to the initial hit <b>3</b>. The amide subseries generally showed better selectivity than the tetrazoles. Lipophilicity, indexed by Log <i>D</i>, was high throughout both subseries and metabolic stability was generally poor, although we were able to make some improvements in aqueous solubility.</div><div class="NLM_p">Profiling of a panel of drug-sensitive or -resistant strains provided the first insights that the <b>3</b>-series might share a common MOA with Hz inhibitors such as CQ. Direct biochemical evidence that the <b>3</b>-series compounds inhibit heme polymerization was obtained both <i>in vitro</i> and in cell-based assays. We showed that <b>9</b> and <b>10</b> inhibited heme biomineralization in the <i>in vitro</i> βH inhibition assay, while in the cell-based assay, treatment with these compounds caused a CQ-like signature of an accumulation of free heme with commensurate decreases in Hz levels. These effects titrated with the same dose response as parasite killing. Taken together, these data strongly implicate inhibition of Hz formation as one, but perhaps not the sole, MOA of this series. Interestingly, the levels of free heme generated in the presence of <b>9</b> and <b>10</b> are three- to fourfold higher than those observed for CQ across the dose response range, with the larger differences observed at higher drug concentrations. These results could reflect divergent interactions of the two compound classes with heme molecules during heme–drug complex formation. Indeed atomic-force microscopy studies have shown that the various antimalarial 4-aminoquinolines affect the biomineralization of heme molecules in different ways, with CQ and quinine providing the most efficient blocking by forming interactions across the flat surface face (“step-pinning”), whereas MFQ and amodiaquine block the addition of heme only to the step edge (“kink-blocking”).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p">Resistance selection studies uncovered resistance mechanisms that overlapped with the CQ-related quinolines such as MFQ, providing an additional link between the <b>3</b>-series and quinoline compounds. First, we observed that the <b>3</b>-series has a relatively low propensity to develop resistance as selections with 10<sup>9</sup> parasites yielded EC<sub>50</sub> shifts of only two- to threefold. Our WGS analysis found that the one genetic change common to all the resistant clones was three- to fivefold amplification of the <i>pfmdr1</i> gene, which encodes the <i>P</i>-glycoprotein transporter Pgp1. <i>pfmdr1</i> amplification is a major driver of clinical and parasite <i>in vitro</i> resistance to MFQ.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> The level of resistance observed for <b>9</b> was less than that reported for MFQ selection studies, where a lower level of amplification of the <i>pfmdr1</i> locus (twofold) yielded a fivefold IC<sub>50</sub> increase and which could be selected with a lower starting inocula (∼10<sup>8</sup> parasites).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> A greater impact of amplification was also reported for dihydroorotate dehydrogenase (DHODH) inhibitors, where threefold amplification of the <i>dhodh</i> locus led to a fivefold EC<sub>50</sub> increase from ∼10<sup>7</sup> parasites<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and five- to sixfold amplification arising from ∼10<sup>8</sup> parasites led to a sevenfold EC<sub>50</sub> increase.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Additionally, for DHODH inhibitors, multiple SNPs resulting in >10 to 30-fold shifts in EC<sub>50</sub> have been identified at a frequency of ∼10<sup>8</sup> parasites.<a onclick="showRef(event, 'ref25 ref59'); return false;" href="javascript:void(0);" class="ref ref25 ref59">(25,59)</a> Similar findings have also been reported for other antimalarials in preclinical development where minimum inoculum of resistance of 10<sup>6</sup> to 10<sup>8</sup> parasites, mediated often by SNPs or CNVs, led to resistance levels that can range from 2- up to 1000-fold based on the target, the genetic change, and the compound (e.g., <i>Pf</i>ATP4 or eEF2 inhibited by SNPs in KAE609 or DDD107498, respectively<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a>). In this light, our finding of low-level resistance mediated by <i>pfmdr1</i> amplification is a favorable feature of the <b>3</b>-series.</div><div class="NLM_p">The interplay between <i>Pf</i>MDR1 and <i>Pf</i>CRT and the impact of their allelic variation on drug resistance are complex and compound-dependent. While CQ resistance is primarily associated with <i>Pf</i>CRT mutations,<a onclick="showRef(event, 'ref23 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref23 ref43 ref44 ref45">(23,43−45)</a> low-grade resistance to other quinolines such as MFQ and the arylaminoalcohol LUM is associated with <i>Pf</i>MDR1 genetic changes (amplifications or point mutations).<a onclick="showRef(event, 'ref46 ref47 ref60'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref60">(46,47,60)</a><i>Pf</i>CRT is localized to the DV membrane and transports compounds out of the DV. <i>Pf</i>MDR1 also appears to be primarily localized to the <i>Plasmodium</i> DV membrane of the trophozoite,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> where it has been associated with solute uptake into the vacuole.<a onclick="showRef(event, 'ref55 ref60 ref62'); return false;" href="javascript:void(0);" class="ref ref55 ref60 ref62">(55,60,62)</a> Low-level expression of <i>Pf</i>MDR1 at the plasma membrane has also been reported,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> leaving open the possibility that it could be involved in efflux of compounds out of the parasitized red cell, similar to its mechanism of resistance in mammalian cells. Within this complex milieu, the potency of any given compound is dependent on the concentrations that can reach the DV, which could be influenced by binding affinity to the parasite line-specific transporter isoforms of <i>Pf</i>CRT and <i>Pf</i>MDR1 and by nonreceptor-mediated partitioning between the various cellular compartments related to the physical properties of the compound. Our studies on the <b>3</b>-series suggests that like MFQ and LUM, their efficacy can also be modulated by both transporters but to a lesser extent than for the quinolines. Analysis of the gene-edited lines showed that <b>9</b> and <b>10</b> were more potent on lines harboring <i>Pf</i>CRT mutations that are observed in CQ-resistant parasites than on parasites expressing the wild-type allele. These data provide direct evidence that the <i>pfcrt</i> allele impacts the potency of <b>3</b>-series compounds and suggest that the wild-type isoform might bind to and transport these compounds better than isoforms found in CQ-resistant parasites. This result is similar to earlier reports for LUM.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Importantly, these data provide evidence that the <b>3</b>-series will be fully effective against CQ-resistant parasites harboring <i>Pf</i>CRT mutations found in malaria-endemic regions.</div><div class="NLM_p">An identified exception to the promising activity on CQ-resistant strains was identified for <b>3</b>-series analogues that contained 5-Pyr in the B-ring (e.g., <b>10</b>). These tended to show poorer activity against Dd2, while still being effective against 3D7 and 7G8. Some analogues also exhibited biphasic concentration response curves versus Dd2 parasites. The Dd2 line has a separate <i>Pf</i>CRT isoform compared to the 7G8 line<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> for which higher potency for both <b>9</b> and <b>10</b> was observed, but data on the gene-edited lines that harbored only the <i>Pf</i>CRT changes associated with Dd2 suggested that the poor activity of <b>10</b> on Dd2 is unrelated to <i>Pf</i>CRT. <i>Pf</i>MDR1 SNPs might also impact the potency in these cases. Dd2 encodes the N86Y mutation, whereas 7G8 carries the S1034C/N1042D/D1246Y haplotype. Both <i>Pf</i>MDR1 isoforms sensitize parasites to MFQ and LUM (when expressed in parasites with a single copy of <i>pfmdr1</i>) and impact multiple antimalarials that engage with the heme degradation pathway, either by causing increased sensitivity or by mediating a degree of resistance.<a onclick="showRef(event, 'ref60 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref60 ref63 ref64">(60,63,64)</a> These data suggest that the N86Y mutation could be associated with the poor activity of some <b>3</b>-series analogues against Dd2 and could support a model whereby the N86Y <i>Pf</i>MDR1 mutation leads to reduced levels of 5-Pyr analogues such as <b>10</b> in the DV, while not impacting localization of the 3-Py analogues such as <b>9</b>. The interplay between the two transporters might also contribute to the biphasic curves observed with the 5-Pyr <b>3</b>-series analogues (e.g., <b>10</b>). Dd2 parasites also express 2 to 3 copies of <i>pfmdr1</i>, contrasting with the single copy of <i>pfmdr1</i> expressed by 3D7 and 7G8 parasites, which may further contribute to the observed differences between Dd2 and other parasite lines. These differences in potency provide a path forward for future medicinal chemistry as compounds with 5-Pyr in the B-ring would be disfavored going forward.</div><div class="NLM_p last">An open question that remains is how the <b>3</b>-series analogues interact with heme. The crystal structure of halofantrine–ferriprotoporphyrin IX shows that the basic amine of halofantrine (related to quinine) interacts with a carboxylate from heme, while the hydroxyl coordinates to the heme iron.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Indeed, a characteristic of nearly all heme-interacting antimalarials is the presence of a protonatable amine. These groups appear to be important for interaction with heme and for accumulation in the low pH environment of the DV. All of the <b>3</b>-series compounds with EC<sub>50</sub> <1 μM have predicted p<i>K</i><sub>a</sub> values within reasonable physiological pH ranges, with the central tertiary nitrogen present in all molecules and calculated p<i>K</i><sub>a</sub> values around 5–6, suggesting that <b>3</b>-series compounds may also interact with heme through this basic amine (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). For example, the acetamide <b>15</b> lacks a basic amine and is essentially inactive. Similar to the crystal structure of halofantrine, the structure of MFQ bound to ferriprotoporphyrin IX shows an alkoxide bound to Fe and a salt bridge between a basic amine and the porphyrin carboxylate.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In this context, we note that the amine-tetrazole or amine-amide distance in the <b>3</b>-series is similar to the amine-alcohol distance in MFQ. This observation prompts the speculation that the tetrazole or amide might bind Fe, while orienting the basic amine in a position to interact with the heme carboxylate.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67,68)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein, we have described a novel tetrazole-based series with antimalarial activity against ABS parasites. The compound class exhibits a fast kill rate and a relatively low propensity to develop resistance, both desirable properties for new antimalarial drugs. The MOA of the series appears to be inhibition of heme polymerization in the parasite DV, similar to 4-aminoquinolines such as CQ. The series thus provides a new chemical scaffold that functions at least in part by this highly effective mechanism for killing malaria parasites. Novel compounds that function by blocking heme biomineralization have been sought through secondary screening of HTS hits from phenotypic ABS screens, and while some new chemical entities that target this mechanism have been discovered, none have yet progressed to preclinical development.<a onclick="showRef(event, 'ref50 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref50 ref69 ref70">(50,69,70)</a> Our initial SAR exploration has revealed areas of the scaffold that are subject to modification to optimize activity and physicochemical properties and has shown that substantial improvements are possible. Further efforts will be required to identify compounds with improved potency and ADME properties that will support <i>in vivo</i> efficacy and eventual development. The <b>3</b>-series also provides new tools for studying the heme biomineralization mechanism and the impact of inhibiting this process on the parasite.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Human Samples</h3><div class="NLM_p last">Human biological samples were sourced ethically, and their research use was in accordance with the terms of the informed consents under approved IRB/EC protocols for each site.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>P. falciparum</i> Culture</h3><div class="NLM_p last"><i>P. falciparum</i> cultures were maintained at 2% hematocrit using human blood type O+ RBCs (Valley Biomedical) employing a culturing method adapted from Trager and Jensen.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Culture media contained the RPMI 1640 medium (Gibco) + 25 mM HEPES and 0.5% Albumax-I, supplemented with 23 mM sodium bicarbonate and 92 μM σ-hypoxanthine.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Determination of Compound Potency against <i>P. falciparum</i><i>In Vitro</i></h3><div class="NLM_p last">Antiplasmodial activity was evaluated using a parasite growth SYBR Green-based inhibition assay adapted from published methods.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> For the primary screen (plated at 5 μM) and for hit validation three-point cherry pick concentration response curves (plated at 5, 1.7, and 0.42 μM), we acoustically dispensed compounds [30 nL of 5 mM stocks in dimethyl sulfoxide (DMSO)] into wells using a Labcyte-Echo-555 dispenser. Concentration response curves on repurchased or synthetized compounds were generated from serial dilutions prepared in DMSO in triplicate and plated using a Tecan D300e digital dispenser. The DHODH inhibitor DSM265<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> served as a positive control, and 0.5% DMSO was plated as a negative control, with all wells normalized to a final concentration of 0.5% DMSO. Culture suspensions were prepared to a 0.5% starting parasitemia at 2% hematocrit and were dispensed (60 μL) using a BioTek-MultiFlo dispenser into 384-well plates containing prespotted library compounds. Prepared plates were then incubated for 72 h at 37 °C in 5% CO<sub>2</sub>, 80% humidity. Reference thick film smears from select control wells were made prior to sealing each plate in aluminum foil and storing at −80 °C for 24 h. Plates were thawed at room temperature (RT), and all ensuing steps were conducted under reduced light. SYBR Green stock solution was prepared by mixing σ-SYBR Green I nucleic acid gel stock (1.2 μL) into 1 mL of lysis buffer (80 mM Tris-HCl pH 7.52, 20 mM EDTA, 0.032% w/v Saponin, 0.32% v/v 100% Triton X-100). SYBR Green stock solution (15 μL) was dispensed into each well of the assay plates, and plates were sealed in aluminum foil and stored in the dark for 4 h at RT. Fluorescence was measured by detecting emission at 535 nm after excitation at 485 nm using a BioTek Synergy H1 hybrid reader. Data were fitted to the log(inhibitor) versus response—variable slope (four parameters) model in Graph Pad Prism to determine the effective concentration that led to a 50% reduction in parasitemia (EC<sub>50</sub>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Phenotypic Screen Chemical Library</h3><div class="NLM_p last">The chemical library used for the screen is an 8K subset of the UT Southwestern compound collection assembled with support from computational chemists at Chemical Diversity Inc (Chem Div) to represent a plate-based diversity subset of our 200K chemical library. Compounds in this subset are compliant with a relaxed set of Lipinski’s rules, with 99% having a molecular weight less than 550. The abovementioned SYBR Green assay was optimized on our HTS core platforms as a readout for <i>P. falciparum</i> growth using the 384-well plate format. <i>Z</i>′ was evaluated as a measure of assay robustness where a <i>Z</i>′ >0.5 represents a robust assay. Hits were identified based on an RZ score cutoff of <−3, where the RZ score represents the number of RSDs that a measurement for a library compound is from the corrected robust median, which is determined after correction for systematic errors (plate, row, and column effects) as described.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>Pf</i> Drug-Resistant Laboratory Strains and Cross-Resistance Testing</h3><div class="NLM_p last">Drug sensitivity testing was performed using the modified [<sup>3</sup>H]-hypoxanthine incorporation assay, as previously reported.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> HepG2 <i>In Vitro</i> Cytotoxicity Evaluation</h3><div class="NLM_p last">Cytotoxicity was evaluated against HepG2 human hepatoma cell suspensions in the σ-EMEM medium supplemented with 5% heat inactivated fetal bovine serum (Gibco) and 2 mM glutamine. Compounds were dispensed into 384-well plates using a Labcyte Echo555 acoustic dispenser. Methotrexate (Sigma) and 0.5% DMSO were used as positive and negative controls, respectively. All wells were normalized to an upper limit of 0.5% DMSO. A volume of 60 μL/well was added using a BioTek-MultiFlo dispenser from a 10,000 cells/mL cell suspension preparation of HepG2 cells for a final seeding density of 600 cells/well. Plates were then incubated for 72 h in a humidity chamber at 37 °C, 5% CO<sub>2</sub>, and 80% humidity. Cell viability was established by quantifying intracellular ATP using a luciferase-coupled ATP quantification assay (Promega-CellTiter Glo) following the manufacturer’s instructions. Data were fitted to the log(inhibitor) vs response—variable slope (four parameters) model in Graph Pad Prism to determine the cytotoxic concentration that led to 50% reduction in the signal (CC<sub>50</sub>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>P. falciparum</i> Relative Rate of Kill Bioluminescence Assay (BRRoK)</h3><div class="NLM_p last">The parasite kill rate was estimated as previously described<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> using a transgenic luciferase-expressing <i>P. falciparum</i> strain, NF54-luc<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (BEI Resources) that had the advantage of expressing luciferase throughout the asexual life cycle. Cultures were maintained in WR99210 (5 nM), but the drug was removed by washing and replating in drug-free media for 2 days prior to the kill rate studies. Briefly, NF54-luc cultures were sequentially synchronized to ring stages using 5% <span class="smallcaps smallerCapital">d</span>-sorbitol as described.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The assay was then conducted with trophozoite stage cultures (20–26 h postinvasion) at 2% parasitaemia and 4% haematocrit. NF54-luc parasites (200 μL/well) were added to 96-well plates at 2% hematocrit and 2% parasitemia. Triplicate concentrations (30× EC<sub>50</sub> to 0.33× EC<sub>50</sub>) of benchmark antimalarials and experimental compounds were added to each well and then incubated for 6 h at 37 °C, 5% CO<sub>2</sub>, and 80% humidity. Culture samples (40 μL/well) were then transferred to a white-clear bottom 96-well plate, and parasite viability was determined by luciferase quantification using a luciferase bioluminescence assay (Promega-Luciferase Assay system).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Two-Color Flow Cytometry Kill Rate Assay</h3><div class="NLM_p last">Double-colorimetric FACS analysis was used to quantify invasion of prestained human RBCs by drug-treated parasites as described.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Briefly, killing profiles were estimated by culturing unlabeled RBCs infected with <i>P. falciparum</i> 3D7 parasites in the presence of compounds at 10× EC<sub>50</sub> for 24 or 48 h. The initial % parasitemia was 0.5% with a hematocrit of 2%. Compound EC<sub>50</sub> was determined prior to the start of the study using the 48 h <i>in vitro</i><sup>3</sup>H-hypoxanthine incorporation assay as described<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> for parasites cultured in standard RPMI 1640 media supplemented with 25 mM HEPES and 0.225% NaHCO<sub>3</sub> supplemented with 2% <span class="smallcaps smallerCapital">d</span>-sucrose, 0.3% <span class="smallcaps smallerCapital">l</span>-glutamine, 0.005 mM hypoxanthine, and 0.5% AlbuMax II. Culture media for the kill rate study was identical but contained 0.15 mM hypoxanthine. After drug treatment, compounds were removed and infected RBCs were diluted using fresh RBCs previously labeled with carboxylfluorescein diacetate succinimidyl ester (10 μM for 30 min at 37 °C). Following a further 48 h incubation under standard conditions, the ability of treated parasites to establish infection in fresh labeled RBCs was detected by two-color flow cytometry after labeling parasite DNA with Hoechst 33342 solution (2 μM). Parasite viability was measured based on the percentage of infected CFDA-SE-stained RBCs in drug-treated samples versus untreated samples of the initial inocula after 48 h incubations with labeled RBCs.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> PRR Kill Rate Assay</h3><div class="NLM_p last">PRR was assessed using the standard drug washout assay that has been previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Briefly, parasites were treated with compounds for either 24 or 48 h at 10× EC<sub>50</sub> (determined as described above) with the compound renewed daily over the treatment period. Parasite samples were removed at the determined time points (0, for the control of the initial number of parasites, 24, and 48 h), the drug was washed out, and drug-free parasites were cultured in 96-well plates after the addition of fresh RBCs and new media in microtiter plates over a threefold serial dilution. Cultures were maintained for up to 28 days to enable parasites to recrudesce. Four independent serial dilutions were carried out with each sample to correct for experimental variation. The number of viable parasites was back-calculated based on <i>X</i><sup><i>n</i>–1</sup> where <i>n</i> is the number of wells where growth was observed and <i>X</i> is the dilution factor.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Liver-Stage and Gametocidal Assays</h3><div class="NLM_p"><i>P. berghei</i> liver-stage assays were performed in the Winzeler lab (UCSD) as described.<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19,21)</a><i>P. berghei</i>-ANKA-GFP-Luc-SMCON (Pb-Luc) sporozoites were used to infect HepG2-A16-CD81EGFP cells for this assay, which monitors the ability of compounds to block liver-stage development of luciferase-expressing parasites. Assay media (DMEM without Phenol Red (Life Technology, CA) supplemented with 5% fetal bovine serum, 1.45 mg/mL glutamine, 500 units of penicillin, and 500 μg/mL streptomycin) was used for the <i>Pbluc</i> and <i>HepG2tox</i> assays.</div><div class="NLM_p last">Gametocyte assays measuring the viability of mature stage V gametocytes were conducted to determine the ability of compounds to block formation of male and female gametes in the Baum lab (Imperial College, London) as described.<a onclick="showRef(event, 'ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76">(74−76)</a> The assay identifies compounds that either kill stage V gametocytes, cause sterilization, or interfere with the process of gamete formation.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>In Vitro</i> Heme Polymerization Assay</h3><div class="NLM_p last">Lipid-mediated Hz formation was quantified by measuring the formation of βH from hematin, in a detergent-mediated assay that substitutes neutral lipids for the commercially available lipophilic detergent Nonidet P-40 (NP-40).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Unreacted hematin was detected through the formation of the bis-pyridyl-Fe(III)PPIX complex which absorbs at a wavelength of 405 nm. Compound stocks (20 mM) of <b>3</b>-derivatives (<b>3</b>, <b>9</b>, and <b>10</b>) and pyrimethamine were prepared in DMSO, while CQ was prepared in water. These stocks were then diluted to 2 mM with a water/NP40 detergent solution, resulting in a final solution of compound in 61.1 mM NP40/10% DMSO. Solubility of <b>3</b>, <b>9</b>, and <b>10</b> to 2 mM in this buffer was confirmed (see <i>in vitro</i><a class="ref internalNav" href="#sec5_15" aria-label="ADME methods">ADME methods</a> section). Serial dilutions into this same buffer were then made for each compound. A 25 mM hematin stock solution was prepared by sonicating hemin in DMSO for 1 min and then suspending 179 μL of this stock in a 1 M acetate buffer (20 mL, pH 4.8). The homogenous suspension was then added to the wells to give final buffer and hematin concentrations of 0.5 M and 100 mM, respectively. Plates were covered and incubated at 37 °C for 5 h. A solution of 50% (v/v) pyridine, 30% (v/v) H<sub>2</sub>O, 20% (v/v) acetone, and 2 M HEPES buffer (pH 7.4) was prepared, and 32 μL of the solution was added to each well to give a final pyridine concentration of 5% (v/v). Acetone (60 μL) was then added to each well to assist with hematin dispersion. The UV–vis absorbance of the plate wells was read on a SpectraMax P340 plate reader. Sigmoidal concentration–response curves were fitted to the absorbance data using GraphPad Prism version 8 to obtain a 50% inhibitory concentration (IC<sub>50</sub>) for each compound.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Cellular Heme Polymerization Assay</h3><div class="NLM_p last">Inhibition of Hz formation was measured in cultured ABS <i>Pf</i>NF54 parasites through a heme fractionation assay,<a onclick="showRef(event, 'ref53 ref78'); return false;" href="javascript:void(0);" class="ref ref53 ref78">(53,78)</a> where both % “free” heme and levels of “free” heme-Fe were quantified in femtogram per cell (fg/cell) using a heme standard curve from the mass of each heme-Fe species per trophozoite. Percent free heme and amounts of free heme-Fe were quantified over a range of drug concentrations (0.5–3× EC<sub>50</sub>) and compared to the vehicle control. Briefly, early ring-stage NF54 parasites were treated with a combination of successive sorbitol and Percoll treatments to prepare young rings synchronized to within 3 h postinvasion.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Young rings were incubated with the test drugs at various multiples of their IC<sub>50</sub> values with a no-drug control included (culture conditions and media as described above). After 32 h, late trophozoites/early schizonts were harvested by lysis of the RBCs with 0.05% saponin followed by multiple washes with 1× PBS (pH 7.5) to remove traces of the RBC hemoglobin. Pellets were then resuspended in 1× PBS (pH 7.5). An aliquot of the trophozoite suspension was used to quantify, using flow cytometry, the total number of trophozoites isolated. Contents of the remaining trophozoite pellet were then released by hypotonic lysis and sonication. Following centrifugation, treatment with HEPES buffer (pH 7.4), sodium dodecyl sulfate, pyridine, and NaOH, the fractions corresponding to digested hemoglobin, “free” heme, and Hz were carefully recovered. The UV–visible spectrum of each heme fraction as an Fe(III)heme–pyridine complex was measured using a multiwell plate reader (Spectramax 340PC; Molecular Devices). The total amount of each heme species was quantified using a heme standard curve whereby the mass of each heme-Fe species per trophozoite (fg/cell) was calculated by dividing the total amount of each heme species by the corresponding number of parasites in that fraction as determined by flow cytometry. Statistical comparisons and analyses for trends were made on GraphPad Prism version 8 using Students’ <i>t</i>-test (GraphPad Software Inc., La Jolla, CA, USA).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>In Vitro</i> Selection of Drug-Resistant <i>P. falciparum</i> Lines</h3><div class="NLM_p last"><i>P. falciparum</i> 3D7 parasites (clone A10) resistant to <b>9</b> were selected using previously described methods for single-step drug selections.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Briefly, the EC<sub>50</sub> of <b>9</b> versus 3D7-A10 (genetically homogenous clonal line) ring-stage parasites (0.2% parasitemia and 1% hematocrit, cultured in RPMI-1640 media supplemented with 0.5% Albumax) was determined in a 72 h assay for a twofold dilution series (10 points) of <b>9</b> (final DMSO concentration was <0.5%) in duplicate along with DMSO solvent controls. Parasite survival was assessed by flow cytometry on an Accuri C6 (BD Biosciences) using SYBR Green and MitoTracker Deep Red FM (Life Technologies) as nuclear stain and vital dyes, respectively. A single-step selection with 2 × 10<sup>9</sup> parasites in duplicate was set up at 2% parasitemia and 5% hematocrit using 3× EC<sub>50</sub> of <b>9</b> (0.78 μM). Wells were monitored daily by blood smears until the culture was cleared of live parasites. Drug-containing media was replaced daily until cultures cleared and then every other day thereafter. Cultures were passaged once a week by replacing a fourth of the culture with media and fresh RBCs, with monitoring by blood smears twice a week for up to 60 days to allow for parasite recrudescence.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> WGS and Analyses of Drug-Resistant <i>P. falciparum</i> Clones</h3><div class="NLM_p last">For WGS, genomic DNA was used to prepare libraries using the Illumina Nextera DNA Flex library kit with dual indices, as previously reported.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The samples were multiplexed and sequenced on an Illumina MiSeq to obtain 300 bp paired end reads at 19–44× depth of coverage across the samples. Sequence reads were aligned to the <i>P. falciparum</i> 3D7 genome (PlasmoDB version 36) using BWA (Burrow–Wheeler Alignment). PCR duplicates and unmapped reads were filtered out using Samtools and Picard. The reads were realigned around indels using GATK RealignerTargetCreator, and base quality scores were recalibrated using GATK BaseRecalibrator. GATK HaplotypeCaller (version 4.1.6) was used to identify any SNVs in clones. These were filtered based on quality scores (variant quality as a function of depth QD > 1.5, mapping quality > 40, and min base quality score > 18) and read depth (depth of read > 5) to obtain high-quality SNPs that were annotated using snpEFF. Comparative SNP analysis between the resistant clones and parent was performed to generate a final list of SNPs that were present exclusively in the resistant clones. BIC-Seq was used to discover CNVs in the resistant mutants against the parent, using the Bayesian statistical model.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Integrated genome viewer was used to visually verify the presence of these SNPs and CNVs in the clones.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> ADME: Solubility Measurements</h3><div class="NLM_p last">Methods used to assess kinetic solubility in PBS pH 6.5 and pH 2.0 buffers have been previously described.<a onclick="showRef(event, 'ref25 ref83'); return false;" href="javascript:void(0);" class="ref ref25 ref83">(25,83)</a> Solubility of <b>3</b>, <b>9</b>, and <b>10</b> in the buffer used for the <i>in vitro</i> heme biomineralization studies was conducted by spiking a 40 μL aliquot of test compound stock solution into 80 μL of NP-40 solution followed by 280 μL of Milli-Q water. The resulting mixtures contained a final compound concentration of 2 mM in 10% (v/v) DMSO and 61.1 mM NP-40. Samples were maintained in a 37 °C incubator for the duration of the study. After 1, 2, 4, and 24 h incubations at 37 °C, the bulk samples were centrifuged (3 min at 10,000 rpm) and a single aliquot of the supernatant was taken and diluted 20-fold in 50% aqueous acetonitrile for quantitative analysis by HPLC with detection by UV–vis absorbance at 244 nm.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> ADME: <i>In Vitro</i> Metabolism and Calculation of Physical Chemical Properties</h3><div class="NLM_p last">Compounds (1 μM) were incubated (up to 60 min at 37 °C) with human liver microsomes (Xenotech LLC, Kansas City, KS) at a protein concentration of 0.4 mg/mL with an NADPH regenerating buffer system, as described previously.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Degradation half-life and <i>in vitro</i> intrinsic clearance were calculated from the apparent first-order degradation rate constant. Physical–chemical properties were calculated using the ChemAxon chemistry cartridge via JChem for Excel software (version16.4.11).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Chemical Methods</h3><div id="sec5_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> General</h4><div class="NLM_p last">All tested compounds have a purity of >95% as judged by HPLC analysis (UV detection at 210 nM). Chemical shifts δ are in ppm, and spectra were referenced using the residual solvent peak. The following abbreviations are used: singlet (s), doublet (d), triplet (t), quartet (q), double doublet (dd), quintet (quin), multiplet (m), and broad signal (bs). Mass spectra (<i>m</i>/<i>z</i>) were recorded on an Agilent LC–MS 1290 Infinity using ESI ionization. All chemicals were used as received unless otherwise noted.</div></div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> HPLC/MS Analysis</h3><div class="NLM_p">An Agilent 1290 Infinity HPLC system using an Eclipse XDB-C18 column (4.6 × 150 mm, 5 μm; Agilent) that was coupled to an Agilent 6130 quadrupole ESI mass spectrometer run in the positive mode with a scan range of 100–1100 <i>m</i>/<i>z</i> was used. LC was carried out at a flow rate of 0.5 mL/min at 20 °C with a 5 μL injection volume, using a gradient elution with aqueous acetonitrile containing 0.1% formic acid, 0 min: 30% acetonitrile/water; 0 → 6 min: gradient to 95% acetonitrile/water; 6 → 12 min 95% acetonitrile/water.</div><div id="sec5_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3-Chlorophenyl)-2-(3-methyl-2-oxo-5-phenyl-2,3-dihydro-1<i>H</i>-benzo[<i>e</i>][1,4]diazepin-1-yl)butanamide (<b>1</b>)</h4><div class="NLM_p last"><i>t</i><sub>R</sub> = 9.0 min. ESI-MS (<i>m</i>/<i>z</i>): 446.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_18_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(4-((4-Acetylphenyl)carbamoyl)phenyl)-2,3-dihydrobenzo[<i>b</i>][1,4]dioxine-2-carboxamide (<b>2</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0012.gif" alt="" id="dgr1" /></img><i>t</i><sub>R</sub> = 4.24 min. ESI-MS (<i>m</i>/<i>z</i>): 417.0 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> General Syntheses of Tetrazole Derivatives<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h3><div class="NLM_p">Isocyanide (1.0 mmol), aromatic aldehyde (1.0 mmol), <i>N</i>-benzylamine (1.0 mmol), and trimethylsilyl azide (1.0 mmol) were dissolved in MeOH (2.0 mL, 2 M) under a N<sub>2</sub> atmosphere. The resulting solution was stirred at RT for 2–3 days. MeOH was evaporated, and the residue was purified by flash column chromatography.</div><div id="sec5_19_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(5-Bromo-2-methoxybenzyl)-<i>N</i>-methyl-1-phenyl-1-(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methenamine (<b>3</b>)</h4><div class="NLM_p last">The target compound was obtained in 73% yield as a colorless thick liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.48–7.42 (m, 2H), 7.33–7.19 (m, 8H), 7.02 (d, <i>J</i> = 8.4 Hz, 1H), 6.64 (d, <i>J</i> = 8.6 Hz, 1H), 4.94 (s, 1H), 3.69–3.61 (m, 4H), 3.46 (d, <i>J</i> = 14.8 Hz, 1H), 2.23 (s, 3H), 1.69 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 156.7, 155.2, 136.0, 135.5, 132.6, 132.1, 131.6, 131.3, 130.6, 129.2, 128.6 (d, <i>J</i> = 20.8 Hz), 127.3, 127.0, 113.0, 112.0, 63.3, 55.5, 51.7, 39.6, 17.1. ESI-MS (<i>m</i>/<i>z</i>): 478.1 [M + H]<sup>+</sup>. The enantiomers were separated by chiral HPLC (CHIRALCEL OD-H column, 1% isopropanol in hexane, 1.0 mL/min, <i>t</i><sub>R</sub> = 25, 32 min). <b>Enantiomer 1</b>, [α]<sub class="stack">D</sub><sup class="stack">25</sup> +7.99 (<i>c</i> 0.15, EtOH); <b>Enantiomer 2</b>, [α]<sub class="stack">D</sub><sup class="stack">25</sup> −7.99 (<i>c</i> 0.15, EtOH).</div></div><div id="sec5_19_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(2-Methoxybenzyl)-<i>N</i>-methyl-1-phenyl-1-(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methanamine (<b>4</b>)</h4><div class="NLM_p last">The target compound was obtained in 78% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45 (t, <i>J</i> = 7.6 Hz, 1H), 7.38–7.25 (m, 8H), 7.20 (t, <i>J</i> = 7.8 Hz, 1H), 7.01 (d, <i>J</i> = 7.9 Hz, 1H), 6.90 (t, <i>J</i> = 7.4 Hz, 1H), 6.80 (d, <i>J</i> = 8.2 Hz, 1H), 4.94 (s, 1H), 3.74–3.66 (m, 4H), 3.50 (d, <i>J</i> = 14.1 Hz, 1H), 2.26 (s, 3H), 1.73 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 157.6, 155.3, 135.9, 135.7, 132.6, 131.5, 131.1, 129.9, 129.2, 128.4 (d, <i>J</i> = 32.0 Hz), 128.1, 127.2, 126.9, 126.5, 120.4, 110.3, 62.9, 55.2, 52.2, 39.2, 17.1. ESI-MS (<i>m</i>/<i>z</i>): 400.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(2-Methoxy-5-(trifluoromethyl)benzyl)-<i>N</i>-methyl-1-phenyl-1-(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methanamine (<b>5</b>)</h4><div class="NLM_p last">The target compound was obtained in 70% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.59 (s, 1H), 7.48–7.39 (m, 2H), 7.20–7.31 (m, 7H), 7.00 (d, <i>J</i> = 7.7 Hz, 1H), 6.82 (d, <i>J</i> = 8.5 Hz, 1H), 4.98 (s, 1H), 3.78–3.70 (m, 4H), 3.52 (d, <i>J</i> = 14.8 Hz, 1H), 2.24 (s, 3H), 1.69 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 159.9, 155.0, 135.9, 135.5, 132.5, 131.6, 131.2, 129.1, 128.6 (d, <i>J</i> = 16.0 Hz), 127.6, 127.1, 126.9, 126.4 (q, <i>J</i> = 15.0 Hz), 125.4 (q, <i>J</i> = 16.0 Hz), 122.7 (q, <i>J</i> = 131.9 Hz), 109.9, 63.2, 55.5, 51.6, 39.6, 17.1. ESI-MS (<i>m</i>/<i>z</i>): 468.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(2-Methoxy-5-(trifluoromethyl)benzyl)-<i>N</i>-methyl-1-(pyridin-3-yl)-1-(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methenamine (<b>6</b>)</h4><div class="NLM_p last">The target compound was obtained in 63% yield as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.56 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.49 (d, <i>J</i> = 2.4 Hz, 1H), 7.91 (td, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.52–7.44 (m, 3H), 7.38–7.27 (m, 3H), 7.06 (d, <i>J</i> = 8.0 Hz, 1H), 6.85 (d, <i>J</i> = 8.0 Hz, 1H), 5.03 (s, 1H), 3.73 (s, 3H), 3.71 (d, <i>J</i> = 14.8 Hz, 1H), 3.51 (d, <i>J</i> = 14.8 Hz, 1H), 2.24 (s, 3H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 159.9, 154.0, 150.3, 149.8, 137.0, 135.6, 132.3, 131.9, 131.5, 131.1, 127.2, 126.9 (d, <i>J</i> = 8.68 Hz), 126.6 (q, <i>J</i> = 14.4 Hz), 125.8 (q, <i>J</i> = 16.0 Hz), 123.5, 122.6 (q, <i>J</i> = 134.0 Hz), 110.2, 60.5, 55.5, 51.7, 39.1, 17.2. ESI-MS (<i>m</i>/<i>z</i>): 469.3 [M + H]<sup>+</sup>. The enantiomers were separated by chiral HPLC (CHIRALCEL OD-H column, 10% isopropanol in hexane, 1.0 mL/min, <i>t</i><sub>R</sub> = 15, 17 min). <b>Enantiomer 1</b>, [α]<sub class="stack">D</sub><sup class="stack">25</sup> +5.16 (<i>c</i> 0.15, EtOH); <b>Enantiomer 2</b>, [α]<sub class="stack">D</sub><sup class="stack">25</sup> −5.16 (<i>c</i> 0.15, EtOH).</div></div><div id="sec5_19_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(2-Methoxy-5-(trifluoromethyl)benzyl)-<i>N</i>-(pyridin-3-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)cyclopropanamine (<b>7</b>)</h4><div class="NLM_p last">The target compound was obtained in 61% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.55 (m, 2H), 8.08 (d, <i>J</i> = 8 Hz, 1H), 7.48–7.20 (m, 6H), 7.00 (d, <i>J</i> = 8.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.4 Hz, 1H), 5.12 (s, 1H), 4.20 (d, <i>J</i> = 12 Hz, 1H), 3.69 (d, <i>J</i> = 13.2 Hz, 1H), 3.64 (s, 3H), 1.89 (s, 4H), 0.24–0.15 (m, 2H), −0.05 to −0.11 (m, 1H), −0.29 to −0.39 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 159.9, 153.8, 150.9, 149.8, 137.4, 135.5, 132.3, 131.7, 131.4, 130.2, 129.1 (q <i>J</i> = 14.6 Hz), 127.6, 127.1 (d, <i>J</i> = 7.0 Hz), 125.7 (q, <i>J</i> = 15.0 Hz), 123.2, 122.2 (q, <i>J</i> = 130 Hz), 109.9, 58.5, 55.4, 49.5, 35.1, 17.2, 8.1, 7.5. ESI-MS (<i>m</i>/<i>z</i>): 495.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(2-Fluoro-5-(trifluoromethyl)benzyl)-<i>N</i>-(pyridin-3-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)cyclopropanamine (<b>8</b>)</h4><div class="NLM_p last">The target compound was obtained in 61% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.57 (td, <i>J</i> = 4.8, 1.8 Hz, 1H), 8.52 (bs, 1H), 8.01–7.92 (m, 1H), 7.52–7.22 (m, 6H), 7.00 (t, <i>J</i> = 8.8 Hz, 2H), 5.19 (s, 1H), 4.27 (d, <i>J</i> = 13.8 Hz, 1H), 3.87 (d, <i>J</i> = 13.8 Hz, 1H), 1.91 (bs, 4H), 0.35–0.16 (m, 2H), 0.00 to −0.07 (m, 1H), −0.16 to −0.27 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 153.5, 150.7, 150.0, 137.2, 135.5, 132.2, 131.9, 131.5, 130.3, 129.2–129.0 (m), 127.2, 127.0, 123.3, 115.9, 115.7, 58.7, 48.4, 35.2, 17.3, 8.1, 7.7. ESI-MS (<i>m</i>/<i>z</i>): 483.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(Pyridin-3-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)-<i>N</i>-(3-(trifluoromethyl)benzyl) Cyclopropanamine (<b>9</b>)</h4><div class="NLM_p last">The target compound was obtained in 62% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.54 (d, <i>J</i> = 4.4 Hz, 1H), 8.45 (bs, 1H), 7.83 (d, <i>J</i> = 7.2 Hz, 1H), 7.47–7.37 (m, 2H), 7.35–7.18 (m, 6H), 6.88 (d, <i>J</i> = 7.2 Hz, 1H), 5.16 (s, 1H), 4.10 (d, <i>J</i> = 14.4 Hz, 1H), 3.93 (d, <i>J</i> = 14.0 Hz, 1H), 2.05–1.98 (m, 1H), 1.85 (s, 3H), 0.31–0.18 (m, 2H), 0.06 to −0.01 (m, 1H), −0.14 to −0.21 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 153.7, 150.7, 149.9, 140.3, 137.2, 135.5, 132.2 (d, <i>J</i> = 20.7 Hz), 131.9, 131.5, 130.9, 130.2 (q, <i>J</i> = 135.0 Hz) 128.7, 127.3, 126.9, 125.6 (q, <i>J</i> = 15.1 Hz), 123.9 (q, <i>J</i> = 14.8 Hz), 123.4, 58.4, 55.6, 35.1, 17.4, 8.9, 7.5. ESI-MS (<i>m</i>/<i>z</i>): 465.1.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(Pyrimidin-5-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)-<i>N</i>-(3-(trifluoromethyl) benzyl)cyclopropanamine (<b>10</b>)</h4><div class="NLM_p last">The target compound was obtained in 53% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.17 (s, 1H), 8.80 (s, 2H), 7.52–7.43 (m, 2H), 7.40–7.27 (m, 4H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 6.93 (d, <i>J</i> = 7.2 Hz, 1H), 5.16 (s, 1H), 4.07 (d, <i>J</i> = 14.0 Hz, 1H), 3.91 (d, <i>J</i> = 13.6 Hz, 1H), 2.09–2.01 (m, 1H), 1.90 (s, 3H), 0.39–0.24 (m, 2H), 0.09–0.01 (m, 1H), −0.12 to −0.20 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.7, 157.7, 152.5, 139.3, 135.3, 132.2, 132.1, 132.0, 131.8, 130.8 (q, <i>J</i> = 130.0 Hz), 128.9, 128.7, 127.4, 126.8, 125.6 (q, <i>J</i> = 15.2 Hz), 124.3 (q, <i>J</i> = 17.6 Hz), 56.6, 55.8, 35.0, 17.4, 8.9, 7.7. ESI-MS (<i>m</i>/<i>z</i>): 466.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(3-Fluoro-5-(trifluoromethyl)benzyl)-<i>N</i>-(pyrimidin-5-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)cyclopropanamine (<b>11</b>)</h4><div class="NLM_p last">The target compound was obtained in 51% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.18 (s, 1H), 8.81 (s, 2H), 7.50 (t, <i>J</i> = 7.2 Hz, 1H), 7.40 (d, <i>J</i> = 7.6 Hz, 1H), 7.31 (t, <i>J</i> = 7.6 Hz, 1H), 7.15 (d, <i>J</i> = 8.0 Hz, 1H), 7.07 (s, 1H), 6.99–6.91 (m, 2H), 5.17 (s, 1H), 4.09 (d, <i>J</i> = 14.4 Hz, 1H), 3.91 (d, <i>J</i> = 14.4 Hz, 1H), 2.07–1.99 (m, 1H), 1.92 (s, 3H), 0.41–0.26 (m, 2H), 0.12–0.04 (m, 1H), −0.05 to −0.15 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 163.6, 161.2, 158.8, 157.7, 152.4, 142.6 (d, <i>J</i> = 25.2 Hz), 135.3, 132.2, 131.9, 131.8, 128.6, 127.5, 126.7, 121.3–121.1 (m), 119.2, 118.9, 112.0 (q, <i>J</i> = 18.7 Hz), 111.8 (q, <i>J</i> = 15.2 Hz), 56.7, 55.4, 35.3, 17.5, 8.9, 7.7. ESI-MS (<i>m</i>/<i>z</i>): 484.0 [M + H]<sup>+</sup>. The enantiomers were separated by chiral HPLC (CHIRACEL OD-H column, 10% isopropanol in hexane, 1.0 mL/min, <i>t</i><sub>R</sub> = 10, 12 min). <b>Enantiomer 1</b>, [α]<sub class="stack">D</sub><sup class="stack">25</sup> +24.609 (<i>c</i> 0.195, EtOH); <b>Enantiomer 2</b>, [α]<sub class="stack">D</sub><sup class="stack">25</sup> −21.558 (<i>c</i> 0.195, EtOH).</div></div><div id="sec5_19_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(4-Fluoro-3-(trifluoromethyl)benzyl)-<i>N</i>-(pyrimidin-5-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl) methyl)cyclopropanamine (<b>12</b>)</h4><div class="NLM_p last">The target compound was obtained in 51% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.18 (s, 1H), 8.80 (s, 2H), 7.51 (dt, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.40 (d, <i>J</i> = 7.6 Hz, 1H), 7.31 (t, <i>J</i> = 7.6 Hz, 1H), 7.24–7.18 (m, 2H), 7.03 (t, <i>J</i> = 10 Hz, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 1H), 5.16 (s, 1H), 4.06 (d, <i>J</i> = 14.0 Hz, 1H), 3.85 (d, <i>J</i> = 14.0 Hz, 1H), 2.00–1.88 (m, 4H), 0.39–0.23 (m, 2H), 0.06–0.01 (m, 1H), −0.11 to −0.19 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.8, 157.7, 152.4, 135.3, 134.7, 134.6, 134.2, 134.1, 132.1, 131.9, 131.8, 128.7, 127.5, 126.8, 117.0, 116.8, 56.9, 54.9, 35.1, 17.4, 8.8, 7.8. ESI-MS (<i>m</i>/<i>z</i>): 484.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(2-Fluoro-3-(trifluoromethyl)benzyl)-<i>N</i>-(pyrimidin-5-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)cyclopropanamine (<b>13</b>)</h4><div class="NLM_p last">The target compound was obtained in 50% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.20 (s, 1H), 8.88 (s, 2H), 7.52–7.44 (m, 2H), 7.39 (d, <i>J</i> = 7.6 Hz, 1H), 7.34–7.27 (m, 2H), 7.11–7.02 (m, 2H), 5.15 (s, 1H), 4.21 (d, <i>J</i> = 13.2 Hz, 1H), 3.79 (d, <i>J</i> = 13.6 Hz, 1H), 1.97–1.86 (m, 4H), 0.36–0.19 (m, 2H), −0.02 to −0.09 (m, 1H), −0.20 to −0.27 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.8, 157.7, 152.5, 135.6 (d, <i>J</i> = 11.5 Hz), 135.4, 132.0 (d, <i>J</i> = 10.1 Hz), 134.6, 131.7, 128.4, 127.4, 126.9, 126.5 (q, <i>J</i> = 11.6 Hz), 123.7 (d, <i>J</i> = 11.6 Hz), 57.0, 48.5, 35.0, 17.4, 8.2, 7.9. ESI-MS (<i>m</i>/<i>z</i>): 484.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(Cyclopropyl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)-<i>N</i>-(3-(trifluoromethyl)benzyl) Cyclo Propanamine (<b>14</b>)</h4><div class="NLM_p last">The target compound was obtained in 71% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.50–7.42 (m, 2H), 7.40–7.36 (m, 2H), 7.34–7.27 (m, 3H), 7.08 (d, <i>J</i> = 6.8 Hz, 1H), 4.17 (d, <i>J</i> = 14.4 Hz, 1H), 4.07 (d, <i>J</i> = 14.4 Hz, 1H), 3.18 (d, <i>J</i> = 10.0 Hz, 1H), 2.13–2.00 (m, 4H), 1.65–1.56 (m, 1H), 0.72–0.64 (m, 1H), 0.61–0.53 (m, 1H), 0.41–0.31 (m, 1H), 0.22–0.09 (m, 2H), −0.03 to −0.12 (m, 1H), −0.21 to −0.37 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 155.9, 141.0, 135.8, 132.8, 132.3, 131.7, 131.2, 130.3 (q, <i>J</i> = 127.1 Hz), 128.5, 127.2, 127.0, 125.8 (q, <i>J</i> = 14.6 Hz), 123.7 (q, <i>J</i> = 14.9 Hz), 62.0, 55.3, 35.4, 17.5, 11.4, 8.5, 6.8, 5.6, 3.9. ESI-MS (<i>m</i>/<i>z</i>): 428.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(Pyrimidin-5-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)-<i>N</i>-(3-(trifluoromethyl)benzyl)acetamide (<b>15</b>)</h4><div class="NLM_p last">1-(Pyrimidin-5-yl)-1-(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)-<i>N</i>-(3-(trifluoromethyl)benzyl)methanamine was synthesized using (3-(trifluoromethyl)phenyl)methanamine via a general procedure. To a suspension of the abovementioned amine (1.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> was added Et<sub>3</sub>N (2.0 mmol) at 0 °C. Acetyl chloride (2.0 mmol) was then added dropwise over 5 min. After stirring at RT for 1 h, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated under vacuum. The residue obtained was purified by flash column chromatography (EtOAc/hexane) to furnish the target compound in 51% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.97 (bs, 1H), 8.55 (bs, 2H), 7.55–7.27 (m, 5H), 7.20–6.81 (m, 3H), 5.02 (s, 2H), 2.14 (s, 3H), 1.95 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 172.2, 159.0, 157.9, 153.2, 137.2, 135.7, 132.2, 131.9, 131.6, 129.7, 129.3–129.2 (m), 127.5, 127.0, 124.6 (q, <i>J</i> = 12.5 Hz), 122.5 (q, <i>J</i> = 16.3 Hz), 49.5, 47.5, 22.2, 17.4. ESI-MS (<i>m</i>/<i>z</i>): 468.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-(2-Fluoro-5-(trifluoromethyl)benzyl)-<i>N</i>-methyl-1-(pyridin-3-yl)-1-(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methenamine (<b>16</b>)</h4><div class="NLM_p last">The target compound was obtained in 61% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.57 (dt, <i>J</i> = 4.8, 1.3 Hz, 1H), 8.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.89 (dt, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.55 (dd, <i>J</i> = 6.6, 2.4 Hz, 1H), 7.53–7.43 (m, 2H), 7.38–7.27 (m, 3H), 7.10–7.00 (m, 2H), 4.98 (s, 1H), 3.74 (d, <i>J</i> = 14.0 Hz, 1H), 3.58 (d, <i>J</i> = 14.1 Hz, 1H), 2.22 (s, 3H), 1.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 164.2, 161.6, 153.9, 150.3 (d, <i>J</i> = 22.7 Hz), 136.9, 135.6, 132.2, 131.9, 131.6, 130.7, 128.1–127.9 (m), 127.3, 126.9, 126.5–126.3 (m), 126.1, 125.2, 125.1, 123.6, 122.4, 116.2, 115.9, 60.5, 50.5 (d, <i>J</i> = 8.8 Hz), 39.0, 17.2. ESI-MS (<i>m</i>/<i>z</i>): 457.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(1-Cyclohexyl-1<i>H</i>-tetrazol-5-yl)-<i>N</i>-(2-fluoro-5-(trifluoromethyl)benzyl)-<i>N</i>-methyl-1-(pyridin-3-yl)methanamine (<b>17</b>)</h4><div class="NLM_p last">The target compound was obtained in 62% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.69 (d, <i>J</i> = 2.4 Hz, 1H), 8.62 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 7.94 (td, <i>J</i> = 8.4, 4.0, 1.6 Hz, 1H), 7.62 (dd, <i>J</i> = 6.4, 2.0 Hz, 1H), 7.57–7.52 (m, 1H), 7.39–7.35 (m, 1H), 7.15 (t, <i>J</i> = 18, 9.6 Hz, 1H), 5.26 (s, 1H), 4.44–4.35 (m, 1H), 3.70 (t, <i>J</i> = 16.0 Hz, 2H), 2.23 (s, 3H), 2.07–1.70 (m, 7H), 1.42–1.23 (m, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 164.4, 161.9, 152.1, 150.3, 137.2, 130.1, 128.2–128.0 (m), 126.9–126.7 (m) 126.2, 126.1, 125.1, 123.7, 122.4, 116.5, 116.2, 61.2, 58.4, 51.4 (d, <i>J</i> = 8.0 Hz), 38.8, 33.3, 32.9, 25.3 (d, <i>J</i> = 22.1 Hz), 24.8. ESI-MS (<i>m</i>/<i>z</i>): 449.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-((1-Cyclopropyl-1<i>H</i>-tetrazol-5-yl)(pyridin-3-yl)methyl)-<i>N</i>-(3-(trifluoromethyl)benzyl)cyclopropanamine (<b>18</b>)</h4><div class="NLM_p last">The target compound was obtained in 59% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.44 (d, <i>J</i> = 2.4 Hz, 1H), 8.41 (dd, <i>J</i> = 5.2, 1.6 Hz, 1H), 7.73 (td, <i>J</i> = 7.6, 2.0 Hz, 1H), 7.30 (d, <i>J</i> = 7.6 Hz, 1H), 7.23–7.12 (m, 3.5H), 7.07 (s, 0.5H), 5.34 (s, 1H), 3.86 (d, <i>J</i> = 14.0 Hz, 1H), 3.73 (d, <i>J</i> = 14.0 Hz, 1H), 3.12–3.05 (m, 1H), 2.04–1.97 (m, 1H), 1.15–1.05 (m, 1H), 1.00–0.76 (m, 3H), 0.31–0.20 (m, 2H), 0.04 to −0.09 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 154.3, 150.3, 149.4, 139.9, 138.1, 132.4, 130.7, 128.9, 125.7 (q, <i>J</i> = 14.6 Hz), 124.2 (q, <i>J</i> = 15.2 Hz), 123.6, 58.1, 56.1, 34.7, 28.5, 8.8, 7.7, 7.3, 6.9. ESI-MS (<i>m</i>/<i>z</i>): 415.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-Cyclopropyl-<i>N</i>-((1-cyclopropyl-1<i>H</i>-tetrazol-5-yl)(2-methylpyridin-3-yl)methyl)-1-(3-(trifluoromethyl)phenyl)cyclopropan-1-amine (<b>19</b>)</h4><div id="sec5_19_17_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Step 1: Synthesis of 1-(3-(Trifluoromethyl)phenyl)cyclopropan-1-amine</h5><div class="NLM_p last">Ethylmagnesium bromide (0.7 mL, 2.2 mmol, 3 M in ether) was added to a solution of 3-trifluoromethyl benzonitrile (171 mg, 1.0 mmol) and Ti(O<i>i</i>-Pr)<sub>4</sub> (312 mg, 1.1 mmol) in Et<sub>2</sub>O (5 mL) at −70 °C. The yellow solution was stirred for 10 min. After the solution was warmed to RT (1 h), BF<sub>3</sub> OEt<sub>2</sub> (292 mg, 2.2 mmol) was added. After the mixture was stirred for 1 h, 1 N HCl (3 mL) and ether (15 mL) were added. NaOH (10% aq, 10 mL) was added to the resulting two clear phases, and the mixture was extracted with ether. The combined ether layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by flash column chromatography to furnish the target compound in 63% yield as a colorless oil.</div></div><div id="sec5_19_17_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Step 2: Synthesis of <i>N</i>-Cyclopropyl-1-(3-(trifluoromethyl)phenyl)cyclopropan-1-amine</h5><div class="NLM_p last">This was synthesized via a general procedure used for synthesis of <i>N</i>-benzylamine.</div></div><div id="sec5_19_17_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Step 3</h5><div class="NLM_p last">The target compound was obtained in 52% yield as a colorless liquid using the general procedure for synthesis of tetrazoles. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.39 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 7.47–7.28 (m, 5H), 7.02 (dd, <i>J</i> = 8.0, 4.8 Hz, 1H), 5.92 (s, 1H), 3.18–3.11 (m, 1H), 2.80–2.73 (m, 1H), 2.47 (s, 3H), 1.49–1.41 (m, 1H), 1.37–1.27 (m, 1H), 1.25–1.16 (m, 2H), 1.06–0.85 (m, 4H), 0.68–0.50 (m, 2H), 0.32–0.23 (m, 1H), −0.24 to −0.33 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 156.4, 156.0, 148.0, 142.1, 139.0, 132.7, 130.7, 130.2 (q, <i>J</i> = 130 Hz), 128.7, 125.4 (q, <i>J</i> = 14.8 Hz), 124.2 (q, <i>J</i> = 15.6 Hz), 121.3, 56.6, 48.8, 30.5, 28.1, 21.7, 16.7, 13.0, 10.5, 6.8, 6.7, 6.6. ESI-MS (<i>m</i>/<i>z</i>): 455.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_19_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-Propyl-<i>N</i>-(pyrimidin-5-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)-1-(3-(trifluoromethyl)phenyl)cyclopropan-1-amine (<b>20</b>)</h4><div class="NLM_p last">The target compound was obtained in 49% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.09 (s, 1H), 8.48 (s, 2H), 7.49 (td, <i>J</i> = 7.6, 1.3 Hz, 1H), 7.39 (dd, <i>J</i> = 10.2, 7.8 Hz, 2H), 7.33–7.24 (m, 3H), 7.16 (s, 1H), 6.87 (d, <i>J</i> = 7.9 Hz, 1H), 5.18 (s, 1H), 2.88 (m, 2H), 1.90 (s, 3H), 1.52–1.34 (m, 2H), 1.18–1.08 (m, 1H), 0.95–0.86 (m, 1H), 0.85–0.78 (m, 1H), 0.71 (t, <i>J</i> = 7.3 Hz, 3H), 0.55–0.48 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.4, 157.2, 154.3, 143.6, 135.1, 132.2, 131.9, 131.8, 131.7, 131.0, 129.0, 127.4, 126.6, 124.3 (q, <i>J</i> = 13.1 Hz), 124.0 (q, <i>J</i> = 14.4 Hz), 55.4, 48.3, 45.8, 23.6, 17.6, 17.2, 11.4. ESI-MS (<i>m</i>/<i>z</i>): 494.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_19_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-Propyl-<i>N</i>-(pyridin-3-yl(1-(<i>o</i>-tolyl)-1<i>H</i>-tetrazol-5-yl)methyl)-1-(3-(trifluoromethyl)phenyl)cyclopropan-1-amine (<b>21</b>)</h4><div class="NLM_p last">The target compound was obtained in 56% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.48 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.21 (d, <i>J</i> = 2.4 Hz, 1H), 7.52–7.36 (m, 3H), 7.34–7.26 (m, 3H), 7.24–7.14 (m, 3H), 6.77 (d, <i>J</i> = 7.2 Hz, 1H), 5.14 (s, 1H), 2.94–2.88 (m, 2H), 1.83 (s, 3H), 1.50–1.27 (m, 2H), 1.20–1.12 (m, 1H), 0.95–0.87 (m, 1H), 0.84–0.77 (m, 1H), 0.70–0.60 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 155.4, 150.4, 149.6, 144.4, 136.5, 135.2, 133.1, 132.0, 131.4, 130.4 (q, <i>J</i> = 128 Hz), 128.8, 127.2, 126.5, 124.1 (q, <i>J</i> = 14.8 Hz), 123.6 (q, <i>J</i> = 15.2 Hz), 123.2, 57.1, 48.3, 45.7, 23.6, 17.5, 17.0, 11.3. ESI-MS (<i>m</i>/<i>z</i>): 493.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> General Synthesis of Amide Derivatives<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></h3><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0013.gif" alt="" id="dgr2" /></img>Isocyanide (1 mmol), aromatic aldehyde (1 mmol), <i>N</i>-benzylamine (1 mmol), and phosphinic acid (0.1 mmol) were dissolved in anhydrous toluene (1 mL) under a N<sub>2</sub> atmosphere. The resulting solution was heated at 80 °C for 12 h. Toluene was evaporated under reduced pressure, and the residue was purified by flash chromatography.</div><div class="NLM_p">To a solution of the abovementioned amide (0.5 mmol) in dry tetrahydrofuran was added NaH (0.6 mmol) at 0 °C in one portion; then, after 5 min, MeI (1.0 mmol) was added to the reaction mixture at the same temperature. The resulting mixture was allowed to warm at RT and stirred for 30 min. After completion of reaction monitored by LC–MS, the reaction mixture was quenched with cold H<sub>2</sub>O, extracted with ethyl acetate, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was then concentrated under reduced pressure and purified by flash chromatography.</div><div id="sec5_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-(Cyclopropyl(3-(trifluoromethyl)benzyl)amino)-<i>N</i>-methyl-2-(pyridin-3-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>22</b>)</h4><div class="NLM_p last">The target compound was obtained in 61% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 8.49–8.44 (m, 2H, mixture of rotamers), 8.26 (d, <i>J</i> = 2.3 Hz, 1H, one rotamer), 8.15 (d, <i>J</i> = 2.4 Hz, 1H, one rotamer), 7.63 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H, one rotamer), 7.58 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H, one rotamer), 7.45–7.40 (m, 1H, one rotamer), 7.39–7.31 (m, 4H, mixture of rotamers), 7.25–7.13 (m, 8H, mixture of rotamers), 7.09–7.01 (m, 2H, mixture of rotamers), 6.85 (m, 2H, mixture of rotamers), 6.29 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H, one rotamer), 4.54 (s, 1H, one rotamer), 4.39 (s, 1H, one rotamer), 4.30 (d, <i>J</i> = 14.9 Hz, 1H, one rotamer), 4.24 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.97 (d, <i>J</i> = 14.7 Hz, 1H, one rotamer), 3.95 (d, <i>J</i> = 14.7 Hz, 1H, one rotamer), 3.23 (s, 3H, one rotamer), 3.19 (s, 3H, one rotamer), 2.36–2.28 (m, 2H, mixture of rotamers), 2.27 (s, 3H, one rotamer), 1.50 (s, 3H, one rotamer), 0.36–0.18 (m, 4H, mixture of rotamers), 0.07 to −0.01 (m, 2H, mixture of rotamers), −0.13 to −0.26 (m, 2H, mixture of rotamers). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 171.5, 171.3, 151.2, 151.0, 149.2, 149.1, 142.5, 141.9, 141.2, 141.1, 137.5, 137.1, 135.8, 135.1, 132.7, 132.0, 131.7, 131.6, 131.5, 131.4, 128.7 (d, <i>J</i> = 13.6 Hz), 128.5 (d, <i>J</i> = 12.0 Hz), 128.2, 128.1, 127.2, 126.9, 125.3 (q, <i>J</i> = 14.4 Hz), 125.1 (q, <i>J</i> = 16.0 Hz), 123.5 (q, <i>J</i> = 16.0 Hz), 123.2 (q, <i>J</i> = 14.4 Hz), 123.1, 123.0, 65.0, 63.5, 56.2, 55.5, 36.2, 35.7, 35.0, 17.5, 16.8, 8.9, 8.7, 7.6, 7.3. ESI-MS (<i>m</i>/<i>z</i>): 454.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-(Cyclopropyl(3-(trifluoromethyl)benzyl)amino)-<i>N</i>-methyl-2-(pyrimidin-5-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>23</b>)</h4><div class="NLM_p last">The target compound was obtained in 45% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, MeOD, 1:1 mixture of rotamers): δ 9.04–9.00 (m, 2H, mixture of rotamers), 8.52–8.46 (m, 4H, mixture of rotamers), 7.53–7.22 (m, 11H, mixture of rotamers), 7.18–7.11 (m, 2H, mixture of rotamers), 7.02–6.91 (m, 2H, mixture of rotamers), 6.45 (d, <i>J</i> = 7.8 Hz, 1H, one rotamer), 4.57 (s, 1H, one rotamer), 4.50 (s, 1H, one rotamer), 4.24 (d, <i>J</i> = 14.5 Hz, 1H, one rotamer), 4.18 (d, <i>J</i> = 14.5 Hz, 1H, one rotamer), 4.05–3.98 (m, 2H, mixture of rotamers), 3.25 (s, 3H, one rotamer), 3.21 (s, 3H, one rotamer), 2.38–2.25 (m, 5H, mixture of rotamers), 1.61 (s, 3H, one rotamer), 0.41–0.26 (m, 4H, mixture of rotamers), 0.16–0.05 (m, 2H, mixture of rotamers), −0.07 to −0.15 (m, 1H, one rotamer), −0.16 to −0.24 (m, 1H, one rotamer). <sup>13</sup>C NMR (101 MHz, MeOD, 1:1 mixture of rotamers): δ 171.9, 171.6, 159.1, 158.9, 158.6, 158.5, 143.2, 142.6, 142.1, 136.5 (d, <i>J</i> = 22.0 Hz), 133.5, 133.2, 132.9, 132.8, 132.3, 131.5, 130.3 (d, <i>J</i> = 21.6 Hz), 130.1, 129.8, 129.5, 129.4, 128.6, 128.0, 126.2 (q, <i>J</i> = 15.2 Hz), 125.9 (q, <i>J</i> = 15.2 Hz), 124.8 (q, <i>J</i> = 16.4 Hz), 124.5 (q, <i>J</i> = 16.4 Hz), 64.4, 63.2, 57.4, 56.9, 36.9, 36.8, 36.7, 36.0, 17.7, 17.0, 9.6, 9.3, 8.5, 8.3. ESI-MS (<i>m</i>/<i>z</i>): 455.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(Cyclopropyl(3-((trifluoromethyl)thio)benzyl)amino)-<i>N</i>-methyl-2-(pyridin-3-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>24</b>)</h4><div class="NLM_p last">The target compound was obtained in 59% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 8.50–8.45 (m, 2H, mixture of rotamers), 8.27 (d, <i>J</i> = 2.3 Hz, 1H, one rotamer), 8.17 (d, <i>J</i> = 2.4 Hz, 1H, one rotamer), 7.64 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H, one rotamer), 7.57 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H, one rotamer), 7.50–7.30 (m, 4H, mixture of rotamers), 7.25–7.22 (m, 4H, mixture of rotamers), 7.20–7.11 (m, 5H, mixture of rotamers), 7.10–7.00 (m, 2H, mixture of rotamers), 6.93–6.80 (m, 2H, mixture of rotamers), 6.29 (d, <i>J</i> = 7.8 Hz, 1H, one rotamer), 4.55 (s, 1H, one rotamer), 4.39 (s, 1H, one rotamer), 4.27 (d, <i>J</i> = 14.9 Hz, 1H, one rotamer), 4.22 (d, <i>J</i> = 14.5 Hz, 1H, one rotamer), 3.93 (d, <i>J</i> = 14.7 Hz, 1H, one rotamer), 3.91 (d, <i>J</i> = 14.7 Hz, 1H, one rotamer), 3.24 (s, 3H, one rotamer), 3.20 (s, 3H, one rotamer), 2.36–2.29 (m, 2H, mixture of rotamers), 2.26 (s, 3H, one rotamer), 1.52 (s, 3H, one rotamer), 0.34–0.25 (m, 2H, one rotamer), 0.24–0.16 (m, 2H, one rotamer), 0.06 to −0.02 (m, 2H, mixture of rotamer), −0.14 to −0.28 (m, 2H, mixture of rotamer). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 171.3, 150.4, 150.2, 148.4, 141.1, 138.3, 137.9, 136.5, 136.3, 135.7, 135.1, 134.8, 134.5, 131.7, 131.5, 131.2, 131.0, 130.8, 129.2, 129.0, 128.8, 128.7, 128.4, 128.1, 127.2, 126.9, 123.9, 123.7, 123.3, 123.2, 64.9, 63.4, 56.0, 55.5, 36.3 (d, <i>J</i> = 26.4 Hz), 35.6, 35.0, 17.5, 16.9, 8.8 (d, <i>J</i> = 55.0 Hz), 7.6, 7.2. ESI-MS (<i>m</i>/<i>z</i>): 486.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-(Cyclopropyl(3-((trifluoromethyl)thio)benzyl)amino)-<i>N</i>-methyl-2-(pyrimidin-5-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>25</b>)</h4><div class="NLM_p last">The target compound was obtained in 46% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 9.11–9.08 (m, 2H, mixture of rotamers), 8.50 (s, 2H, one rotamer), 8.48 (s, 2H, one rotamer), 7.51 (dt, <i>J</i> = 7.5, 1.8 Hz, 1H, one rotamer), 7.48–7.38 (m, 2H, mixture of rotamers), 7.36–7.27 (m, 3H, mixture of rotamers), 7.25–7.14 (m, 5H, mixture of rotamers), 7.09–7.00 (m, 2H, mixture of rotamers), 6.89 (td, <i>J</i> = 7.6, 1.7 Hz, 1H, one rotamer), 6.82 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H, one rotamer), 6.33 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H, one rotamer), 4.49 (s, 1H, one rotamer), 4.38 (s, 1H, one rotamer), 4.29 (d, <i>J</i> = 14.8 Hz, 1H, one rotamer), 4.22 (d, <i>J</i> = 14.3 Hz, 1H, one rotamer), 3.92 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.90 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.24 (s, 3H, one rotamer), 3.21 (s, 3H, one rotamer), 2.39–2.28 (m, 2H, mixture of rotamers), 2.22 (s, 3H, one rotamer), 1.59 (s, 3H, one rotamer), 0.37–0.27 (m, 2H, one rotamer), 0.27–0.18 (m, 2H, one rotamer), 0.05 to −0.03 (m, 2H, mixture of rotamers), 0.19 to −0.26 (m, 1H, one rotamer), −0.32 to −0.39 (m, 1H, one rotamer). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 170.3, 170.1, 158.2–157.8 (m), 157.7, 142.4, 141.8, 140.8, 136.4, 136.2, 135.3, 135.2, 135.0, 134.7, 131.7 (d, <i>J</i> = 12.0 Hz), 131.2, 130.9, 130.6, 129.6, 129.4, 129.1 (d, <i>J</i> = 26.0 Hz), 129.0, 128.3, 128.1, 127.3, 127.0, 62.9, 61.6, 56.2, 55.7, 36.3 (d, <i>J</i> = 7.2 Hz), 35.3, 34.5, 17.4, 16.9, 9.1, 8.9, 7.8, 7.5. ESI-MS (<i>m</i>/<i>z</i>): 487.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-(Cyclopropyl(3-(trifluoromethoxy)benzyl)amino)-<i>N</i>-methyl-2-(pyridin-3-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>26</b>)</h4><div class="NLM_p last">The target compound was obtained in 56% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 8.50–8.45 (m, 2H, mixture of rotamers), 8.26 (bs, 1H, one rotamer), 8.15 (bs, 1H, one rotamer), 7.62 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H, one rotamer), 7.56 (dt, <i>J</i> = 7.8, 2.0 Hz, 1H, one rotamer), 7.25–7.22 (m, 2H, mixture of rotamers), 7.22–7.11 (m, 5H, mixture of rotamers), 7.10–6.98 (m, 5H, mixture of rotamers), 6.98–6.81 (m, 5H, mixture of rotamers), 6.32–6.25 (m, 1H, one rotamer), 4.54 (s, 1H, one rotamer), 4.38 (s, 1H, one rotamer), 4.26 (d, <i>J</i> = 15.0 Hz, 1H, one rotamer), 4.20 (d, <i>J</i> = 14.7 Hz, 1H, one rotamer), 3.96 (d, <i>J</i> = 14.8 Hz, 1H, one rotamer), 3.94 (d, <i>J</i> = 14.8 Hz, 1H, one rotamer), 3.23 (s, 3H, one rotamer), 3.19 (s, 3H, one rotamer), 2.40–2.29 (m, 2H, mixture of rotamers), 2.25 (s, 3H, one rotamer), 1.49 (s, 3H, one rotamer), 0.36–0.17 (m, 4H, mixture of rotamers), 0.08 to −0.00 (m, 2H, mixture of rotamers), −0.09 to −0.27 (m, 2H, mixture of rotamers). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 149.1, 148.9, 140.9, 135.5, 135.0, 131.5, 131.4, 129.3 (m), 129.1, 128.8, 128.3, 128.0 (m), 127.2, 126.6 (m), 123.3 (m), 120.7, 119.5, 118.9, 64.6, 63.1, 56.0, 55.4, 36.2, 36.1, 35.5, 34.8, 17.3, 16.7, 8.8, 8.6, 7.1. ESI-MS (<i>m</i>/<i>z</i>): 470.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-(Cyclopropyl(3-(trifluoromethoxy)benzyl)amino)-<i>N</i>-methyl-2-(pyrimidin-5-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>27</b>)</h4><div class="NLM_p last">The target compound was obtained in 43% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 9.09 (bs, 2H, mixture of rotamers), 8.48 (s, 2H, one rotamer), 8.47 (s, 2H, one rotamer), 7.30–7.27 (m, 1H, one rotamer), 7.25–7.23 (m, 1H, one rotamer), 7.22–7.14 (m, 3H, mixture of rotamers), 7.12–6.95 (m, 7H, mixture of rotamers), 6.94–6.84 (m, 2H, mixture of rotamers), 6.83–6.76 (m, 1H, one rotamer), 6.32 (dd, <i>J</i> = 7.8, 1.3 Hz, 1H, one rotamer), 4.48 (s, 1H, one rotamer), 4.37 (s, 1H, one rotamer), 4.27 (d, <i>J</i> = 15.0 Hz, 1H, one rotamer), 4.20 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.96 (d, <i>J</i> = 14.8 Hz, 1H, one rotamer), 3.94 (d, <i>J</i> = 14.8 Hz, 1H, one rotamer), 3.24 (s, 3H, one rotamer), 3.20 (s, 3H, one rotamer), 2.45–2.39 (m, 1H, one rotamer), 2.37–2.32 (m, 1H, one rotamer), 2.22 (s, 3H, one rotamer), 1.57 (s, 3H, one rotamer), 0.41–0.19 (m, 4H, mixture of rotamers), 0.10 to −0.01 (m, 2H, mixture of rotamers), −0.15 to −0.19 (m, 1H, one rotamer), −0.28 to −0.32 (m, 1H, one rotamer). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 170.4, 170.1, 158.0 (m), 157.7, 143.2, 142.6, 140.9, 135.3, 135.2, 131.7, 130.7, 129.6 (d), 129.3, 129.1, 129.0, 128.3, 128.1, 127.3, 127.0, 126.9, 126.6, 121.0, 120.7, 119.6, 119.2, 62.8, 61.5, 56.3, 55.7, 36.3, 35.4, 34.5, 17.4, 16.9, 9.3, 9.0, 7.8, 7.5. ESI-MS (<i>m</i>/<i>z</i>): 471.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-(Cyclopropyl(3-(trifluoromethyl)benzyl)amino)-<i>N</i>-(2-ethylphenyl)-<i>N</i>-methyl-2-(pyridin-3-yl)acetamide (<b>28</b>)</h4><div class="NLM_p last">The target compound was obtained in 53% yield as a colorless liquid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 8.48 (d, <i>J</i> = 4.8 Hz, 2H, mixture of rotamers), 8.24 (s, 1H, one rotamer), 8.19 (s, 1H, one rotamer), 7.73 (s, 1H, one rotamer), 7.63 (d, <i>J</i> = 8.2 Hz, 1H, one rotamer), 7.48–7.27 (m, 7H, mixture of rotamers), 7.27–7.19 (m, 6H, mixture of rotamers), 7.16–7.03 (m, 2H, mixture of rotamers), 6.94–6.81 (m, 2H, mixture of rotamers), 6.28 (d, <i>J</i> = 7.8 Hz, 1H, one rotamer), 4.54 (s, 1H, one rotamer), 4.40 (s, 1H, one rotamer), 4.34 (d, <i>J</i> = 14.8 Hz, 1H, one rotamer), 4.25 (d, <i>J</i> = 14.3 Hz, 1H, one rotamer), 3.95 (s, 1H, one rotamer), 3.93 (s, 1H, one rotamer), 3.25 (s, 3H, one rotamer), 3.22 (s, 3H, one rotamer), 2.69–2.61 (m, 1H, one rotamer), 2.57–2.50 (m, 1H, one rotamer), 2.34–2.24 (m, 2H, mixture of rotamers), 2.05–1.95 (m, 1H, one rotamer), 1.25–1.21 (m, 4H), 0.82 (t, <i>J</i> = 7.6, 1.5 Hz, 3H, one rotamer), 0.38–0.25 (m, 2H, one rotamer), 0.24–0.21 (m, 2H, one rotamer), 0.01 (bs, 2H, mixture of rotamers), −0.189 to −0.24 (m, 2H, mixture of rotamers). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 150.1, 150.01, 148.2, 141.4, 140.8, 140.5, 138.5, 138.1, 132.1, 131.7, 129.5, 129.3, 129.1 (d, <i>J</i> = 22.3 Hz), 128.5 (d), 128.3, 128.0, 127.1, 126.7, 125.4, 125.2, 123.4 (d, <i>J</i> = 28.8 Hz), 64.9, 63.3, 56.1, 55.6, 37.1, 37.0, 35.7, 35.1, 29.8, 23.3, 22.8, 14.4, 14.1, 8.7, 8.5, 7.7, 7.5. ESI-MS (<i>m</i>/<i>z</i>): 468.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 2-(Cyclopropyl(3-(trifluoromethyl)benzyl)amino)-<i>N</i>-(2-ethylphenyl)-<i>N</i>-methyl-2-(pyrimidin-5-yl)acetamide (<b>29</b>)</h4><div class="NLM_p last">The target compound was obtained in 42% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 9.08 (bs, 2H, mixture of rotamers), 8.48 (s, 2H, one rotamer), 8.45 (s, 2H, one rotamer), 7.48 (d, <i>J</i> = 7.3 Hz, 1H, one rotamer), 7.43–7.25 (m, 10H mixture of rotamers), 7.13 (d, <i>J</i> = 7.7 Hz, 1H, one rotamer), 7.05 (t, <i>J</i> = 7.6, 1H, one rotamer), 6.88 (t, <i>J</i> = 7.6 Hz, 1H, one rotamer), 6.83 (d, <i>J</i> = 7.9 Hz, 1H, one rotamer), 6.32 (d, <i>J</i> = 7.8 Hz, 1H, one rotamer), 4.46 (s, 1H, one rotamer), 4.40–4.32 (m, 2H, mixture of rotamers), 4.25 (d, <i>J</i> = 14.4 Hz, 1H, one rotamer), 3.94 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.92 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.25 (s, 3H, one rotamer), 3.22 (s, 3H, one rotamer), 2.68–2.57 (m, 1H, one rotamer), 2.52–2.43 (m, 1H, one rotamer), 2.37–2.27 (m, 2H, mixture of rotamers), 2.09–1.99 (m, 1H, one rotamer), 1.36–1.15 (m, 4H, one rotamer), 0.88 (t, <i>J</i> = 7.6 Hz, 3H, one rotamer), 0.36–0.20 (m, 4H, mixture of rotamers), 0.09 to −0.01 (m, 2H, mixture of rotamers), −0.20 to −0.27 (m, 1H, one rotamer), −0.29 to −0.39 (m, 1H, one rotamer). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 170.4, 170.1, 158.1, 158.0 (d, <i>J</i> = 18.0 Hz), 157.6, 141.7, 141.1 (d, <i>J</i> = 6.8 Hz), 140.9, 140.3, 132.0, 131.7, 130.5, 129.7, 129.5 (d, <i>J</i> = 18.0 Hz), 128.7, 128.5, 128.4, 128.0, 127.20, 126.9, 125.3 (q, <i>J</i> = 14.8 Hz), 125.1 (q, <i>J</i> = 14.8 Hz), 123.8 (q, <i>J</i> = 16.0 Hz), 123.5 (q, <i>J</i> = 17.6 Hz), 62.9, 61.5, 56.3, 55.8, 37.2, 37.1, 35.4, 34.7, 23.3, 22.9, 14.4, 14.3, 9.03, 8.7, 7.9, 7.7. ESI-MS (<i>m</i>/<i>z</i>): 469.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2-(Cyclopropyl(3-(trifluoromethyl)benzyl)amino)-<i>N</i>-methyl-<i>N</i>-phenyl-2-(pyrimidin-5-yl)acetamide (<b>30</b>)</h4><div class="NLM_p last">The target compound was obtained in 45% yield as a colorless liquid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.10 (s, 1H), 8.50 (s, 2H), 7.46 (d, <i>J</i> = 7.5 Hz, 1H), 7.38 (bs, 1H), 7.36–7.29 (m, 2H), 7.26–7.23 (m, 1H), 7.19 (t, <i>J</i> = 8.1 Hz, 2H), 6.72 (s, 2H), 4.53 (s, 1H), 4.16 (d, <i>J</i> = 14.4 Hz, 1H), 3.97 (d, <i>J</i> = 14.5 Hz, 1H), 3.30 (s, 3H), 2.45–2.40 (m, 1H), 0.37–0.31 (m, 1H), 0.28–0.22 (m, 1H), 0.06–0.0 (m, 1H), −0.24 to −0.30 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 169.8, 158.1, 157.7, 142.5, 141.1, 132.0, 130.6, 129.8, 128.7, 128.6, 127.2, 125.3 (q, <i>J</i> = 16.8 Hz), 123.8 (q, <i>J</i> = 16.4 Hz), 61.7, 56.5, 37.6, 34.6, 9.6, 7.2. ESI-MS (<i>m</i>/<i>z</i>): 441.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-(Cyclopropyl(3-(trifluoromethyl)benzyl)amino)-<i>N</i>-methyl-2-(2-methyl-pyrimidin-5-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>31</b>)</h4><div class="NLM_p last">The target compound was obtained in 41% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 8.37 (s, 2H, one rotamer), 8.36 (s, 2H, one rotamer), 7.48–7.44 (m, 1H, one rotamer), 7.41–7.31 (m, 4H, mixture of rotamers), 7.31–7.15 (m, 6H, mixture of rotamers), 7.11–6.99 (m, 2H, mixture of rotamers), 6.92 (td, <i>J</i> = 7.7, 1.4 Hz, 1H, one rotamer), 6.84 (d, <i>J</i> = 8.0 Hz, 1H, one rotamer), 6.37 (d, <i>J</i> = 7.8 Hz, 1H, one rotamer), 4.44 (s, 1H, one rotamer), 4.35 (s, 1H, one rotamer), 4.29 (d, <i>J</i> = 14.8 Hz, 1H, one rotamer), 4.23 (d, <i>J</i> = 14.5 Hz, 1H, one rotamer), 3.96 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.93 (d, <i>J</i> = 14.6 Hz, 1H, one rotamer), 3.23 (s, 3H, one rotamer), 3.20 (s, 3H, one rotamer), 2.70 (d, 6H, mixture of rotamers), 2.37–2.24 (m, 5H, mixture of rotamers), 1.60 (s, 3H, one rotamer), 0.40–0.19 (m, 4H, mixture of rotamers), 0.09 to −0.04 (m, 2H, mixture of rotamers), −0.14 to −0.21 (m, 1H, one rotamer), −0.24 to −0.31 (m, 1H, one rotamer). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 170.6, 170.3, 167.6 (d, <i>J</i> = 14.8 Hz), 158.1, 157.8, 141.9, 141.3, 141.0 (d, <i>J</i> = 14.4 Hz), 135.4, 135.2, 132.0, 131.7 (d, <i>J</i> = 27.2 Hz), 129.0, 128.9, 128.7, 128.4 (d, <i>J</i> = 28.4 Hz), 128.1, 127.3, 127.1 (d, <i>J</i> = 19.2 Hz), 126.1, 125.3 (q, <i>J</i> = 13.6 Hz), 125.1 (q, <i>J</i> = 15.2 Hz), 123.7 (q, <i>J</i> = 15.2 Hz), 123.4 (d, <i>J</i> = 16.4 Hz), 62.7, 61.5, 56.2, 55.7, 36.3 (d, <i>J</i> = 13.2 Hz), 35.5, 34.8, 25.8, 17.4, 17.0, 8.9, 8.7, 7.9, 7.6. ESI-MS (<i>m</i>/<i>z</i>): 469.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-(Cyclopropyl(2-Fluoro-5-(trifluoromethyl)benzyl)amino)-<i>N</i>-methyl-2-(pyridin-3-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>32</b>)</h4><div class="NLM_p last">The target compound was obtained in 46% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 8.48 (m, 2H, mixture of rotamers), 8.32–8.26 (bs, 1H, one rotamer), 8.26–8.21 (bs, 1H, one rotamer), 7.72–7.68 (m, 1H, one rotamer), 7.61–7.57 (m, 1H, one rotamer), 7.45–7.38 (m, 2H, mixture of rotamers), 7.36–7.31 (m, 2H, mixture of rotamers), 7.28–7.26 (m, 1H, one rotamer), 7.24–7.12 (m, 5H, mixture of rotamers), 7.10–7.05 (m, 2H, mixture of rotamers), 7.01 (t, <i>J</i> = 8.8 Hz, 1H, one rotamer), 6.93 (t, <i>J</i> = 8.8 Hz, 1H, one rotamer), 6.86 (t, <i>J</i> = 7.6 Hz, 1H, one rotamer), 6.33 (d, <i>J</i> = 8.0 Hz, 1H), 4.56 (s, 1H, one rotamer), 4.45–4.34 (m, 3H, mixture of rotamers), 4.01 (d, <i>J</i> = 15.1 Hz, 1H, one rotamer), 3.92 (d, <i>J</i> = 14.7 Hz, 1H, one rotamer), 3.24 (d, <i>J</i> = 1.2 Hz, 3H, one rotamer), 3.22 (d, <i>J</i> = 1.2 Hz, 3H, one rotamer), 2.33–2.18 (m, 5H, mixture of rotamers), 1.59 (s, 3H, one rotamer), 0.40–0.18 (m, 4H, mixture of rotamers), 0.10 to −0.06 (m, 2H, mixture of rotamers), 0.11 to −0.19 (m, 1H, one rotamer), −0.19 to −0.30 (m, 1H, one rotamer). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 171.3, 171.0, 151.2, 150.9, 149.3, 149.2, 141.4, 141.2, 137.5, 137.2, 135.8, 135.2, 132.3, 131.7, 131.5, 131.2, 128.8 (d, <i>J</i> = 6.4 Hz), 128.5, 128.2, 127.3, 126.9, 125.7–125.3 (m), 123.0 (d, <i>J</i> = 21.9 Hz), 115.7, 115.5, 115.5, 115.3, 65.0, 63.8, 48.6 (d, <i>J</i> = 8.0 Hz), 48.2 (d <i>J</i> = 9.6 Hz), 36.3, 36.2, 35.8, 35.4, 17.5, 16.9, 8.3, 8.0, 7.8, 7.3. ESI-MS (<i>m</i>/<i>z</i>): 472.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i>-Methyl-2-(propyl(1-(3-(trifluoromethyl)phenyl)cyclopropyl)amino)-2-(pyridin-3-yl)-<i>N</i>-(<i>o</i>-tolyl)acetamide (<b>33</b>)</h4><div class="NLM_p last">The target compound was obtained in 42% yield as a colorless liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 8.46–8.42 (m, 2H, mixture of rotamers), 8.04 (bs, 1H, one rotamer), 8.01 (bs, 1H, one rotamer), 7.51–7.27 (m, 10H, mixture of rotamers), 7.20–6.90 (m, 8H, mixture of rotamers), 6.75 (t, <i>J</i> = 7.6 Hz, 1H, one rotamer), 6.12 (d, <i>J</i> = 7.8 Hz, 1H, one rotamer), 4.57 (s, 1H, one rotamer), 4.29 (s, 1H, one rotamer), 3.16 (s, 3H, one rotamer), 3.12 (s, 3H, one rotamer), 3.01–2.88 (m, 2H, one rotamer), 2.85–2.68 (m, 2H, one rotamer), 2.22 (s, 3H, one rotamer), 1.46–1.34 (m, 4H), 1.41–1.12 (m, 7H, mixture of rotamers), 1.11–0.99 (m, 2H, one rotamer), 0.89–0.81 (m, 2H, one rotamer), 0.65–0.56 (m, 6H, mixture of rotamers). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 1:1 mixture of rotamers): δ 173.1, 172.7, 151.1, 150.9, 148.9, 148.8, 146.4, 146.0, 141.2, 140.9, 137.2, 136.9, 135.9, 134.8, 134.2, 133.1, 131.7, 131.4, 130.6 (d, <i>J</i> = 29.6 Hz), 128.83–128.54 (m), 128.1, 127.2, 126.6, 123.6 (m), 123.0–122.8 (m), 64.0, 63.0, 49.0, 45.6, 45.3, 36.5, 36.3, 31.1, 29.8, 23.7 (d, <i>J</i> = 21.2 Hz), 18.2, 17.6, 16.8, 15.4, 11.4 (d, <i>J</i> = 29.2 Hz). ESI-MS (<i>m</i>/<i>z</i>): 482.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-(Cyclopropyl(3-(trifluoromethyl)benzyl)amino)-1-(piperidin-1-yl)-2-(pyridin-3-yl)ethan-1-one (<b>34</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0014.gif" alt="" id="dgr3" /></img>To a solution of <i>N</i>-(3-(trifluoromethyl)benzyl)cyclopropanamine (200 mg, 0.92 mmol) in trifluoroethanol (2 mL) was added nicotinaldehyde (90 μL, 0.92 mmol), and the solution was stirred for 30 min at 60 °C. The solution was cooled to RT, and TMSCN (0.11 mL, 0.92 mmol) was added. The mixture was stirred at 60 °C for 30 min. The solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography using EtOAc/hexane as the eluent to furnish 2-(cyclopropyl(3-(trifluoromethyl)benzyl)amino)-2-(pyridin-3-yl)acetonitrile as a colorless liquid in 82% yield.</div><div class="NLM_p">To a solution of the abovementioned 2-(cyclopropyl(3-(trifluoromethyl)benzyl)amino)-2-(pyridin-3-yl)acetonitrile (100 mg, 0.3 mmol) in EtOH/H<sub>2</sub>O (3:3) was added NaOH (600 mg, 50 mmol), and the mixture was stirred at 95 °C for 6 h. Progress of the reaction was monitored by HPLC/MS. After completion of the reaction, 6 N HCl was added to pH 7, and the aqueous layer was extracted with EtOAc, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The compound was used for the next reaction without any further purification.</div><div class="NLM_p">To a solution of the abovementioned acid derivative (40 mg, 0.11 mmol) in dry dimethylformamide (2 mL) at 0 °C were added piperidine (12 mg, 13 μL, 0.13 mmol), HATU (52 mg, 0.13 mmol), and <i>i</i>-Pr<sub>2</sub>NEt (39 μL, 0.22 mmol). The reaction mixture was stirred for 15 min at RT, then diluted with ethyl acetate, and washed with water and brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated under vacuum. The residue obtained was purified by flash column chromatography (MeOH/DCM 1:20) to furnish the desired product in 73% yield as a colorless thick liquid.</div><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, MeOD): δ 8.53 (d, <i>J</i> = 2.2 Hz, 1H), 8.46 (dd, <i>J</i> = 4.9, 1.6 Hz, 1H), 7.86 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 7.48 (m, 1H), 7.45–7.39 (m, 4H), 5.07 (s, 1H), 4.13 (d, <i>J</i> = 14.5 Hz, 1H), 3.97 (d, <i>J</i> = 14.5 Hz, 1H), 3.69–3.63 (m, 1H), 3.59–3.54 (m, 1H), 3.39–3.32 (m, 1H), 3.24 (m, 1H), 2.37 (m, 1H), 1.70–1.53 (m, 4H), 1.39 (m, 1H), 1.20–1.11 (m, 1H), 0.44–0.37 (m, 1H), 0.36–0.27 (m, 2H), 0.06 to −0.04 (m, 1H). <sup>13</sup>C NMR (151 MHz, MeOD): δ 170.6, 151.5, 149.5, 143.1, 139.7, 134.5, 133.5, 131.2 (q, <i>J</i> = 128 Hz), 129.8, 126.3 (q, <i>J</i> = 15.6 Hz), 125.0, 124.5 (d, <i>J</i> = 13.2 Hz), 65.1, 57.3, 47.8, 44.1, 35.9, 27.2, 26.8, 25.2, 9.2, 7.6. ESI-MS (<i>m</i>/<i>z</i>): 418.1 [M + H]<sup>+</sup>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02022" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02022?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02022</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">EC<sub>50</sub> values against NF54-luc <i>P. falciparum</i> parasites; EC<sub>50</sub> values associated with cellular heme fractionation; free heme and Hz levels in drug-treated NF54 parasites; whole-genome sequence metrics from Illumina MiSeq (300 bp paired end reads) for the four <b>9</b>-resistant 3D7 clones; CNVs identified in <b>9</b>-resistant 3D7 clones; SNPs observed in <b>9</b>-resistant 3D7 resistant clones; relative rate of kill versus control antimalarials; reduced efficacy of 3-analogues containing 5-Pyr on Dd2 compared to 3D7; snapshots from Integrated Genomics Viewer showing CNVs; and NMR spectra for compounds <b>3–34</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf">jm0c02022_si_001.pdf (5.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_002.csv">jm0c02022_si_002.csv (5.68 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c02022" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph M. Ready</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Texas Southwestern
Medical Center, Dallas, Texas 75390, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1305-9581" title="Orcid link">http://orcid.org/0000-0003-1305-9581</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0b6164786e7b6325796e6a6f724b7e7f78647e7f637c6e787f6e7965256e6f7e"><span class="__cf_email__" data-cfemail="fd97928e988d95d38f989c9984bd88898e928889958a988e89988f93d3989988">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margaret A. Phillips</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Texas Southwestern
Medical Center, Dallas, Texas 75390, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5250-5578" title="Orcid link">http://orcid.org/0000-0001-5250-5578</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#127f736075736077663c627a7b7e7e7b6261526766617d67667a6577616677607c3c777667"><span class="__cf_email__" data-cfemail="d9b4b8abbeb8abbcadf7a9b1b0b5b5b0a9aa99acadaab6acadb1aebcaaadbcabb7f7bcbdac">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aloysus Lawong</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Texas Southwestern
Medical Center, Dallas, Texas 75390, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suraksha Gahalawat</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Texas Southwestern
Medical Center, Dallas, Texas 75390, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Okombo</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josefine Striepen</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomas Yeo</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sachel Mok</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ioanna Deni</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica L. Bridgford</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanspeter Niederstrasser</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Texas Southwestern
Medical Center, Dallas, Texas 75390, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anwu Zhou</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Texas Southwestern
Medical Center, Dallas, Texas 75390, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Posner</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Texas Southwestern
Medical Center, Dallas, Texas 75390, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergio Wittlin</span> - <span class="hlFld-Affiliation affiliation">Swiss
Tropical and Public Health Institute, 4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Basel, 4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Javier Gamo</span> - <span class="hlFld-Affiliation affiliation">Medicines
Development Campus, GlaxoSmithKline, Tres Cantos, 28760 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1854-2882" title="Orcid link">http://orcid.org/0000-0002-1854-2882</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benigno Crespo</span> - <span class="hlFld-Affiliation affiliation">Medicines
Development Campus, GlaxoSmithKline, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alisje Churchyard</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Sciences, Imperial College London, SW7 2AZ South Kensington, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jake Baum</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Sciences, Imperial College London, SW7 2AZ South Kensington, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nimisha Mittal</span> - <span class="hlFld-Affiliation affiliation">Division
of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Winzeler</span> - <span class="hlFld-Affiliation affiliation">Division
of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4049-2113" title="Orcid link">http://orcid.org/0000-0002-4049-2113</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoît Laleu</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture, 1215 Geneva, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7530-2113" title="Orcid link">http://orcid.org/0000-0002-7530-2113</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Palmer</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture, 1215 Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan A. Charman</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drug Candidate Optimisation, Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Fidock</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.L. designed, conducted, and analyzed data from the HTS and performed parasite and cytotox assays on synthesized compounds and kill rate studies; S.G. performed synthetic chemistry; J.O. performed heme binding and heme/Hz quantitation assays in drug-treated parasites; J.S., T.Y., S.M., and I.D. performed resistance selections, WGS, or data analysis; H.N., A.Z., and B.P. contributed to the design and implementation of the HTS; S.W., F.J.G., B.C., A.C., J.B., N.M., and E.W. performed parasite assays related to life-cycle profiling and/or kill rate; B.L. and M.J.P. contributed to chemical triage; S.A.C. supervised ADME studies; D.A.F. supervised heme binding and heme/Hz quantitation assays and resistance selections; J.M.R. supervised the medicinal chemistry program; and M.A.P. supervised the HTS and various biological studies. J.M.R. and M.A.P. were responsible for the overall coordination of the project, and they wrote the paper with help from D.A.F. All authors reviewed the manuscript and verified the integrity of their data.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was funded in part by funds from the United States National Institutes of Health grant, R01AI103947 (to M.A.P.), NIGMS predoctoral training grant GM007062 (to A.L.), R37 AI50234 (to D.A.F.), and by Medicines for Malaria Venture through their assay support network to D.A.F., J.B. (RD-08-2800), and E.W. J.B. also holds an Investigator Award from the Wellcome Trust (100993/Z/13/Z). B.P. acknowledges the support of the HTS Core facility by U. T. Southwestern Medical Center and the State of Texas. M.A.P. and J.M.R. acknowledge the support of the Welch Foundation (I-1257, I-1612). M.A.P. holds the Sam G. Winstead and F. Andrew Bell Distinguished Chair in Biochemistry. S.M. is grateful for the support of the Human Frontier Science Program Long-term Postdoctoral Fellowship LT000976/2016-L.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to acknowledge the use of the PlasmoDB <i>Plasmodium</i> informatics resource as part of the work of this paper. We thank Christian Scheurer for technical assistance with the [<sup>3</sup>H]-hypoxanthine incorporation assay.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">After this paper was published ASAP on February 23, 2021, minor changes were made to Table 6. The corrected version was reposted February 25, 2021.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">MOA</td><td class="NLM_def"><p class="first last">modes of action</p></td></tr><tr><td class="NLM_term">ABS</td><td class="NLM_def"><p class="first last">asexual blood stage parasites</p></td></tr><tr><td class="NLM_term">ACTs</td><td class="NLM_def"><p class="first last">artemisinin-based combination therapy</p></td></tr><tr><td class="NLM_term">CQ</td><td class="NLM_def"><p class="first last">chloroquine</p></td></tr><tr><td class="NLM_term">ART</td><td class="NLM_def"><p class="first last">artemisinin</p></td></tr><tr><td class="NLM_term">ATQ</td><td class="NLM_def"><p class="first last">atovaquone</p></td></tr><tr><td class="NLM_term">MFQ</td><td class="NLM_def"><p class="first last">mefloquine</p></td></tr><tr><td class="NLM_term">LUM</td><td class="NLM_def"><p class="first last">lumefantrine</p></td></tr><tr><td class="NLM_term">PPQ</td><td class="NLM_def"><p class="first last">piperaquine</p></td></tr><tr><td class="NLM_term">WGS</td><td class="NLM_def"><p class="first last">whole genome sequencing</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">Hz</td><td class="NLM_def"><p class="first last">hemozoin</p></td></tr><tr><td class="NLM_term">βH</td><td class="NLM_def"><p class="first last">β-hematin</p></td></tr><tr><td class="NLM_term">DV</td><td class="NLM_def"><p class="first last">digestive vacuole</p></td></tr><tr><td class="NLM_term">BRRoK</td><td class="NLM_def"><p class="first last">bioluminescence relative rate of kill</p></td></tr><tr><td class="NLM_term">DGFA</td><td class="NLM_def"><p class="first last">dual gamete formation assay</p></td></tr><tr><td class="NLM_term"><i>Pf</i>CRT</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> CQ resistance transporter</p></td></tr><tr><td class="NLM_term">CNV</td><td class="NLM_def"><p class="first last">copy number variations</p></td></tr><tr><td class="NLM_term">SNPs</td><td class="NLM_def"><p class="first last">single nucleotide polymorphisms</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 90 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>World Malaria Report</i>. <a href="https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020" class="extLink">https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020</a>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=World+Health+Organization&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyando, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17050</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2017.50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnrdp.2017.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28770814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17050&author=M.+A.+Phillipsauthor=J.+N.+Burrowsauthor=C.+Manyandoauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhisauthor=T.+N.+C.+Wells&title=Malaria&doi=10.1038%2Fnrdp.2017.50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">Phillips Margaret A; Burrows Jeremy N; van Huijsduijnen Rob Hooft; Wells Timothy N C; Manyando Christine; Van Voorhis Wesley C</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17050</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is caused in humans by five species of single-celled eukaryotic Plasmodium parasites (mainly Plasmodium falciparum and Plasmodium vivax) that are transmitted by the bite of Anopheles spp. mosquitoes.  Malaria remains one of the most serious infectious diseases; it threatens nearly half of the world's population and led to hundreds of thousands of deaths in 2015, predominantly among children in Africa.  Malaria is managed through a combination of vector control approaches (such as insecticide spraying and the use of insecticide-treated bed nets) and drugs for both treatment and prevention.  The widespread use of artemisinin-based combination therapies has contributed to substantial declines in the number of malaria-related deaths; however, the emergence of drug resistance threatens to reverse this progress.  Advances in our understanding of the underlying molecular basis of pathogenesis have fuelled the development of new diagnostics, drugs and insecticides.  Several new combination therapies are in clinical development that have efficacy against drug-resistant parasites and the potential to be used in single-dose regimens to improve compliance.  This ambitious programme to eliminate malaria also includes new approaches that could yield malaria vaccines or novel vector control strategies.  However, despite these achievements, a well-coordinated global effort on multiple fronts is needed if malaria elimination is to be achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcfdgTdv0RVI2y4bB4mnvYfW6udTcc2eamhhymUFkzl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D&md5=ec450ab6baef0a6c2b6bd6bac030771a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.50%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DManyando%26aufirst%3DC.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DMalaria%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2017%26volume%3D3%26spage%3D17050%26doi%3D10.1038%2Fnrdp.2017.50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanboonkunupakarn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">The threat of antimalarial drug resistance</span>. <i>Trop Dis Travel Med Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/s40794-016-0027-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs40794-016-0027-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28883954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC1cblvFSqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=10&author=B.+Hanboonkunupakarnauthor=N.+J.+White&title=The+threat+of+antimalarial+drug+resistance&doi=10.1186%2Fs40794-016-0027-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The threat of antimalarial drug resistance</span></div><div class="casAuthors">Hanboonkunupakarn Borimas; Hanboonkunupakarn Borimas; White Nicholas J; White Nicholas J</div><div class="citationInfo"><span class="NLM_cas:title">Tropical diseases, travel medicine and vaccines</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn">2055-0936</span>.
    </div><div class="casAbstract">The battle between man and malaria has continued for thousands of years.  Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria control and jeopardizing renewed hopes for elimination.  As 2016 is the first year under WHO Global Technical Strategy for Malaria 2016-2030, it is a good time to ponder the progress of both sides and plan for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTTkMenqw7Vsyail4HZd-ifW6udTcc2eamhhymUFkzl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cblvFSqsw%253D%253D&md5=6835aad4d563aafe3a09a5895dffc4a0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Fs40794-016-0027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40794-016-0027-8%26sid%3Dliteratum%253Aachs%26aulast%3DHanboonkunupakarn%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520threat%2520of%2520antimalarial%2520drug%2520resistance%26jtitle%3DTrop%2520Dis%2520Travel%2520Med%2520Vaccines%26date%3D2016%26volume%3D2%26spage%3D10%26doi%3D10.1186%2Fs40794-016-0027-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1038/nm.4381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnm.4381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28777791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=917-928&author=B.+Blascoauthor=D.+Leroyauthor=D.+A.+Fidock&title=Antimalarial+drug+resistance%3A+linking+Plasmodium+falciparum+parasite+biology+to+the+clinic&doi=10.1038%2Fnm.4381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic</span></div><div class="casAuthors">Blasco, Benjamin; Leroy, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">917-928</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The global adoption of artemisinin-based combination therapies (ACTs) in the early 2000s heralded a new era in effectively treating drug-resistant Plasmodium falciparum malaria.  However, several Southeast Asian countries have now reported the emergence of parasites that have decreased susceptibility to artemisinin (ART) derivs. and ACT partner drugs, resulting in increasing rates of treatment failures.  Here we review recent advances in understanding how antimalarials act and how resistance develops, and discuss new strategies for effectively combating resistance, optimizing treatment and advancing the global campaign to eliminate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbN71qlYUi97Vg90H21EOLACvtfcHk0lhvKSfxZD9b4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO&md5=832e6fdea00ba5ddc25308c682758eb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm.4381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4381%26sid%3Dliteratum%253Aachs%26aulast%3DBlasco%26aufirst%3DB.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DAntimalarial%2520drug%2520resistance%253A%2520linking%2520Plasmodium%2520falciparum%2520parasite%2520biology%2520to%2520the%2520clinic%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D917%26epage%3D928%26doi%3D10.1038%2Fnm.4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanboonkunupakarn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Advances and roadblocks in the treatment of malaria</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1111/bcp.14474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fbcp.14474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=32656850" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=B.+Hanboonkunupakarnauthor=N.+J.+White&title=Advances+and+roadblocks+in+the+treatment+of+malaria&doi=10.1111%2Fbcp.14474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fbcp.14474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.14474%26sid%3Dliteratum%253Aachs%26aulast%3DHanboonkunupakarn%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DAdvances%2520and%2520roadblocks%2520in%2520the%2520treatment%2520of%2520malaria%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2020%26doi%3D10.1111%2Fbcp.14474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Artemisinin action and resistance in Plasmodium falciparum</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2016.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27289273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=682-696&author=L.+Tilleyauthor=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=S.+A.+Ralphauthor=D.+A.+Fidock&title=Artemisinin+action+and+resistance+in+Plasmodium+falciparum&doi=10.1016%2Fj.pt.2016.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin Action and Resistance in Plasmodium falciparum</span></div><div class="casAuthors">Tilley, Leann; Straimer, Judith; Gnadig, Nina F.; Ralph, Stuart A.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">682-696</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The worldwide use of artemisinin-based combination therapies (ACTs) has contributed in recent years to a substantial redn. in deaths resulting from Plasmodium falciparum malaria.  Resistance to artemisinins, however, has emerged in Southeast Asia.  Clin., resistance is defined as a slower rate of parasite clearance in patients treated with an artemisinin deriv. or an ACT.  These slow clearance rates assoc. with enhanced survival rates of ring-stage parasites briefly exposed in vitro to dihydroartemisinin.  We describe recent progress made in defining the mol. basis of artemisinin resistance, which has identified a primary role for the P. falciparum K13 protein.  Using K13 mutations as mol. markers, epidemiol. studies are now tracking the emergence and spread of artemisinin resistance.  Mechanistic studies suggest potential ways to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTqDTZppoE1bVg90H21EOLACvtfcHk0lhvKSfxZD9b4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D&md5=8a1cb66eab2962ca73ea6d6e2cbf8f21</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DArtemisinin%2520action%2520and%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D682%26epage%3D696%26doi%3D10.1016%2Fj.pt.2016.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Intharabut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingston, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinamon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepniewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin resistance and stage dependency of parasite clearance in falciparum malaria</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>219</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiy673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1093%2Finfdis%2Fjiy673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30657916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlGnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2019&pages=1483-1489&author=B.+Intharabutauthor=H.+W.+Kingstonauthor=K.+Srinamonauthor=E.+A.+Ashleyauthor=M.+Imwongauthor=M.+Dhordaauthor=C.+Woodrowauthor=K.+Stepniewskaauthor=K.+Silamutauthor=N.+P.+J.+Dayauthor=A.+M.+Dondorpauthor=N.+J.+White&title=Artemisinin+resistance+and+stage+dependency+of+parasite+clearance+in+falciparum+malaria&doi=10.1093%2Finfdis%2Fjiy673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance and stage dependency of parasite clearance in falciparum malaria</span></div><div class="casAuthors">Intharabut, Benjamas; Kingston, Hugh W.; Srinamon, Ketsanee; Ashley, Elizabeth A.; Imwong, Mallika; Dhorda, Mehul; Woodrow, Charles; Stepniewska, Kasia; Silamut, Kamolrat; Day, Nicholas P. J.; Dondorp, Arjen M.; White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1483-1489</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Artemisinin resistance in falciparum malaria is assocd. with kelch13 propeller mutations, reduced ring stage parasite killing, and, consequently, slow parasite clearance.  We assessed how parasite age affects parasite clearance in artemisinin resistance.  Developmental stages of Plasmodium falciparum parasites on blood films performed at hospital admission and their kelch13 genotypes were assessed for 816 patients enrolled in a multinational clin. trial of artemisinin combination therapy.  Early changes in parasitemia level (ie, 0-6 h after admission) were detd. mainly by modal stage of asexual parasite development, whereas the subsequent log-linear decline was detd. mainly by kelch13 propeller mutations.  Older circulating parasites on admission were assocd. with more-rapid parasite clearance, particularly in kelch13 mutant infections.  The geometric mean parasite clearance half-life decreased by 11.6% (95% CI 3.4%-19.1%) in kelch13 wild-type infections and by 30% (95% CI 17.8%-40.4%) in kelch13 mutant infections as the mean age of circulating parasites rose from 3 to 21 h.  Conclusion.  Following the start of antimalarial treatment, ongoing parasite sequestration and schizogony both affect initial changes in parasitemia.  The greater dependency of parasite clearance half-life on parasite age in artemisinin resistant infections is consistent with ring stage resistance and consequent parasite clearance by sequestration.  The stage of parasite development should be incorporated in individual assessments of artemisinin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSyKbnArB51rVg90H21EOLACvtfcHk0lhvKSfxZD9b4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlGnu7g%253D&md5=664cad0f1017bb564b1ff8c6243a0e55</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiy673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiy673%26sid%3Dliteratum%253Aachs%26aulast%3DIntharabut%26aufirst%3DB.%26aulast%3DKingston%26aufirst%3DH.%2BW.%26aulast%3DSrinamon%26aufirst%3DK.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DWoodrow%26aufirst%3DC.%26aulast%3DStepniewska%26aufirst%3DK.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DDay%26aufirst%3DN.%2BP.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DArtemisinin%2520resistance%2520and%2520stage%2520dependency%2520of%2520parasite%2520clearance%2520in%2520falciparum%2520malaria%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2019%26volume%3D219%26spage%3D1483%26epage%3D1489%26doi%3D10.1093%2Finfdis%2Fjiy673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span> <span> </span><span class="NLM_article-title">K13, the cytostome, and artemisinin resistance</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2020.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2020.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=32359872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntFCmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2020&pages=533-544&author=S.+C.+Xieauthor=S.+A.+Ralphauthor=L.+Tilley&title=K13%2C+the+cytostome%2C+and+artemisinin+resistance&doi=10.1016%2Fj.pt.2020.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">K13, the Cytostome, and Artemisinin Resistance</span></div><div class="casAuthors">Xie, Stanley C.; Ralph, Stuart A.; Tilley, Leann</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-544</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Artemisinins the frontline antimalarial drug class are compromised by emerging resistance, putting at risk the lives of hundreds of thousands of people each year.  Resistance is assocd. with mutations in a malaria parasite protein, called Kelch 13 (K13).  Recent work suggests that K13 is located at the cytostome (cell mouth) that the parasite uses to take up Hb.  Here we explore the proposal that K13 mutations confer artemisinin resistance by dampening Hb endocytosis.  This model suggests that the resultant decrease in Hb-derived heme reduces artemisinin activation, which is sufficient to enable parasite survival in the early ring stage of infection.  A fuller understanding of the resistance mechanism will underpin efforts to develop alternative antimalarial strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5KtqLFMyUo7Vg90H21EOLACvtfcHk0lihDp2A9lFYQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntFCmt70%253D&md5=8da990185af4ac8437f78e458acdea44</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2020.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2020.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DK13%252C%2520the%2520cytostome%252C%2520and%2520artemisinin%2520resistance%26jtitle%3DTrends%2520Parasitol.%26date%3D2020%26volume%3D36%26spage%3D533%26epage%3D544%26doi%3D10.1016%2Fj.pt.2020.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug resistance: a threat to malaria elimination</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a025619</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a025619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1101%2Fcshperspect.a025619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28289248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisFKqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a025619&author=D.+Menardauthor=A.+Dondorp&title=Antimalarial+drug+resistance%3A+a+threat+to+malaria+elimination&doi=10.1101%2Fcshperspect.a025619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: a threat to malaria elimination</span></div><div class="casAuthors">Menard, Didier; Dondorp, Arjen</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a025619/1-a025619/25</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Increasing antimalarial drug resistance once again threatens effective antimalarial drug treatment, malaria control, and elimination.  Artemisinin combination therapies (ACTs) are first-line treatment for uncomplicated falciparum malaria in all endemic countries, yet partial resistance to artemisinins has emerged in the Greater Mekong Subregion.  Concomitant emergence of partner drug resistance is now causing high ACT treatment failure rates in several areas.  Genetic markers for artemisinin resistance and several of the partner drugs have been established, greatly facilitating surveillance.  Single point mutations in the gene coding for the Kelch propeller domain of the K13 protein strongly correlate with artemisinin resistance.  Novel regimens and strategies using existing antimalarial drugs will be needed until novel compds. can be deployed.  Elimination of artemisinin resistance will imply elimination of all falciparum malaria from the same areas.  In vivax malaria, chloroquine resistance is an increasing problem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAcvouDhij-7Vg90H21EOLACvtfcHk0lihDp2A9lFYQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisFKqurw%253D&md5=77170984fbae885dc193c9e0c9b3f6e5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025619%26sid%3Dliteratum%253Aachs%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DDondorp%26aufirst%3DA.%26atitle%3DAntimalarial%2520drug%2520resistance%253A%2520a%2520threat%2520to%2520malaria%2520elimination%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da025619%26doi%3D10.1101%2Fcshperspect.a025619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Pluijm, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoa, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Nhien, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jittamala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanboonkunupakarn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chutasmit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saelow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runjarern, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaewmok, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waithira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maude, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span> <span> </span><span class="NLM_article-title">Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(19)30391-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2FS1473-3099%2819%2930391-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31345710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVeltb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=952-961&author=R.+W.+van%0Ader+Pluijmauthor=M.+Imwongauthor=N.+H.+Chauauthor=N.+T.+Hoaauthor=N.+T.+Thuy-Nhienauthor=N.+V.+Thanhauthor=P.+Jittamalaauthor=B.+Hanboonkunupakarnauthor=K.+Chutasmitauthor=C.+Saelowauthor=R.+Runjarernauthor=W.+Kaewmokauthor=R.+Tripuraauthor=T.+J.+Petoauthor=S.+Yokauthor=S.+Suonauthor=S.+Srengauthor=S.+Maoauthor=S.+Ounauthor=S.+Yenauthor=C.+Amaratungaauthor=D.+Lekauthor=R.+Huyauthor=M.+Dhordaauthor=K.+Chotivanichauthor=E.+A.+Ashleyauthor=M.+Mukakaauthor=N.+Waithiraauthor=P.+Y.+Cheahauthor=R.+J.+Maudeauthor=R.+Amatoauthor=R.+D.+Pearsonauthor=S.+Gon%C3%A7alvesauthor=C.+G.+Jacobauthor=W.+L.+Hamiltonauthor=R.+M.+Fairhurstauthor=J.+Tarningauthor=M.+Winterbergauthor=D.+P.+Kwiatkowskiauthor=S.+Pukrittayakameeauthor=T.+T.+Hienauthor=N.+P.+Dayauthor=O.+Miottoauthor=N.+J.+Whiteauthor=A.+M.+Dondorp&title=Determinants+of+dihydroartemisinin-piperaquine+treatment+failure+in+Plasmodium+falciparum+malaria+in+Cambodia%2C+Thailand%2C+and+Vietnam%3A+a+prospective+clinical%2C+pharmacological%2C+and+genetic+study&doi=10.1016%2Fs1473-3099%2819%2930391-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study</span></div><div class="casAuthors">van der Pluijm, Rob W.; Imwong, Mallika; Chau, Nguyen Hoang; Hoa, Nhu Thi; Thuy-Nhien, Nguyen Thanh; Thanh, Ngo Viet; Jittamala, Podjanee; Hanboonkunupakarn, Borimas; Chutasmit, Kitipumi; Saelow, Chalermpon; Runjarern, Ratchadaporn; Kaewmok, Weerayuth; Tripura, Rupam; Peto, Thomas J.; Yok, Sovann; Suon, Seila; Sreng, Sokunthea; Mao, Sivanna; Oun, Savuth; Yen, Sovannary; Amaratunga, Chanaki; Lek, Dysoley; Huy, Rekol; Dhorda, Mehul; Chotivanich, Kesinee; Ashley, Elizabeth A.; Mukaka, Mavuto; Waithira, Naomi; Cheah, Phaik Yeong; Maude, Richard J.; Amato, Roberto; Pearson, Richard D.; Goncalves, Sonia; Jacob, Christopher G.; Hamilton, William L.; Fairhurst, Rick M.; Tarning, Joel; Winterberg, Markus; Kwiatkowski, Dominic P.; Pukrittayakamee, Sasithon; Hien, Tran Tinh; Day, Nicholas P. J.; Miotto, Olivo; White, Nicholas J.; Dondorp, Arjen M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">952-961</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The current study is part of a multi-country, open-label, randomised clin. trial (TRACII, 2015-18) evaluating the efficacy, safety, and tolerability of triple artemisinin combination therapies.  A very high rate of treatment failure after treatment with dihydroartemisinin-piperaquine was obsd. in Thailand, Cambodia, and Vietnam.  Patients aged between 2 and 65 years presenting with uncomplicated P falciparum or mixed species malaria at seven sites in Thailand, Cambodia, and Vietnam were randomly assigned to receive dihydroartemisinin-piperaquine with or without mefloquine, as part of the TRACII trial.  The primary outcome was the PCR-cor. efficacy at day 42.  Next-generation sequencing was used to assess the prevalence of mol. markers assocd. with artemisinin resistance (kelch13 mutations, in particular Cys580Tyr) and piperaquine resistance (plasmepsin-2 and plasmepsin-3 amplifications and crt mutations).  Between Sept 28, 2015, and Jan 18, 2018, 539 patients with acute P falciparum malaria were screened for eligibility, 292 were enrolled, and 140 received dihydroartemisinin-piperaquine.  The overall Kaplan-Meier est. of PCR-cor. efficacy of dihydroartemisinin-piperaquine at day 42 was 50·0% (95% CI 41·1-58·3).  Treatment failure was assocd. independently with plasmepsin2/3 amplification status and four mutations in the crt gene (Thr93Ser, His97Tyr, Phe145Ile, and Ile218Phe).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpscjzMhmc-97Vg90H21EOLACvtfcHk0lhGb8Z75GoK1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVeltb%252FJ&md5=e2c8bf51cf812518a46186a49a07894f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2819%2930391-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252819%252930391-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DR.%2BW.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChau%26aufirst%3DN.%2BH.%26aulast%3DHoa%26aufirst%3DN.%2BT.%26aulast%3DThuy-Nhien%26aufirst%3DN.%2BT.%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DHanboonkunupakarn%26aufirst%3DB.%26aulast%3DChutasmit%26aufirst%3DK.%26aulast%3DSaelow%26aufirst%3DC.%26aulast%3DRunjarern%26aufirst%3DR.%26aulast%3DKaewmok%26aufirst%3DW.%26aulast%3DTripura%26aufirst%3DR.%26aulast%3DPeto%26aufirst%3DT.%2BJ.%26aulast%3DYok%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DOun%26aufirst%3DS.%26aulast%3DYen%26aufirst%3DS.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLek%26aufirst%3DD.%26aulast%3DHuy%26aufirst%3DR.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DMukaka%26aufirst%3DM.%26aulast%3DWaithira%26aufirst%3DN.%26aulast%3DCheah%26aufirst%3DP.%2BY.%26aulast%3DMaude%26aufirst%3DR.%2BJ.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DPearson%26aufirst%3DR.%2BD.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DS.%26aulast%3DJacob%26aufirst%3DC.%2BG.%26aulast%3DHamilton%26aufirst%3DW.%2BL.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DWinterberg%26aufirst%3DM.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26atitle%3DDeterminants%2520of%2520dihydroartemisinin-piperaquine%2520treatment%2520failure%2520in%2520Plasmodium%2520falciparum%2520malaria%2520in%2520Cambodia%252C%2520Thailand%252C%2520and%2520Vietnam%253A%2520a%2520prospective%2520clinical%252C%2520pharmacological%252C%2520and%2520genetic%2520study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2019%26volume%3D19%26spage%3D952%26epage%3D961%26doi%3D10.1016%2Fs1473-3099%2819%2930391-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hovlid, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Phenotypic screens in antimalarial drug discovery</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2016.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27247245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVCgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=697-707&author=M.+L.+Hovlidauthor=E.+A.+Winzeler&title=Phenotypic+screens+in+antimalarial+drug+discovery&doi=10.1016%2Fj.pt.2016.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic Screens in Antimalarial Drug Discovery</span></div><div class="casAuthors">Hovlid, Marisa L.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phenotypic high-throughput screens are a valuable tool for identifying new chem. compds. with antimalarial activity.  Traditionally, these screens have focused solely on the symptomatic asexual blood stage of the parasite life cycle; however, to discover new medicines for malaria treatment and prevention, robust screening technologies against other parasite life-cycle stages are required.  This review highlights recent advances and progress toward phenotypic screening methodologies over the past several years, with a focus on exoerythrocytic stage screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXuC2T-aeVzrVg90H21EOLACvtfcHk0lhGb8Z75GoK1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVCgsbs%253D&md5=591911796d7781522d9a890002426396</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DHovlid%26aufirst%3DM.%2BL.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DPhenotypic%2520screens%2520in%2520antimalarial%2520drug%2520discovery%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D697%26epage%3D707%26doi%3D10.1016%2Fj.pt.2016.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherbuin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanneret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug discovery - the path towards eradication</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1017/s0031182013000826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1017%2FS0031182013000826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23863111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=128-139&author=J.+N.+Burrowsauthor=E.+Burlotauthor=B.+Campoauthor=S.+Cherbuinauthor=S.+Jeanneretauthor=D.+Leroyauthor=T.+Spangenbergauthor=D.+Watersonauthor=T.+N.+Wellsauthor=P.+Willis&title=Antimalarial+drug+discovery+-+the+path+towards+eradication&doi=10.1017%2Fs0031182013000826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - the path towards eradication</span></div><div class="casAuthors">Burrows Jeremy N; Burlot Emilie; Campo Brice; Cherbuin Stephanie; Jeanneret Sarah; Leroy Didier; Spangenberg Thomas; Waterson David; Wells Timothy Nc; Willis Paul</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is a disease that still affects a significant proportion of the global human population.  Whilst advances have been made in lowering the numbers of cases and deaths, it is clear that a strategy based solely on disease control year on year, without reducing transmission and ultimately eradicating the parasite, is unsustainable.  This article highlights the current mainstay treatments alongside a selection of emerging new clinical molecules from the portfolio of Medicines for Malaria Venture (MMV) and our partners.  In each case, the key highlights from each research phase are described to demonstrate how these new potential medicines were discovered.  Given the increased focus of the community on eradicating the disease, the strategy for next generation combination medicines that will provide such potential is explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3YKOgrIcfkIvKgEt20y1XfW6udTcc2eb8WWox58RR1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D&md5=24b1b3b746eb152a54f68c090cad3421</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FS0031182013000826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182013000826%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DBurlot%26aufirst%3DE.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DCherbuin%26aufirst%3DS.%26aulast%3DJeanneret%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DSpangenberg%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3DWillis%26aufirst%3DP.%26atitle%3DAntimalarial%2520drug%2520discovery%2520-%2520the%2520path%2520towards%2520eradication%26jtitle%3DParasitology%26date%3D2014%26volume%3D141%26spage%3D128%26epage%3D139%26doi%3D10.1017%2Fs0031182013000826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharia, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Paez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jegla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">Spiroindolones, a potent compound class for the treatment of malaria</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1126/science.1193225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.1193225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=20813948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=1175-1180&author=M.+Rottmannauthor=C.+McNamaraauthor=B.+K.+S.+Yeungauthor=M.+C.+S.+Leeauthor=B.+Zouauthor=B.+Russellauthor=P.+Seitzauthor=D.+M.+Plouffeauthor=N.+V.+Dhariaauthor=J.+Tanauthor=S.+B.+Cohenauthor=K.+R.+Spencerauthor=G.+E.+Gonzalez-Paezauthor=S.+B.+Lakshminarayanaauthor=A.+Gohauthor=R.+Suwanaruskauthor=T.+Jeglaauthor=E.+K.+Schmittauthor=H.-P.+Beckauthor=R.+Brunauthor=F.+Nostenauthor=L.+Reniaauthor=V.+Dartoisauthor=T.+H.+Kellerauthor=D.+A.+Fidockauthor=E.+A.+Winzelerauthor=T.+T.+Diagana&title=Spiroindolones%2C+a+potent+compound+class+for+the+treatment+of+malaria&doi=10.1126%2Fscience.1193225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Spiroindolones, a Potent Compound Class for the Treatment of Malaria</span></div><div class="casAuthors">Rottmann, Matthias; McNamara, Case; Yeung, Bryan K. S.; Lee, Marcus C. S.; Zou, Bin; Russell, Bruce; Seitz, Patrick; Plouffe, David M.; Dharia, Neekesh V.; Tan, Jocelyn; Cohen, Steven B.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Lakshminarayana, Suresh B.; Goh, Anne; Suwanarusk, Rossarin; Jegla, Timothy; Schmitt, Esther K.; Beck, Hans-Peter; Brun, Reto; Nosten, Francois; Renia, Laurent; Dartois, Veronique; Keller, Thomas H.; Fidock, David A.; Winzeler, Elizabeth A.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">5996</span>),
    <span class="NLM_cas:pages">1175-1180</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Recent reports of increased tolerance to artemisinin derivs.-the most recently adopted class of antimalarials-have prompted a need for new treatments.  The spirotetrahydro-β-carbolines, or spiroindolones, are potent drugs that kill the blood stages of Plasmodium falciparum and Plasmodium vivax clin. isolates at low nanomolar concn.  Spiroindolones rapidly inhibit protein synthesis in P. falciparum, an effect that is ablated in parasites bearing nonsynonymous mutations in the gene encoding the P-type cation-transporter ATPase4 (PfATP4).  The optimized spiroindolone NITD609 shows pharmacokinetic properties compatible with once-daily oral dosing and has single-dose efficacy in a rodent malaria model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6O1WaX-1b7Vg90H21EOLACvtfcHk0lhmcwEuVR1ICA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ&md5=239bc9babd5cb5f07e2be38741038e2c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1193225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1193225%26sid%3Dliteratum%253Aachs%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DZou%26aufirst%3DB.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSeitz%26aufirst%3DP.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DSpencer%26aufirst%3DK.%2BR.%26aulast%3DGonzalez-Paez%26aufirst%3DG.%2BE.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DJegla%26aufirst%3DT.%26aulast%3DSchmitt%26aufirst%3DE.%2BK.%26aulast%3DBeck%26aufirst%3DH.-P.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DSpiroindolones%252C%2520a%2520potent%2520compound%2520class%2520for%2520the%2520treatment%2520of%2520malaria%26jtitle%3DScience%26date%3D2010%26volume%3D329%26spage%3D1175%26epage%3D1180%26doi%3D10.1126%2Fscience.1193225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spillman, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K.</span></span> <span> </span><span class="NLM_article-title">Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.chom.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23414762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVOhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=227-237&author=N.+J.+Spillmanauthor=R.+J.+W.+Allenauthor=C.+W.+McNamaraauthor=B.+K.+S.+Yeungauthor=E.+A.+Winzelerauthor=T.+T.+Diaganaauthor=K.+Kirk&title=Na%28%2B%29+regulation+in+the+malaria+parasite+Plasmodium+falciparum+involves+the+cation+ATPase+PfATP4+and+is+a+target+of+the+spiroindolone+antimalarials&doi=10.1016%2Fj.chom.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials</span></div><div class="casAuthors">Spillman, Natalie J.; Allen, Richard J. W.; McNamara, Case W.; Yeung, Bryan K. S.; Winzeler, Elizabeth A.; Diagana, Thierry T.; Kirk, Kiaran</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The malaria parasite Plasmodium falciparum establishes in the host erythrocyte plasma membrane new permeability pathways that mediate nutrient uptake into the infected cell.  These pathways simultaneously allow Na+ influx, causing [Na+] in the infected erythrocyte cytosol to increase to high levels.  The intraerythrocytic parasite itself maintains a low cytosolic [Na+] via unknown mechanisms.  Here the authors present evidence that the intraerythrocytic parasite actively extrudes Na+ against an inward gradient via PfATP4, a parasite plasma membrane protein with sequence similarities to Na+-ATPases of lower eukaryotes.  Mutations in PfATP4 confer resistance to a potent class of antimalarials, the spiroindolones.  Consistent with this, the spiroindolones cause a profound disruption in parasite Na+ homeostasis, which is attenuated in parasites bearing resistance-conferring mutations in PfATP4.  The mutant parasites also show some impairment of Na+ regulation.  Taken together, the authors' results are consistent with PfATP4 being a Na+ efflux ATPase and a target of the spiroindolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTK9LqgiWhDLVg90H21EOLACvtfcHk0lhmcwEuVR1ICA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVOhtL4%253D&md5=415ec48b192ee6ea4681c97695b2b208</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DSpillman%26aufirst%3DN.%2BJ.%26aulast%3DAllen%26aufirst%3DR.%2BJ.%2BW.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DKirk%26aufirst%3DK.%26atitle%3DNa%2528%252B%2529%2520regulation%2520in%2520the%2520malaria%2520parasite%2520Plasmodium%2520falciparum%2520involves%2520the%2520cation%2520ATPase%2520PfATP4%2520and%2520is%2520a%2520target%2520of%2520the%2520spiroindolone%2520antimalarials%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2013%26volume%3D13%26spage%3D227%26epage%3D237%26doi%3D10.1016%2Fj.chom.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: hit to lead optimization of new antimalarial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5116</span>– <span class="NLM_lpage">5130</span>, <span class="refDoi"> DOI: 10.1021/jm2003359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2003359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5116-5130&author=T.+Wuauthor=A.+Nagleauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=A.+Gohauthor=S.+B.+Lakshminarayanaauthor=J.+Wuauthor=H.+Q.+Angauthor=P.+Zengauthor=M.+L.+Kangauthor=W.+Tanauthor=M.+Tanauthor=N.+Yeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=C.+Fischliauthor=R.+Brunauthor=M.+Rottmannauthor=V.+Dartoisauthor=T.+Kellerauthor=T.+Diaganaauthor=E.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+hit+to+lead+optimization+of+new+antimalarial+agents&doi=10.1021%2Fjm2003359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents</span></div><div class="casAuthors">Wu, Tao; Nagle, Advait; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Goh, Anne; Lakshminarayana, Suresh B.; Wu, Jeanette; Ang, Hui Qing; Zeng, Peiting; Kang, Min Low; Tan, William; Tan, Maria; Ye, Nicole; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Fischli, Christoph; Brun, Reto; Rottmann, Matthias; Dartois, Veronique; Keller, Thomas; Diagana, Thierry; Winzeler, Elizabeth; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5116-5130</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from a hit series from a GNF compd. library collection and based on a cell-based proliferation assay of Plasmodium falciparum, a novel imidazolopiperazine scaffold was optimized.  SAR for this series of compds. is discussed, focusing on optimization of cellular potency against wild-type and drug resistant parasites and improvement of physiochem. and pharmacokinetic properties.  The lead compds. in this series showed good potencies in vitro and decent oral exposure levels in vivo.  In a Plasmodium berghei mouse infection model, one lead compd. lowered the parasitemia level by 99.4% after administration of 100 mg/kg single oral dose and prolonged mice survival by an av. of 17.0 days.  The lead compds. were also well-tolerated in the preliminary in vitro toxicity studies and represents an interesting lead for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaD1QipkA-QLVg90H21EOLACvtfcHk0ljKFSQ9rv76kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D&md5=eab02c18fda60302ffbcc581256cf149</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2003359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003359%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAng%26aufirst%3DH.%2BQ.%26aulast%3DZeng%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DM.%2BL.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%26aulast%3DWinzeler%26aufirst%3DE.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520hit%2520to%2520lead%2520optimization%2520of%2520new%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5116%26epage%3D5130%26doi%3D10.1021%2Fjm2003359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonamy, G. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharia, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, T.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froissard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattabongkot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1377</span>, <span class="refDoi"> DOI: 10.1126/science.1211936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.1211936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22096101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=1372-1377&author=S.+Meisterauthor=D.+M.+Plouffeauthor=K.+L.+Kuhenauthor=G.+M.+C.+Bonamyauthor=T.+Wuauthor=S.+W.+Barnesauthor=S.+E.+Boppauthor=R.+Borboaauthor=A.+T.+Brightauthor=J.+Cheauthor=S.+Cohenauthor=N.+V.+Dhariaauthor=K.+Gagaringauthor=M.+Gettayacaminauthor=P.+Gordonauthor=T.+Groesslauthor=N.+Katoauthor=M.+C.+S.+Leeauthor=C.+W.+McNamaraauthor=D.+A.+Fidockauthor=A.+Nagleauthor=T.-g.+Namauthor=W.+Richmondauthor=J.+Rolandauthor=M.+Rottmannauthor=B.+Zhouauthor=P.+Froissardauthor=R.+J.+Glynneauthor=D.+Mazierauthor=J.+Sattabongkotauthor=P.+G.+Schultzauthor=T.+Tuntlandauthor=J.+R.+Walkerauthor=Y.+Zhouauthor=A.+Chatterjeeauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Imaging+of+Plasmodium+liver+stages+to+drive+next-generation+antimalarial+drug+discovery&doi=10.1126%2Fscience.1211936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery</span></div><div class="casAuthors">Meister, Stephan; Plouffe, David M.; Kuhen, Kelli L.; Bonamy, Ghislain M. C.; Wu, Tao; Barnes, S. Whitney; Bopp, Selina E.; Borboa, Rachel; Bright, A. Taylor; Che, Jianwei; Cohen, Steve; Dharia, Neekesh V.; Gagaring, Kerstin; Gettayacamin, Montip; Gordon, Perry; Groessl, Todd; Kato, Nobutaka; Lee, Marcus C. S.; McNamara, Case W.; Fidock, David A.; Nagle, Advait; Nam, Tae-gyu; Richmond, Wendy; Roland, Jason; Rottmann, Matthias; Zhou, Bin; Froissard, Patrick; Glynne, Richard J.; Mazier, Dominique; Sattabongkot, Jetsumon; Schultz, Peter G.; Tuntland, Tove; Walker, John R.; Zhou, Yingyao; Chatterjee, Arnab; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6061</span>),
    <span class="NLM_cas:pages">1372-1377</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Most malaria drug development focuses on parasite stages detected in red blood cells, even though, to achieve eradication, next-generation drugs active against both erythrocytic and exo-erythrocytic forms would be preferable.  We applied a multifactorial approach to a set of >4000 com. available compds. with previously demonstrated blood-stage activity (median inhibitory concn. < 1 micromolar) and identified chem. scaffolds with potent activity against both forms.  From this screen, we identified an imidazolopiperazine scaffold series that was highly enriched among compds. active against Plasmodium liver stages.  The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 mg/kg) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity.  The open-source chem. tools resulting from our effort provide starting points for future drug discovery programs, as well as opportunities for researchers to investigate the biol. of exo-erythrocytic forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyO41naZtcdrVg90H21EOLACvtfcHk0ljKFSQ9rv76kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN&md5=45b2993be36e36eabe1d9280c86c3db2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.1211936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1211936%26sid%3Dliteratum%253Aachs%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DBonamy%26aufirst%3DG.%2BM.%2BC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DBopp%26aufirst%3DS.%2BE.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBright%26aufirst%3DA.%2BT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DNam%26aufirst%3DT.-g.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DFroissard%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DImaging%2520of%2520Plasmodium%2520liver%2520stages%2520to%2520drive%2520next-generation%2520antimalarial%2520drug%2520discovery%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D1372%26epage%3D1377%26doi%3D10.1126%2Fscience.1211936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manary, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, T. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rameh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Targeting Plasmodium PI(4)K to eliminate malaria</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1038/nature12782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnature12782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=24284631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=248-253&author=C.+W.+McNamaraauthor=M.+C.+S.+Leeauthor=C.+S.+Limauthor=S.+H.+Limauthor=J.+Rolandauthor=A.+Nagleauthor=O.+Simonauthor=B.+K.+S.+Yeungauthor=A.+K.+Chatterjeeauthor=S.+L.+McCormackauthor=M.+J.+Manaryauthor=A.-M.+Zeemanauthor=K.+J.+Decheringauthor=T.+R.+S.+Kumarauthor=P.+P.+Henrichauthor=K.+Gagaringauthor=M.+Ibanezauthor=N.+Katoauthor=K.+L.+Kuhenauthor=C.+Fischliauthor=M.+Rottmannauthor=D.+M.+Plouffeauthor=B.+Bursulayaauthor=S.+Meisterauthor=L.+Ramehauthor=J.+Trappeauthor=D.+Haasenauthor=M.+Timmermanauthor=R.+W.+Sauerweinauthor=R.+Suwanaruskauthor=B.+Russellauthor=L.+Reniaauthor=F.+Nostenauthor=D.+C.+Tullyauthor=C.+H.+M.+Kockenauthor=R.+J.+Glynneauthor=C.+Bodenreiderauthor=D.+A.+Fidockauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Targeting+Plasmodium+PI%284%29K+to+eliminate+malaria&doi=10.1038%2Fnature12782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Plasmodium PI(4)K to eliminate malaria</span></div><div class="casAuthors">McNamara, Case W.; Lee, Marcus C. S.; Lim, Chek Shik; Lim, Siau Hoi; Roland, Jason; Nagle, Advait; Simon, Oliver; Yeung, Bryan K. S.; Chatterjee, Arnab K.; McCormack, Susan L.; Manary, Micah J.; Zeeman, Anne-Marie; Dechering, Koen J.; Kumar, T. R. Santha; Henrich, Philipp P.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Fischli, Christoph; Rottmann, Matthias; Plouffe, David M.; Bursulaya, Badry; Meister, Stephan; Rameh, Lucia; Trappe, Joerg; Haasen, Dorothea; Timmerman, Martijn; Sauerwein, Robert W.; Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent; Nosten, Francois; Tully, David C.; Kocken, Clemens H. M.; Glynne, Richard J.; Bodenreider, Christophe; Fidock, David A.; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7479</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Achieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages.  Here the authors identify a lipid kinase, phosphatidylinositol-4-OH kinase (PI(4)K), as the target of imidazopyrazines, a new antimalarial compd. class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host.  Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria models, are active against blood-stage field isolates of the major human pathogens P. falciparum and P. vivax, and inhibit liver-stage hypnozoites in the simian parasite P. cynomolgi.  The authors show that imidazopyrazines exert their effect through inhibitory interaction with the ATP-binding pocket of PI(4)K, altering the intracellular distribution of phosphatidylinositol-4-phosphate.  Collectively, the authors' data define PI(4)K as a key Plasmodium vulnerability, opening up new avenues of target-based discovery to identify drugs with an ideal activity profile for the prevention, treatment and elimination of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTOmMeWluIubVg90H21EOLACvtfcHk0lgby8jAgXnL2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP&md5=9ed8f3e41d257bb4535b4c813abd54cf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature12782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12782%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DO.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DMcCormack%26aufirst%3DS.%2BL.%26aulast%3DManary%26aufirst%3DM.%2BJ.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DKumar%26aufirst%3DT.%2BR.%2BS.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DRameh%26aufirst%3DL.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DTimmerman%26aufirst%3DM.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DTargeting%2520Plasmodium%2520PI%25284%2529K%2520to%2520eliminate%2520malaria%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature12782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Manach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagborough, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakutansky, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanachayangkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witty, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Díaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaad9735</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscitranslmed.aad9735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28446690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaad9735&author=T.+Paquetauthor=C.+Le+Manachauthor=D.+G.+Cabreraauthor=Y.+Younisauthor=P.+P.+Henrichauthor=T.+S.+Abrahamauthor=M.+C.+S.+Leeauthor=R.+Basakauthor=S.+Ghidelli-Disseauthor=M.+J.+Lafuente-Monasterioauthor=M.+Bantscheffauthor=A.+Rueckerauthor=A.+M.+Blagboroughauthor=S.+E.+Zakutanskyauthor=A.-M.+Zeemanauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=J.+Mannilaauthor=J.+Morizziauthor=C.+Scheurerauthor=I.+Angulo-Barturenauthor=M.+S.+Mart%C3%ADnezauthor=S.+Ferrerauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=J.+Readerauthor=M.+Bothaauthor=K.+J.+Decheringauthor=R.+W.+Sauerweinauthor=A.+Tungtaengauthor=P.+Vanachayangkulauthor=C.+S.+Limauthor=J.+Burrowsauthor=M.+J.+Wittyauthor=K.+C.+Marshauthor=C.+Bodenreiderauthor=R.+Rochfordauthor=S.+M.+Solapureauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=C.+Doniniauthor=B.+Campoauthor=L.-M.+Birkholtzauthor=K.+K.+Hansonauthor=G.+Drewesauthor=C.+H.+M.+Kockenauthor=M.+J.+Delvesauthor=D.+Leroyauthor=D.+A.+Fidockauthor=D.+Watersonauthor=L.+J.+Streetauthor=K.+Chibale&title=Antimalarial+efficacy+of+MMV390048%2C+an+inhibitor+of+Plasmodium+phosphatidylinositol+4-kinase&doi=10.1126%2Fscitranslmed.aad9735"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9735%26sid%3Dliteratum%253Aachs%26aulast%3DPaquet%26aufirst%3DT.%26aulast%3DLe%2BManach%26aufirst%3DC.%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DAbraham%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DBasak%26aufirst%3DR.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DBlagborough%26aufirst%3DA.%2BM.%26aulast%3DZakutansky%26aufirst%3DS.%2BE.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DMannila%26aufirst%3DJ.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBotha%26aufirst%3DM.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DVanachayangkul%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DSolapure%26aufirst%3DS.%2BM.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonini%26aufirst%3DC.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26aulast%3DHanson%26aufirst%3DK.%2BK.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAntimalarial%2520efficacy%2520of%2520MMV390048%252C%2520an%2520inhibitor%2520of%2520Plasmodium%2520phosphatidylinositol%25204-kinase%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaad9735%26doi%3D10.1126%2Fscitranslmed.aad9735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godinez-Macias, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribez, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Probing the open global health chemical diversity library for multistage-active starting points for next-generation antimalarials</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjsVOmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=613-628&author=M.+Abrahamauthor=K.+Gagaringauthor=M.+L.+Martinoauthor=M.+Vanaerschotauthor=D.+M.+Plouffeauthor=J.+Callaauthor=K.+P.+Godinez-Maciasauthor=A.+Y.+Duauthor=M.+Wreeauthor=Y.+Antonova-Kochauthor=K.+Eribezauthor=M.+R.+Luthauthor=S.+Ottilieauthor=D.+A.+Fidockauthor=C.+W.+McNamaraauthor=E.+A.+Winzeler&title=Probing+the+open+global+health+chemical+diversity+library+for+multistage-active+starting+points+for+next-generation+antimalarials&doi=10.1021%2Facsinfecdis.9b00482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials</span></div><div class="casAuthors">Abraham, Matthew; Gagaring, Kerstin; Martino, Marisa L.; Vanaerschot, Manu; Plouffe, David M.; Calla, Jaeson; Godinez-Macias, Karla P.; Du, Alan Y.; Wree, Melanie; Antonova-Koch, Yevgeniya; Eribez, Korina; Luth, Madeline R.; Ottilie, Sabine; Fidock, David A.; McNamara, Case W.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-628</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most phenotypic screens aiming to discover new antimalarial chemotypes begin with low cost, high-throughput tests against the asexual blood stage (ABS) of the malaria parasite life cycle.  Compds. active against the ABS are then sequentially tested in more difficult assays that predict whether a compd. has other beneficial attributes.  Although applying this strategy to new chem. libraries may yield new leads, repeated iterations may lead to diminishing returns and the rediscovery of chemotypes hitting well-known targets.  Here, we adopted a different strategy to find starting points, testing ∼70,000 open source small mols. from the Global Health Chem. Diversity Library for activity against the liver stage, mature sexual stage, and asexual blood stage malaria parasites in parallel.  In addn., instead of using an asexual assay that measures accumulated parasite DNA in the presence of compd. (SYBR green), a real time luciferase-dependent parasite viability assay was used that distinguishes slow-acting (delayed death) from fast-acting compds.  Among 382 scaffolds with the activity confirmed by dose response (<10 μM), we discovered 68 novel delayed-death, 84 liver stage, and 68 stage V gametocyte inhibitors as well.  Although 89% of the evaluated compds. had activity in only a single life cycle stage, we discovered six potent (half-maximal inhibitory concn. of <1 μM) multistage scaffolds, including a novel cytochrome bc1 chemotype.  Our data further show the luciferase-based assays have higher sensitivity.  Chemoinformatic anal. of pos. and neg. compds. identified scaffold families with a strong enrichment for activity against specific or multiple stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruhJOTvyVYsLVg90H21EOLACvtfcHk0lgby8jAgXnL2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjsVOmsLY%253D&md5=6ee44448c30e2dff0d6707d8a7ad3d1a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00482%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DMartino%26aufirst%3DM.%2BL.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DCalla%26aufirst%3DJ.%26aulast%3DGodinez-Macias%26aufirst%3DK.%2BP.%26aulast%3DDu%26aufirst%3DA.%2BY.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DEribez%26aufirst%3DK.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DProbing%2520the%2520open%2520global%2520health%2520chemical%2520diversity%2520library%2520for%2520multistage-active%2520starting%2520points%2520for%2520next-generation%2520antimalarials%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D613%26epage%3D628%26doi%3D10.1021%2Facsinfecdis.9b00482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almela, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelièvre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colmenarejo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coterón, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span> <span> </span><span class="NLM_article-title">A New set of chemical starting points with plasmodium falciparum transmission-blocking potential for antimalarial drug discovery</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0135139</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0135139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.pone.0135139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26317851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0135139&author=M.+J.+Almelaauthor=S.+Lozanoauthor=J.+Leli%C3%A8vreauthor=G.+Colmenarejoauthor=J.+M.+Coter%C3%B3nauthor=J.+Rodriguesauthor=C.+Gonzalezauthor=E.+Herreros&title=A+New+set+of+chemical+starting+points+with+plasmodium+falciparum+transmission-blocking+potential+for+antimalarial+drug+discovery&doi=10.1371%2Fjournal.pone.0135139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A new set of chemical starting points with plasmodium falciparum transmission- blocking potential for antimalarial drug discovery</span></div><div class="casAuthors">Almela, Maria Jesus; Lozano, Sonia; Lelievre, Joel; Colmenarejo, Gonzalo; Coteron, Jose Miguel; Rodrigues, Janneth; Gonzalez, Carolina; Herreros, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0135139/1-e0135139/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The discovery of new antimalarials with transmission blocking activity remains a key issue in efforts to control malaria and eventually eradicate the disease.  Recently, high-throughput screening (HTS) assays have been successfully applied to Plasmodium falciparum asexual stages to screen millions of compds., with the identification of thousands of new active mols., some of which are already in clin. phases.  The same approach has now been applied to identify compds. that are active against P. falciparum gametocytes, the parasite stage responsible for transmission.  This study reports screening results for the Tres Cantos Antimalarial Set (TCAMS), of approx. 13,533 mols., against P. falciparum stage V gametocytes.  Secondary confirmation and cytotoxicity assays led to the identification of 98 selective mols. with dual activity against gametocytes and asexual stages.  Hit compds. were chem. clustered and analyzed for appropriate physicochem. properties.  The TCAMS chem. space around the prioritized hits was also studied.  A selection of hit compds. was assessed ex vivo in the std. membrane feeding assay and demonstrated complete block in transmission.  As a result of this effort, new chem. structures not connected to previously described antimalarials have been identified.  This new set of compds. may serve as starting points for future drug discovery programs as well as tool compds. for identifying new modes of action involved in malaria transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEGJRruPhfrVg90H21EOLACvtfcHk0lhyUrPQuvclVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFyrsA%253D%253D&md5=3e90515522f1c9e4261a886445cafe2c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0135139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0135139%26sid%3Dliteratum%253Aachs%26aulast%3DAlmela%26aufirst%3DM.%2BJ.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DCoter%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DHerreros%26aufirst%3DE.%26atitle%3DA%2520New%2520set%2520of%2520chemical%2520starting%2520points%2520with%2520plasmodium%2520falciparum%2520transmission-blocking%2520potential%2520for%2520antimalarial%2520drug%2520discovery%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0135139%26doi%3D10.1371%2Fjournal.pone.0135139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata-Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jado, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaumeau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribez, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taggard, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambachew, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouillier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinás, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Open-source discovery of chemical leads for next-generation chemoprotective antimalarials</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">eaat9446</span>, <span class="refDoi"> DOI: 10.1126/science.aat9446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.aat9446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30523084" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2018&pages=eaat9446&author=Y.+Antonova-Kochauthor=S.+Meisterauthor=M.+Abrahamauthor=M.+R.+Luthauthor=S.+Ottilieauthor=A.+K.+Lukensauthor=T.+Sakata-Katoauthor=M.+Vanaerschotauthor=E.+Owenauthor=J.+C.+Jadoauthor=S.+P.+Maherauthor=J.+Callaauthor=D.+Plouffeauthor=Y.+Zhongauthor=K.+Chenauthor=V.+Chaumeauauthor=A.+J.+Conwayauthor=C.+W.+McNamaraauthor=M.+Ibanezauthor=K.+Gagaringauthor=F.+N.+Serranoauthor=K.+Eribezauthor=C.+M.+Taggardauthor=A.+L.+Cheungauthor=C.+Lincolnauthor=B.+Ambachewauthor=M.+Rouillierauthor=D.+Siegelauthor=F.+Nostenauthor=D.+E.+Kyleauthor=F.-J.+Gamoauthor=Y.+Zhouauthor=M.+Llin%C3%A1sauthor=D.+A.+Fidockauthor=D.+F.+Wirthauthor=J.+Burrowsauthor=B.+Campoauthor=E.+A.+Winzeler&title=Open-source+discovery+of+chemical+leads+for+next-generation+chemoprotective+antimalarials&doi=10.1126%2Fscience.aat9446"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.aat9446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aat9446%26sid%3Dliteratum%253Aachs%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DSakata-Kato%26aufirst%3DT.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DE.%26aulast%3DJado%26aufirst%3DJ.%2BC.%26aulast%3DMaher%26aufirst%3DS.%2BP.%26aulast%3DCalla%26aufirst%3DJ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChaumeau%26aufirst%3DV.%26aulast%3DConway%26aufirst%3DA.%2BJ.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DSerrano%26aufirst%3DF.%2BN.%26aulast%3DEribez%26aufirst%3DK.%26aulast%3DTaggard%26aufirst%3DC.%2BM.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DLincoln%26aufirst%3DC.%26aulast%3DAmbachew%26aufirst%3DB.%26aulast%3DRouillier%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLlin%25C3%25A1s%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DOpen-source%2520discovery%2520of%2520chemical%2520leads%2520for%2520next-generation%2520chemoprotective%2520antimalarials%26jtitle%3DScience%26date%3D2018%26volume%3D362%26spage%3Deaat9446%26doi%3D10.1126%2Fscience.aat9446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carolino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">The antimalarial resistome - finding new drug targets and their modes of action</span>. <i>Curr. Opin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.mib.2020.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.mib.2020.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=32682267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlaju77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2020&pages=49-55&author=K.+Carolinoauthor=E.+A.+Winzeler&title=The+antimalarial+resistome+-+finding+new+drug+targets+and+their+modes+of+action&doi=10.1016%2Fj.mib.2020.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The antimalarial resistome - finding new drug targets and their modes of action</span></div><div class="casAuthors">Carolino, Krypton; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-55</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  To this day, malaria remains a global burden, affecting millions of people, esp. those in sub-Saharan Africa and Asia.  The rise of drug resistance to current antimalarial treatments, including artemisinin-based combination therapies, has made discovering new small mol. compds. with novel modes of action an urgent matter.  The concerted effort to construct enormous compd. libraries and develop high-throughput phenotypic screening assays to find compds. effective at specifically clearing malaria-causing Plasmodium parasites at any stage of the life cycle has provided many antimalarial prospects, but does not indicate their target or mode of action.  Here, we review recent advances in antimalarial drug discovery efforts, focusing on the following 'omics' approaches in mode of action studies: IVIEWGA, CETSA, metabolomic profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89BcN2JrkmLVg90H21EOLACvtfcHk0lhyUrPQuvclVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlaju77I&md5=66b977eedbf79997dbf956b50101c13e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2020.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2020.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DCarolino%26aufirst%3DK.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DThe%2520antimalarial%2520resistome%2520-%2520finding%2520new%2520drug%2520targets%2520and%2520their%2520modes%2520of%2520action%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2020%26volume%3D57%26spage%3D49%26epage%3D55%26doi%3D10.1016%2Fj.mib.2020.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Elucidating mechanisms of drug-resistant Plasmodium falciparum</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2019.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.chom.2019.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31295423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=35-47&author=L.+S.+Rossauthor=D.+A.+Fidock&title=Elucidating+mechanisms+of+drug-resistant+Plasmodium+falciparum&doi=10.1016%2Fj.chom.2019.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum</span></div><div class="casAuthors">Ross, Leila S.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-47</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Intensified treatment and control efforts since the early 2000s have dramatically reduced the burden of Plasmodium falciparum malaria.  However, drug resistance threatens to derail this progress.  In this review, we present four antimalarial resistance case studies that differ in timeline, tech. approaches, mechanisms of action, and categories of resistance: chloroquine, sulfadoxine-pyrimethamine, artemisinin, and piperaquine.  Lessons learned from prior losses of treatment efficacy, drug combinations, and control strategies will help advance mechanistic research into how P. falciparum parasites acquire resistance to current first-line artemisinin-based combination therapies.  Understanding resistance in the clinic and lab. is essential to prolong the effectiveness of current antimalarial drugs and to optimize the pipeline of future medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmX21YbTO1LVg90H21EOLACvtfcHk0lgYiR1cNJgCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FO&md5=801b9192e7b47dc2046a2d03ce9af4f4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2019.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2019.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DL.%2BS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DElucidating%2520mechanisms%2520of%2520drug-resistant%2520Plasmodium%2520falciparum%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2019%26volume%3D26%26spage%3D35%26epage%3D47%26doi%3D10.1016%2Fj.chom.2019.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llanos-Cuentas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casapia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuquiyauri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinojosa, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toovey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arch, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowell, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araeipour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andenmatten, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(18)30309-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2FS1473-3099%2818%2930309-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=29909069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFyqurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=874-883&author=A.+Llanos-Cuentasauthor=M.+Casapiaauthor=R.+Chuquiyauriauthor=J.-C.+Hinojosaauthor=N.+Kerrauthor=M.+Rosarioauthor=S.+Tooveyauthor=R.+H.+Archauthor=M.+A.+Phillipsauthor=F.+D.+Rozenbergauthor=J.+Bathauthor=C.+L.+Ngauthor=A.+N.+Cowellauthor=E.+A.+Winzelerauthor=D.+A.+Fidockauthor=M.+Bakerauthor=J.+J.+M%C3%B6hrleauthor=R.+Hooft+van+Huijsduijnenauthor=N.+Gobeauauthor=N.+Araeipourauthor=N.+Andenmattenauthor=T.+R%C3%BCckleauthor=S.+Duparc&title=Antimalarial+activity+of+single-dose+DSM265%2C+a+novel+plasmodium+dihydroorotate+dehydrogenase+inhibitor%2C+in+patients+with+uncomplicated+Plasmodium+falciparum+or+Plasmodium+vivax+malaria+infection%3A+a+proof-of-concept%2C+open-label%2C+phase+2a+study&doi=10.1016%2Fs1473-3099%2818%2930309-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study</span></div><div class="casAuthors">Llanos-Cuentas, Alejandro; Casapia, Martin; Chuquiyauri, Raul; Hinojosa, Juan-Carlos; Kerr, Nicola; Rosario, Maria; Toovey, Stephen; Arch, Robert H.; Phillips, Margaret A.; Rozenberg, Felix D.; Bath, Jade; Ng, Caroline L.; Cowell, Annie N.; Winzeler, Elizabeth A.; Fidock, David A.; Baker, Mark; Mohrle, Jorg J.; Hooft van Huijsduijnen, Rob; Gobeau, Nathalie; Araeipour, Nada; Andenmatten, Nicole; Ruckle, Thomas; Duparc, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">874-883</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">DSM265 is a novel, long-duration inhibitor of plasmodium dihydroorotate dehydrogenase (DHODH) with excellent selectivity over human DHODH and activity against blood and liver stages of Plasmodium falciparum.  This study aimed to assess the efficacy of DSM265 in patients with P falciparum or Plasmodium vivax malaria infection.  This proof-of-concept, open-label, phase 2a study was conducted at the Asociacio´n Civil Selva Amazo´nica in Iquitos, Peru.  Patients aged 18-70 years, weighing 45-90 kg, who had clin. malaria (P falciparum or P vivax monoinfection) and fever within the previous 24 h were eligible.  Exclusion criteria were clin. or lab. signs of severe malaria, inability to take oral medicine, and use of other antimalarial treatment in the preceding 14 days.  Patients were divided into cohorts of those with P falciparum (cohort a) or P vivax (cohort b) infection.  Two initial cohorts received single oral doses of 400 mg DSM265.  Patients were followed up for efficacy for 28 days and safety for 35 days.  Further cohorts received escalated or de-escalated doses of DSM265, after safety and efficacy assessment of the initial dose.  The primary endpoints were the proportion of patients achieving PCR-adjusted adequate clin. and parasitol. response (ACPR) by day 14 for patients infected with P falciparum and the proportion of patients achieving a crude cure by day 14 for those infected with P vivax.  Cohort success, the criteria for dose escalation, was defined as ACPR (P falciparum) or crude cure (P vivax) in at least 80% of patients in the cohort.  The primary anal. was done in the intention-to-treat population (ITT) and the per-protocol population, and safety analyses were done in all patients who received the study drug.  This study is registered at ClinicalTrials.gov (NCT02123290).  Between Jan 12, 2015, and Dec 2, 2015, 45 Peruvian patients (24 with P falciparum [cohort a] and 21 with P vivax [cohort b] infection) were sequentially enrolled.  For patients with P falciparum malaria in the per-protocol population, all 11 (100%) in the 400 mg group and eight (80%) of ten in the 250 mg group achieved ACPR on day 14.  In the ITT anal., 11 (85%) of 13 in the 400 mg group and eight (73%) of 11 in the 250 mg group achieved ACPR at day 14.  For the patients with P vivax malaria, the primary endpoint was not met.  In the per-protocol anal., none of four patients who had 400 mg, three (50%) of six who had 600 mg, and one (25%) of four who had 800 mg DSM265 achieved crude cure at day 14.  In the ITT anal., none of five in the 400 mg group, three (33%) of nine in the 600 mg group, and one (14%) of seven in the 800 mg group achieved crude cure at day 14.  During the 28-day extended observation of P falciparum patients, a resistance-assocd. mutation in the gene encoding the DSM265 target DHODH was obsd. in two of four recurring patients.  DSM265 was well tolerated.  The most common adverse events were pyrexia (20 [44%] of 45) and headache (18 [40%] of 45), which are both common symptoms of malaria, and no patients had any treatment-related serious adverse events or adverse events leading to study discontinuation.  After a single dose of DSM265, P falciparum parasitemia was rapidly cleared, whereas against P vivax, DSM265 showed less effective clearance kinetics.  Its long duration of action provides the potential to prevent recurrence of P falciparum after treatment with a single dose, which should be further assessed in future combination studies.  The Global Health Innovative Technol. Fund, the Bill & Melinda Gates Foundation, the National Institutes of Health (R01 AI103058), the Wellcome Trust, and the UK Department of International Development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgJbUWoNq8m7Vg90H21EOLACvtfcHk0lgYiR1cNJgCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFyqurnI&md5=05eacd75b07eee65fca20ec28ea3c1c4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930309-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930309-8%26sid%3Dliteratum%253Aachs%26aulast%3DLlanos-Cuentas%26aufirst%3DA.%26aulast%3DCasapia%26aufirst%3DM.%26aulast%3DChuquiyauri%26aufirst%3DR.%26aulast%3DHinojosa%26aufirst%3DJ.-C.%26aulast%3DKerr%26aufirst%3DN.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DToovey%26aufirst%3DS.%26aulast%3DArch%26aufirst%3DR.%2BH.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DRozenberg%26aufirst%3DF.%2BD.%26aulast%3DBath%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DCowell%26aufirst%3DA.%2BN.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DGobeau%26aufirst%3DN.%26aulast%3DAraeipour%26aufirst%3DN.%26aulast%3DAndenmatten%26aufirst%3DN.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DDuparc%26aufirst%3DS.%26atitle%3DAntimalarial%2520activity%2520of%2520single-dose%2520DSM265%252C%2520a%2520novel%2520plasmodium%2520dihydroorotate%2520dehydrogenase%2520inhibitor%252C%2520in%2520patients%2520with%2520uncomplicated%2520Plasmodium%2520falciparum%2520or%2520Plasmodium%2520vivax%2520malaria%2520infection%253A%2520a%2520proof-of-concept%252C%2520open-label%252C%2520phase%25202a%2520study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2018%26volume%3D18%26spage%3D874%26epage%3D883%26doi%3D10.1016%2Fs1473-3099%2818%2930309-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotharius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito, F. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, L. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazaga, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haselden, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louttit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickham, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gahagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirsalis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathhurst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span> <span> </span><span class="NLM_article-title">A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">296ra111</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa6645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscitranslmed.aaa6645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26180101" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=296ra111&author=M.+A.+Phillipsauthor=J.+Lothariusauthor=K.+Marshauthor=J.+Whiteauthor=A.+Dayanauthor=K.+L.+Whiteauthor=J.+W.+Njorogeauthor=F.+El+Mazouniauthor=Y.+Laoauthor=S.+Kokkondaauthor=D.+R.+Tomchickauthor=X.+Dengauthor=T.+Lairdauthor=S.+N.+Bhatiaauthor=S.+Marchauthor=C.+L.+Ngauthor=D.+A.+Fidockauthor=S.+Wittlinauthor=M.+Lafuente-Monasterioauthor=F.+J.+G.+Benitoauthor=L.+M.+S.+Alonsoauthor=M.+S.+Martinezauthor=M.+B.+Jimenez-Diazauthor=S.+F.+Bazagaauthor=I.+Angulo-Barturenauthor=J.+N.+Haseldenauthor=J.+Louttitauthor=Y.+Cuiauthor=A.+Sridharauthor=A.-M.+Zeemanauthor=C.+Kockenauthor=R.+Sauerweinauthor=K.+Decheringauthor=V.+M.+Averyauthor=S.+Duffyauthor=M.+Delvesauthor=R.+Sindenauthor=A.+Rueckerauthor=K.+S.+Wickhamauthor=R.+Rochfordauthor=J.+Gahagenauthor=L.+Iyerauthor=E.+Riccioauthor=J.+Mirsalisauthor=I.+Bathhurstauthor=T.+Rueckleauthor=X.+Dingauthor=B.+Campoauthor=D.+Leroyauthor=M.+J.+Rogersauthor=P.+K.+Rathodauthor=J.+N.+Burrowsauthor=S.+A.+Charman&title=A+long-duration+dihydroorotate+dehydrogenase+inhibitor+%28DSM265%29+for+prevention+and+treatment+of+malaria&doi=10.1126%2Fscitranslmed.aaa6645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa6645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa6645%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DLotharius%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DDayan%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DNjoroge%26aufirst%3DJ.%2BW.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DLao%26aufirst%3DY.%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLaird%26aufirst%3DT.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26aulast%3DMarch%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%26aulast%3DBenito%26aufirst%3DF.%2BJ.%2BG.%26aulast%3DAlonso%26aufirst%3DL.%2BM.%2BS.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DBazaga%26aufirst%3DS.%2BF.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DHaselden%26aufirst%3DJ.%2BN.%26aulast%3DLouttit%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DKocken%26aufirst%3DC.%26aulast%3DSauerwein%26aufirst%3DR.%26aulast%3DDechering%26aufirst%3DK.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DDelves%26aufirst%3DM.%26aulast%3DSinden%26aufirst%3DR.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DWickham%26aufirst%3DK.%2BS.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DGahagen%26aufirst%3DJ.%26aulast%3DIyer%26aufirst%3DL.%26aulast%3DRiccio%26aufirst%3DE.%26aulast%3DMirsalis%26aufirst%3DJ.%26aulast%3DBathhurst%26aufirst%3DI.%26aulast%3DRueckle%26aufirst%3DT.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DA%2520long-duration%2520dihydroorotate%2520dehydrogenase%2520inhibitor%2520%2528DSM265%2529%2520for%2520prevention%2520and%2520treatment%2520of%2520malaria%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D296ra111%26doi%3D10.1126%2Fscitranslmed.aaa6645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paguio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gligorijevic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seudieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roepe, P. D.</span></span> <span> </span><span class="NLM_article-title">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1810</span>, <span class="refDoi"> DOI: 10.1128/aac.48.5.1807-1810.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.48.5.1807-1810.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15105139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1807-1810&author=T.+N.+Bennettauthor=M.+Paguioauthor=B.+Gligorijevicauthor=C.+Seudieuauthor=A.+D.+Kosarauthor=E.+Davidsonauthor=P.+D.+Roepe&title=Novel%2C+rapid%2C+and+inexpensive+cell-based+quantification+of+antimalarial+drug+efficacy&doi=10.1128%2Faac.48.5.1807-1810.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span></div><div class="casAuthors">Bennett, Tyler N.; Paguio, Michelle; Gligorijevic, Bojana; Seudieu, Clement; Kosar, Andrew D.; Davidson, Eugene; Roepe, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1807-1810</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the development of a new SYBR Green I-based plate assay for analyzing the activities of antimalarial drugs against intraerythrocytic Plasmodium falciparum.  This assay is considerably faster, less labor-intensive, and less expensive than conventional radiotracer (e.g., [3H]hypoxanthine and [3H]ethanolamine)-based assays or P. falciparum lactate dehydrogenase activity-based assays.  The assay significantly improves the pace at which antimalarial drug discovery efforts may proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFhAlJNQSwX7Vg90H21EOLACvtfcHk0lhOlSbMptfVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D&md5=87ee6c113aefaf11160624c8fe8c8354</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1807-1810.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1807-1810.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DT.%2BN.%26aulast%3DPaguio%26aufirst%3DM.%26aulast%3DGligorijevic%26aufirst%3DB.%26aulast%3DSeudieu%26aufirst%3DC.%26aulast%3DKosar%26aufirst%3DA.%2BD.%26aulast%3DDavidson%26aufirst%3DE.%26aulast%3DRoepe%26aufirst%3DP.%2BD.%26atitle%3DNovel%252C%2520rapid%252C%2520and%2520inexpensive%2520cell-based%2520quantification%2520of%2520antimalarial%2520drug%2520efficacy%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1807%26epage%3D1810%26doi%3D10.1128%2Faac.48.5.1807-1810.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1128/aac.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+inexpensive+fluorescence-based+technique+for+high-throughput+antimalarial+drug+screening&doi=10.1128%2Faac.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0lhOlSbMptfVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520inexpensive%2520fluorescence-based%2520technique%2520for%2520high-throughput%2520antimalarial%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2Faac.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brideau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikounis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, A.</span></span> <span> </span><span class="NLM_article-title">Improved statistical methods for hit selection in high-throughput screening</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1177/1087057103258285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1177%2F1087057103258285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=14711389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=634-647&author=C.+Brideauauthor=B.+Gunterauthor=B.+Pikounisauthor=A.+Liaw&title=Improved+statistical+methods+for+hit+selection+in+high-throughput+screening&doi=10.1177%2F1087057103258285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Improved statistical methods for hit selection in high-throughput screening</span></div><div class="casAuthors">Brideau Christine; Gunter Bert; Pikounis Bill; Liaw Andy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">634-47</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">High-throughput screening (HTS) plays a central role in modern drug discovery, allowing the rapid screening of large compound collections against a variety of putative drug targets.  HTS is an industrial-scale process, relying on sophisticated automation, control, and state-of-the art detection technologies to organize, test, and measure hundreds of thousands to millions of compounds in nano- to microliter volumes.  Despite this high technology, hit selection for HTS is still typically done using simple data analysis and basic statistical methods.  The authors discuss in this article some shortcomings of these methods and present alternatives based on modern methods of statistical data analysis.  Most important, they describe and show numerous real examples from the biologist-friendly Stat Server HTS application (SHS), a custom-developed software tool built on the commercially available S-PLUS and StatServer statistical analysis and server software.  This system remotely processes HTS data using powerful and sophisticated statistical methodology but insulates users from the technical details by outputting results in a variety of readily interpretable graphs and tables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC1RVHw8Iwb-RS7coPn-RtfW6udTcc2eZwAMtzsEdTCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D&md5=ddc5921a0776f3372c664d6e91446ba3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F1087057103258285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057103258285%26sid%3Dliteratum%253Aachs%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DGunter%26aufirst%3DB.%26aulast%3DPikounis%26aufirst%3DB.%26aulast%3DLiaw%26aufirst%3DA.%26atitle%3DImproved%2520statistical%2520methods%2520for%2520hit%2520selection%2520in%2520high-throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D634%26epage%3D647%26doi%3D10.1177%2F1087057103258285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Y.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1177/1087057107312628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1177%2F1087057107312628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=18216390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=159-167&author=Z.+Wuauthor=D.+Liuauthor=Y.+Sui&title=Quantitative+assessment+of+hit+detection+and+confirmation+in+single+and+duplicate+high-throughput+screenings&doi=10.1177%2F1087057107312628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings</span></div><div class="casAuthors">Wu, Zhijin; Liu, Dongmei; Sui, Yunxia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-167</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The process of identifying active targets (hits) in high-throughput screening (HTS) usually involves 2 steps: first, removing or adjusting for systematic variation in the measurement process so that extreme values represent strong biol. activity instead of systematic biases such as plate effect or edge effect and, second, choosing a meaningful cutoff on the calcd. statistic to declare pos. compds.  Both false-pos. and false-neg. errors are inevitable in this process.  Common control or estn. of error rates is often based on an assumption of normal distribution of the noise.  The error rates in hit detection, esp. false-neg. rates, are hard to verify because in most assays, only compds. selected in primary screening are followed up in confirmation expts.  In this article, the authors take advantage of a quant. HTS expt. in which all compds. are tested 42 times over a wide range of 14 concns. so true positives can be found through a dose-response curve.  Using the activity status defined by dose curve, the authors analyzed the effect of various data-processing procedures on the sensitivity and specificity of hit detection, the control of error rate, and hit confirmation.  A new summary score is proposed and demonstrated to perform well in hit detection and useful in confirmation rate estn.  In general, adjusting for positional effects is beneficial, but a robust test can prevent overadjustment.  Error rates estd. based on normal assumption do not agree with actual error rates, for the tails of noise distribution deviate from normal distribution.  However, false discovery rate based on empirically estd. null distribution is very close to obsd. false discovery proportion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq0POuJ0JE3bVg90H21EOLACvtfcHk0liRWdHV0BFuDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCitbc%253D&md5=bf394a1b7ebbffe88570942775878f80</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1087057107312628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107312628%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DSui%26aufirst%3DY.%26atitle%3DQuantitative%2520assessment%2520of%2520hit%2520detection%2520and%2520confirmation%2520in%2520single%2520and%2520duplicate%2520high-throughput%2520screenings%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D159%26epage%3D167%26doi%3D10.1177%2F1087057107312628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Seven year itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00903</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=36-44&author=J.+B.+Baellauthor=J.+W.+M.+Nissink&title=Seven+year+itch%3A+pan-assay+interference+compounds+%28PAINS%29+in+2017-utility+and+limitations&doi=10.1021%2Facschembio.7b00903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations</span></div><div class="casAuthors">Baell, Jonathan B.; Nissink, J. Willem M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on all necessary considerations for the appropriate use of PAINs filters formulated to process hundreds and thousands of compds. in seconds, and identify PAINS in order to exclude them from further anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocZ7E_j7zxfbVg90H21EOLACvtfcHk0liRWdHV0BFuDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK&md5=051115704137d6a91b8271702c619682</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00903%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DSeven%2520year%2520itch%253A%2520pan-assay%2520interference%2520compounds%2520%2528PAINS%2529%2520in%25202017-utility%2520and%2520limitations%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D36%26epage%3D44%26doi%3D10.1021%2Facschembio.7b00903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/s1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2Fs1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2ebHVWVCbxDpkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2Fs1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">New developments in anti-malarial target candidate and product profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>, <span class="refDoi"> DOI: 10.1186/s12936-016-1675-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+Hooft+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+Mohrleauthor=T.+N.+C.+Wells&title=New+developments+in+anti-malarial+target+candidate+and+product+profiles&doi=10.1186%2Fs12936-016-1675-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0lgNEO8rJllizA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DMohrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DNew%2520developments%2520in%2520anti-malarial%2520target%2520candidate%2520and%2520product%2520profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26doi%3D10.1186%2Fs12936-016-1675-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istvan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magistrado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn-Flynn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata-Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnadig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgof, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lorenzo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cozar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaseichuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">A broad analysis of resistance development in the malaria parasite</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11901</span>, <span class="refDoi"> DOI: 10.1038/ncomms11901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fncomms11901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27301419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaiu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11901&author=V.+C.+Coreyauthor=A.+K.+Lukensauthor=E.+S.+Istvanauthor=M.+C.+S.+Leeauthor=V.+Francoauthor=P.+Magistradoauthor=O.+Coburn-Flynnauthor=T.+Sakata-Katoauthor=O.+Fuchsauthor=N.+F.+Gnadigauthor=G.+Goldgofauthor=M.+Linaresauthor=M.+G.+Gomez-Lorenzoauthor=C.+De+Cozarauthor=M.+J.+Lafuente-Monasterioauthor=S.+Pratsauthor=S.+Meisterauthor=O.+Tanaseichukauthor=M.+Wreeauthor=Y.+Zhouauthor=P.+A.+Willisauthor=F.+J.+Gamoauthor=D.+E.+Goldbergauthor=D.+A.+Fidockauthor=D.+F.+Wirthauthor=E.+A.+Winzeler&title=A+broad+analysis+of+resistance+development+in+the+malaria+parasite&doi=10.1038%2Fncomms11901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A broad analysis of resistance development in the malaria parasite</span></div><div class="casAuthors">Corey, Victoria C.; Lukens, Amanda K.; Istvan, Eva S.; Lee, Marcus C. S.; Franco, Virginia; Magistrado, Pamela; Coburn-Flynn, Olivia; Sakata-Kato, Tomoyo; Fuchs, Olivia; Gnadig, Nina F.; Goldgof, Greg; Linares, Maria; Gomez-Lorenzo, Maria G.; De Cozar, Cristina; Lafuente-Monasterio, Maria Jose; Prats, Sara; Meister, Stephan; Tanaseichuk, Olga; Wree, Melanie; Zhou, Yingyao; Willis, Paul A.; Gamo, Francisco-Javier; Goldberg, Daniel E.; Fidock, David A.; Wirth, Dyann F.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11901</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microbial resistance to chemotherapy has caused countless deaths where malaria is endemic.  Chemotherapy may fail either due to pre-existing resistance or evolution of drug-resistant parasites.  Here we use a diverse set of antimalarial compds. to investigate the acquisition of drug resistance and the degree of cross-resistance against common resistance alleles.  We assess cross-resistance using a set of 15 parasite lines carrying resistance-conferring alleles in pfatp4, cytochrome bc1, pfcarl, pfdhod, pfcrt, pfmdr, pfdhfr, cytoplasmic prolyl tRNA synthetase, or hsp90.  Subsequently, we assess whether resistant parasites can be obtained after several rounds of drug selection.  Twenty-three of the 48 in vitro selections result in resistant parasites, with time to resistance onset ranging 15-300 days.  Our data indicate that pre-existing resistance may not be a major hurdle for novel-target antimalarial candidates, and focusing our attention on fast-killing compds. may result in a slower onset of clin. resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3nnd-3RIUGrVg90H21EOLACvtfcHk0lgNEO8rJllizA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaiu7nE&md5=e9f026d8d5cd9114b4e0aae909cc09f5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fncomms11901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11901%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DV.%2BC.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DIstvan%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DFranco%26aufirst%3DV.%26aulast%3DMagistrado%26aufirst%3DP.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DSakata-Kato%26aufirst%3DT.%26aulast%3DFuchs%26aufirst%3DO.%26aulast%3DGnadig%26aufirst%3DN.%2BF.%26aulast%3DGoldgof%26aufirst%3DG.%26aulast%3DLinares%26aufirst%3DM.%26aulast%3DGomez-Lorenzo%26aufirst%3DM.%2BG.%26aulast%3DDe%2BCozar%26aufirst%3DC.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DPrats%26aufirst%3DS.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DTanaseichuk%26aufirst%3DO.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DA%2520broad%2520analysis%2520of%2520resistance%2520development%2520in%2520the%2520malaria%2520parasite%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11901%26doi%3D10.1038%2Fncomms11901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Cózar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llergo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.-J.</span></span> <span> </span><span class="NLM_article-title">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e30949</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-C%C3%B3zarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.-J.+Gamo&title=P.+falciparum+in+vitro+killing+rates+allow+to+discriminate+between+different+antimalarial+mode-of-action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0lgNEO8rJllizA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-C%25C3%25B3zar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.-J.%26atitle%3DP.%2520falciparum%2520in%2520vitro%2520killing%2520rates%2520allow%2520to%2520discriminate%2520between%2520different%2520antimalarial%2520mode-of-action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ullah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horrocks, P.</span></span> <span> </span><span class="NLM_article-title">A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1093/jac/dkw449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1093%2Fjac%2Fdkw449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27999014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKju7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2017&pages=717-726&author=I.+Ullahauthor=R.+Sharmaauthor=G.+A.+Biaginiauthor=P.+Horrocks&title=A+validated+bioluminescence-based+assay+for+the+rapid+determination+of+the+initial+rate+of+kill+for+discovery+antimalarials&doi=10.1093%2Fjac%2Fdkw449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials</span></div><div class="casAuthors">Ullah, Imran; Sharma, Raman; Biagini, Giancarlo A.; Horrocks, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">717-726</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">1460-2091</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: A future treatment for uncomplicated malaria will contain at least one component that exerts a rapid rate of kill.  We describe here the validation and application of a simple, robust and rapid bioluminescence-based assay for the detn. of the initial rate of kill in intra-erythrocytic asexual stages of Plasmodium falciparum.  Methods: A modification to the concn.-response bioluminescence [here termed bioluminescence relative rate of kill (BRRoK)] assay, utilizing exposure to fold-IC50 concns. (0.33× to 9×), was used to monitor the immediate cytocidal effect of 372 open-source compds. for antimalarial drug discovery available through the Medicines for Malaria Venture Malaria Box.  Results: Antimalarial drugs that exert a rapid cytocidal effect produce a concn.-dependent loss of bioluminescence signal that correlates with available in vitro and in vivo ests. of parasite clearance time and parasite redn. ratio.  Following the measurement of IC50 for the Malaria Box compds. in Dd2luc, the BRRoK assay was used to identify and rank 372 compds. for their initial cytocidal activity.  Fifty-three compds. in the Malaria Box show an initial relative rate of kill greater than that of chloroquine, with 17 of these having an initial relative rate of kill greater than that of dihydroartemisinin.  Conclusions: The BRRoK assay provides a rapid assay format for the estn. of a key pharmacodynamic property of antimalarial drug action.  The simplicity and robustness of the assay suggests it would be readily scalable for high-throughput screening and a crit. decision-making tool for antimalarial drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0QRFxCJcPLrVg90H21EOLACvtfcHk0ljUKdqSzf7KLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKju7nF&md5=1ef989b244532563d5d5398e83a6b3e9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkw449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkw449%26sid%3Dliteratum%253Aachs%26aulast%3DUllah%26aufirst%3DI.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DHorrocks%26aufirst%3DP.%26atitle%3DA%2520validated%2520bioluminescence-based%2520assay%2520for%2520the%2520rapid%2520determination%2520of%2520the%2520initial%2520rate%2520of%2520kill%2520for%2520discovery%2520antimalarials%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2017%26volume%3D72%26spage%3D717%26epage%3D726%26doi%3D10.1093%2Fjac%2Fdkw449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolajczak, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, J. C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H. I.</span></span> <span> </span><span class="NLM_article-title">A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2012.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.molbiopara.2012.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23107927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2012&pages=143-147&author=A.+M.+Vaughanauthor=S.+A.+Mikolajczakauthor=N.+Camargoauthor=V.+Lakshmananauthor=M.+Kennedyauthor=S.+E.+Lindnerauthor=J.+L.+Millerauthor=J.+C.+C.+Humeauthor=S.+H.+I.+Kappe&title=A+transgenic+Plasmodium+falciparum+NF54+strain+that+expresses+GFP-luciferase+throughout+the+parasite+life+cycle&doi=10.1016%2Fj.molbiopara.2012.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle</span></div><div class="casAuthors">Vaughan, Ashley M.; Mikolajczak, Sebastian A.; Camargo, Nelly; Lakshmanan, Viswanathan; Kennedy, Mark; Lindner, Scott E.; Miller, Jessica L.; Hume, Jen C. C.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Plasmodium falciparum is the pathogenic agent of the most lethal of human malarias.  Transgenic P. falciparum parasites expressing luciferase have been created to study drug interventions of both asexual and sexual blood stages but luciferase-expressing mosquito stage and liver stage parasites have not been created which has prevented the easy quantification of mosquito stage development (e.g. for transmission blocking interventions) and liver stage development (for interventions that prevent infection).  To overcome this obstacle, we have created a transgenic P. falciparum NF54 parasite that expresses a GFP-luciferase transgene throughout the life cycle.  Luciferase expression is robust and measurable at all life cycle stages, including midgut oocyst, salivary gland sporozoites and liver stages, where in vivo development is easily measurable using humanized mouse infections in conjunction with an in vivo imaging system.  This parasite reporter strain will accelerate testing of interventions against pre-erythrocytic life cycle stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEiYLv5gv3C7Vg90H21EOLACvtfcHk0ljUKdqSzf7KLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmtbvE&md5=44f08828a763df0fb20a3cf8f110478c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2012.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DA.%2BM.%26aulast%3DMikolajczak%26aufirst%3DS.%2BA.%26aulast%3DCamargo%26aufirst%3DN.%26aulast%3DLakshmanan%26aufirst%3DV.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DLindner%26aufirst%3DS.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DHume%26aufirst%3DJ.%2BC.%2BC.%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26atitle%3DA%2520transgenic%2520Plasmodium%2520falciparum%2520NF54%2520strain%2520that%2520expresses%2520GFP-luciferase%2520throughout%2520the%2520parasite%2520life%2520cycle%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2012%26volume%3D186%26spage%3D143%26epage%3D147%26doi%3D10.1016%2Fj.molbiopara.2012.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giustiniano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirali, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massarotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biletta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiglia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">A Practical synthesis of 5-aroyl-1-aryltetrazoles using an Ugi-like 4-component reaction followed by a biomimetic transamination</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_fpage">4107</span>– <span class="NLM_lpage">4118</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1258273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1055%2Fs-0030-1258273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=4107-4118&author=M.+Giustinianoauthor=T.+Piraliauthor=A.+Massarottiauthor=B.+Bilettaauthor=E.+Novellinoauthor=P.+Campigliaauthor=G.+Sorbaauthor=G.+C.+Tron&title=A+Practical+synthesis+of+5-aroyl-1-aryltetrazoles+using+an+Ugi-like+4-component+reaction+followed+by+a+biomimetic+transamination&doi=10.1055%2Fs-0030-1258273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A practical synthesis of 5-aroyl-1-aryltetrazoles using an Ugi-like 4-component reaction followed by a biomimetic transamination</span></div><div class="casAuthors">Giustiniano, Mariateresa; Pirali, Tracey; Massarotti, Alberto; Biletta, Beatrice; Novellino, Ettore; Campiglia, Pietro; Sorba, Giovanni; Tron, Gian Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4107-4118</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Multicomponent reactions, followed by subsequent transformations, are fascinating tools for the rapid and effective synthesis of mol. scaffolds with potential pharmacol. relevance.  The authors became interested in the prepn. of novel 5-aroyl-1-aryltetrazoles as (1) they still represent challenging structures not easily accessible through the methods described in literature, and (2) the α-ketotetrazolic framework may be considered as a potential bioisostere of the enonic linker of chalcones.  In the present work, a novel, simple, effective and general synthesis for this class of compds. is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq56LDvOFXjLVg90H21EOLACvtfcHk0ljUKdqSzf7KLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslymtg%253D%253D&md5=4c7bc04af602825b4739ae13fd6cf854</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1258273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1258273%26sid%3Dliteratum%253Aachs%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DBiletta%26aufirst%3DB.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiglia%26aufirst%3DP.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DA%2520Practical%2520synthesis%2520of%25205-aroyl-1-aryltetrazoles%2520using%2520an%2520Ugi-like%25204-component%2520reaction%2520followed%2520by%2520a%2520biomimetic%2520transamination%26jtitle%3DSynthesis%26date%3D2010%26spage%3D4107%26epage%3D4118%26doi%3D10.1055%2Fs-0030-1258273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, B.</span></span> <span> </span><span class="NLM_article-title">Catalytic three-component Ugi reaction</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3622</span>– <span class="NLM_lpage">3625</span>, <span class="refDoi"> DOI: 10.1002/anie.200800494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1002%2Fanie.200800494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=18383491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD1c3ns1OrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=3622-3625&author=S.+C.+Panauthor=B.+List&title=Catalytic+three-component+Ugi+reaction&doi=10.1002%2Fanie.200800494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic three-component Ugi reaction</span></div><div class="casAuthors">Pan Subhas Chandra; List Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3622-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFAZsCYMEUNa__Jf7-eMvJfW6udTcc2eYKBAOioBUkKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3ns1OrtA%253D%253D&md5=22d858a74c1acfa22d61b15a19609e2b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fanie.200800494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200800494%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%2BC.%26aulast%3DList%26aufirst%3DB.%26atitle%3DCatalytic%2520three-component%2520Ugi%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2008%26volume%3D47%26spage%3D3622%26epage%3D3625%26doi%3D10.1002%2Fanie.200800494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferdig, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span> <span> </span><span class="NLM_article-title">Dissecting the loci of low-level quinine resistance in malaria parasites</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04035.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fj.1365-2958.2004.04035.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15130119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlKktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=985-997&author=M.+T.+Ferdigauthor=R.+A.+Cooperauthor=J.+Muauthor=B.+Dengauthor=D.+A.+Joyauthor=X.-z.+Suauthor=T.+E.+Wellems&title=Dissecting+the+loci+of+low-level+quinine+resistance+in+malaria+parasites&doi=10.1111%2Fj.1365-2958.2004.04035.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the loci of low-level quinine resistance in malaria parasites</span></div><div class="casAuthors">Ferdig, Michael T.; Cooper, Roland A.; Mu, Jianbing; Deng, Bingbing; Joy, Deirdre A.; Su, Xin-zhuan; Wellems, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">985-997</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Quinine (QN) remains effective against Plasmodium falciparum, but its decreasing efficacy is documented from different continents.  Multiple genes are likely to contribute to the evolution of QN resistance.  To locate genes contributing to QN response variation, the authors have searched a P. falciparum genetic cross for quant. trait loci (QTL).  Results identify additive QTL in segments of chromosomes (Chrs) 13, 7 and 5, and pair-wise effects from two addnl. loci of Chrs 9 and 6 that interact, resp., with the QTL of Chrs 13 and 7.  The mapped segments of Chrs 7 and 5 contain pfcrt, the determinant of chloroquine resistance (CQR), and pfmdr1, a gene known to affect QN responses.  Assocn. of pfcrt with a QTL of QN resistance supports anecdotal evidence for an evolutionary relation between CQR and reduced QN sensitivity.  The Chr 13 segment contains several candidate genes, one of which (pfnhe-1) encodes a putative Na+/H+ exchanger.  A repeat polymorphism in pfnhe-1 shows significant assocn. with low QN response in a collection of P. falciparum strains from Asia, Africa and Central and South America.  Dissection of the genes and modifiers involved in QN response will require exptl. strategies that can evaluate multiple genes from different chromosomes in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6utR13qyRQ7Vg90H21EOLACvtfcHk0liH-FStGQseVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlKktro%253D&md5=1880310764971a757ec3379cfd38378b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04035.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04035.x%26sid%3Dliteratum%253Aachs%26aulast%3DFerdig%26aufirst%3DM.%2BT.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DJoy%26aufirst%3DD.%2BA.%26aulast%3DSu%26aufirst%3DX.-z.%26aulast%3DWellems%26aufirst%3DT.%2BE.%26atitle%3DDissecting%2520the%2520loci%2520of%2520low-level%2520quinine%2520resistance%2520in%2520malaria%2520parasites%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D52%26spage%3D985%26epage%3D997%26doi%3D10.1111%2Fj.1365-2958.2004.04035.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panton, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluzman, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Rosario, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwadz, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker-Jonah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogstad, D. J.</span></span> <span> </span><span class="NLM_article-title">Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1038/345253a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2F345253a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1970614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADyaK3cXksFGksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=1990&pages=253-255&author=T.+E.+Wellemsauthor=L.+J.+Pantonauthor=I.+Y.+Gluzmanauthor=V.+E.+do+Rosarioauthor=R.+W.+Gwadzauthor=A.+Walker-Jonahauthor=D.+J.+Krogstad&title=Chloroquine+resistance+not+linked+to+mdr-like+genes+in+a+Plasmodium+falciparum+cross&doi=10.1038%2F345253a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross</span></div><div class="casAuthors">Wellems, Thomas E.; Panton, Lindsey J.; Gluzman, Ilya Y.; Do Rosario, Virgilio E.; Gwadz, Robert W.; Walker-Jonah, Annie; Krogstad, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6272</span>),
    <span class="NLM_cas:pages">253-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Chloroquine is thought to act against falciparum malaria by accumulating in the acid vesicles of the parasite and interfering with their function.  Parasites resistant to chloroquine expel the drug rapidly in an unaltered form, thereby reducing levels of accumulation in the vesicles.  The discovery that verapamil partially reverses chloroquinone resistance in vitro led to the proposal that efflux may involve an ATP-driven P-glycoprotein pump similar to that in mammalian multidrug-resistant (mdr) tumor cell lines.  Indeed, P. falciparum contains ≥2 mdr-like genes, 1 of which has been suggested to confer the chloroquine resistant (CQR) phenotype.  To det. if either of these genes is linked to chloroquine resistance, a genetic cross between CQR and chloroquine-susceptible clones of P. falciparum was performed.  Examn. of 16 independent recombinant progeny indicated that the rapid efflux phenotype is controlled by a single gene or a closely linked group of genes.  But there was no linkage between the rapid efflux, CQR phenotype, and either of the mdr-like P. falciparum genes or amplification of those genes.  These data indicate that the genetic locus governing chloroquine efflux and resistance is independent of the known mdr-like genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOs02xXBAdbVg90H21EOLACvtfcHk0liH-FStGQseVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFGksrY%253D&md5=9d48bc57a7f172bf87985167be16529a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2F345253a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F345253a0%26sid%3Dliteratum%253Aachs%26aulast%3DWellems%26aufirst%3DT.%2BE.%26aulast%3DPanton%26aufirst%3DL.%2BJ.%26aulast%3DGluzman%26aufirst%3DI.%2BY.%26aulast%3Ddo%2BRosario%26aufirst%3DV.%2BE.%26aulast%3DGwadz%26aufirst%3DR.%2BW.%26aulast%3DWalker-Jonah%26aufirst%3DA.%26aulast%3DKrogstad%26aufirst%3DD.%2BJ.%26atitle%3DChloroquine%2520resistance%2520not%2520linked%2520to%2520mdr-like%2520genes%2520in%2520a%2520Plasmodium%2520falciparum%2520cross%26jtitle%3DNature%26date%3D1990%26volume%3D345%26spage%3D253%26epage%3D255%26doi%3D10.1038%2F345253a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lorenzo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span> <span> </span><span class="NLM_article-title">Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">441</span>, <span class="refDoi"> DOI: 10.1186/s12936-015-0962-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-015-0962-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26542470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=441&author=M.+Linaresauthor=S.+Vieraauthor=B.+Crespoauthor=V.+Francoauthor=M.+G.+Gomez-Lorenzoauthor=M.+B.+Jimenez-Diazauthor=I.+Angulo-Barturenauthor=L.+M.+Sanzauthor=F.+J.+Gamo&title=Identifying+rapidly+parasiticidal+anti-malarial+drugs+using+a+simple+and+reliable+in+vitro+parasite+viability+fast+assay&doi=10.1186%2Fs12936-015-0962-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay</span></div><div class="casAuthors">Linares, Maria; Viera, Sara; Crespo, Benigno; Franco, Virginia; Gomez-Lorenzo, Maria G.; Jimenez-Diaz, Maria Belen; Angulo-Barturen, Inigo; Sanz, Laura Maria; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">441/1-441/8</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The emergence of Plasmodium falciparum resistance to artemisinins threatens to undermine the effectiveness of artemisinin-based combination anti-malarial therapy.  Developing suitable drugs to replace artemisinins requires the identification of new compds. that display rapid parasite killing kinetics.  However, no current methods fully meet the requirements to screen large compd. libraries for candidates with such properties.  This study describes the development and validation of an in vitro parasite viability fast assay for identifying rapidly parasiticidal anti-malarial drugs.  Methods: Parasite killing kinetics were detd. by first culturing unlabeled erythrocytes with P. falciparum in the presence of anti-malarial drugs for 24 or 48 h.  After removing the drug, samples were added to erythrocytes prelabeled with intracellular dye to allow their subsequent identification.  The ability of viable parasites to re-establish infection in labeled erythrocytes could then be detected by two-color flow cytometry after tagging of parasite DNA.  Thus, double-stained erythrocytes (with the pre-labeled intracellular dye and the parasite DNA dye) result only after establishment of new infections by surviving parasites.  The capacity of the test anti-malarial drugs to eliminate viable parasites within 24 or 48 h could, therefore, be detd.  Results: The parasite viability fast assay could be completed within 48 h following drug treatment and distinguished between rapidly parasiticidal anti-malarial drugs vs. those acting more slowly.  The assay was validated against ten std. anti-malarial agents with known properties and results correlated well with established methods.  An abbreviated assay, suitable for adaptation to medium-high throughput screening, was validated and applied against a set of 20 compds. retrieved from the publically available Medicines for Malaria Venture 'Malaria Box'.  Conclusion: The quantification of new infections to det. parasite viability offers important advantages over existing methods, and is amenable to medium-high throughput screening.  In particular, the parasite viability fast assay allows discrimination of rapidly parasiticidal anti-malarial candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKa5S_QxclMbVg90H21EOLACvtfcHk0liH-FStGQseVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVamsQ%253D%253D&md5=d40ccaff6ca43c12627fdfe5db7a1d49</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-0962-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-0962-2%26sid%3Dliteratum%253Aachs%26aulast%3DLinares%26aufirst%3DM.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DFranco%26aufirst%3DV.%26aulast%3DGomez-Lorenzo%26aufirst%3DM.%2BG.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26atitle%3DIdentifying%2520rapidly%2520parasiticidal%2520anti-malarial%2520drugs%2520using%2520a%2520simple%2520and%2520reliable%2520in%2520vitro%2520parasite%2520viability%2520fast%2520assay%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26spage%3D441%26doi%3D10.1186%2Fs12936-015-0962-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span> <span> </span><span class="NLM_article-title">The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e1001169</span>, <span class="refDoi"> DOI: 10.1371/journal.pmed.1001169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.pmed.1001169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22363211" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=e1001169&author=M.+Delvesauthor=D.+Plouffeauthor=C.+Scheurerauthor=S.+Meisterauthor=S.+Wittlinauthor=E.+A.+Winzelerauthor=R.+E.+Sindenauthor=D.+Leroy&title=The+activities+of+current+antimalarial+drugs+on+the+life+cycle+stages+of+Plasmodium%3A+a+comparative+study+with+human+and+rodent+parasites&doi=10.1371%2Fjournal.pmed.1001169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.1001169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.1001169%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DLeroy%26aufirst%3DD.%26atitle%3DThe%2520activities%2520of%2520current%2520antimalarial%2520drugs%2520on%2520the%2520life%2520cycle%2520stages%2520of%2520Plasmodium%253A%2520a%2520comparative%2520study%2520with%2520human%2520and%2520rodent%2520parasites%26jtitle%3DPLoS%2520Med.%26date%3D2012%26volume%3D9%26spage%3De1001169%26doi%3D10.1371%2Fjournal.pmed.1001169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehane, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">PfCRT and its role in antimalarial drug resistance</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2012.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2012.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23020971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCqsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=504-514&author=A.+Eckerauthor=A.+M.+Lehaneauthor=J.+Clainauthor=D.+A.+Fidock&title=PfCRT+and+its+role+in+antimalarial+drug+resistance&doi=10.1016%2Fj.pt.2012.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">PfCRT and its role in antimalarial drug resistance</span></div><div class="casAuthors">Ecker, Andrea; Lehane, Adele M.; Clain, Jerome; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">504-514</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Plasmodium falciparum resistance to chloroquine, the former gold std. antimalarial drug, is mediated primarily by mutant forms of the chloroquine resistance transporter (PfCRT).  These mutations impart upon PfCRT the ability to efflux chloroquine from the intracellular digestive vacuole, the site of drug action.  Recent studies reveal that PfCRT variants can also affect parasite fitness, protect immature gametocytes against chloroquine action, and alter P. falciparum susceptibility to current first-line therapies.  These results highlight the need to be vigilant in screening for the appearance of novel pfcrt alleles that could contribute to new multi-drug resistance phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJYBQpU1odbVg90H21EOLACvtfcHk0ljeNOR1Jlp0vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCqsrnF&md5=c3875a84466125ca660ba11ae38026b3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2012.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2012.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DEcker%26aufirst%3DA.%26aulast%3DLehane%26aufirst%3DA.%2BM.%26aulast%3DClain%26aufirst%3DJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DPfCRT%2520and%2520its%2520role%2520in%2520antimalarial%2520drug%2520resistance%26jtitle%3DTrends%2520Parasitol.%26date%3D2012%26volume%3D28%26spage%3D504%26epage%3D514%26doi%3D10.1016%2Fj.pt.2012.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicht, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erramilli, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okombo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendome, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenah, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacometti, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roepe, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kossiakoff, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancia, F.</span></span> <span> </span><span class="NLM_article-title">Structure and drug resistance of the Plasmodium falciparum transporter PfCRT</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>576</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1795-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fs41586-019-1795-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31776516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1OitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=2019&pages=315-320&author=J.+Kimauthor=Y.+Z.+Tanauthor=K.+J.+Wichtauthor=S.+K.+Erramilliauthor=S.+K.+Dhingraauthor=J.+Okomboauthor=J.+Vendomeauthor=L.+M.+Hagenahauthor=S.+I.+Giacomettiauthor=A.+L.+Warrenauthor=K.+Nosolauthor=P.+D.+Roepeauthor=C.+S.+Potterauthor=B.+Carragherauthor=A.+A.+Kossiakoffauthor=M.+Quickauthor=D.+A.+Fidockauthor=F.+Mancia&title=Structure+and+drug+resistance+of+the+Plasmodium+falciparum+transporter+PfCRT&doi=10.1038%2Fs41586-019-1795-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and drug resistance of the Plasmodium falciparum transporter PfCRT</span></div><div class="casAuthors">Kim, Jonathan; Tan, Yong Zi; Wicht, Kathryn J.; Erramilli, Satchal K.; Dhingra, Satish K.; Okombo, John; Vendome, Jeremie; Hagenah, Laura M.; Giacometti, Sabrina I.; Warren, Audrey L.; Nosol, Kamil; Roepe, Paul D.; Potter, Clinton S.; Carragher, Bridget; Kossiakoff, Anthony A.; Quick, Matthias; Fidock, David A.; Mancia, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">7786</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The emergence and spread of drug-resistant Plasmodium falciparum impedes global efforts to control and eliminate malaria.  For decades, treatment of malaria has relied on chloroquine (CQ), a safe and affordable 4-aminoquinoline that was highly effective against intra-erythrocytic asexual blood-stage parasites, until resistance arose in Southeast Asia and South America and spread worldwide1.  Clin. resistance to the chem. related current first-line combination drug piperaquine (PPQ) has now emerged regionally, reducing its efficacy2.  Resistance to CQ and PPQ has been assocd. with distinct sets of point mutations in the P. falciparum CQ-resistance transporter PfCRT, a 49-kDa member of the drug/metabolite transporter superfamily that traverses the membrane of the acidic digestive vacuole of the parasite3-9.  Here we present the structure, at 3.2 Å resoln., of the PfCRT isoform of CQ-resistant, PPQ-sensitive South American 7G8 parasites, using single-particle cryo-electron microscopy and antigen-binding fragment technol.  Mutations that contribute to CQ and PPQ resistance localize primarily to moderately conserved sites on distinct helixes that line a central neg. charged cavity, indicating that this cavity is the principal site of interaction with the pos. charged CQ and PPQ.  Binding and transport studies reveal that the 7G8 isoform binds both drugs with comparable affinities, and that these drugs are mutually competitive.  The 7G8 isoform transports CQ in a membrane potential- and pH-dependent manner, consistent with an active efflux mechanism that drives CQ resistance5, but does not transport PPQ.  Functional studies on the newly emerging PfCRT F145I and C350R mutations, assocd. with decreased PPQ susceptibility in Asia and South America, resp.6,9, reveal their ability to mediate PPQ transport in 7G8 variant proteins and to confer resistance in gene-edited parasites.  Structural, functional and in silico analyses suggest that distinct mechanistic features mediate the resistance to CQ and PPQ in PfCRT variants.  These data provide at.-level insights into the mol. mechanism of this key mediator of antimalarial treatment failures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu5Qp28Tv1MrVg90H21EOLACvtfcHk0ljeNOR1Jlp0vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1OitbjJ&md5=2aeb0261d31cbaf435b7ace937f65b5e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1795-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1795-x%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DY.%2BZ.%26aulast%3DWicht%26aufirst%3DK.%2BJ.%26aulast%3DErramilli%26aufirst%3DS.%2BK.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DOkombo%26aufirst%3DJ.%26aulast%3DVendome%26aufirst%3DJ.%26aulast%3DHagenah%26aufirst%3DL.%2BM.%26aulast%3DGiacometti%26aufirst%3DS.%2BI.%26aulast%3DWarren%26aufirst%3DA.%2BL.%26aulast%3DNosol%26aufirst%3DK.%26aulast%3DRoepe%26aufirst%3DP.%2BD.%26aulast%3DPotter%26aufirst%3DC.%2BS.%26aulast%3DCarragher%26aufirst%3DB.%26aulast%3DKossiakoff%26aufirst%3DA.%2BA.%26aulast%3DQuick%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMancia%26aufirst%3DF.%26atitle%3DStructure%2520and%2520drug%2520resistance%2520of%2520the%2520Plasmodium%2520falciparum%2520transporter%2520PfCRT%26jtitle%3DNature%26date%3D2019%26volume%3D576%26spage%3D315%26epage%3D320%26doi%3D10.1038%2Fs41586-019-1795-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small-Saunders, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e00303</span>, <span class="refDoi"> DOI: 10.1128/mbio.02731-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FmBio.02731-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31088920" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=e00303&author=S.+K.+Dhingraauthor=S.+J.+Gabryszewskiauthor=J.+L.+Small-Saundersauthor=T.+Yeoauthor=P.+P.+Henrichauthor=S.+Mokauthor=D.+A.+Fidock&title=Global+spread+of+mutant+PfCRT+and+its+pleiotropic+impact+on+Plasmodium+falciparum+multidrug+resistance+and+fitness&doi=10.1128%2Fmbio.02731-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FmBio.02731-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02731-18%26sid%3Dliteratum%253Aachs%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DSmall-Saunders%26aufirst%3DJ.%2BL.%26aulast%3DYeo%26aufirst%3DT.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DGlobal%2520spread%2520of%2520mutant%2520PfCRT%2520and%2520its%2520pleiotropic%2520impact%2520on%2520Plasmodium%2520falciparum%2520multidrug%2520resistance%2520and%2520fitness%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26spage%3De00303%26doi%3D10.1128%2Fmbio.02731-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modchang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musset, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chookajorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Combinatorial genetic modeling of pfcrt-mediated drug resistance evolution in Plasmodium falciparum</span>. <i>Mol. Biol. Evol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1554</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1093/molbev/msw037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1093%2Fmolbev%2Fmsw037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26908582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGntLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=1554-1570&author=S.+J.+Gabryszewskiauthor=C.+Modchangauthor=L.+Mussetauthor=T.+Chookajornauthor=D.+A.+Fidock&title=Combinatorial+genetic+modeling+of+pfcrt-mediated+drug+resistance+evolution+in+Plasmodium+falciparum&doi=10.1093%2Fmolbev%2Fmsw037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial genetic modeling of pfcrt-mediated drug resistance evolution in Plasmodium falciparum</span></div><div class="casAuthors">Gabryszewski, Stanislaw J.; Modchang, Charin; Musset, Lise; Chookajorn, Thanat; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology and Evolution</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1554-1570</span>CODEN:
                <span class="NLM_cas:coden">MBEVEO</span>;
        ISSN:<span class="NLM_cas:issn">0737-4038</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The emergence of drug resistance continuously threatens global control of infectious diseases, including malaria caused by the protozoan parasite Plasmodium falciparum.  A crit. parasite determinant is the P. falciparum chloroquine resistance transporter (PfCRT), the primary mediator of chloroquine (CQ) resistance (CQR), and a pleiotropic modulator of susceptibility to several first-line artemisinin-based combination therapy partner drugs.  Aside from the validated CQR mol. marker K76T, P. falciparum parasites have acquired at least three addnl. pfcrt mutations, whose contributions to resistance and fitness have been heretofore unclear.  Focusing on the quadruple-mutant Ecuadorian PfCRT haplotype Ecu1110 (K76T/A220S/N326D/I356L), we genetically modified the pfcrt locus of isogenic, asexual blood stage P. falciparum parasites using zinc-finger nucleases, producing all possible combinations of intermediate pfcrt alleles.  Our anal. included the related quintuple-mutant PfCRT haplotype 7G8 (Ecu1110 + C72S) that is widespread throughout South America and the Western Pacific.  Drug susceptibilities and in vitro growth profiles of our combinatorial pfcrt-modified parasites were used to simulate the mutational trajectories accessible to parasites as they evolved CQR.  Our results uncover unique contributions to parasite drug resistance and growth for mutations beyond K76T and predict crit. roles for the CQ metabolite monodesethyl-CQ and the related quinoline-type drug amodiaquine in driving mutant pfcrt evolution.  Modeling outputs further highlight the influence of parasite proliferation rates alongside gains in drug resistance in dictating successful trajectories.  Our findings suggest that P. falciparum parasites have navigated constrained pfcrt adaptive landscapes by means of probabilistically rare mutational bursts that led to the infrequent emergence of pfcrt alleles in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAW3iJo3w18LVg90H21EOLACvtfcHk0lj8vrpEDy2pDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGntLvN&md5=464e9739dcc1d77523571041b4b95b2c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fmolbev%2Fmsw037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmolbev%252Fmsw037%26sid%3Dliteratum%253Aachs%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DModchang%26aufirst%3DC.%26aulast%3DMusset%26aufirst%3DL.%26aulast%3DChookajorn%26aufirst%3DT.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DCombinatorial%2520genetic%2520modeling%2520of%2520pfcrt-mediated%2520drug%2520resistance%2520evolution%2520in%2520Plasmodium%2520falciparum%26jtitle%3DMol.%2520Biol.%2520Evol.%26date%3D2016%26volume%3D33%26spage%3D1554%26epage%3D1570%26doi%3D10.1093%2Fmolbev%2Fmsw037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palatulan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn-Flynn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehane, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1111/mmi.13035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fmmi.13035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=25898991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=381-395&author=I.+Petersenauthor=S.+J.+Gabryszewskiauthor=G.+L.+Johnstonauthor=S.+K.+Dhingraauthor=A.+Eckerauthor=R.+E.+Lewisauthor=M.+J.+de+Almeidaauthor=J.+Straimerauthor=P.+P.+Henrichauthor=E.+Palatulanauthor=D.+J.+Johnsonauthor=O.+Coburn-Flynnauthor=C.+Sanchezauthor=A.+M.+Lehaneauthor=M.+Lanzerauthor=D.+A.+Fidock&title=Balancing+drug+resistance+and+growth+rates+via+compensatory+mutations+in+the+Plasmodium+falciparum+chloroquine+resistance+transporter&doi=10.1111%2Fmmi.13035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter</span></div><div class="casAuthors">Petersen, Ines; Gabryszewski, Stanislaw J.; Johnston, Geoffrey L.; Dhingra, Satish K.; Ecker, Andrea; Lewis, Rebecca E.; Justino de Almeida, Mariana; Straimer, Judith; Henrich, Philipp P.; Palatulan, Eugene; Johnson, David J.; Coburn-Flynn, Olivia; Sanchez, Cecilia; Lehane, Adele M.; Lanzer, Michael; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">381-395</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The widespread use of chloroquine to treat Plasmodium falciparum infections has resulted in the selection and dissemination of variant haplotypes of the primary resistance determinant PfCRT.  These haplotypes have encountered drug pressure and within-host competition with wild-type drug-sensitive parasites.  To examine these selective forces in vitro, the authors genetically engineered P. falciparum to express geog. diverse PfCRT haplotypes.  Variant alleles from the Philippines (PH1 and PH2, which differ solely by the C72S mutation) both conferred a moderate gain of chloroquine resistance and a redn. in growth rates in vitro.  Of the two, PH2 showed higher IC50 values, contrasting with reduced growth.  Furthermore, a highly mutated pfcrt allele from Cambodia (Cam734) conferred moderate chloroquine resistance and enhanced growth rates, when tested against wild-type pfcrt in coculture competition assays.  These three alleles mediated cross-resistance to amodiaquine, an antimalarial drug widely used in Africa.  Each allele, along with the globally prevalent Dd2 and 7G8 alleles, rendered parasites more susceptible to lumefantrine, the partner drug used in the leading first-line artemisinin-based combination therapy.  These data reveal ongoing region-specific evolution of PfCRT that impacts drug susceptibility and relative fitness in settings of mixed infections, and raise important considerations about optimal agents to treat chloroquine-resistant malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS7oO_1IwPzbVg90H21EOLACvtfcHk0lj8vrpEDy2pDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFOgtLg%253D&md5=24e1efdbff8359b7bd8e8bf5876e193a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fmmi.13035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.13035%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DI.%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DJohnston%26aufirst%3DG.%2BL.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DEcker%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DR.%2BE.%26aulast%3Dde%2BAlmeida%26aufirst%3DM.%2BJ.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DPalatulan%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DD.%2BJ.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DLehane%26aufirst%3DA.%2BM.%26aulast%3DLanzer%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DBalancing%2520drug%2520resistance%2520and%2520growth%2520rates%2520via%2520compensatory%2520mutations%2520in%2520the%2520Plasmodium%2520falciparum%2520chloroquine%2520resistance%2520transporter%26jtitle%3DMol.%2520Microbiol.%26date%3D2015%26volume%3D97%26spage%3D381%26epage%3D395%26doi%3D10.1111%2Fmmi.13035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mungthin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.molcel.2004.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15383277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosl2jsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=867-877&author=D.+J.+Johnsonauthor=D.+A.+Fidockauthor=M.+Mungthinauthor=V.+Lakshmananauthor=A.+B.+S.+Sidhuauthor=P.+G.+Brayauthor=S.+A.+Ward&title=Evidence+for+a+central+role+for+PfCRT+in+conferring+Plasmodium+falciparum+resistance+to+diverse+antimalarial+agents&doi=10.1016%2Fj.molcel.2004.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents</span></div><div class="casAuthors">Johnson, David J.; Fidock, David A.; Mungthin, Mathirut; Lakshmanan, Viswanathan; Sidhu, Amar Bir Singh; Bray, Patrick G.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">867-877</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Chloroquine resistance in Plasmodium falciparum is primarily conferred by mutations in pfcrt.  Parasites resistant to chloroquine can display hypersensitivity to other antimalarials; however, the patterns of cross-resistance are complex, and the genetic basis has remained elusive.  The authors show that stepwise selection for resistance to amantadine or halofantrine produced previously unknown pfcrt mutations (including S163R), which were assocd. with a loss of verapamil-reversible chloroquine resistance.  This was accompanied by restoration of efficient chloroquine binding to hematin in these selected lines.  This S163R mutation provides insight into a mechanism by which PfCRT could gate the transport of protonated chloroquine through the digestive vacuole membrane.  Evidence for the presence of this mutation in a Southeast Asian isolate supports the argument for a broad role for PfCRT in detg. levels of susceptibility to structurally diverse antimalarials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_N46vdIaMD7Vg90H21EOLACvtfcHk0lj8vrpEDy2pDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosl2jsbw%253D&md5=20c0cc8f064d73bdf6543b616ebb4afc</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMungthin%26aufirst%3DM.%26aulast%3DLakshmanan%26aufirst%3DV.%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DBray%26aufirst%3DP.%2BG.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DEvidence%2520for%2520a%2520central%2520role%2520for%2520PfCRT%2520in%2520conferring%2520Plasmodium%2520falciparum%2520resistance%2520to%2520diverse%2520antimalarial%2520agents%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D867%26epage%3D877%26doi%3D10.1016%2Fj.molcel.2004.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicht, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpornsin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takala-Harrison, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3314</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05652-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fs41467-018-05652-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30115924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ovFWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3314&author=L.+S.+Rossauthor=S.+K.+Dhingraauthor=S.+Mokauthor=T.+Yeoauthor=K.+J.+Wichtauthor=K.+Kumpornsinauthor=S.+Takala-Harrisonauthor=B.+Witkowskiauthor=R.+M.+Fairhurstauthor=F.+Arieyauthor=D.+Menardauthor=D.+A.+Fidock&title=Emerging+Southeast+Asian+PfCRT+mutations+confer+Plasmodium+falciparum+resistance+to+the+first-line+antimalarial+piperaquine&doi=10.1038%2Fs41467-018-05652-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine</span></div><div class="casAuthors">Ross Leila S; Dhingra Satish K; Mok Sachel; Yeo Tomas; Wicht Kathryn J; Kumpornsin Krittikorn; Fidock David A; Kumpornsin Krittikorn; Takala-Harrison Shannon; Witkowski Benoit; Menard Didier; Fairhurst Rick M; Fairhurst Rick M; Ariey Frederic; Menard Didier; Fidock David A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3314</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The widely used antimalarial combination therapy dihydroartemisinin + piperaquine (DHA + PPQ) has failed in Cambodia.  Here, we perform a genomic analysis that reveals a rapid increase in the prevalence of novel mutations in the Plasmodium falciparum chloroquine resistance transporter PfCRT following DHA + PPQ implementation.  These mutations occur in parasites harboring the K13 C580Y artemisinin resistance marker.  By introducing PfCRT mutations into sensitive Dd2 parasites or removing them from resistant Cambodian isolates, we show that the H97Y, F145I, M343L, or G353V mutations each confer resistance to PPQ, albeit with fitness costs for all but M343L.  These mutations sensitize Dd2 parasites to chloroquine, amodiaquine, and quinine.  In Dd2 parasites, multicopy plasmepsin 2, a candidate molecular marker, is not necessary for PPQ resistance.  Distended digestive vacuoles were observed in pfcrt-edited Dd2 parasites but not in Cambodian isolates.  Our findings provide compelling evidence that emerging mutations in PfCRT can serve as a molecular marker and mediator of PPQ resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTexkzFIUjqpDUE-swuRqsHfW6udTcc2eYxU6LOfYUoCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ovFWrug%253D%253D&md5=6a946bc2c1ee06687682ace15c931b6f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05652-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05652-0%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DL.%2BS.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DYeo%26aufirst%3DT.%26aulast%3DWicht%26aufirst%3DK.%2BJ.%26aulast%3DKumpornsin%26aufirst%3DK.%26aulast%3DTakala-Harrison%26aufirst%3DS.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DEmerging%2520Southeast%2520Asian%2520PfCRT%2520mutations%2520confer%2520Plasmodium%2520falciparum%2520resistance%2520to%2520the%2520first-line%2520antimalarial%2520piperaquine%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3314%26doi%3D10.1038%2Fs41467-018-05652-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. W.</span></span> <span> </span><span class="NLM_article-title">Hemozoin and antimalarial drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1450</span>, <span class="refDoi"> DOI: 10.4155/fmc.13.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.4155%2Ffmc.13.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23919553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1437-1450&author=K.+Y.+Fongauthor=D.+W.+Wright&title=Hemozoin+and+antimalarial+drug+discovery&doi=10.4155%2Ffmc.13.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Hemozoin and antimalarial drug discovery</span></div><div class="casAuthors">Fong, Kim Y.; Wright, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1437-1450</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent initiatives to develop more effective and affordable drugs, controlling mosquitoes and development of a preventative vaccine have been launched with the goal of completely eradicating malaria.  To this end, Novartis (Surrey, UK) and GlaxoSmithKline (Middlesex, UK) screened their chem. libraries of approx. two million small mols. for antimalarial properties, which resulted in a set of over 20,000 highly druggable' initial hits.  Efforts in academia are centered on specific pathway targets.  One such high-throughput screening effort has been focused on hemozoin formation, a unique heme detoxification pathway found in the malaria parasite.  This review discusses the current approaches and limitations of high-throughput screening discovery of hemozoin inhibitors.  In the future, new methods must be developed to validate the mechanism of action of these hit compds. within the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMTZ2S5wds7LVg90H21EOLACvtfcHk0lggAK7Zt4D6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amurnN&md5=7a899b8fa8c03df274f99ecd30143d97</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.113%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DK.%2BY.%26aulast%3DWright%26aufirst%3DD.%2BW.%26atitle%3DHemozoin%2520and%2520antimalarial%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1437%26epage%3D1450%26doi%3D10.4155%2Ffmc.13.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, D. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Quinolines block every step of malaria heme crystal growth</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7483</span>– <span class="NLM_lpage">7485</span>, <span class="refDoi"> DOI: 10.1073/pnas.1708153114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1708153114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28696317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFygurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7483-7485&author=D.+J.+Sullivan&title=Quinolines+block+every+step+of+malaria+heme+crystal+growth&doi=10.1073%2Fpnas.1708153114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolines block every step of malaria heme crystal growth</span></div><div class="casAuthors">Sullivan, David J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7483-7485</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In this new work, Olafson et al.(1) use at.-force microscopy to capture the in situ growth of heme crystals to show how step propagation is inhibited by the quinoline class of antimalarials.  The authors also obsd. the effects of artemisin, another important antimalarial that binds heme, but does not inhibit crystn. (1).  Direct observations of how these compds. affect growth lead Olafson et al. to detail three classes of quinoline inhibition mechanisms.  This work opens new opportunities for a lock-and-key approach to targeted drug development that is rooted in the phys. basis for hemozoin crystal growth inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohJ7Ku-JfyZbVg90H21EOLACvtfcHk0lhwnIo--eesmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFygurbO&md5=f5a42957c470816d88d72de26b4cb135</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1708153114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1708153114%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DD.%2BJ.%26atitle%3DQuinolines%2520block%2520every%2520step%2520of%2520malaria%2520heme%2520crystal%2520growth%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D7483%26epage%3D7485%26doi%3D10.1073%2Fpnas.1708153114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bray, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mungthin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span> <span> </span><span class="NLM_article-title">Access to hematin: the basis of chloroquine resistance</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1124/mol.54.1.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1124%2Fmol.54.1.170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=9658203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=170-179&author=P.+G.+Brayauthor=M.+Mungthinauthor=R.+G.+Ridleyauthor=S.+A.+Ward&title=Access+to+hematin%3A+the+basis+of+chloroquine+resistance&doi=10.1124%2Fmol.54.1.170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Access to hematin: the basis of chloroquine resistance</span></div><div class="casAuthors">Bray, Patrick G.; Mungthin, Mathirut; Ridley, Robert G.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-179</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The saturable uptake of chloroquine by parasites of Plasmodium falciparum has been attributed to specific carrier-mediated transport of chloroquine.  It is suggested that chloroquine is transported in exchange for protons by the parasite membrane Na+/H+ exchanger [J Biol Chem 272:2652-2658 (1997)].  Once inside the parasite, it is proposed that chloroquine inhibits the polymn. of hematin, allowing this toxic Hb metabolite to accumulate and kill the cell [Pharmacol Ther 57:203-235 (1993)].  To date, the contribution of these proposed mechanisms to the uptake and antimalarial activity of chloroquine has not been assessed.  Using sodium-free medium, we demonstrate that chloroquine is not directly exchanged for protons by the plasmodial Na+/H+ exchanger.  Furthermore, we show that saturable chloroquine uptake at equil. is due solely to the binding of chloroquine to hematin rather than active uptake: using Ro 40-4388, a potent and specific inhibitor of Hb digestion and, by implication, hematin release, we demonstrate a concn.-dependent redn. in the no. of chloroquine binding sites.  An equal no. of chloroquine binding sites are found in both resistant and susceptible clones, but the apparent affinity of chloroquine binding is found to correlate with drug activity (r2 = 0.93, p < 0.0001).  This completely accounts for both the reduced drug accumulation and activity obsd. in resistant clones and the "reversal" of resistance produced by verapamil.  The data presented here reconcile most of the available biochem. data from studies of the mode of action of chloroquine and the mechanism of chloroquine resistance.  We show that the activity of chloroquine and amodiaquine is directly dependent on the saturable binding of the drugs to hematin and that the inhibition of hematin polymn. may be secondary to this binding.  The chloroquine-resistance mechanism regulates the access of chloroquine to hematin.  Our model is consistent with a resistance mechanism that acts specifically at the food vacuole to alter the binding of chloroquine to hematin rather than changing the active transport of chloroquine across the parasite plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXajT--H2nkrVg90H21EOLACvtfcHk0lhwnIo--eesmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKqtb8%253D&md5=ed9524c10245179621baa0614464c719</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fmol.54.1.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.54.1.170%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DP.%2BG.%26aulast%3DMungthin%26aufirst%3DM.%26aulast%3DRidley%26aufirst%3DR.%2BG.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DAccess%2520to%2520hematin%253A%2520the%2520basis%2520of%2520chloroquine%2520resistance%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D170%26epage%3D179%26doi%3D10.1124%2Fmol.54.1.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combrinck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabotha, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ncokazi, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambele, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppe, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">Insights into the role of heme in the mechanism of action of antimalarials</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1021/cb300454t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300454t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKrsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=133-137&author=J.+M.+Combrinckauthor=T.+E.+Mabothaauthor=K.+K.+Ncokaziauthor=M.+A.+Ambeleauthor=D.+Taylorauthor=P.+J.+Smithauthor=H.+C.+Hoppeauthor=T.+J.+Egan&title=Insights+into+the+role+of+heme+in+the+mechanism+of+action+of+antimalarials&doi=10.1021%2Fcb300454t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the Role of Heme in the Mechanism of Action of Antimalarials</span></div><div class="casAuthors">Combrinck, Jill M.; Mabotha, Tebogo E.; Ncokazi, Kanyile K.; Ambele, Melvin A.; Taylor, Dale; Smith, Peter J.; Hoppe, Heinrich C.; Egan, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-137</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using cell fractionation and measurement of Fe(III)heme-pyridine, the antimalarial chloroquine (CQ) has been shown to cause a dose-dependent decrease in hemozoin and concomitant increase in toxic free heme in cultured Plasmodium falciparum that is directly correlated with parasite survival.  Transmission electron microscopy techniques have further shown that heme is redistributed from the parasite digestive vacuole to the cytoplasm and that CQ disrupts hemozoin crystal growth, resulting in mosaic boundaries in the crystals formed in the parasite.  Extension of the cell fractionation study to other drugs has shown that artesunate, amodiaquine, lumefantrine, mefloquine, and quinine, all clin. important antimalarials, also inhibit hemozoin formation in the parasite cell, while the antifolate pyrimethamine and its combination with sulfadoxine do not.  This study finally provides direct evidence in support of the hemozoin inhibition hypothesis for the mechanism of action of CQ and shows that other quinoline and related antimalarials inhibit cellular hemozoin formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnlmATMRqwkbVg90H21EOLACvtfcHk0lhwnIo--eesmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKrsLjK&md5=237f5287c6ac189902358fb005b469a8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fcb300454t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300454t%26sid%3Dliteratum%253Aachs%26aulast%3DCombrinck%26aufirst%3DJ.%2BM.%26aulast%3DMabotha%26aufirst%3DT.%2BE.%26aulast%3DNcokazi%26aufirst%3DK.%2BK.%26aulast%3DAmbele%26aufirst%3DM.%2BA.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26aulast%3DHoppe%26aufirst%3DH.%2BC.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DInsights%2520into%2520the%2520role%2520of%2520heme%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520antimalarials%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D133%26epage%3D137%26doi%3D10.1021%2Fcb300454t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrzypek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, R.</span></span> <span> </span><span class="NLM_article-title">The “pushmi-pullyu” of resistance to chloroquine in malaria</span>. <i>Essays Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1042/ebc20160060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1042%2FEBC20160060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28258239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC1czis1yjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=167-175&author=R.+Skrzypekauthor=R.+Callaghan&title=The+%E2%80%9Cpushmi-pullyu%E2%80%9D+of+resistance+to+chloroquine+in+malaria&doi=10.1042%2Febc20160060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The "pushmi-pullyu" of resistance to chloroquine in malaria</span></div><div class="casAuthors">Skrzypek Ruth; Callaghan Richard</div><div class="citationInfo"><span class="NLM_cas:title">Essays in biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">167-175</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malarial infection continues to impart devastating health problems in the developing world.  Treatment of malaria has involved chemotherapy since 168 BC, with the most prevalent and successful forms using plant alkaloids.  Perhaps the greatest treatment success against malaria was by chloroquine, a synthetic derivative of the quinines found in the Cinchona tree bark.  Chloroquine is able to kill parasites by interfering with haem metabolism in the parasite's digestive vacuole.  The widespread use of chloroquine predictably resulted in the development of drug-resistant malaria and the most highly implicated resistance mediators are the transporter proteins P-glycoprotein (P-gp) homologue 1 (P-gh1) and Plasmodium falciparum chloroquine-resistance transporter (PfCRT), which reside on the parasite's digestive vacuole.  The presence of PfCRT and P-gh1 on the vacuole membrane is analogous to the two-headed fictional creature known as the "Pushmi-Pullyu".  P-gh1 (Pushmi) increases influx of chloroquine into the vacuole, while PfCRT (Pullmi) causes efflux of chloroquine from the vacuole.  This review describes how drug-resistant malarial parasites co-ordinate chloroquine distribution through adaptive mutations to promote their survival in the presence of this cytotoxic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9b0lxx8xJh5PlX7E30qdzfW6udTcc2eZ-P6cVZqB7O7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czis1yjtQ%253D%253D&md5=479cfe4ebf676bda79b55e6260443787</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1042%2FEBC20160060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FEBC20160060%26sid%3Dliteratum%253Aachs%26aulast%3DSkrzypek%26aufirst%3DR.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DThe%2520%25E2%2580%259Cpushmi-pullyu%25E2%2580%259D%2520of%2520resistance%2520to%2520chloroquine%2520in%2520malaria%26jtitle%3DEssays%2520Biochem.%26date%3D2017%26volume%3D61%26spage%3D167%26epage%3D175%26doi%3D10.1042%2Febc20160060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Transporters involved in resistance to antimalarial drugs</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.tips.2006.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16996622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=594-601&author=S.+G.+Valderramosauthor=D.+A.+Fidock&title=Transporters+involved+in+resistance+to+antimalarial+drugs&doi=10.1016%2Fj.tips.2006.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Transporters involved in resistance to antimalarial drugs</span></div><div class="casAuthors">Valderramos, Stephanie G.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">594-601</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ability to treat and control Plasmodium falciparum infection through chemotherapy has been compromised by the advent and spread of resistance to antimalarial drugs.  Research in this area has identified the P. falciparum chloroquine resistance transporter (PfCRT) and the multidrug resistance-1 (PfMDR1) transporter as key determinants of decreased in vitro susceptibility to several principal antimalarial drugs.  Transfection-based in vitro studies are consistent with clin. findings of an assocn. between mutations in the pfcrt gene and failure of chloroquine treatment, and between amplification of the pfmdr1 gene and failure of mefloquine treatment.  Many countries are now switching to artemisinin-based combination therapies.  These incorporate partner drugs of which some have an in vitro efficacy that can be modulated by changes in pfcrt or pfmdr1.  Here, we summarize investigations of these and other recently identified P. falciparum transporters in the context of antimalarial mode of action and mechanisms of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUd4TGzuaQv7Vg90H21EOLACvtfcHk0lgMdhtWE-koJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7nJ&md5=7c139fdb3de3f8625f988e5e5d7bc73a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DValderramos%26aufirst%3DS.%2BG.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DTransporters%2520involved%2520in%2520resistance%2520to%2520antimalarial%2520drugs%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D594%26epage%3D601%26doi%3D10.1016%2Fj.tips.2006.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1086/507115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1086%2F507115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16845638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD28vit1alug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2006&pages=528-535&author=A.+B.+S.+Sidhuauthor=A.+C.+Uhlemannauthor=S.+G.+Valderramosauthor=J.+C.+Valderramosauthor=S.+Krishnaauthor=D.+A.+Fidock&title=Decreasing+pfmdr1+copy+number+in+Plasmodium+falciparum+malaria+heightens+susceptibility+to+mefloquine%2C+lumefantrine%2C+halofantrine%2C+quinine%2C+and+artemisinin&doi=10.1086%2F507115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin</span></div><div class="casAuthors">Sidhu Amar Bir Singh; Uhlemann Anne-Catrin; Valderramos Stephanie G; Valderramos Juan-Carlos; Krishna Sanjeev; Fidock David A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">528-35</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The global dissemination of drug-resistant Plasmodium falciparum is spurring intense efforts to implement artemisinin (ART)-based combination therapies for malaria, including mefloquine (MFQ)-artesunate and lumefantrine (LUM)-artemether.  Clinical studies have identified an association between an increased risk of MFQ, MFQ-artesunate, and LUM-artemether treatment failures and pfmdr1 gene amplification.  To directly address the contribution that pfmdr1 copy number makes to drug resistance, we genetically disrupted 1 of the 2 pfmdr1 copies in the drug-resistant FCB line, which resulted in reduced pfmdr1 mRNA and protein expression.  These knockdown clones manifested a 3-fold decrease in MFQ IC(50) values, compared with that for the FCB line, verifying the role played by pfmdr1 expression levels in mediating resistance to MFQ.  These clones also showed increased susceptibility to LUM, halofantrine, quinine, and ART.  No change was observed for chloroquine.  These results highlight the importance of pfmdr1 copy number in determining P. falciparum susceptibility to multiple agents currently being used to combat malaria caused by multidrug-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1o6ybd2Dyzo2y4bB4mnvYfW6udTcc2eYfzePNeo6LMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vit1alug%253D%253D&md5=630ecb75857529bfcbf4e6db1fa3d779</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1086%2F507115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F507115%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DUhlemann%26aufirst%3DA.%2BC.%26aulast%3DValderramos%26aufirst%3DS.%2BG.%26aulast%3DValderramos%26aufirst%3DJ.%2BC.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DDecreasing%2520pfmdr1%2520copy%2520number%2520in%2520Plasmodium%2520falciparum%2520malaria%2520heightens%2520susceptibility%2520to%2520mefloquine%252C%2520lumefantrine%252C%2520halofantrine%252C%2520quinine%252C%2520and%2520artemisinin%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D194%26spage%3D528%26epage%3D535%26doi%3D10.1086%2F507115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preechapornkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pongtavornpinyo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span> <span> </span><span class="NLM_article-title">Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1515</span>, <span class="refDoi"> DOI: 10.1128/aac.00241-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.00241-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=19164150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksFWksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1509-1515&author=P.+Preechapornkulauthor=M.+Imwongauthor=K.+Chotivanichauthor=W.+Pongtavornpinyoauthor=A.+M.+Dondorpauthor=N.+P.+J.+Dayauthor=N.+J.+Whiteauthor=S.+Pukrittayakamee&title=Plasmodium+falciparum+pfmdr1+amplification%2C+mefloquine+resistance%2C+and+parasite+fitness&doi=10.1128%2Faac.00241-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness</span></div><div class="casAuthors">Preechapornkul, Piyanuch; Imwong, Mallika; Chotivanich, Kesinee; Pongtavornpinyo, Wirichada; Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.; Pukrittayakamee, Sasithon</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1509-1515</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mefloquine is widely used in combination with artemisinin derivs. for the treatment of falciparum malaria.  Mefloquine resistance in Plasmodium falciparum has been related to increased copy nos. of multidrug-resistant gene 1 (pfmdr1).  We studied the ex vivo dynamics of pfmdr1 gene amplification in culture-adapted P. falciparum in relation to mefloquine resistance and parasite fitness.  A Thai P. falciparum isolate (isolate TM036) was assessed by the use of multiple genetic markers as a single genotype.  Resistance was selected by exposure to stepwise increasing concns. of mefloquine up to 30 ng/mL in continuous culture.  The pfmdr1 gene copy nos. increased as susceptibility to mefloquine declined (P = 0.03).  No codon mutations at positions 86, 184, 1034, 1042, and 1246 in the pfmdr1 gene were detected.  Two subclones of selected parasites (av. copy nos., 2.3 and 3.1, resp.) showed a fitness disadvantage when they were grown together with the original parasites contg. a single pfmdr1 gene copy in the absence of mefloquine; the multiplication rates were 6.3% and 8.7% lower, resp. (P < 0.01).  Modeling of the dynamics of the pfmdr1 copy nos. over time in relation to the relative fitness of the parasites suggested that net pfmdr1 gene amplification from one to two copies occurs once in every 108 parasites and that amplification from two to three copies occurs once in every 103 parasites.  Pfmdr1 gene amplification in P. flaciparum is a frequent event and confers mefloquine resistance.  Parasites with multiple copies of the pfmdr1 gene have decreased survival fitness in the absence of drug pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovGPZpoua8crVg90H21EOLACvtfcHk0lgMdhtWE-koJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksFWksLc%253D&md5=d2d7a241d83a07bc8638132645277a71</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.00241-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00241-08%26sid%3Dliteratum%253Aachs%26aulast%3DPreechapornkul%26aufirst%3DP.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DPongtavornpinyo%26aufirst%3DW.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DDay%26aufirst%3DN.%2BP.%2BJ.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26atitle%3DPlasmodium%2520falciparum%2520pfmdr1%2520amplification%252C%2520mefloquine%2520resistance%252C%2520and%2520parasite%2520fitness%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1509%26epage%3D1515%26doi%3D10.1128%2Faac.00241-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahyong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrapuvich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span> <span> </span><span class="NLM_article-title">Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e1003375</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1003375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.ppat.1003375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23717205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003375&author=J.+L.+Gulerauthor=D.+L.+Freemanauthor=V.+Ahyongauthor=R.+Patrapuvichauthor=J.+Whiteauthor=R.+Gujjarauthor=M.+A.+Phillipsauthor=J.+DeRisiauthor=P.+K.+Rathod&title=Asexual+populations+of+the+human+malaria+parasite%2C+Plasmodium+falciparum%2C+use+a+two-step+genomic+strategy+to+acquire+accurate%2C+beneficial+DNA+amplifications&doi=10.1371%2Fjournal.ppat.1003375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications</span></div><div class="casAuthors">Guler, Jennifer L.; Freeman, Daniel L.; Ahyong, Vida; Patrapuvich, Rapatbhorn; White, John; Gujjar, Ramesh; Phillips, Margaret A.; DeRisi, Joseph; Rathod, Pradipsinh K.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1003375</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Malaria drug resistance contributes to up to a million annual deaths.  Judicious deployment of new antimalarials and vaccines could benefit from an understanding of early mol. events that promote the evolution of parasites.  Continuous in vitro challenge of Plasmodium falciparum parasites with a novel dihydroorotate dehydrogenase (DHODH) inhibitor reproducibly selected for resistant parasites.  Genome-wide anal. of independently-derived resistant clones revealed a two-step strategy to evolutionary success.  Some haploid blood-stage parasites first survive antimalarial pressure through fortuitous DNA duplications that always included the DHODH gene.  Independently-selected parasites had different sized amplification units but they were always flanked by distant A/T tracks.  Higher level amplification and resistance was attained using a second, more efficient and more accurate, mechanism for head-to-tail expansion of the founder unit.  This second homol.-based process could faithfully tune DNA copy nos. in either direction, always retaining the unique DNA amplification sequence from the original A/T-mediated duplication for that parasite line.  Pseudo-polyploidy at relevant genomic loci sets the stage for gaining addnl. mutations at the locus of interest.  Overall, we reveal a population-based genomic strategy for mutagenesis that operates in human stages of P. falciparum to efficiently yield resistance-causing genetic changes at the correct locus in a successful parasite.  Importantly, these founding events arise with precision; no other new amplifications are seen in the resistant haploid blood stage parasite.  This minimizes the need for meiotic genetic cleansing that can only occur in sexual stage development of the parasite in mosquitoes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-k9Fm0WQKrVg90H21EOLACvtfcHk0liXWQyMe8vNOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslOhtb8%253D&md5=9b2ad216a436922860c7f29aa5402c52</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003375%26sid%3Dliteratum%253Aachs%26aulast%3DGuler%26aufirst%3DJ.%2BL.%26aulast%3DFreeman%26aufirst%3DD.%2BL.%26aulast%3DAhyong%26aufirst%3DV.%26aulast%3DPatrapuvich%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGujjar%26aufirst%3DR.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DDeRisi%26aufirst%3DJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26atitle%3DAsexual%2520populations%2520of%2520the%2520human%2520malaria%2520parasite%252C%2520Plasmodium%2520falciparum%252C%2520use%2520a%2520two-step%2520genomic%2520strategy%2520to%2520acquire%2520accurate%252C%2520beneficial%2520DNA%2520amplifications%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003375%26doi%3D10.1371%2Fjournal.ppat.1003375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afanador, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification and mechanistic understanding of dihydroorotate dehydrogenase point mutations in Plasmodium falciparum that confer in vitro resistance to the clinical candidate DSM265</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVarurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=90-101&author=J.+Whiteauthor=S.+K.+Dhingraauthor=X.+Dengauthor=F.+El+Mazouniauthor=M.+C.+S.+Leeauthor=G.+A.+Afanadorauthor=A.+Lawongauthor=D.+R.+Tomchickauthor=C.+L.+Ngauthor=J.+Bathauthor=P.+K.+Rathodauthor=D.+A.+Fidockauthor=M.+A.+Phillips&title=Identification+and+mechanistic+understanding+of+dihydroorotate+dehydrogenase+point+mutations+in+Plasmodium+falciparum+that+confer+in+vitro+resistance+to+the+clinical+candidate+DSM265&doi=10.1021%2Facsinfecdis.8b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and mechanistic understanding of dihydroorotate dehydrogenase point mutations in Plasmodium falciparum that confer in vitro resistance to the clinical candidate DSM265</span></div><div class="casAuthors">White, John; Dhingra, Satish K.; Deng, Xiaoyi; El Mazouni, Farah; Lee, Marcus C. S.; Afanador, Gustavo A.; Lawong, Aloysus; Tomchick, Diana R.; Ng, Caroline L.; Bath, Jade; Rathod, Pradipsinh K.; Fidock, David A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-101</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria is one of the most challenging human infectious diseases, and both prevention and control have been hindered by the development of Plasmodium falciparum resistance to existing therapies.  Several new compds. with novel mechanisms are in clin. development for the treatment of malaria, including DSM265, an inhibitor of Plasmodium dihydroorotate dehydrogenase.  To explore the mechanisms by which resistance might develop to DSM265 in the field, we selected for DSM265-resistant P. falciparum parasites in vitro.  Any of five different amino acid changes led to reduced efficacy on the parasite and to decreased DSM265 binding to P. falciparum DHODH.  The DSM265-resistant parasites retained full sensitivity to atovaquone.  All but one of the obsd. mutations were in the DSM265 binding site, and the remaining C276F was in the adjacent flavin cofactor site.  The C276F mutation was previously identified in a recrudescent parasite during a Phase IIa clin. study.  We confirmed that this mutation (and the related C276Y) accounted for the full level of obsd. DSM265 resistance by regenerating the mutation using CRISPR/Cas9 genome editing.  X-ray structure anal. of the C276F mutant enzyme showed that conformational changes of nearby residues were required to accommodate the larger F276 residue, which in turn led to a restriction in the size of the DSM265 binding pocket.  These findings underscore the importance of developing DSM265 as part of a combination therapy with other agents for successful use against malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQMMzkCwd_zrVg90H21EOLACvtfcHk0liXWQyMe8vNOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVarurzN&md5=6b9001020d2332016c7f189a6dbe9380</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00211%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DAfanador%26aufirst%3DG.%2BA.%26aulast%3DLawong%26aufirst%3DA.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DBath%26aufirst%3DJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520and%2520mechanistic%2520understanding%2520of%2520dihydroorotate%2520dehydrogenase%2520point%2520mutations%2520in%2520Plasmodium%2520falciparum%2520that%2520confer%2520in%2520vitro%2520resistance%2520to%2520the%2520clinical%2520candidate%2520DSM265%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D90%26epage%3D101%26doi%3D10.1021%2Facsinfecdis.8b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calcada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baptista, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Pedrosa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veiga, M. I.</span></span> <span> </span><span class="NLM_article-title">Expansion of a specific Plasmodium falciparum PfMDR1 haplotype in Southeast Asia with increased substrate transport</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e02093</span>, <span class="refDoi"> DOI: 10.1128/mbio.02093-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FmBio.02093-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=33262257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitl2ktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=e02093&author=C.+Calcadaauthor=M.+Silvaauthor=V.+Baptistaauthor=V.+Thathyauthor=R.+Silva-Pedrosaauthor=D.+Granjaauthor=P.+E.+Ferreiraauthor=J.+P.+Gilauthor=D.+A.+Fidockauthor=M.+I.+Veiga&title=Expansion+of+a+specific+Plasmodium+falciparum+PfMDR1+haplotype+in+Southeast+Asia+with+increased+substrate+transport&doi=10.1128%2Fmbio.02093-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Expansion of a specific Plasmodium falciparum PfMDR1 haplotype in southeast asia with increased substrate transport</span></div><div class="casAuthors">Calcada, Carla; Silva, Miguel; Baptista, Vitoria; Thathy, Vandana; Silva-Pedrosa, Rita; Granja, Diana; Ferreira, Pedro Eduardo; Gil, Jose Pedro; Fidock, David A.; Veiga, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e02093-20</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Artemisinin-based combination therapies (ACTs) have been vital in reducing malaria mortality rates since the 2000s.  Their efficacy, however, is threatened by the emergence and spread of artemisinin resistance in Southeast Asia.  The Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) transporter plays a central role in parasite resistance to ACT partner drugs through gene copy no. variations (CNV) and/or single nucleotide polymorphisms (SNPs).  Using genomic epidemiol., we show that multiple pfmdr1 copies encoding the N86 and 184F haplotype are prevalent across Southeast Asia.  Applying genome editing tools on the Southeast Asian Dd2 strain and using a surrogate assay to measure transporter activity in infected red blood cells, we demonstrate that parasites harboring multicopy N86/184F PfMDR1 have a higher Fluo-4 transport capacity compared with those expressing the wild-type N86/Y184 haplotype.  Multicopy N86/184F PfMDR1 is also assocd. with decreased parasite susceptibility to lumefantrine.  These findings provide evidence of the geog. selection and expansion of specific multicopy PfMDR1 haplotypes assocd. with multidrug resistance in Southeast Asia.  IMPORTANCE Global efforts to eliminate malaria depend on the continued success of artemisinin-based combination therapies (ACTs) that target Plasmodium asexual blood-stage parasites.  Resistance to ACTs, however, has emerged, creating the need to define the underlying mechanisms.  Mutations in the P. falciparum multidrug resistance protein 1 (PfMDR1) transporter constitute an important determinant of resistance.  Applying gene editing tools combined with an anal. of a public database contg. thousands of parasite genomes, we show geog. selection and expansion of a pfmdr1 gene amplification encoding the N86/184F haplotype in Southeast Asia.  Parasites expressing this PfMDR1 variant possess a higher transport capacity that modulates their responses to antimalarials.  These data could help tailor and optimize antimalarial drug usage in different regions where malaria is endemic by taking into account the regional prevalence of pfmdr1 polymorphisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIJwTd_yqyL7Vg90H21EOLACvtfcHk0liXWQyMe8vNOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitl2ktLg%253D&md5=4e726d0d5d8a353aa495d657249c0a44</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FmBio.02093-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02093-20%26sid%3Dliteratum%253Aachs%26aulast%3DCalcada%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DV.%26aulast%3DThathy%26aufirst%3DV.%26aulast%3DSilva-Pedrosa%26aufirst%3DR.%26aulast%3DGranja%26aufirst%3DD.%26aulast%3DFerreira%26aufirst%3DP.%2BE.%26aulast%3DGil%26aufirst%3DJ.%2BP.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DVeiga%26aufirst%3DM.%2BI.%26atitle%3DExpansion%2520of%2520a%2520specific%2520Plasmodium%2520falciparum%2520PfMDR1%2520haplotype%2520in%2520Southeast%2520Asia%2520with%2520increased%2520substrate%2520transport%26jtitle%3DmBio%26date%3D2020%26volume%3D11%26spage%3De02093%26doi%3D10.1128%2Fmbio.02093-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galatis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culvenor, J. G.</span></span> <span> </span><span class="NLM_article-title">A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1083/jcb.113.5.1033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1083%2Fjcb.113.5.1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1674943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADyaK3MXit1Ggs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=1033-1042&author=A.+F.+Cowmanauthor=S.+Karczauthor=D.+Galatisauthor=J.+G.+Culvenor&title=A+P-glycoprotein+homologue+of+Plasmodium+falciparum+is+localized+on+the+digestive+vacuole&doi=10.1083%2Fjcb.113.5.1033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A P-glycoprotein homolog of Plasmodium falciparum is localized on the digestive vacuole</span></div><div class="casAuthors">Cowman, Alan F.; Karcz, Steve; Galatis, Denise; Culvenor, Janetta G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1033-42</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Resistance to chloroquine in P. falciparum bears a striking similarity to the multi-drug resistance (MDR) phenotype of mammalian tumor cells which is mediated by overexpression of P-glycoprotein.  The P. falciparum homolog of the P-glycoprotein (Pgh1) is shown to be a 160,000-D protein that is expressed throughout the asexual erythrocytic life cycle of the parasite.  Quant. immunoblotting anal. has shown that the protein is expressed at approx. equal levels in chloroquine resistant and sensitive isolates, suggesting that overexpression of Pgh1 is not essential for chloroquine resistance.  The chloroquine-resistant cloned line FAC8 however, does express ∼3-fold more Pgh1 protein than other isolates, probably because of the increased pfmdrl gene copy no. present in this isolate.  Immunofluorescence and immunoelectron microscopy has demonstrated that Pghl is localized on the membrane of the digestive vacuole of mature parasites.  This subcellular localization suggests that Pgh1 may modulate intracellular chloroquine concns. and has important implications for the normal physiol. function of this protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ItQc711SwrVg90H21EOLACvtfcHk0lijoT1bfHJSBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1Ggs7Y%253D&md5=7449c0521688a64814b9710425b0bae0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1083%2Fjcb.113.5.1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.113.5.1033%26sid%3Dliteratum%253Aachs%26aulast%3DCowman%26aufirst%3DA.%2BF.%26aulast%3DKarcz%26aufirst%3DS.%26aulast%3DGalatis%26aufirst%3DD.%26aulast%3DCulvenor%26aufirst%3DJ.%2BG.%26atitle%3DA%2520P-glycoprotein%2520homologue%2520of%2520Plasmodium%2520falciparum%2520is%2520localized%2520on%2520the%2520digestive%2520vacuole%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1991%26volume%3D113%26spage%3D1033%26epage%3D1042%26doi%3D10.1083%2Fjcb.113.5.1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdig, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzer, M.</span></span> <span> </span><span class="NLM_article-title">Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3000</span>– <span class="NLM_lpage">3011</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fsj.emboj.7601203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16794577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFaju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3000-3011&author=P.+Rohrbachauthor=C.+P.+Sanchezauthor=K.+Haytonauthor=O.+Friedrichauthor=J.+Patelauthor=A.+B.+S.+Sidhuauthor=M.+T.+Ferdigauthor=D.+A.+Fidockauthor=M.+Lanzer&title=Genetic+linkage+of+pfmdr1+with+food+vacuolar+solute+import+in+Plasmodium+falciparum&doi=10.1038%2Fsj.emboj.7601203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum</span></div><div class="casAuthors">Rohrbach, Petra; Sanchez, Cecilia P.; Hayton, Karen; Friedrich, Oliver; Patel, Jigar; Sidhu, Amar Bir Singh; Ferdig, Michael T.; Fidock, David A.; Lanzer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3000-3011</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The P-glycoprotein homolog of the human malaria parasite Plasmodium falciparum (Pgh-1) has been implicated in decreased susceptibility to several antimalarial drugs, including quinine, mefloquine and artemisinin.  Pgh-1 mainly resides within the parasite's food vacuolar membrane.  Here, the authors describe a surrogate assay for Pgh-1 function based on the subcellular distribution of Fluo-4 acetoxymethylester and its free fluorochrome.  They identified two distinct Fluo-4 staining phenotypes: preferential staining of the food vacuole vs. a more diffuse staining of the entire parasite.  Genetic, positional cloning and pharmacol. data causatively link the food vacuolar Fluo-4 phenotype to those Pgh-1 variants that are assocd. with altered drug responses.  The authors propose that Pgh-1 imports solutes, including certain antimalarial drugs, into the parasite's food vacuole.  The implications of these findings for drug resistance mechanisms and testing are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLKuHOZnsHbVg90H21EOLACvtfcHk0lijoT1bfHJSBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFaju78%253D&md5=58b5e18769365c45c76eb5ade1116b34</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601203%26sid%3Dliteratum%253Aachs%26aulast%3DRohrbach%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DC.%2BP.%26aulast%3DHayton%26aufirst%3DK.%26aulast%3DFriedrich%26aufirst%3DO.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DFerdig%26aufirst%3DM.%2BT.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DLanzer%26aufirst%3DM.%26atitle%3DGenetic%2520linkage%2520of%2520pfmdr1%2520with%2520food%2520vacuolar%2520solute%2520import%2520in%2520Plasmodium%2520falciparum%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3000%26epage%3D3011%26doi%3D10.1038%2Fsj.emboj.7601203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2005.04729.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fj.1365-2958.2005.04729.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16091034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFCltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=913-926&author=A.+B.+S.+Sidhuauthor=S.+G.+Valderramosauthor=D.+A.+Fidock&title=pfmdr1+mutations+contribute+to+quinine+resistance+and+enhance+mefloquine+and+artemisinin+sensitivity+in+Plasmodium+falciparum&doi=10.1111%2Fj.1365-2958.2005.04729.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum</span></div><div class="casAuthors">Sidhu, Amar Bir Singh; Valderramos, Stephanie Gaw; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">913-926</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The emergence and spread of multidrug resistant Plasmodium falciparum has severely limited the therapeutic options for the treatment of malaria.  With ever-increasing failure rates assocd. with chloroquine or sulfadoxine-pyrimethamine treatment, attention has turned to the few alternatives, which include quinine and mefloquine.  Here, we have investigated the role of pfmdr1 3' coding region point mutations in antimalarial drug susceptibility by allelic exchange in the GC03 and 3BA6 parasite lines.  Results with pfmdr1-recombinant clones indicate a significant role for the N1042D mutation in contributing to resistance to quinine and its diastereomer quinidine.  The triple mutations S1034C/N1042D/D1246Y, highly prevalent in South America, were also found to enhance parasite susceptibility to mefloquine, halofantrine and artemisinin.  Pfmdr1 3' mutations showed minimal effect on P. falciparum resistance to chloroquine or its metabolite mono-desethylchloroquine in these parasite lines, in contrast to previously published results obtained with 7G8 parasites.  This study supports the hypothesis that pfmdr1 3' point mutations can significantly affect parasite susceptibility to a wide range of antimalarials in a strain-specific manner that depends on the parasite genetic background.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79sbmkOdCnrVg90H21EOLACvtfcHk0lijoT1bfHJSBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFCltb4%253D&md5=95a4627c0035fcbd0e0f2cd07aff26b3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2005.04729.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2005.04729.x%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DValderramos%26aufirst%3DS.%2BG.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3Dpfmdr1%2520mutations%2520contribute%2520to%2520quinine%2520resistance%2520and%2520enhance%2520mefloquine%2520and%2520artemisinin%2520sensitivity%2520in%2520Plasmodium%2520falciparum%26jtitle%3DMol.%2520Microbiol.%26date%3D2005%26volume%3D57%26spage%3D913%26epage%3D926%26doi%3D10.1111%2Fj.1365-2958.2005.04729.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veiga, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnadig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehane, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11553</span>, <span class="refDoi"> DOI: 10.1038/ncomms11553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fncomms11553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27189525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1GrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11553&author=M.+I.+Veigaauthor=S.+K.+Dhingraauthor=P.+P.+Henrichauthor=J.+Straimerauthor=N.+Gnadigauthor=A.+C.+Uhlemannauthor=R.+E.+Martinauthor=A.+M.+Lehaneauthor=D.+A.+Fidock&title=Globally+prevalent+PfMDR1+mutations+modulate+Plasmodium+falciparum+susceptibility+to+artemisinin-based+combination+therapies&doi=10.1038%2Fncomms11553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies</span></div><div class="casAuthors">Veiga, M. Isabel; Dhingra, Satish K.; Henrich, Philipp P.; Straimer, Judith; Gnadig, Nina; Uhlemann, Anne-Catrin; Martin, Rowena E.; Lehane, Adele M.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11553</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antimalarial chemotherapy, globally reliant on artemisinin-based combination therapies (ACTs), is threatened by the spread of drug resistance in Plasmodium falciparum parasites.  Here we use zinc-finger nucleases to genetically modify the multidrug resistance-1 transporter PfMDR1 at amino acids 86 and 184, and demonstrate that the widely prevalent N86Y mutation augments resistance to the ACT partner drug amodiaquine and the former first-line agent chloroquine.  In contrast, N86Y increases parasite susceptibility to the partner drugs lumefantrine and mefloquine, and the active artemisinin metabolite dihydroartemisinin.  The PfMDR1 N86 plus Y184F isoform moderately reduces piperaquine potency in strains expressing an Asian/African variant of the chloroquine resistance transporter PfCRT.  Mutations in both digestive vacuole-resident transporters are thought to differentially regulate ACT drug interactions with host haem, a product of parasite-mediated Hb degrdn.  Global mapping of these mutations illustrates where the different ACTs could be selectively deployed to optimize treatment based on regional differences in PfMDR1 haplotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1g2E2xblEvbVg90H21EOLACvtfcHk0lgKq6wnRn1yRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1GrtLY%253D&md5=f9cf4b37ad7e5956e33de6e792c412ca</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fncomms11553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11553%26sid%3Dliteratum%253Aachs%26aulast%3DVeiga%26aufirst%3DM.%2BI.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGnadig%26aufirst%3DN.%26aulast%3DUhlemann%26aufirst%3DA.%2BC.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DLehane%26aufirst%3DA.%2BM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DGlobally%2520prevalent%2520PfMDR1%2520mutations%2520modulate%2520Plasmodium%2520falciparum%2520susceptibility%2520to%2520artemisinin-based%2520combination%2520therapies%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11553%26doi%3D10.1038%2Fncomms11553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Villiers, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1667</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2008.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.jinorgbio.2008.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=18508124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVylsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2008&pages=1660-1667&author=K.+A.+de%0AVilliersauthor=H.+M.+Marquesauthor=T.+J.+Egan&title=The+crystal+structure+of+halofantrine-ferriprotoporphyrin+IX+and+the+mechanism+of+action+of+arylmethanol+antimalarials&doi=10.1016%2Fj.jinorgbio.2008.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials</span></div><div class="casAuthors">de Villiers, Katherine A.; Marques, Helder M.; Egan, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1660-1667</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The crystal structure of the complex formed between the antimalarial drug halofantrine and ferriprotoporphyrin IX (Fe(III)PPIX) has been detd. by single crystal X-ray diffraction.  The structure shows that halofantrine coordinates to the Fe(III) center through its alc. functionality in addn. to π-stacking of the phenanthrene ring over the porphyrin.  The length of the Fe(III)-O bond is consistent with an alkoxide and not an alc. coordinating group.  The iron porphyrin is five coordinate and monomeric.  Changes in the electronic spectrum of Fe(III)PPIX upon addn. of halofantrine base in acetonitrile soln. are almost identical to those obsd. upon addn. of quinidine free base in the same solvent.  This suggests homologous binding.  Mol. mechanics modeling of Fe(III)PPIX complexes of quinidine, quinine, 9-epiquinine, and 9-epiquinidine based on this homol. suggests that the antimalarially active quinidine and quinine can readily adopt conformations that permit formation of an intramol. salt bridge between the protonated quinuclidine tertiary amino group and unprotonated heme propionate group, while the inactive epimers 9-epiquinidine and 9-epiquinine have to adopt high energy conformations in order to accommodate such salt bridge formation.  We propose that salt bridge formation may interrupt formation of the hemozoin precursor dimer formed during the heme detoxification pathway and so account for the strong activity of the two active isomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP3NeDvvyihLVg90H21EOLACvtfcHk0lgKq6wnRn1yRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVylsrw%253D&md5=52eebdf4f26b8eb6e7c01ecc336f12cb</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2008.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2008.04.001%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVilliers%26aufirst%3DK.%2BA.%26aulast%3DMarques%26aufirst%3DH.%2BM.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520crystal%2520structure%2520of%2520halofantrine-ferriprotoporphyrin%2520IX%2520and%2520the%2520mechanism%2520of%2520action%2520of%2520arylmethanol%2520antimalarials%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2008%26volume%3D102%26spage%3D1660%26epage%3D1667%26doi%3D10.1016%2Fj.jinorgbio.2008.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gildenhuys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streltsov, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">le Roex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villiers, K. A.</span></span> <span> </span><span class="NLM_article-title">Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">16767</span>– <span class="NLM_lpage">16777</span>, <span class="refDoi"> DOI: 10.1039/c5dt02671g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1039%2FC5DT02671G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26335948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVahtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=16767-16777&author=J.+Gildenhuysauthor=C.+J.+Sammyauthor=R.+M%C3%BCllerauthor=V.+A.+Streltsovauthor=T.+le+Roexauthor=D.+Kuterauthor=K.+A.+de+Villiers&title=Alkoxide+coordination+of+iron%28III%29+protoporphyrin+IX+by+antimalarial+quinoline+methanols%3A+a+key+interaction+observed+in+the+solid-state+and+solution&doi=10.1039%2Fc5dt02671g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution</span></div><div class="casAuthors">Gildenhuys, Johandie; Sammy, Chandre J.; Muller, Ronel; Streltsov, Victor A.; le Roex, Tanya; Kuter, David; de Villiers, Katherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16767-16777</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The quinoline methanol antimalarial drug mefloquine is a structural analog of the Cinchona alkaloids, quinine and quinidine.  The authors have elucidated the single crystal x-ray diffraction structure of the complexes formed between racemic erythro mefloquine and ferriprotoporphyrin IX (Fe(III)PPIX) and show that alkoxide coordination is a key interaction in the solid-state.  Mass spectrometry confirms the existence of coordination complexes of quinine, quinidine and mefloquine to Fe(III)PPIX in acetonitrile.  The length of the iron(III)-O bond in the quinine and quinidine complexes as detd. by Extended x-ray Absorption Fine Structure (EXAFS) spectroscopy unequivocally confirms that coordination of the quinoline methanol compds. to Fe(III)PPIX occurs in nonaq. aprotic soln. via their benzylic alkoxide functional group.  UV-visible spectrophotometric titrns. of the low-spin bis-pyridyl-Fe(III)PPIX complex with each of the quinoline methanol compds. results in the displacement of a single pyridine mol. and subsequent formation of a six-coordinate pyridine-Fe(III)PPIX-drug complex.  Probably formation of the drug-Fe(III)PPIX coordination complexes is favored in a nonaq. environment, such as that found in lipid bodies or membranes in the malaria parasite, and that their existence may contribute to the mechanism of haemozoin inhibition or other toxicity effects that lead ultimately to parasite death.  In either case, coordination is a key interaction to be considered in the design of novel antimalarial drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS21SeNW7VlbVg90H21EOLACvtfcHk0lgKq6wnRn1yRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVahtb%252FF&md5=074842359d592fea07acac50a92bf242</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2FC5DT02671G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5DT02671G%26sid%3Dliteratum%253Aachs%26aulast%3DGildenhuys%26aufirst%3DJ.%26aulast%3DSammy%26aufirst%3DC.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26aulast%3DStreltsov%26aufirst%3DV.%2BA.%26aulast%3Dle%2BRoex%26aufirst%3DT.%26aulast%3DKuter%26aufirst%3DD.%26aulast%3Dde%2BVilliers%26aufirst%3DK.%2BA.%26atitle%3DAlkoxide%2520coordination%2520of%2520iron%2528III%2529%2520protoporphyrin%2520IX%2520by%2520antimalarial%2520quinoline%2520methanols%253A%2520a%2520key%2520interaction%2520observed%2520in%2520the%2520solid-state%2520and%2520solution%26jtitle%3DDalton%2520Trans.%26date%3D2015%26volume%3D44%26spage%3D16767%26epage%3D16777%26doi%3D10.1039%2Fc5dt02671g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaschula, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misplon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walden, J.</span></span> <span> </span><span class="NLM_article-title">Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1021/jm990437l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990437l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=283-291&author=T.+J.+Eganauthor=R.+Hunterauthor=C.+H.+Kaschulaauthor=H.+M.+Marquesauthor=A.+Misplonauthor=J.+Walden&title=Structure-function+relationships+in+aminoquinolines%3A+effect+of+amino+and+chloro+groups+on+quinoline-hematin+complex+formation%2C+inhibition+of+beta-hematin+formation%2C+and+antiplasmodial+activity&doi=10.1021%2Fjm990437l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Function Relationships in Aminoquinolines: Effect of Amino and Chloro Groups on Quinoline-Hematin Complex Formation, Inhibition of β-Hematin Formation, and Antiplasmodial Activity</span></div><div class="casAuthors">Egan, Timothy J.; Hunter, Roger; Kaschula, Catherine H.; Marques, Helder M.; Misplon, Ashley; Walden, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparison of 19 aminoquinolines supports the hypothesis that chloroquine and related antimalarials act by complexing ferriprotoporphyrin IX (Fe(III)PPIX), inhibiting its conversion to β-hematin (hemozoin) and hence its detoxification.  The study suggests that a basic amino side chain is also essential for antiplasmodial activity.  2- And 4-aminoquinolines are unique in their strong affinity for Fe(III)PPIX, and attachment of side chains to the amino group has relatively little influence on the strength of complex formation.  Assocn. with Fe(III)PPIX is necessary, but not sufficient, for inhibiting β-hematin formation.  Presence of a 7-chloro group in the 4-aminoquinoline ring is a requirement for β-hematin inhibitory activity, and this is also unaffected by side chains attached to the amino group.  In turn, β-hematin inhibitory activity is necessary, but not sufficient, for antiplasmodial activity as the presence of an aminoalkyl group attached to the 4-amino-7-chloroquinoline template is essential for strong activity.  We thus propose that the 4-aminoquinoline nucleus of chloroquine and related antimalarials is responsible for complexing Fe(III)PPIX, the 7-chloro group is required for inhibition of β-hematin formation, and the basic amino side chain is required for drug accumulation in the food vacuole of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq7Z8ChnMTWLVg90H21EOLACvtfcHk0ljq-tRrYrBz8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVWkug%253D%253D&md5=ebfd428cdc81ed7761c9b79859e9d0ce</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm990437l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990437l%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DKaschula%26aufirst%3DC.%2BH.%26aulast%3DMarques%26aufirst%3DH.%2BM.%26aulast%3DMisplon%26aufirst%3DA.%26aulast%3DWalden%26aufirst%3DJ.%26atitle%3DStructure-function%2520relationships%2520in%2520aminoquinolines%253A%2520effect%2520of%2520amino%2520and%2520chloro%2520groups%2520on%2520quinoline-hematin%2520complex%2520formation%252C%2520inhibition%2520of%2520beta-hematin%2520formation%252C%2520and%2520antiplasmodial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D283%26epage%3D291%26doi%3D10.1021%2Fjm990437l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olafson, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekilov, P. G.</span></span> <span> </span><span class="NLM_article-title">Antimalarials inhibit hematin crystallization by unique drug-surface site interactions</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7536</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700125114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1700125114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28559329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVSisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7531-7536&author=K.+N.+Olafsonauthor=T.+Q.+Nguyenauthor=J.+D.+Rimerauthor=P.+G.+Vekilov&title=Antimalarials+inhibit+hematin+crystallization+by+unique+drug-surface+site+interactions&doi=10.1073%2Fpnas.1700125114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarials inhibit hematin crystallization by unique drug-surface site interactions</span></div><div class="casAuthors">Olafson, Katy N.; Nguyen, Tam Q.; Rimer, Jeffrey D.; Vekilov, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In malaria pathophysiol., divergent hypotheses on the inhibition of hematin crystn. posit that drugs act either by the sequestration of sol. hematin or their interaction with crystal surfaces.  We use physiol. relevant, time-resolved in situ surface observations and show that quinoline antimalarials inhibit β-hematin crystal surfaces by three distinct modes of action: step pinning, kink blocking, and step bunch induction.  Detailed exptl. evidence of kink blocking validates classical theory and demonstrates that this mechanism is not the most effective inhibition pathway.  Quinolines also form various complexes with sol. hematin, but complexation is insufficient to suppress heme detoxification and is a poor indicator of drug specificity.  Collectively, our findings reveal the significance of drug-crystal interactions and open avenues for rationally designing antimalarial compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozIH1yd-Lw47Vg90H21EOLACvtfcHk0ljq-tRrYrBz8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVSisro%253D&md5=71b34aad88ded63bbc23f23618923347</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700125114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700125114%26sid%3Dliteratum%253Aachs%26aulast%3DOlafson%26aufirst%3DK.%2BN.%26aulast%3DNguyen%26aufirst%3DT.%2BQ.%26aulast%3DRimer%26aufirst%3DJ.%2BD.%26aulast%3DVekilov%26aufirst%3DP.%2BG.%26atitle%3DAntimalarials%2520inhibit%2520hematin%2520crystallization%2520by%2520unique%2520drug-surface%2520site%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D7531%26epage%3D7536%26doi%3D10.1073%2Fpnas.1700125114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandlin, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. W.</span></span> <span> </span><span class="NLM_article-title">Identification of beta-hematin inhibitors in the MMV Malaria Box</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2015.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.ijpddr.2015.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26150923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FgvVKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=84-91&author=K.+Y.+Fongauthor=R.+D.+Sandlinauthor=D.+W.+Wright&title=Identification+of+beta-hematin+inhibitors+in+the+MMV+Malaria+Box&doi=10.1016%2Fj.ijpddr.2015.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of β-hematin inhibitors in the MMV Malaria Box</span></div><div class="casAuthors">Fong Kim Y; Sandlin Rebecca D; Wright David W</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">84-91</span>
        ISSN:<span class="NLM_cas:issn">2211-3207</span>.
    </div><div class="casAbstract">The Malaria Box, assembled by the Medicines for Malaria Venture, is a set of 400 structurally diverse, commercially available compounds with demonstrated activity against blood-stage Plasmodium falciparum.  The compounds are a representative subset of the 20,000 in vitro antimalarials identified from the high-throughput screening efforts of St.  Jude Children's Research Hospital (TN, USA), Novartis and GlaxoSmithKline.  In addition, a small set of active compounds from commercially available libraries was added to this group, but it has not previously been published.  Elucidation of the biochemical pathways on which these compounds act is a major challenge; therefore, access to these compounds has been made available free of charge to the investigator community.  Here, the Malaria Box compounds were tested for activity against the formation of β-hematin, a synthetic form of the heme detoxification biomineral, hemozoin.  Further, the mechanism of action of these compounds within the malaria parasite was explored.  Ten of the Malaria Box compounds demonstrated significant inhibition of β-hematin formation.  In this assay, dose-response data revealed IC50 values ranging from 8.7 to 22.7 μM for these hits, each of which is more potent than chloroquine (a known inhibitor of hemozoin formation).  The in vitro antimalarial activity of these ten hits was confirmed in cultures of the chloroquine sensitive D6 strain of the parasite resulting in IC50 values of 135-2165 nM, followed by testing in the multidrug resistant strain, C235.  Cultures of P. falciparum (D6) were then examined for their heme distribution following treatment with nine of the commercially available confirmed compounds, seven of which disrupted the hemozoin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqxCXYj5rt8Rcr74wzj5o5fW6udTcc2ebQq4wr2BZCELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FgvVKiug%253D%253D&md5=7fc760552c08c112ea9fde62e45433f0</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2015.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2015.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DK.%2BY.%26aulast%3DSandlin%26aufirst%3DR.%2BD.%26aulast%3DWright%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520beta-hematin%2520inhibitors%2520in%2520the%2520MMV%2520Malaria%2520Box%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2015%26volume%3D5%26spage%3D84%26epage%3D91%26doi%3D10.1016%2Fj.ijpddr.2015.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okombo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mambwe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Watt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanches-Vaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezuidenhout, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauterbach, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coetzer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudêncio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Multistage antiplasmodium activity of astemizole analogues and inhibition of hemozoin formation as a contributor to their mode of action</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=303-315&author=M.+Kumarauthor=J.+Okomboauthor=D.+Mambweauthor=D.+Taylorauthor=N.+Lawrenceauthor=J.+Readerauthor=M.+van+der%0AWattauthor=D.+Fontinhaauthor=M.+Sanches-Vazauthor=B.+C.+Bezuidenhoutauthor=S.+B.+Lauterbachauthor=D.+Liebenbergauthor=L.-M.+Birkholtzauthor=T.+L.+Coetzerauthor=M.+Prud%C3%AAncioauthor=T.+J.+Eganauthor=S.+Wittlinauthor=K.+Chibale&title=Multistage+antiplasmodium+activity+of+astemizole+analogues+and+inhibition+of+hemozoin+formation+as+a+contributor+to+their+mode+of+action&doi=10.1021%2Facsinfecdis.8b00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action</span></div><div class="casAuthors">Kumar, Malkeet; Okombo, John; Mambwe, Dickson; Taylor, Dale; Lawrence, Nina; Reader, Janette; van der Watt, Mariette; Fontinha, Diana; Sanches-Vaz, Margarida; Bezuidenhout, Belinda C.; Lauterbach, Sonja B.; Liebenberg, Dale; Birkholtz, Lyn-Marie; Coetzer, Theresa L.; Prudencio, Miguel; Egan, Timothy J.; Wittlin, Sergio; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-315</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A drug repositioning approach was leveraged to derivatize astemizole (AST), an antihistamine drug whose antimalarial activity was previously identified in a high-throughput screen.  The multistage activity potential against Plasmodium parasite's life cycle of the subsequent analogs was examd. by evaluating against the parasite asexual blood, liver and gametocyte stages.  In addn., the previously reported contribution of heme detoxification to the compd.'s mode of action was interrogated.  Ten of the seventeen derivs. showed IC50s < 0.1 μM against the chloroquine (CQ)-sensitive Plasmodium falciparum NF54 (PfNF54) strain while maintaining submicromolar potency against the multidrug resistant strain, PfK1, with most showing low likelihood of cross-resistance with CQ.  Selected analogs (PfNF54- IC50 < 0.1 μM) were tested for cytotoxicity on CHO cells and found to be highly selective (selectivity index > 100).  The first ever gametocytes screening of AST and its analogs revealed their moderate activity (IC50: 1-5 μM) against late stage P. falciparum gametocytes, while the evaluation of activity against P. berghei liver stages identified one compd. (3) with three-fold greater activity than the parent AST compd.  Mechanistic studies showed a strong correlation between in vitro inhibition of β-hematin formation by the AST derivs. and their antiplasmodium IC50s.  Analyses of intracellular inhibition of hemozoin formation within the parasite further yielded signatures attributable to a possible perturbation of the heme detoxification machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy4gh2bMFlULVg90H21EOLACvtfcHk0ljq-tRrYrBz8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbjI&md5=84f0b65a7d17715aea48271a7cf1bbeb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00272%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DOkombo%26aufirst%3DJ.%26aulast%3DMambwe%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BWatt%26aufirst%3DM.%26aulast%3DFontinha%26aufirst%3DD.%26aulast%3DSanches-Vaz%26aufirst%3DM.%26aulast%3DBezuidenhout%26aufirst%3DB.%2BC.%26aulast%3DLauterbach%26aufirst%3DS.%2BB.%26aulast%3DLiebenberg%26aufirst%3DD.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26aulast%3DCoetzer%26aufirst%3DT.%2BL.%26aulast%3DPrud%25C3%25AAncio%26aufirst%3DM.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DMultistage%2520antiplasmodium%2520activity%2520of%2520astemizole%2520analogues%2520and%2520inhibition%2520of%2520hemozoin%2520formation%2520as%2520a%2520contributor%2520to%2520their%2520mode%2520of%2520action%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D303%26epage%3D315%26doi%3D10.1021%2Facsinfecdis.8b00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trager, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J.</span></span> <span> </span><span class="NLM_article-title">Human malaria parasites in continuous culture</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1126/science.781840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.781840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=781840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1976&pages=673-675&author=W.+Tragerauthor=J.+Jensen&title=Human+malaria+parasites+in+continuous+culture&doi=10.1126%2Fscience.781840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Human malaria parasites in continuous culture</span></div><div class="casAuthors">Trager W; Jensen J B</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4254</span>),
    <span class="NLM_cas:pages">673-5</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Plasmodium falciparum can now be maintained in continuous culture in human erythrocytes incubated at 38 degrees C in RPMI 1640 medium with human serum under an atmosphere with 7 percent carbon dioxide and low oxygen (1 or 5 percent).  The original parasite material, derived from an infected Aotus trivirgatus monkey, was diluted more than 100 million times by the addition of human erythrocytes at 3- or 4-day intervals.  The parasites continued to reproduce in their normal asexual cycle of approximately 48 hours but were no longer highly synchronous.  The have remained infective to Aotus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPnKdQ--_afmyYR5VtavbzfW6udTcc2eZ2eu6-kuKYYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D&md5=a7f43c2255b75d9841c36338433c78b8</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.781840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.781840%26sid%3Dliteratum%253Aachs%26aulast%3DTrager%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DJ.%26atitle%3DHuman%2520malaria%2520parasites%2520in%2520continuous%2520culture%26jtitle%3DScience%26date%3D1976%26volume%3D193%26spage%3D673%26epage%3D675%26doi%3D10.1126%2Fscience.781840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santo-Tomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.exppara.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=17087929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=296-300&author=C.+Snyderauthor=J.+Cholletauthor=J.+Santo-Tomasauthor=C.+Scheurerauthor=S.+Wittlin&title=In+vitro+and+in+vivo+interaction+of+synthetic+peroxide+RBx11160+%28OZ277%29+with+piperaquine+in+Plasmodium+models&doi=10.1016%2Fj.exppara.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models</span></div><div class="casAuthors">Snyder, Christopher; Chollet, Jacques; Santo-Tomas, Josefina; Scheurer, Christian; Wittlin, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">296-300</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RBx11160 (OZ277) is a promising antimalarial drug candidate that Ranbaxy Labs. Limited and Medicines for Malaria Venture (MMV) are currently developing as a fixed combination with piperaquine.  Here, we describe the in vitro (Plasmodium falciparum) and in vivo (Plasmodium berghei) activities of piperaquine in combination with RBx11160 and artemether.  In vitro, both combinations demonstrated a slight tendency towards antagonism with mean sums of fractional inhibitory concns. (mean ΣFICs) of 1.5.  In vivo, piperaquine and artemether were borderline antagonistic (mean ΣFIC of 1.4).  However, an additive in vivo interaction of piperaquine and RBx11160 (mean ΣFIC of 1.1) was identified, suggesting that a RBx11160-piperaquine combination therapy in humans should allow each mol. to exert its full antimalarial effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsaEePIfPhrVg90H21EOLACvtfcHk0lgF9z2TfD6qHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ&md5=e1513c45d411887f6e65d7d31a61ad6d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DSanto-Tomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520interaction%2520of%2520synthetic%2520peroxide%2520RBx11160%2520%2528OZ277%2529%2520with%2520piperaquine%2520in%2520Plasmodium%2520models%26jtitle%3DExp.%2520Parasitol.%26date%3D2007%26volume%3D115%26spage%3D296%26epage%3D300%26doi%3D10.1016%2Fj.exppara.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambros, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderberg, J. P.</span></span> <span> </span><span class="NLM_article-title">Synchronization of Plasmodium falciparum erythrocytic stages in culture</span>. <i>J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">418</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.2307/3280287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.2307%2F3280287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=383936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1979&pages=418-420&author=C.+Lambrosauthor=J.+P.+Vanderberg&title=Synchronization+of+Plasmodium+falciparum+erythrocytic+stages+in+culture&doi=10.2307%2F3280287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synchronization of Plasmodium falciparum erythrocytic stages in culture</span></div><div class="casAuthors">Lambros C; Vanderberg J P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">418-20</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Synchronous development of the erythrocytic stages of a human malaria parasite, Plasmodium falciparum, in culture was accomplished by suspending cultured parasites in 5% D-sorbitol and subsequent reintroduction into culture.  Immediately after sorbitol treatment, cultures consisted mainly of single and multiple ring-form infections.  At the same time, varying degrees of lysis of erythrocytes infected with the more mature stages of the parasite was evident.  Approximately 95% of the parasites were in the ring stage of development at 48 and 96 hr after sorbitol treatment-likewise, a high percentage of trophozoite and schizont stages was observed at 24, 72, and 120 hr.  D-Mannitol produced similar, selective, lytic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8OaabOIODNFUIs6wFK5xJfW6udTcc2eZ2eu6-kuKYYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D&md5=b1f79ae8156db4fdef9b290140de2298</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2307%2F3280287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3280287%26sid%3Dliteratum%253Aachs%26aulast%3DLambros%26aufirst%3DC.%26aulast%3DVanderberg%26aufirst%3DJ.%2BP.%26atitle%3DSynchronization%2520of%2520Plasmodium%2520falciparum%2520erythrocytic%2520stages%2520in%2520culture%26jtitle%3DJ.%2520Parasitol.%26date%3D1979%26volume%3D65%26spage%3D418%26epage%3D420%26doi%3D10.2307%2F3280287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel-Blanco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straschil, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda-Zubiaurre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, J.</span></span> <span> </span><span class="NLM_article-title">A high throughput screen for next-generation leads targeting malaria parasite transmission</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3805</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05777-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fs41467-018-05777-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30228275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BB3czgtFSlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3805&author=M.+J.+Delvesauthor=C.+Miguel-Blancoauthor=H.+Matthewsauthor=I.+Molinaauthor=A.+Rueckerauthor=S.+Yahiyaauthor=U.+Straschilauthor=M.+Abrahamauthor=M.+L.+Leonauthor=O.+J.+Fischerauthor=A.+Rueda-Zubiaurreauthor=J.+R.+Brandtauthor=A.+Cortesauthor=A.+Barnardauthor=M.+J.+Fuchterauthor=F.+Calderonauthor=E.+A.+Winzelerauthor=R.+E.+Sindenauthor=E.+Herrerosauthor=F.+J.+Gamoauthor=J.+Baum&title=A+high+throughput+screen+for+next-generation+leads+targeting+malaria+parasite+transmission&doi=10.1038%2Fs41467-018-05777-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">A high throughput screen for next-generation leads targeting malaria parasite transmission</span></div><div class="casAuthors">Delves Michael J; Miguel-Blanco Celia; Matthews Holly; Ruecker Andrea; Yahiya Sabrina; Straschil Ursula; Sinden Robert E; Baum Jake; Miguel-Blanco Celia; Molina Irene; Leon Maria Luisa; Cortes Alvaro; Calderon Felix; Herreros Esperanza; Gamo Francisco J; Abraham Matthew; Winzeler Elizabeth A; Fischer Oliver J; Rueda-Zubiaurre Ainoa; Brandt Jochen R; Barnard Anna; Fuchter Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3805</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Spread of parasite resistance to artemisinin threatens current frontline antimalarial therapies, highlighting the need for new drugs with alternative modes of action.  Since only 0.2-1% of asexual parasites differentiate into sexual, transmission-competent forms, targeting this natural bottleneck provides a tangible route to interrupt disease transmission and mitigate resistance selection.  Here we present a high-throughput screen of gametogenesis against a ~70,000 compound diversity library, identifying seventeen drug-like molecules that target transmission.  Hit molecules possess varied activity profiles including male-specific, dual acting male-female and dual-asexual-sexual, with one promising N-((4-hydroxychroman-4-yl)methyl)-sulphonamide scaffold found to have sub-micromolar activity in vitro and in vivo efficacy.  Development of leads with modes of action focussed on the sexual stages of malaria parasite development provide a previously unexplored base from which future therapeutics can be developed, capable of preventing parasite transmission through the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm0WpjOO-yVDUE-swuRqsHfW6udTcc2eZif6MT7JItAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czgtFSlsg%253D%253D&md5=d62b545c247a6ef26d1521aea097d629</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05777-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05777-2%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DMiguel-Blanco%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DH.%26aulast%3DMolina%26aufirst%3DI.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DYahiya%26aufirst%3DS.%26aulast%3DStraschil%26aufirst%3DU.%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DLeon%26aufirst%3DM.%2BL.%26aulast%3DFischer%26aufirst%3DO.%2BJ.%26aulast%3DRueda-Zubiaurre%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DJ.%2BR.%26aulast%3DCortes%26aufirst%3DA.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DCalderon%26aufirst%3DF.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DBaum%26aufirst%3DJ.%26atitle%3DA%2520high%2520throughput%2520screen%2520for%2520next-generation%2520leads%2520targeting%2520malaria%2520parasite%2520transmission%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3805%26doi%3D10.1038%2Fs41467-018-05777-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straschil, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelièvre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Barragán, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span> <span> </span><span class="NLM_article-title">Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3268</span>– <span class="NLM_lpage">3274</span>, <span class="refDoi"> DOI: 10.1128/aac.00325-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.00325-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23629698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVartrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=3268-3274&author=M.+J.+Delvesauthor=A.+Rueckerauthor=U.+Straschilauthor=J.+Leli%C3%A8vreauthor=S.+Marquesauthor=M.+J.+L%C3%B3pez-Barrag%C3%A1nauthor=E.+Herrerosauthor=R.+E.+Sinden&title=Male+and+female+Plasmodium+falciparum+mature+gametocytes+show+different+responses+to+antimalarial+drugs&doi=10.1128%2Faac.00325-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs</span></div><div class="casAuthors">Delves, Michael J.; Ruecker, Andrea; Straschil, Ursula; Lelievre, Joel; Marques, Sara; Lopez-Barragan, Maria Jose; Herreros, Esperanza; Sinden, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3268-3274</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">It is the mature gametocytes of Plasmodium that are solely responsible for parasite transmission from the mammalian host to the mosquito.  They are therefore a logical target for transmission-blocking antimalarial interventions, which aim to break the cycle of reinfection and reduce the prevalence of malaria cases.  Gametocytes, however, are not a homogeneous cell population.  They are sexually dimorphic, and both males and females are required for parasite transmission.  Using two bioassays, we explored the effects of 20 antimalarials on the functional viability of both male and female mature gametocytes of Plasmodium falciparum.  We show that mature male gametocytes (as reported by their ability to produce male gametes, i.e., to exflagellate) are sensitive to antifolates, some endoperoxides, methylene blue, and thiostrepton, with submicromolar 50% inhibitory concns. (IC50s), whereas female gametocytes (as reported by their ability to activate and form gametes expressing the marker Pfs25) are much less sensitive to antimalarial intervention, with only methylene blue and thiostrepton showing any significant activity.  These findings show firstly that the antimalarial responses of male and female gametocytes differ and secondly that the mature male gametocyte should be considered a more vulnerable target than the female gametocyte for transmission-blocking drugs.  Given the female-biased sex ratio of Plasmodium falciparum (∼3 to 5 females:1 male), current gametocyte assays without a sex-specific readout are unlikely to identify male-targeted compds. and prioritize them for further development.  Both assays reported here are being scaled up to at least medium throughput and will permit identification of key transmission-blocking mols. that have been overlooked by other screening campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXL2JCR3jpE7Vg90H21EOLACvtfcHk0lgjbUgYl1jr1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVartrfF&md5=7ef11a016fe88572a0d1faea7100ae8f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1128%2FAAC.00325-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00325-13%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DStraschil%26aufirst%3DU.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DMarques%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez-Barrag%25C3%25A1n%26aufirst%3DM.%2BJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26atitle%3DMale%2520and%2520female%2520Plasmodium%2520falciparum%2520mature%2520gametocytes%2520show%2520different%2520responses%2520to%2520antimalarial%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D3268%26epage%3D3274%26doi%3D10.1128%2Faac.00325-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straschil, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel-Blanco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span> <span> </span><span class="NLM_article-title">Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1038/nprot.2016.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnprot.2016.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27560172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCgsb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1668-1680&author=M.+J.+Delvesauthor=U.+Straschilauthor=A.+Rueckerauthor=C.+Miguel-Blancoauthor=S.+Marquesauthor=A.+C.+Dufourauthor=J.+Baumauthor=R.+E.+Sinden&title=Routine+in+vitro+culture+of+P.+falciparum+gametocytes+to+evaluate+novel+transmission-blocking+interventions&doi=10.1038%2Fnprot.2016.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions</span></div><div class="casAuthors">Delves, Michael J.; Straschil, Ursula; Ruecker, Andrea; Miguel-Blanco, Celia; Marques, Sara; Baum, Jake; Sinden, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1680</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevention of parasite transmission from the human host to the mosquito has been recognized as a vital tool for malaria eradication campaigns.  However, transmission-blocking antimalarial drug and/or vaccine discovery and development is currently hampered by the expense and difficulty of producing mature Plasmodium falciparum gametocytes in vitro-the parasite stage responsible for mosquito infection.  Current protocols for P. falciparum gametocyte culture usually require complex parasite synchronization and addn. of stimulating and/or inhibitory factors, and they may not have demonstrated the essential property of mosquito infectivity.  This protocol details all the steps required for reliable P. falciparum gametocyte prodn. and highlights common factors that influence culture success.  The protocol can be completed in 15 d, and particular emphasis is placed upon operating a gametocyte culture facility on a continuous cycle.  In addn., we show how functionally viable gametocytes can be used to evaluate transmission-blocking drugs both in a field setting and at high throughput (HTP) for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomtyKdEiN1lLVg90H21EOLACvtfcHk0lgjbUgYl1jr1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCgsb%252FL&md5=cb055e9f91b4446b238f0a6383abd49b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2016.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2016.096%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DStraschil%26aufirst%3DU.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DMiguel-Blanco%26aufirst%3DC.%26aulast%3DMarques%26aufirst%3DS.%26aulast%3DDufour%26aufirst%3DA.%2BC.%26aulast%3DBaum%26aufirst%3DJ.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26atitle%3DRoutine%2520in%2520vitro%2520culture%2520of%2520P.%2520falciparum%2520gametocytes%2520to%2520evaluate%2520novel%2520transmission-blocking%2520interventions%26jtitle%3DNat.%2520Protoc.%26date%3D2016%26volume%3D11%26spage%3D1668%26epage%3D1680%26doi%3D10.1038%2Fnprot.2016.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ncokazi, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.ab.2004.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15745752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVaqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=306-319&author=K.+K.+Ncokaziauthor=T.+J.+Egan&title=A+colorimetric+high-throughput+beta-hematin+inhibition+screening+assay+for+use+in+the+search+for+antimalarial+compounds&doi=10.1016%2Fj.ab.2004.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A colorimetric high-throughput β-hematin inhibition screening assay for use in the search for antimalarial compounds</span></div><div class="casAuthors">Ncokazi, Kanyile K.; Egan, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">306-319</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Antimalarial drugs such as chloroquine are believed to act by inhibiting hemozoin formation in the food vacuole of the malaria parasite.  We have developed a new assay for measuring and detecting inhibition of synthetic hemozoin (β-hematin) formation.  Aq. pyridine (5% vol./vol., pH 7.5) forms a low-spin complex with hematin but not with β-hematin.  Its absorbance obeys Beer's law, making it useful for quantitating hematin concn. in hematin/β-hematin mixts., allowing compds. to be investigated for inhibition of β-hematin formation.  The assay is rapid (60 min incubation) and requires no centrifugation.  The β-hematin inhibition data show good agreement with alternative assay methods reported by four labs.  The assay was adapted for high-throughput colorimetric screening, allowing visual identification of β-hematin inhibitors.  In this mode, the assay successfully detected all 18 β-hematin inhibitors in a set of 47 compds. tested, with no false pos. results.  The quant. in vitro antimalarial activities of a set of 13 aminoquinolines and quinoline methanols were found to correlate significantly with β-hematin inhibition values detd. using the assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uXeKrfDEtbVg90H21EOLACvtfcHk0lieqMzZkZ1ung"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVaqu74%253D&md5=a4475a05f1e33e9465c97f9832bdbfb2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DNcokazi%26aufirst%3DK.%2BK.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DA%2520colorimetric%2520high-throughput%2520beta-hematin%2520inhibition%2520screening%2520assay%2520for%2520use%2520in%2520the%2520search%2520for%2520antimalarial%2520compounds%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D338%26spage%3D306%26epage%3D319%26doi%3D10.1016%2Fj.ab.2004.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combrinck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibhard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">253</span>, <span class="refDoi"> DOI: 10.1186/s12936-015-0729-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-015-0729-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26099266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC2MblvVOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=253&author=J.+M.+Combrinckauthor=K.+Y.+Fongauthor=L.+Gibhardauthor=P.+J.+Smithauthor=D.+W.+Wrightauthor=T.+J.+Egan&title=Optimization+of+a+multi-well+colorimetric+assay+to+determine+haem+species+in+Plasmodium+falciparum+in+the+presence+of+anti-malarials&doi=10.1186%2Fs12936-015-0729-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials</span></div><div class="casAuthors">Combrinck Jill M; Gibhard Liezl; Smith Peter J; Fong Kim Y; Wright David W; Egan Timothy J</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">253</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The activity of several well-known anti-malarials, including chloroquine (CQ), is attributed to their ability to inhibit the formation of haemozoin (Hz) in the malaria parasite.  The formation of inert Hz, or malaria pigment, from toxic haem acquired from the host red blood cell of the parasite during haemoglobin digestion represents a pathway essential for parasite survival.  Inhibition of this critical pathway therefore remains a desirable target for novel anti-malarials.  A recent publication described the results of a haem fractionation assay used to directly determine haemoglobin, free haem and Hz in Plasmodium falciparum inoculated with CQ.  CQ was shown to cause a dose-dependent increase in cellular-free haem that was correlated with decreased parasite survival.  The method provided valuable information but was limited due to its low throughput and high demand on parasite starting material.  Here, this haem fractionation assay has been successfully adapted to a higher throughput method in 24-well plates, significantly reducing lead times and starting material volumes.  METHODS:  All major haem species in P. falciparum trophozoites, isolated through a series of cellular fractionation steps were determined spectrophotometrically in aqueous pyridine (5 % v/v, pH 7.5) as a low spin complex with haematin.  Cell counts were determined using a haemocytometer and a rapid novel fluorescent flow cytometry method.  RESULTS:  A higher throughput haem fractionation assay in 24-well plates, containing at most ten million trophozoites was validated against the original published method using CQ and its robustness was confirmed.  It provided a minimum six-fold improvement in productivity and 24-fold reduction in starting material volume.  The assay was successfully applied to amodiaquine (AQ), which was shown to inhibit Hz formation, while the antifolate pyrimethamine (PYR) and the mitochondrial electron transporter inhibitor atovaquone (Atov) demonstrated no increase in toxic cellular free haem.  CONCLUSIONS:  This higher throughput cellular haem fractionation assay can easily be applied to novel anti-malarials with a significantly decreased lead time, providing a valuable tool with which to probe the mechanisms of action of both new and established anti-malarials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSkYd91Hqw8CO2kE7krGOBfW6udTcc2eZx6pC32aKGTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblvVOjsg%253D%253D&md5=69f2d3755b60d8b90d5c354bef46461a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-0729-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-0729-9%26sid%3Dliteratum%253Aachs%26aulast%3DCombrinck%26aufirst%3DJ.%2BM.%26aulast%3DFong%26aufirst%3DK.%2BY.%26aulast%3DGibhard%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26aulast%3DWright%26aufirst%3DD.%2BW.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DOptimization%2520of%2520a%2520multi-well%2520colorimetric%2520assay%2520to%2520determine%2520haem%2520species%2520in%2520Plasmodium%2520falciparum%2520in%2520the%2520presence%2520of%2520anti-malarials%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26spage%3D253%26doi%3D10.1186%2Fs12936-015-0729-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnadig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadani, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacheux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urnov, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit-Vical, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1126/science.1260867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.1260867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=25502314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=428-431&author=J.+Straimerauthor=N.+F.+Gnadigauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=V.+Duruauthor=A.+P.+Ramadaniauthor=M.+Dacheuxauthor=N.+Khimauthor=L.+Zhangauthor=S.+Lamauthor=P.+D.+Gregoryauthor=F.+D.+Urnovauthor=O.+Mercereau-Puijalonauthor=F.+Benoit-Vicalauthor=R.+M.+Fairhurstauthor=D.+Menardauthor=D.+A.+Fidock&title=K13-propeller+mutations+confer+artemisinin+resistance+in+Plasmodium+falciparum+clinical+isolates&doi=10.1126%2Fscience.1260867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span></div><div class="casAuthors">Straimer, Judith; Gnaedig, Nina F.; Witkowski, Benoit; Amaratunga, Chanaki; Duru, Valentine; Ramadani, Arba Pramundita; Dacheux, Melanie; Khim, Nimol; Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.; Mercereau-Puijalon, Odile; Benoit-Vical, Francoise; Fairhurst, Rick M.; Menard, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6220</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden.  We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients.  With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations.  Conversely, survival rates in wild-type parasites increased from ≤0.6% to 2 to 29% after the insertion of K13 mutations.  These mutations conferred elevated resistance to recent Cambodian isolates compared with that of ref. lines, suggesting a contemporary contribution of addnl. genetic factors.  Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ml-eUMKETLVg90H21EOLACvtfcHk0lieqMzZkZ1ung"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D&md5=5776238fb78428d16bcaed8d16fa73af</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1126%2Fscience.1260867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1260867%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGnadig%26aufirst%3DN.%2BF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DRamadani%26aufirst%3DA.%2BP.%26aulast%3DDacheux%26aufirst%3DM.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DGregory%26aufirst%3DP.%2BD.%26aulast%3DUrnov%26aufirst%3DF.%2BD.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DK13-propeller%2520mutations%2520confer%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520clinical%2520isolates%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D428%26epage%3D431%26doi%3D10.1126%2Fscience.1260867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Plasmodium falciparum In vitro drug resistance selections and gene editing</span>. <i>Methods Mol. Biol</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-9550-9_9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1007%2F978-1-4939-9550-9_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31267498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1ahs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2019&pages=123-140&author=C.+L.+Ngauthor=D.+A.+Fidock&title=Plasmodium+falciparum+In+vitro+drug+resistance+selections+and+gene+editing&doi=10.1007%2F978-1-4939-9550-9_9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum In Vitro Drug Resistance Selections and Gene Editing</span></div><div class="casAuthors">Ng, Caroline L.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue">Malaria Control and Elimination</span>),
    <span class="NLM_cas:pages">123-140</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Malaria continues to be a global health burden, threatening over 40% of the world's population.  Drug resistance in Plasmodium falciparum , the etiol. agent of the majority of human malaria cases, is compromising elimination efforts.  New approaches to treating drug-resistant malaria benefit from defining resistance liabilities of known antimalarial agents and compds. in development and defining genetic changes that mediate loss of parasite susceptibility.  Here, we present protocols for in vitro selection of drug-resistant parasites and for site-directed gene editing of candidate resistance mediators to test for causality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEsswlUQlg6LVg90H21EOLACvtfcHk0ljrUdTcLpwf0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1ahs78%253D&md5=ab48e78ea27ca7e4389071d6bad17e0a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-9550-9_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-9550-9_9%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DPlasmodium%2520falciparum%2520In%2520vitro%2520drug%2520resistance%2520selections%2520and%2520gene%2520editing%26jtitle%3DMethods%2520Mol.%2520Biol%26date%3D2019%26volume%3D2013%26spage%3D123%26epage%3D140%26doi%3D10.1007%2F978-1-4939-9550-9_9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onguka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foe, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieplak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpornsin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linington, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">The antimalarial natural product salinipostin a identifies essential alpha/beta serine hydrolases involved in lipid metabolism in P. falciparum parasites</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2020.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.chembiol.2020.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31978322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFyitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=143-157&author=E.+Yooauthor=C.+J.+Schulzeauthor=B.+H.+Stokesauthor=O.+Ongukaauthor=T.+Yeoauthor=S.+Mokauthor=N.+F.+Gn%C3%A4digauthor=Y.+Zhouauthor=K.+Kuritaauthor=I.+T.+Foeauthor=S.+M.+Terrellauthor=M.+J.+Boucherauthor=P.+Cieplakauthor=K.+Kumpornsinauthor=M.+C.+S.+Leeauthor=R.+G.+Liningtonauthor=J.+Z.+Longauthor=A.-C.+Uhlemannauthor=E.+Weerapanaauthor=D.+A.+Fidockauthor=M.+Bogyo&title=The+antimalarial+natural+product+salinipostin+a+identifies+essential+alpha%2Fbeta+serine+hydrolases+involved+in+lipid+metabolism+in+P.+falciparum+parasites&doi=10.1016%2Fj.chembiol.2020.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites</span></div><div class="casAuthors">Yoo, Euna; Schulze, Christopher J.; Stokes, Barbara H.; Onguka, Ouma; Yeo, Tomas; Mok, Sachel; Gnadig, Nina F.; Zhou, Yani; Kurita, Kenji; Foe, Ian T.; Terrell, Stephanie M.; Boucher, Michael J.; Cieplak, Piotr; Kumpornsin, Krittikorn; Lee, Marcus C. S.; Linington, Roger G.; Long, Jonathan Z.; Uhlemann, Anne-Catrin; Weerapana, Eranthie; Fidock, David A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-157.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Salinipostin A (Sal A) is a potent antiplasmodial marine natural product with an undefined mechanism of action. Using a Sal A-derived activity-based probe, we identify its targets in the Plasmodium falciparum parasite. All of the identified proteins contain α/β serine hydrolase domains and several are essential for parasite growth. One of the essential targets displays a high degree of homol. to human monoacylglycerol lipase (MAGL) and is able to process lipid esters including a MAGL acylglyceride substrate. This Sal A target is inhibited by the anti-obesity drug Orlistat, which disrupts lipid metab.  Resistance selections yielded parasites that showed only minor redns. in sensitivity and that acquired mutations in a PRELI domain-contg. protein linked to drug resistance in Toxoplasma gondii. This inability to evolve efficient resistance mechanisms combined with the non-essentiality of human homologs makes the serine hydrolases identified here promising antimalarial targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOgOe9iPSaVbVg90H21EOLACvtfcHk0ljrUdTcLpwf0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFyitb0%253D&md5=236485f5855092e9e7e2acde4d3b9ac4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2020.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2020.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DSchulze%26aufirst%3DC.%2BJ.%26aulast%3DStokes%26aufirst%3DB.%2BH.%26aulast%3DOnguka%26aufirst%3DO.%26aulast%3DYeo%26aufirst%3DT.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DKurita%26aufirst%3DK.%26aulast%3DFoe%26aufirst%3DI.%2BT.%26aulast%3DTerrell%26aufirst%3DS.%2BM.%26aulast%3DBoucher%26aufirst%3DM.%2BJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKumpornsin%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DLinington%26aufirst%3DR.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DUhlemann%26aufirst%3DA.-C.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DThe%2520antimalarial%2520natural%2520product%2520salinipostin%2520a%2520identifies%2520essential%2520alpha%252Fbeta%2520serine%2520hydrolases%2520involved%2520in%2520lipid%2520metabolism%2520in%2520P.%2520falciparum%2520parasites%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2020%26volume%3D27%26spage%3D143%26epage%3D157%26doi%3D10.1016%2Fj.chembiol.2020.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipanayis, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luquette, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. J.</span></span> <span> </span><span class="NLM_article-title">Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">E1128</span>– <span class="NLM_lpage">E1136</span>, <span class="refDoi"> DOI: 10.1073/pnas.1110574108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1110574108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22065754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Wis7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E1128-E1136&author=R.+Xiauthor=A.+G.+Hadjipanayisauthor=L.+J.+Luquetteauthor=T.-M.+Kimauthor=E.+Leeauthor=J.+Zhangauthor=M.+D.+Johnsonauthor=D.+M.+Muznyauthor=D.+A.+Wheelerauthor=R.+A.+Gibbsauthor=R.+Kucherlapatiauthor=P.+J.+Park&title=Copy+number+variation+detection+in+whole-genome+sequencing+data+using+the+Bayesian+information+criterion&doi=10.1073%2Fpnas.1110574108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion</span></div><div class="casAuthors">Xi, Ruibin; Hadjipanayis, Angela G.; Luquette, Lovelace J.; Kim, Tae-Min; Lee, Eunjung; Zhang, Jianhua; Johnson, Mark D.; Muzny, Donna M.; Wheeler, David A.; Gibbs, Richard A.; Kucherlapati, Raju; Park, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">E1128-E1136, SE1128/1-SE1128/22</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">DNA copy no. variations (CNVs) play an important role in the pathogenesis and progression of cancer and confer susceptibility to a variety of human disorders.  Array comparative genomic hybridization has been used widely to identify CNVs genome wide, but the next-generation sequencing technol. provides an opportunity to characterize CNVs genome wide with unprecedented resoln.  In this study, the authors developed an algorithm to detect CNVs from whole-genome sequencing data and applied it to a newly sequenced glioblastoma genome with a matched control.  This read-depth algorithm, called BIC-seq, can accurately and efficiently identify CNVs via minimizing the Bayesian information criterion.  Using BIC-seq, the authors identified hundreds of CNVs as small as 40 bp in the cancer genome sequenced at 10x coverage, whereas they could only detect large CNVs (> 15 kb) in the array comparative genomic hybridization profiles for the same genome.  Eighty percent (14/16) of the small variants tested (110 bp to 14 kb) were exptl. validated by quant. PCR, demonstrating high sensitivity and true pos. rate of the algorithm.  The authors also extended the algorithm to detect recurrent CNVs in multiple samples as well as deriving error bars for breakpoints using a Gibbs sampling approach.  The authors propose this statistical approach as a principled yet practical and efficient method to est. CNVs in whole-genome sequencing data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKT3hljOFfJbVg90H21EOLACvtfcHk0lgKDaZPU5Ffgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Wis7nP&md5=862295af13a43f0a9288a572da10bd86</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1110574108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1110574108%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DR.%26aulast%3DHadjipanayis%26aufirst%3DA.%2BG.%26aulast%3DLuquette%26aufirst%3DL.%2BJ.%26aulast%3DKim%26aufirst%3DT.-M.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DP.%2BJ.%26atitle%3DCopy%2520number%2520variation%2520detection%2520in%2520whole-genome%2520sequencing%2520data%2520using%2520the%2520Bayesian%2520information%2520criterion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3DE1128%26epage%3DE1136%26doi%3D10.1073%2Fpnas.1110574108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crighton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katneni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moehrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abla, N.</span></span> <span> </span><span class="NLM_article-title">An in vitro toolbox to accelerate anti-malarial drug discovery and development</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1186/s12936-019-3075-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-019-3075-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31898492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&pages=1&author=S.+A.+Charmanauthor=A.+Andreuauthor=H.+Barkerauthor=S.+Blundellauthor=A.+Campbellauthor=M.+Campbellauthor=G.+Chenauthor=F.+C.+K.+Chiuauthor=E.+Crightonauthor=K.+Katneniauthor=J.+Morizziauthor=R.+Patilauthor=T.+Phamauthor=E.+Ryanauthor=J.+Saundersauthor=D.+M.+Shacklefordauthor=K.+L.+Whiteauthor=L.+Almondauthor=M.+Dickinsauthor=D.+A.+Smithauthor=J.+J.+Moehrleauthor=J.+N.+Burrowsauthor=N.+Abla&title=An+in+vitro+toolbox+to+accelerate+anti-malarial+drug+discovery+and+development&doi=10.1186%2Fs12936-019-3075-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro toolbox to accelerate anti-malarial drug discovery and development</span></div><div class="casAuthors">Charman, Susan A.; Andreu, Alice; Barker, Helena; Blundell, Scott; Campbell, Anna; Campbell, Michael; Chen, Gong; Chiu, Francis C. K.; Crighton, Elly; Katneni, Kasiram; Morizzi, Julia; Patil, Rahul; Pham, Thao; Ryan, Eileen; Saunders, Jessica; Shackleford, David M.; White, Karen L.; Almond, Lisa; Dickins, Maurice; Smith, Dennis A.; Moehrle, Joerg J.; Burrows, Jeremy N.; Abla, Nada</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Modeling and simulation are being increasingly utilized to support the discovery and development of new anti-malarial drugs.  These approaches require reliable in vitro data for physicochem. properties, permeability, binding, intrinsic clearance and cytochrome P 450 inhibition.  This work was conducted to generate an in vitro data toolbox using standardized methods for a set of 45 anti-malarial drugs and to assess changes in physicochem. properties in relation to changing target product and candidate profiles.  Methods: Ionization consts. were detd. by potentiometric titrn. and partition coeffs. were measured using a shake-flask method.  Soly. was assessed in biorelevant media and permeability coeffs. and efflux ratios were detd. using Caco-2 cell monolayers.  Binding to plasma and media proteins was measured using either ultracentrifugation or rapid equil. dialysis.  Metabolic stability and cytochrome P 450 inhibition were assessed using human liver microsomes.  Sample anal. was conducted by LC-MS/MS.  Results: Both soly. and fraction unbound decreased, and permeability and unbound intrinsic clearance increased, with increasing Log D7.4.  In general, development compds. were somewhat more lipophilic than legacy drugs.  For many compds., permeability and protein binding were challenging to assess and both required the use of exptl. conditions that minimized the impact of non-specific binding.  Intrinsic clearance in human liver microsomes was varied across the data set and several compds. exhibited no measurable substrate loss under the conditions used.  Inhibition of cytochrome P 450 enzymes was minimal for most compds.  Conclusions: This is the first data set to describe in vitro properties for 45 legacy and development anti-malarial drugs.  The studies identified several practical methodol. issues common to many of the more lipophilic compds. and highlighted areas which require more work to customize exptl. conditions for compds. being designed to meet the new target product profiles.  The dataset will be a valuable tool for malaria researchers aiming to develop PBPK models for the prediction of human PK properties and/or drug-drug interactions.  Furthermore, generation of this comprehensive data set within a single lab. allows direct comparison of properties across a large dataset and evaluation of changing property trends that have occurred over time with changing target product and candidate profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz-G7Yo6U877Vg90H21EOLACvtfcHk0lgKDaZPU5Ffgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D&md5=a996cd5a032c9042bc957d0bddecbd3b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-3075-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-3075-5%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DAndreu%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DBlundell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DCrighton%26aufirst%3DE.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DAlmond%26aufirst%3DL.%26aulast%3DDickins%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DMoehrle%26aufirst%3DJ.%2BJ.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DAbla%26aufirst%3DN.%26atitle%3DAn%2520in%2520vitro%2520toolbox%2520to%2520accelerate%2520anti-malarial%2520drug%2520discovery%2520and%2520development%26jtitle%3DMalar.%2520J.%26date%3D2020%26volume%3D19%26spage%3D1%26doi%3D10.1186%2Fs12936-019-3075-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katneni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crighton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas-Valentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittimalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span> <span> </span><span class="NLM_article-title">Lead optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series for the treatment of malaria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4929</span>– <span class="NLM_lpage">4956</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtl2lu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4929-4956&author=S.+Kokkondaauthor=X.+Dengauthor=K.+L.+Whiteauthor=F.+El+Mazouniauthor=J.+Whiteauthor=D.+M.+Shacklefordauthor=K.+Katneniauthor=F.+C.+K.+Chiuauthor=H.+Barkerauthor=J.+McLarenauthor=E.+Crightonauthor=G.+Chenauthor=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=S.+Ferrerauthor=L.+Huertas-Valentinauthor=M.+S.+Martinez-Martinezauthor=M.+J.+Lafuente-Monasterioauthor=R.+Chittimallaauthor=S.+P.+Shahiauthor=S.+Wittlinauthor=D.+Watersonauthor=J.+N.+Burrowsauthor=D.+Matthewsauthor=D.+Tomchickauthor=P.+K.+Rathodauthor=M.+J.+Palmerauthor=S.+A.+Charmanauthor=M.+A.+Phillips&title=Lead+optimization+of+a+pyrrole-based+dihydroorotate+dehydrogenase+inhibitor+series+for+the+treatment+of+malaria&doi=10.1021%2Facs.jmedchem.0c00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria</span></div><div class="casAuthors">Kokkonda, Sreekanth; Deng, Xiaoyi; White, Karen L.; El Mazouni, Farah; White, John; Shackleford, David M.; Katneni, Kasiram; Chiu, Francis C. K.; Barker, Helena; McLaren, Jenna; Crighton, Elly; Chen, Gong; Angulo-Barturen, Inigo; Jimenez-Diaz, Maria Belen; Ferrer, Santiago; Huertas-Valentin, Leticia; Martinez-Martinez, Maria Santos; Lafuente-Monasterio, Maria Jose; Chittimalla, Rajesh; Shahi, Shatrughan P.; Wittlin, Sergio; Waterson, David; Burrows, Jeremy N.; Matthews, Dave; Tomchick, Diana; Rathod, Pradipsinh K.; Palmer, Michael J.; Charman, Susan A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4929-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria puts at risk nearly half the world's population and causes high mortality in sub-Saharan Africa, while drug resistance threatens current therapies.  The pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (DHODH) is a validated target for malaria treatment based on our finding that triazolopyrimidine DSM265 (1) showed efficacy in clin. studies.  Herein, we describe optimization of a pyrrole-based series identified using a target-based DHODH screen.  Compds. with nanomolar potency vs. Plasmodium DHODH and Plasmodium parasites were identified with good pharmacol. properties.  X-ray studies showed that the pyrroles bind an alternative enzyme conformation from 1 leading to improved species selectivity vs. mammalian enzymes and equiv. activity on Plasmodium falciparum and Plasmodium vivax DHODH.  The best lead DSM502 (37)(I) showed in vivo efficacy at similar levels of blood exposure to 1, although metabolic stability was reduced.  Overall, the pyrrole-based DHODH inhibitors provide an attractive alternative scaffold for the development of new antimalarial compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKUG8uEm6XLVg90H21EOLACvtfcHk0lgKDaZPU5Ffgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtl2lu7o%253D&md5=33fcfe54e02132d8fd9a4816d40212b3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00311%26sid%3Dliteratum%253Aachs%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DMcLaren%26aufirst%3DJ.%26aulast%3DCrighton%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DHuertas-Valentin%26aufirst%3DL.%26aulast%3DMartinez-Martinez%26aufirst%3DM.%2BS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DChittimalla%26aufirst%3DR.%26aulast%3DShahi%26aufirst%3DS.%2BP.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DTomchick%26aufirst%3DD.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DLead%2520optimization%2520of%2520a%2520pyrrole-based%2520dihydroorotate%2520dehydrogenase%2520inhibitor%2520series%2520for%2520the%2520treatment%2520of%2520malaria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4929%26epage%3D4956%26doi%3D10.1021%2Facs.jmedchem.0c00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baragaña, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimaldi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proto, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagborough, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porzelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolscher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luksch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakutansky, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Díaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noviyanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Bazaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebrevska, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">A novel multiple-stage antimalarial agent that inhibits protein synthesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>522</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nature14451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnature14451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26085270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeiurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=522&publication_year=2015&pages=315-320&author=B.+Baraga%C3%B1aauthor=I.+Hallyburtonauthor=M.+C.+S.+Leeauthor=N.+R.+Norcrossauthor=R.+Grimaldiauthor=T.+D.+Ottoauthor=W.+R.+Protoauthor=A.+M.+Blagboroughauthor=S.+Meisterauthor=G.+Wirjanataauthor=A.+Rueckerauthor=L.+M.+Uptonauthor=T.+S.+Abrahamauthor=M.+J.+Almeidaauthor=A.+Pradhanauthor=A.+Porzelleauthor=M.+S.+Mart%C3%ADnezauthor=J.+M.+Bolscherauthor=A.+Woodlandauthor=T.+Lukschauthor=S.+Norvalauthor=F.+Zuccottoauthor=J.+Thomasauthor=F.+Simeonsauthor=L.+Stojanovskiauthor=M.+Osuna-Cabelloauthor=P.+M.+Brockauthor=T.+S.+Churcherauthor=K.+A.+Salaauthor=S.+E.+Zakutanskyauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=L.+M.+Sanzauthor=J.+Rileyauthor=R.+Basakauthor=M.+Campbellauthor=V.+M.+Averyauthor=R.+W.+Sauerweinauthor=K.+J.+Decheringauthor=R.+Noviyantiauthor=B.+Campoauthor=J.+A.+Frearsonauthor=I.+Angulo-Barturenauthor=S.+Ferrer-Bazagaauthor=F.+J.+Gamoauthor=P.+G.+Wyattauthor=D.+Leroyauthor=P.+Sieglauthor=M.+J.+Delvesauthor=D.+E.+Kyleauthor=S.+Wittlinauthor=J.+Marfurtauthor=R.+N.+Priceauthor=R.+E.+Sindenauthor=E.+A.+Winzelerauthor=S.+A.+Charmanauthor=L.+Bebrevskaauthor=D.+W.+Grayauthor=S.+Campbellauthor=A.+H.+Fairlambauthor=P.+A.+Willisauthor=J.+C.+Raynerauthor=D.+A.+Fidockauthor=K.+D.+Readauthor=I.+H.+Gilbertauthor=I.+H.+Gilbert&title=A+novel+multiple-stage+antimalarial+agent+that+inhibits+protein+synthesis&doi=10.1038%2Fnature14451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A novel multiple-stage antimalarial agent that inhibits protein synthesis</span></div><div class="casAuthors">Baragana, Beatriz; Hallyburton, Irene; Lee, Marcus C. S.; Norcross, Neil R.; Grimaldi, Raffaella; Otto, Thomas D.; Proto, William R.; Blagborough, Andrew M.; Meister, Stephan; Wirjanata, Grennady; Ruecker, Andrea; Upton, Leanna M.; Abraham, Tara S.; Almeida, Mariana J.; Pradhan, Anupam; Porzelle, Achim; Martinez, Maria Santos; Bolscher, Judith M.; Woodland, Andrew; Luksch, Torsten; Norval, Suzanne; Zuccotto, Fabio; Thomas, John; Simeons, Frederick; Stojanovski, Laste; Osuna-Cabello, Maria; Brock, Paddy M.; Churcher, Tom S.; Sala, Katarzyna A.; Zakutansky, Sara E.; Jimenez-Diaz, Maria Belen; Sanz, Laura Maria; Riley, Jennifer; Basak, Rajshekhar; Campbell, Michael; Avery, Vicky M.; Sauerwein, Robert W.; Dechering, Koen J.; Noviyanti, Rintis; Campo, Brice; Frearson, Julie A.; Angulo-Barturen, Inigo; Ferrer-Bazaga, Santiago; Gamo, Francisco Javier; Wyatt, Paul G.; Leroy, Didier; Siegl, Peter; Delves, Michael J.; Kyle, Dennis E.; Wittlin, Sergio; Marfurt, Jutta; Price, Ric N.; Sinden, Robert E.; Winzeler, Elizabeth A.; Charman, Susan A.; Bebrevska, Lidiya; Gray, David W.; Campbell, Simon; Fairlamb, Alan H.; Willis, Paul A.; Rayner, Julian C.; Fidock, David A.; Read, Kevin D.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">522</span>
        (<span class="NLM_cas:issue">7556</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">There is an urgent need for new drugs to treat malaria, with broad therapeutic potential and novel modes of action, to widen the scope of treatment and to overcome emerging drug resistance.  Here we describe the discovery of DDD107498, a compd. with a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite, with good pharmacokinetic properties and an acceptable safety profile.  DDD107498 demonstrates potential to address a variety of clin. needs, including single-dose treatment, transmission blocking and chemoprotection.  DDD107498 was developed from a screening program against blood-stage malaria parasites; its mol. target has been identified as translation elongation factor 2 (eEF2), which is responsible for the GTP-dependent translocation of the ribosome along mRNA, and is essential for protein synthesis.  This discovery of eEF2 as a viable antimalarial drug target opens up new possibilities for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhDYwtxN92qrVg90H21EOLACvtfcHk0lh0vkE_s9zdnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeiurzE&md5=bd5f1dd3c4389aa8a6f193df0aa068a1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnature14451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14451%26sid%3Dliteratum%253Aachs%26aulast%3DBaraga%25C3%25B1a%26aufirst%3DB.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DGrimaldi%26aufirst%3DR.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DProto%26aufirst%3DW.%2BR.%26aulast%3DBlagborough%26aufirst%3DA.%2BM.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DUpton%26aufirst%3DL.%2BM.%26aulast%3DAbraham%26aufirst%3DT.%2BS.%26aulast%3DAlmeida%26aufirst%3DM.%2BJ.%26aulast%3DPradhan%26aufirst%3DA.%26aulast%3DPorzelle%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DBolscher%26aufirst%3DJ.%2BM.%26aulast%3DWoodland%26aufirst%3DA.%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DSimeons%26aufirst%3DF.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DBrock%26aufirst%3DP.%2BM.%26aulast%3DChurcher%26aufirst%3DT.%2BS.%26aulast%3DSala%26aufirst%3DK.%2BA.%26aulast%3DZakutansky%26aufirst%3DS.%2BE.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DBasak%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer-Bazaga%26aufirst%3DS.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DBebrevska%26aufirst%3DL.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26aulast%3DRayner%26aufirst%3DJ.%2BC.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DA%2520novel%2520multiple-stage%2520antimalarial%2520agent%2520that%2520inhibits%2520protein%2520synthesis%26jtitle%3DNature%26date%3D2015%26volume%3D522%26spage%3D315%26epage%3D320%26doi%3D10.1038%2Fnature14451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenviaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graumans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Vegte-Bolmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattabongkot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinetz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5060</span>– <span class="NLM_lpage">5067</span>, <span class="refDoi"> DOI: 10.1128/aac.02727-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.02727-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=24913172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5060-5067&author=K.+L.+Kuhenauthor=A.+K.+Chatterjeeauthor=M.+Rottmannauthor=K.+Gagaringauthor=R.+Borboaauthor=J.+Buenviajeauthor=Z.+Chenauthor=C.+Francekauthor=T.+Wuauthor=A.+Nagleauthor=S.+W.+Barnesauthor=D.+Plouffeauthor=M.+C.+S.+Leeauthor=D.+A.+Fidockauthor=W.+Graumansauthor=M.+van+de+Vegte-Bolmerauthor=G.+J.+van+Gemertauthor=G.+Wirjanataauthor=B.+Sebayangauthor=J.+Marfurtauthor=B.+Russellauthor=R.+Suwanaruskauthor=R.+N.+Priceauthor=F.+Nostenauthor=A.+Tungtaengauthor=M.+Gettayacaminauthor=J.+Sattabongkotauthor=J.+Taylorauthor=J.+R.+Walkerauthor=D.+Tullyauthor=K.+P.+Patraauthor=E.+L.+Flanneryauthor=J.+M.+Vinetzauthor=L.+Reniaauthor=R.+W.+Sauerweinauthor=E.+A.+Winzelerauthor=R.+J.+Glynneauthor=T.+T.+Diagana&title=KAF156+is+an+antimalarial+clinical+candidate+with+potential+for+use+in+prophylaxis%2C+treatment%2C+and+prevention+of+disease+transmission&doi=10.1128%2Faac.02727-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">KAf156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission</span></div><div class="casAuthors">Kuhen, Kelli L.; Chatterjee, Arnab K.; Rottmann, Matthias; Gagaring, Kerstin; Borboa, Rachel; Buenviaje, Jennifer; Chen, Zhong; Francek, Carolyn; Wu, Tao; Nagle, Advait; Barnes, S. Whitney; Plouffe, David; Lee, Marcus C. S.; Fidock, David A.; Graumans, Wouter; van de Vegte-Bolmer, Marga; van Gemert, Geert J.; Wirjanata, Grennady; Sebayang, Boni; Marfurt, Jutta; Russell, Bruce; Suwanarusk, Rossarin; Price, Ric N.; Nosten, Francois; Tungtaeng, Anchalee; Gettayacamin, Montip; Sattabongkot, Jetsumon; Taylor, Jennifer; Walker, John R.; Tully, David; Patra, Kailash P.; Flannery, Erika L.; Vinetz, Joseph M.; Renia, Laurent; Sauerwein, Robert W.; Winzeler, Elizabeth A.; Glynne, Richard J.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5060-5067, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Renewed global efforts toward malaria eradication have highlighted the need for novel antimalarial agents with activity against multiple stages of the parasite life cycle.  We have previously reported the discovery of a novel class of antimalarial compds. in the imidazolopiperazine series that have activity in the prevention and treatment of blood stage infection in a mouse model of malaria.  Consistent with the previously reported activity profile of this series, the clin. candidate KAF156 shows blood schizonticidal activity with 50% inhibitory concns. of 6 to 17.4 nM against P. falciparum drug-sensitive and drug-resistant strains, as well as potent therapeutic activity in a mouse models of malaria with 50, 90, and 99 % EDs of 0.6, 0.9, and 1.4 mg/kg, resp.  When administered prophylactically in a sporozoite challenge mouse model, KAF156 is completely protective as a single oral dose of 10 mg/kg.  Finally, KAF156 displays potent Plasmodium transmission blocking activities both in vitro and in vivo.  Collectively, our data suggest that KAF156, currently under evaluation in clin. trials, has the potential to treat, prevent, and block the transmission of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4QluxrWtdq7Vg90H21EOLACvtfcHk0lhoUM2k0gzeoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK&md5=c97e07e4832e871885546880084be5ca</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1128%2FAAC.02727-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02727-13%26sid%3Dliteratum%253Aachs%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBuenviaje%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DGraumans%26aufirst%3DW.%26aulast%3Dvan%2Bde%2BVegte-Bolmer%26aufirst%3DM.%26aulast%3Dvan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DSebayang%26aufirst%3DB.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTully%26aufirst%3DD.%26aulast%3DPatra%26aufirst%3DK.%2BP.%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DVinetz%26aufirst%3DJ.%2BM.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DKAF156%2520is%2520an%2520antimalarial%2520clinical%2520candidate%2520with%2520potential%2520for%2520use%2520in%2520prophylaxis%252C%2520treatment%252C%2520and%2520prevention%2520of%2520disease%2520transmission%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5060%26epage%3D5067%26doi%3D10.1128%2Faac.02727-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miley, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickles, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pershing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharov, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5555</span>– <span class="NLM_lpage">5560</span>, <span class="refDoi"> DOI: 10.1128/aac.01183-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.01183-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26124159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOltLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=5555-5560&author=G.+P.+Mileyauthor=S.+Pouauthor=R.+Winterauthor=A.+Nilsenauthor=Y.+Liauthor=J.+X.+Kellyauthor=A.+M.+Sticklesauthor=M.+W.+Matherauthor=I.+P.+Forquerauthor=A.+M.+Pershingauthor=K.+Whiteauthor=D.+Shacklefordauthor=J.+Saundersauthor=G.+Chenauthor=L.-M.+Tingauthor=K.+Kimauthor=L.+N.+Zakharovauthor=C.+Doniniauthor=J.+N.+Burrowsauthor=A.+B.+Vaidyaauthor=S.+A.+Charmanauthor=M.+K.+Riscoe&title=ELQ-300+prodrugs+for+enhanced+delivery+and+single-dose+cure+of+malaria&doi=10.1128%2Faac.01183-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria</span></div><div class="casAuthors">Miley, Galen P.; Pou, Sovitj; Winter, Rolf; Nilsen, Aaron; Li, Yuexin; Kelly, Jane X.; Stickles, Allison M.; Mather, Michael W.; Forquer, Isaac P.; Pershing, April M.; White, Karen; Shackleford, David; Saunders, Jessica; Chen, Gong; Ting, Li-Min; Kim, Kami; Zakharov, Lev N.; Donini, Cristina; Burrows, Jeremy N.; Vaidya, Akhil B.; Charman, Susan A.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5555-5560</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">ELQ-300 is a preclin. candidate that targets the liver and blood stages of Plasmodium falciparum, as well as the forms that are crucial to transmission of disease: gametocytes, zygotes, and ookinetes.  A significant obstacle to the clin. development of ELQ-300 is related to its physicochem. properties.  Its relatively poor aq. soly. and high crystallinity limit absorption to the degree that only low blood concns. can be achieved following oral dosing.  While these low blood concns. are sufficient for therapy, the levels are too low to establish an acceptable safety margin required by regulatory agencies for clin. development.  One way to address the challenging physicochem. properties of ELQ-300 is through the development of prodrugs.  Here, we profile ELQ-337, a bioreversible O-linked carbonate ester prodrug of the parent mol.  At the molar equivalent dose of 3 mg/kg of body wt., the delivery of ELQ-300 from ELQ-337 is enhanced by 3- to 4-fold, reaching a max. concn. of drug in serum (Cmax) of 5.9 μM by 6 h after oral administration, and unlike ELQ-300 at any dose, ELQ-337 provides single-dose cures of patent malaria infections in mice at low-single-digit milligram per kg doses.  Our findings show that the prodrug strategy represents a viable approach to overcome the physicochem. limitations of ELQ-300 to deliver the active drug to the bloodstream at concns. sufficient for safety and toxicol. studies, as well as achieving single-dose cures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtvlwGjW4RGbVg90H21EOLACvtfcHk0lhoUM2k0gzeoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOltLzF&md5=aaeb38b2f2ddf3e60abc9e453b3ca11b</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1128%2FAAC.01183-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01183-15%26sid%3Dliteratum%253Aachs%26aulast%3DMiley%26aufirst%3DG.%2BP.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DR.%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DStickles%26aufirst%3DA.%2BM.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DPershing%26aufirst%3DA.%2BM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DShackleford%26aufirst%3DD.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTing%26aufirst%3DL.-M.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DZakharov%26aufirst%3DL.%2BN.%26aulast%3DDonini%26aufirst%3DC.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DELQ-300%2520prodrugs%2520for%2520enhanced%2520delivery%2520and%2520single-dose%2520cure%2520of%2520malaria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D5555%26epage%3D5560%26doi%3D10.1128%2Faac.01183-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelleau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casteras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkman, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neafsey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musset, L.</span></span> <span> </span><span class="NLM_article-title">Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">11672</span>– <span class="NLM_lpage">11677</span>, <span class="refDoi"> DOI: 10.1073/pnas.1507142112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1507142112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26261345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=11672-11677&author=S.+Pelleauauthor=E.+L.+Mossauthor=S.+K.+Dhingraauthor=B.+Volneyauthor=J.+Casterasauthor=S.+J.+Gabryszewskiauthor=S.+K.+Volkmanauthor=D.+F.+Wirthauthor=E.+Legrandauthor=D.+A.+Fidockauthor=D.+E.+Neafseyauthor=L.+Musset&title=Adaptive+evolution+of+malaria+parasites+in+French+Guiana%3A+Reversal+of+chloroquine+resistance+by+acquisition+of+a+mutation+in+pfcrt&doi=10.1073%2Fpnas.1507142112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt</span></div><div class="casAuthors">Pelleau, Stephane; Moss, Eli L.; Dhingra, Satish K.; Volney, Beatrice; Casteras, Jessica; Gabryszewski, Stanislaw J.; Volkman, Sarah K.; Wirth, Dyann F.; Legrand, Eric; Fidock, David A.; Neafsey, Daniel E.; Musset, Lise</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11672-11677</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In regions with high malaria endemicity, the withdrawal of chloroquine (CQ) as first-line treatment of Plasmodium falciparum infections has typically led to the restoration of CQ susceptibility through the reexpansion of the wild-type (WT) allele K76 of the chloroquine resistance transporter gene (pfcrt) at the expense of less fit mutant alleles carrying the CQ resistance (CQR) marker K76T.  In low-transmission settings, such as South America, drug resistance mutations can attain 100% prevalence, thereby precluding the return of WT parasites after the complete removal of drug pressure.  In French Guiana, despite the fixation of the K76T allele, the prevalence of CQR isolates progressively dropped from >90% to <30% during 17 y after CQ withdrawal in 1995.  Using a genome-wide assocn. study with CQ-sensitive (CQS) and CQR isolates, we have identified a single mutation in pfcrt encoding a C350R substitution that is assocd. with the restoration of CQ susceptibility.  Genome editing of the CQR ref. strain 7G8 to incorporate PfCRT C350R caused a complete loss of CQR.  A retrospective mol. survey on 580 isolates collected from 1997 to 2012 identified all C350R mutant parasites as being CQS.  This mutation emerged in 2002 and rapidly spread throughout the P. falciparum population.  The C350R allele is also assocd. with a significant decrease in piperaquine susceptibility in vitro, suggesting that piperaquine pressure in addn. to potential fitness costs assocd. with the 7G8-type CQR pfcrt allele may have selected for this mutation.  These findings have important implications for understanding the evolutionary dynamics of antimalarial drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNflcEeeRkVLVg90H21EOLACvtfcHk0lhoUM2k0gzeoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7rI&md5=0a13742f5aac3842cdf9ce4d516b0b71</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1507142112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1507142112%26sid%3Dliteratum%253Aachs%26aulast%3DPelleau%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DE.%2BL.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DVolney%26aufirst%3DB.%26aulast%3DCasteras%26aufirst%3DJ.%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DVolkman%26aufirst%3DS.%2BK.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DLegrand%26aufirst%3DE.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DNeafsey%26aufirst%3DD.%2BE.%26aulast%3DMusset%26aufirst%3DL.%26atitle%3DAdaptive%2520evolution%2520of%2520malaria%2520parasites%2520in%2520French%2520Guiana%253A%2520Reversal%2520of%2520chloroquine%2520resistance%2520by%2520acquisition%2520of%2520a%2520mutation%2520in%2520pfcrt%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D11672%26epage%3D11677%26doi%3D10.1073%2Fpnas.1507142112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M. H.</span></span> <span> </span><span class="NLM_article-title">The past, present and future of anti-malarial medicines</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">93</span>, <span class="refDoi"> DOI: 10.1186/s12936-019-2724-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-019-2724-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30902052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=93&author=E.+G.+Tseauthor=M.+Korsikauthor=M.+H.+Todd&title=The+past%2C+present+and+future+of+anti-malarial+medicines&doi=10.1186%2Fs12936-019-2724-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future of anti-malarial medicines</span></div><div class="casAuthors">Tse Edwin G; Korsik Marat; Todd Matthew H; Todd Matthew H</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide.  Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact.  Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead.  New drugs are needed, particularly those with new mechanisms of action.  Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine.  A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated.  Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAJgQVEudAeqqcneEtCi92fW6udTcc2ebz577UIHcI3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D&md5=b15a2176b672dff36de8c4ea6cfb6a54</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-2724-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-2724-z%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DE.%2BG.%26aulast%3DKorsik%26aufirst%3DM.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DThe%2520past%252C%2520present%2520and%2520future%2520of%2520anti-malarial%2520medicines%26jtitle%3DMalar.%2520J.%26date%3D2019%26volume%3D18%26spage%3D93%26doi%3D10.1186%2Fs12936-019-2724-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmquist, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span> <span> </span><span class="NLM_article-title">Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3649</span>– <span class="NLM_lpage">3653</span>, <span class="refDoi"> DOI: 10.1021/jm8001026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8001026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3649-3653&author=M.+A.+Phillipsauthor=R.+Gujjarauthor=N.+A.+Malmquistauthor=J.+Whiteauthor=F.+El+Mazouniauthor=J.+Baldwinauthor=P.+K.+Rathod&title=Triazolopyrimidine-based+dihydroorotate+dehydrogenase+inhibitors+with+potent+and+selective+activity+against+the+malaria+parasite+Plasmodium+falciparum&doi=10.1021%2Fjm8001026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitors with Potent and Selective Activity against the Malaria Parasite Plasmodium falciparum</span></div><div class="casAuthors">Phillips, Margaret A.; Gujjar, Ramesh; Malmquist, Nicholas A.; White, John; El Mazouni, Farah; Baldwin, Jeffrey; Rathod, Pradipsinh K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3649-3653</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitor I that is potent (KI = 15 nM) and species-selective (>5000-fold over the human enzyme) was identified by high-throughput screening.  The substituted triazolopyrimidine and its structural analogs were produced by an inexpensive three-step synthesis, and the series showed good assocn. between PfDHODH inhibition and parasite toxicity.  This study has identified the first nanomolar PfDHODH inhibitor with potent antimalarial activity in whole cells (EC50 = 79 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpklJJmj9EM77Vg90H21EOLACvtfcHk0liOHT4s1xcCDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbs%253D&md5=7bdbdc57d346ef3290623adc4aed89ee</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm8001026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001026%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DGujjar%26aufirst%3DR.%26aulast%3DMalmquist%26aufirst%3DN.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DBaldwin%26aufirst%3DJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26atitle%3DTriazolopyrimidine-based%2520dihydroorotate%2520dehydrogenase%2520inhibitors%2520with%2520potent%2520and%2520selective%2520activity%2520against%2520the%2520malaria%2520parasite%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3649%26epage%3D3653%26doi%3D10.1021%2Fjm8001026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HTS-based identification of compounds that inhibit growth of <i>P. falciparum</i> 3D7 ABS parasites. (A) Range of <i>Z</i>′ values observed for 384-well plates covering the 8K screening library. The black bar shows the mean ± standard deviation (std dev). (B) Representative concentration response curves for validated hits vs 3D7 parasites. Data for each drug concentration were collected in triplicate wells, and error bars represent the std dev. Data were fitted to the log(<i>I</i>) vs response—four-parameter variable slope equation in GraphPad Prism. Replicate data were subsequently collected, yielding the following EC<sub>50</sub>’s: <b>1</b>, 0.31 ± 0.10 μM; <b>2</b>, 0.71 ± 0.075 μM; and <b>3</b>, 3.5 ± 0.71 μM, where errors are the std dev for at least three independent biological replicates. (C) BRRoK rate of kill assay. Serial log-fold dilutions of compounds from 30× EC<sub>50</sub> to 0.33× EC<sub>50</sub> were incubated for 6 h with NF54-luc parasites, and viability was assessed by bioluminescence at the end of the incubation. Bioluminescence signals normalized to untreated controls are plotted and represent mean ± std dev from triplicate wells. EC<sub>50</sub> values against 3D7 parasites were determined in standard 72 h SYBR Green assays prior to the start of the study and were used as indicated for compounds <b>1–3</b>. Benchmark compounds included artemisinin, ART (fast-kill) (EC<sub>50</sub> = 0.013 μM), chloroquine, CQ (fast-kill) (EC<sub>50</sub> = 0.014 μM), atovaquone, ATQ (slow-kill) (EC<sub>50</sub> = 0.0013 μM), and DSM265 (slow-kill) (EC<sub>50</sub> = 0.0050 μM), with EC<sub>50</sub> values used to calculate compound concentrations for the study indicated in parenthesis. Similar EC<sub>50</sub> values were obtained versus NF54-luc parasites using bioluminescence as a readout in a 72 h assay (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Antimalarial Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Relative rate of kill of <b>10</b> vs control antimalarials. (A) BRRoK rate of kill assay. Conditions used were as described in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. The mean EC<sub>50</sub> for <b>10</b> was 0.32 μM, as determined using 72 h SBYR Green assays. DSM265 and ART controls were collected simultaneously to the <b>10</b> data. CQ data were replotted from <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and are provided again in this plot as a reference. (B) Kill rate determination using two-color FACS analysis. Benchmark compounds are described above. Pyrimethamine (PYR) was included as a medium rate of the kill compound. Compounds were plated at 10× EC<sub>50</sub>, where EC<sub>50</sub> values, determined using 48 h hypoxanthine assays, were <b>10</b> (1.7 μM), CQ (0.021 μM), ART (0.03 μM), PYR (0.094 μM), and ATQ (0.001 μM). (C) PRR washout assay. Data show % parasite survival vs h of drug treatment prior to drug washout and replating. PYR data were collected simultaneously to <b>10</b>. CQ and ART data are historical control data collected in a separate study<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and provided as a reference. Triplicate data were collected at each compound concentration, symbols represent the mean, and error bars represent the std dev.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reduced efficacy of <b>3</b>-analogues containing 5-Pyr against <i>P. falciparum</i> Dd2 compared to 3D7 parasites. Comparison of representative concentration response curves for tetrazoles <b>9</b> (A) and <b>10</b> (B) and for amides <b>26</b> (C) and <b>27</b> (D), tested against 3D7 (green circles) and Dd2 (black squares) parasites. Results showed that compounds containing 5-Pyr have poorer activity against Dd2 than do compounds containing 3-Py in the B-ring. Compound structures are shown above the graphs. Data were fitted to the [<i>I</i>] vs response, variable slope (four parameter) equation in GraphPad Prism to determine the EC<sub>50</sub>. Triplicate data were collected at each concentration, symbols represent the mean, and error bars represent the std dev. EC<sub>50</sub> data are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, which contain average data for at least three biological replicates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Biphasic growth curves were observed for select 5-Pyr <b>3</b>-series compounds assayed against Dd2 parasites. Comparison of representative concentration response curves for tetrazoles <b>12</b> (A) and <b>13</b> (B) and for amide <b>30</b> (C) tested against 3D7 (green circles) and Dd2 (black squares) parasites. Compound structures are displayed above the graphs. Triplicate data were collected at each concentration, symbols represent the mean, and error bars represent the std dev. EC<sub>50</sub> data and curve fitting methods are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. β-Hematin inhibition assay (βHIA) for <b>3</b>-series compounds in comparison to antimalarial control compounds. (A) Representative titration data showing inhibition of β-hematin formation vs concentration profiles for <b>3</b>, <b>9</b>, and <b>10</b> in comparison to known antimalarials, using the β-hematin inhibition assay (βHIA).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Positive (pyronaridine, amodiaquine, CQ, and MFQ) and negative controls were assayed, with the latter representing a diverse set of MOAs (the DHODH inhibitor DSM1,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> artesunate, sulfadoxine, and doxycycline). Data show the mean ± std dev for duplicate data at each compound concentration. Data were fitted to the sigmoidal concentration response (variable slope) equation in GraphPad Prism to determine the IC<sub>50</sub>. (B) Fitted IC<sub>50</sub> values. Data represent the mean ± std dev for four independent studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/medium/jm0c02022_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular heme fractionation and concentration response versus parasite survival. Data are shown for (A) CQ, the positive control, for (B) PYR, the negative control, and for two <b>3</b>-analogues, (C) compound <b>9</b> and (D) compound <b>10</b>. Panels (i,ii) Heme species present as “free” heme (panel i) and Hz Fe (fg) (panel ii) isolated per cell from drug-treated <i>Pf</i>NF54 parasites. Data represent the mean ± std dev from three biological replicates, each arising from two technical replicates (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S3</a>). Panel (iii) Overlay of parasite survival with the total amount of “free” heme-Fe as a function of drug concentration. Free heme data represent the mean ± std dev from three biological replicates (taken from panels i), while representative parasite survival data from one biological replicate with technical duplicates is displayed (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S2A</a> for average EC<sub>50</sub>’s from three biological replicates). Data were fitted to the sigmoidal concentration response (variable slope) equation in GraphPad Prism. Calculated EC<sub>50</sub> values for the drug concentration giving 50% response are as follows: CQ, 58 nM (heme) and 15 nM (survival); PYR, >100 nM (heme) and 33 nM (survival); cmpd <b>9</b>, 620 nM (heme) and 440 nM (survival); and cmpd <b>10</b>, 1040 nM (heme) and 910 nM (survival). See <a href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf" class="ext-link">Table S2A,B</a> for error analysis. Significance was assessed using a two-tailed Welch’s <i>t</i>-test, where * <0.05, ** <0.01, and *** <0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02022/20210305/images/large/jm0c02022_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02022&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 90 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>World Malaria Report</i>. <a href="https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020" class="extLink">https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020</a>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=World+Health+Organization&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyando, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17050</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2017.50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnrdp.2017.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28770814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17050&author=M.+A.+Phillipsauthor=J.+N.+Burrowsauthor=C.+Manyandoauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhisauthor=T.+N.+C.+Wells&title=Malaria&doi=10.1038%2Fnrdp.2017.50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">Phillips Margaret A; Burrows Jeremy N; van Huijsduijnen Rob Hooft; Wells Timothy N C; Manyando Christine; Van Voorhis Wesley C</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17050</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is caused in humans by five species of single-celled eukaryotic Plasmodium parasites (mainly Plasmodium falciparum and Plasmodium vivax) that are transmitted by the bite of Anopheles spp. mosquitoes.  Malaria remains one of the most serious infectious diseases; it threatens nearly half of the world's population and led to hundreds of thousands of deaths in 2015, predominantly among children in Africa.  Malaria is managed through a combination of vector control approaches (such as insecticide spraying and the use of insecticide-treated bed nets) and drugs for both treatment and prevention.  The widespread use of artemisinin-based combination therapies has contributed to substantial declines in the number of malaria-related deaths; however, the emergence of drug resistance threatens to reverse this progress.  Advances in our understanding of the underlying molecular basis of pathogenesis have fuelled the development of new diagnostics, drugs and insecticides.  Several new combination therapies are in clinical development that have efficacy against drug-resistant parasites and the potential to be used in single-dose regimens to improve compliance.  This ambitious programme to eliminate malaria also includes new approaches that could yield malaria vaccines or novel vector control strategies.  However, despite these achievements, a well-coordinated global effort on multiple fronts is needed if malaria elimination is to be achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcfdgTdv0RVI2y4bB4mnvYfW6udTcc2eZLDvxPRxN-b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D&md5=ec450ab6baef0a6c2b6bd6bac030771a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.50%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DManyando%26aufirst%3DC.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DMalaria%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2017%26volume%3D3%26spage%3D17050%26doi%3D10.1038%2Fnrdp.2017.50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanboonkunupakarn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">The threat of antimalarial drug resistance</span>. <i>Trop Dis Travel Med Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/s40794-016-0027-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs40794-016-0027-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28883954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC1cblvFSqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=10&author=B.+Hanboonkunupakarnauthor=N.+J.+White&title=The+threat+of+antimalarial+drug+resistance&doi=10.1186%2Fs40794-016-0027-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The threat of antimalarial drug resistance</span></div><div class="casAuthors">Hanboonkunupakarn Borimas; Hanboonkunupakarn Borimas; White Nicholas J; White Nicholas J</div><div class="citationInfo"><span class="NLM_cas:title">Tropical diseases, travel medicine and vaccines</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn">2055-0936</span>.
    </div><div class="casAbstract">The battle between man and malaria has continued for thousands of years.  Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria control and jeopardizing renewed hopes for elimination.  As 2016 is the first year under WHO Global Technical Strategy for Malaria 2016-2030, it is a good time to ponder the progress of both sides and plan for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTTkMenqw7Vsyail4HZd-ifW6udTcc2ea44AQzPDtWk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cblvFSqsw%253D%253D&md5=6835aad4d563aafe3a09a5895dffc4a0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Fs40794-016-0027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40794-016-0027-8%26sid%3Dliteratum%253Aachs%26aulast%3DHanboonkunupakarn%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520threat%2520of%2520antimalarial%2520drug%2520resistance%26jtitle%3DTrop%2520Dis%2520Travel%2520Med%2520Vaccines%26date%3D2016%26volume%3D2%26spage%3D10%26doi%3D10.1186%2Fs40794-016-0027-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1038/nm.4381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnm.4381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28777791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=917-928&author=B.+Blascoauthor=D.+Leroyauthor=D.+A.+Fidock&title=Antimalarial+drug+resistance%3A+linking+Plasmodium+falciparum+parasite+biology+to+the+clinic&doi=10.1038%2Fnm.4381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic</span></div><div class="casAuthors">Blasco, Benjamin; Leroy, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">917-928</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The global adoption of artemisinin-based combination therapies (ACTs) in the early 2000s heralded a new era in effectively treating drug-resistant Plasmodium falciparum malaria.  However, several Southeast Asian countries have now reported the emergence of parasites that have decreased susceptibility to artemisinin (ART) derivs. and ACT partner drugs, resulting in increasing rates of treatment failures.  Here we review recent advances in understanding how antimalarials act and how resistance develops, and discuss new strategies for effectively combating resistance, optimizing treatment and advancing the global campaign to eliminate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbN71qlYUi97Vg90H21EOLACvtfcHk0lgB9yZeRNtnRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO&md5=832e6fdea00ba5ddc25308c682758eb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm.4381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4381%26sid%3Dliteratum%253Aachs%26aulast%3DBlasco%26aufirst%3DB.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DAntimalarial%2520drug%2520resistance%253A%2520linking%2520Plasmodium%2520falciparum%2520parasite%2520biology%2520to%2520the%2520clinic%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D917%26epage%3D928%26doi%3D10.1038%2Fnm.4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanboonkunupakarn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Advances and roadblocks in the treatment of malaria</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1111/bcp.14474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fbcp.14474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=32656850" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=B.+Hanboonkunupakarnauthor=N.+J.+White&title=Advances+and+roadblocks+in+the+treatment+of+malaria&doi=10.1111%2Fbcp.14474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fbcp.14474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.14474%26sid%3Dliteratum%253Aachs%26aulast%3DHanboonkunupakarn%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DAdvances%2520and%2520roadblocks%2520in%2520the%2520treatment%2520of%2520malaria%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2020%26doi%3D10.1111%2Fbcp.14474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Artemisinin action and resistance in Plasmodium falciparum</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2016.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27289273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=682-696&author=L.+Tilleyauthor=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=S.+A.+Ralphauthor=D.+A.+Fidock&title=Artemisinin+action+and+resistance+in+Plasmodium+falciparum&doi=10.1016%2Fj.pt.2016.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin Action and Resistance in Plasmodium falciparum</span></div><div class="casAuthors">Tilley, Leann; Straimer, Judith; Gnadig, Nina F.; Ralph, Stuart A.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">682-696</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The worldwide use of artemisinin-based combination therapies (ACTs) has contributed in recent years to a substantial redn. in deaths resulting from Plasmodium falciparum malaria.  Resistance to artemisinins, however, has emerged in Southeast Asia.  Clin., resistance is defined as a slower rate of parasite clearance in patients treated with an artemisinin deriv. or an ACT.  These slow clearance rates assoc. with enhanced survival rates of ring-stage parasites briefly exposed in vitro to dihydroartemisinin.  We describe recent progress made in defining the mol. basis of artemisinin resistance, which has identified a primary role for the P. falciparum K13 protein.  Using K13 mutations as mol. markers, epidemiol. studies are now tracking the emergence and spread of artemisinin resistance.  Mechanistic studies suggest potential ways to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTqDTZppoE1bVg90H21EOLACvtfcHk0litx-oNo0QJYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D&md5=8a1cb66eab2962ca73ea6d6e2cbf8f21</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DArtemisinin%2520action%2520and%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D682%26epage%3D696%26doi%3D10.1016%2Fj.pt.2016.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Intharabut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingston, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinamon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepniewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin resistance and stage dependency of parasite clearance in falciparum malaria</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>219</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiy673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1093%2Finfdis%2Fjiy673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30657916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlGnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2019&pages=1483-1489&author=B.+Intharabutauthor=H.+W.+Kingstonauthor=K.+Srinamonauthor=E.+A.+Ashleyauthor=M.+Imwongauthor=M.+Dhordaauthor=C.+Woodrowauthor=K.+Stepniewskaauthor=K.+Silamutauthor=N.+P.+J.+Dayauthor=A.+M.+Dondorpauthor=N.+J.+White&title=Artemisinin+resistance+and+stage+dependency+of+parasite+clearance+in+falciparum+malaria&doi=10.1093%2Finfdis%2Fjiy673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance and stage dependency of parasite clearance in falciparum malaria</span></div><div class="casAuthors">Intharabut, Benjamas; Kingston, Hugh W.; Srinamon, Ketsanee; Ashley, Elizabeth A.; Imwong, Mallika; Dhorda, Mehul; Woodrow, Charles; Stepniewska, Kasia; Silamut, Kamolrat; Day, Nicholas P. J.; Dondorp, Arjen M.; White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1483-1489</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Artemisinin resistance in falciparum malaria is assocd. with kelch13 propeller mutations, reduced ring stage parasite killing, and, consequently, slow parasite clearance.  We assessed how parasite age affects parasite clearance in artemisinin resistance.  Developmental stages of Plasmodium falciparum parasites on blood films performed at hospital admission and their kelch13 genotypes were assessed for 816 patients enrolled in a multinational clin. trial of artemisinin combination therapy.  Early changes in parasitemia level (ie, 0-6 h after admission) were detd. mainly by modal stage of asexual parasite development, whereas the subsequent log-linear decline was detd. mainly by kelch13 propeller mutations.  Older circulating parasites on admission were assocd. with more-rapid parasite clearance, particularly in kelch13 mutant infections.  The geometric mean parasite clearance half-life decreased by 11.6% (95% CI 3.4%-19.1%) in kelch13 wild-type infections and by 30% (95% CI 17.8%-40.4%) in kelch13 mutant infections as the mean age of circulating parasites rose from 3 to 21 h.  Conclusion.  Following the start of antimalarial treatment, ongoing parasite sequestration and schizogony both affect initial changes in parasitemia.  The greater dependency of parasite clearance half-life on parasite age in artemisinin resistant infections is consistent with ring stage resistance and consequent parasite clearance by sequestration.  The stage of parasite development should be incorporated in individual assessments of artemisinin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSyKbnArB51rVg90H21EOLACvtfcHk0litx-oNo0QJYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlGnu7g%253D&md5=664cad0f1017bb564b1ff8c6243a0e55</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiy673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiy673%26sid%3Dliteratum%253Aachs%26aulast%3DIntharabut%26aufirst%3DB.%26aulast%3DKingston%26aufirst%3DH.%2BW.%26aulast%3DSrinamon%26aufirst%3DK.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DWoodrow%26aufirst%3DC.%26aulast%3DStepniewska%26aufirst%3DK.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DDay%26aufirst%3DN.%2BP.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DArtemisinin%2520resistance%2520and%2520stage%2520dependency%2520of%2520parasite%2520clearance%2520in%2520falciparum%2520malaria%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2019%26volume%3D219%26spage%3D1483%26epage%3D1489%26doi%3D10.1093%2Finfdis%2Fjiy673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span> <span> </span><span class="NLM_article-title">K13, the cytostome, and artemisinin resistance</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2020.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2020.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=32359872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntFCmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2020&pages=533-544&author=S.+C.+Xieauthor=S.+A.+Ralphauthor=L.+Tilley&title=K13%2C+the+cytostome%2C+and+artemisinin+resistance&doi=10.1016%2Fj.pt.2020.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">K13, the Cytostome, and Artemisinin Resistance</span></div><div class="casAuthors">Xie, Stanley C.; Ralph, Stuart A.; Tilley, Leann</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-544</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Artemisinins the frontline antimalarial drug class are compromised by emerging resistance, putting at risk the lives of hundreds of thousands of people each year.  Resistance is assocd. with mutations in a malaria parasite protein, called Kelch 13 (K13).  Recent work suggests that K13 is located at the cytostome (cell mouth) that the parasite uses to take up Hb.  Here we explore the proposal that K13 mutations confer artemisinin resistance by dampening Hb endocytosis.  This model suggests that the resultant decrease in Hb-derived heme reduces artemisinin activation, which is sufficient to enable parasite survival in the early ring stage of infection.  A fuller understanding of the resistance mechanism will underpin efforts to develop alternative antimalarial strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5KtqLFMyUo7Vg90H21EOLACvtfcHk0litx-oNo0QJYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntFCmt70%253D&md5=8da990185af4ac8437f78e458acdea44</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2020.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2020.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DTilley%26aufirst%3DL.%26atitle%3DK13%252C%2520the%2520cytostome%252C%2520and%2520artemisinin%2520resistance%26jtitle%3DTrends%2520Parasitol.%26date%3D2020%26volume%3D36%26spage%3D533%26epage%3D544%26doi%3D10.1016%2Fj.pt.2020.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug resistance: a threat to malaria elimination</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a025619</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a025619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1101%2Fcshperspect.a025619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28289248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisFKqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a025619&author=D.+Menardauthor=A.+Dondorp&title=Antimalarial+drug+resistance%3A+a+threat+to+malaria+elimination&doi=10.1101%2Fcshperspect.a025619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: a threat to malaria elimination</span></div><div class="casAuthors">Menard, Didier; Dondorp, Arjen</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a025619/1-a025619/25</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Increasing antimalarial drug resistance once again threatens effective antimalarial drug treatment, malaria control, and elimination.  Artemisinin combination therapies (ACTs) are first-line treatment for uncomplicated falciparum malaria in all endemic countries, yet partial resistance to artemisinins has emerged in the Greater Mekong Subregion.  Concomitant emergence of partner drug resistance is now causing high ACT treatment failure rates in several areas.  Genetic markers for artemisinin resistance and several of the partner drugs have been established, greatly facilitating surveillance.  Single point mutations in the gene coding for the Kelch propeller domain of the K13 protein strongly correlate with artemisinin resistance.  Novel regimens and strategies using existing antimalarial drugs will be needed until novel compds. can be deployed.  Elimination of artemisinin resistance will imply elimination of all falciparum malaria from the same areas.  In vivax malaria, chloroquine resistance is an increasing problem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAcvouDhij-7Vg90H21EOLACvtfcHk0li361t2IVxgsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisFKqurw%253D&md5=77170984fbae885dc193c9e0c9b3f6e5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025619%26sid%3Dliteratum%253Aachs%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DDondorp%26aufirst%3DA.%26atitle%3DAntimalarial%2520drug%2520resistance%253A%2520a%2520threat%2520to%2520malaria%2520elimination%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da025619%26doi%3D10.1101%2Fcshperspect.a025619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Pluijm, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoa, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Nhien, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jittamala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanboonkunupakarn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chutasmit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saelow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runjarern, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaewmok, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waithira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maude, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span> <span> </span><span class="NLM_article-title">Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(19)30391-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2FS1473-3099%2819%2930391-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31345710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVeltb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=952-961&author=R.+W.+van%0Ader+Pluijmauthor=M.+Imwongauthor=N.+H.+Chauauthor=N.+T.+Hoaauthor=N.+T.+Thuy-Nhienauthor=N.+V.+Thanhauthor=P.+Jittamalaauthor=B.+Hanboonkunupakarnauthor=K.+Chutasmitauthor=C.+Saelowauthor=R.+Runjarernauthor=W.+Kaewmokauthor=R.+Tripuraauthor=T.+J.+Petoauthor=S.+Yokauthor=S.+Suonauthor=S.+Srengauthor=S.+Maoauthor=S.+Ounauthor=S.+Yenauthor=C.+Amaratungaauthor=D.+Lekauthor=R.+Huyauthor=M.+Dhordaauthor=K.+Chotivanichauthor=E.+A.+Ashleyauthor=M.+Mukakaauthor=N.+Waithiraauthor=P.+Y.+Cheahauthor=R.+J.+Maudeauthor=R.+Amatoauthor=R.+D.+Pearsonauthor=S.+Gon%C3%A7alvesauthor=C.+G.+Jacobauthor=W.+L.+Hamiltonauthor=R.+M.+Fairhurstauthor=J.+Tarningauthor=M.+Winterbergauthor=D.+P.+Kwiatkowskiauthor=S.+Pukrittayakameeauthor=T.+T.+Hienauthor=N.+P.+Dayauthor=O.+Miottoauthor=N.+J.+Whiteauthor=A.+M.+Dondorp&title=Determinants+of+dihydroartemisinin-piperaquine+treatment+failure+in+Plasmodium+falciparum+malaria+in+Cambodia%2C+Thailand%2C+and+Vietnam%3A+a+prospective+clinical%2C+pharmacological%2C+and+genetic+study&doi=10.1016%2Fs1473-3099%2819%2930391-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study</span></div><div class="casAuthors">van der Pluijm, Rob W.; Imwong, Mallika; Chau, Nguyen Hoang; Hoa, Nhu Thi; Thuy-Nhien, Nguyen Thanh; Thanh, Ngo Viet; Jittamala, Podjanee; Hanboonkunupakarn, Borimas; Chutasmit, Kitipumi; Saelow, Chalermpon; Runjarern, Ratchadaporn; Kaewmok, Weerayuth; Tripura, Rupam; Peto, Thomas J.; Yok, Sovann; Suon, Seila; Sreng, Sokunthea; Mao, Sivanna; Oun, Savuth; Yen, Sovannary; Amaratunga, Chanaki; Lek, Dysoley; Huy, Rekol; Dhorda, Mehul; Chotivanich, Kesinee; Ashley, Elizabeth A.; Mukaka, Mavuto; Waithira, Naomi; Cheah, Phaik Yeong; Maude, Richard J.; Amato, Roberto; Pearson, Richard D.; Goncalves, Sonia; Jacob, Christopher G.; Hamilton, William L.; Fairhurst, Rick M.; Tarning, Joel; Winterberg, Markus; Kwiatkowski, Dominic P.; Pukrittayakamee, Sasithon; Hien, Tran Tinh; Day, Nicholas P. J.; Miotto, Olivo; White, Nicholas J.; Dondorp, Arjen M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">952-961</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The current study is part of a multi-country, open-label, randomised clin. trial (TRACII, 2015-18) evaluating the efficacy, safety, and tolerability of triple artemisinin combination therapies.  A very high rate of treatment failure after treatment with dihydroartemisinin-piperaquine was obsd. in Thailand, Cambodia, and Vietnam.  Patients aged between 2 and 65 years presenting with uncomplicated P falciparum or mixed species malaria at seven sites in Thailand, Cambodia, and Vietnam were randomly assigned to receive dihydroartemisinin-piperaquine with or without mefloquine, as part of the TRACII trial.  The primary outcome was the PCR-cor. efficacy at day 42.  Next-generation sequencing was used to assess the prevalence of mol. markers assocd. with artemisinin resistance (kelch13 mutations, in particular Cys580Tyr) and piperaquine resistance (plasmepsin-2 and plasmepsin-3 amplifications and crt mutations).  Between Sept 28, 2015, and Jan 18, 2018, 539 patients with acute P falciparum malaria were screened for eligibility, 292 were enrolled, and 140 received dihydroartemisinin-piperaquine.  The overall Kaplan-Meier est. of PCR-cor. efficacy of dihydroartemisinin-piperaquine at day 42 was 50·0% (95% CI 41·1-58·3).  Treatment failure was assocd. independently with plasmepsin2/3 amplification status and four mutations in the crt gene (Thr93Ser, His97Tyr, Phe145Ile, and Ile218Phe).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpscjzMhmc-97Vg90H21EOLACvtfcHk0li361t2IVxgsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVeltb%252FJ&md5=e2c8bf51cf812518a46186a49a07894f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2819%2930391-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252819%252930391-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DR.%2BW.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChau%26aufirst%3DN.%2BH.%26aulast%3DHoa%26aufirst%3DN.%2BT.%26aulast%3DThuy-Nhien%26aufirst%3DN.%2BT.%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DHanboonkunupakarn%26aufirst%3DB.%26aulast%3DChutasmit%26aufirst%3DK.%26aulast%3DSaelow%26aufirst%3DC.%26aulast%3DRunjarern%26aufirst%3DR.%26aulast%3DKaewmok%26aufirst%3DW.%26aulast%3DTripura%26aufirst%3DR.%26aulast%3DPeto%26aufirst%3DT.%2BJ.%26aulast%3DYok%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DOun%26aufirst%3DS.%26aulast%3DYen%26aufirst%3DS.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLek%26aufirst%3DD.%26aulast%3DHuy%26aufirst%3DR.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DMukaka%26aufirst%3DM.%26aulast%3DWaithira%26aufirst%3DN.%26aulast%3DCheah%26aufirst%3DP.%2BY.%26aulast%3DMaude%26aufirst%3DR.%2BJ.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DPearson%26aufirst%3DR.%2BD.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DS.%26aulast%3DJacob%26aufirst%3DC.%2BG.%26aulast%3DHamilton%26aufirst%3DW.%2BL.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DWinterberg%26aufirst%3DM.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26atitle%3DDeterminants%2520of%2520dihydroartemisinin-piperaquine%2520treatment%2520failure%2520in%2520Plasmodium%2520falciparum%2520malaria%2520in%2520Cambodia%252C%2520Thailand%252C%2520and%2520Vietnam%253A%2520a%2520prospective%2520clinical%252C%2520pharmacological%252C%2520and%2520genetic%2520study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2019%26volume%3D19%26spage%3D952%26epage%3D961%26doi%3D10.1016%2Fs1473-3099%2819%2930391-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hovlid, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Phenotypic screens in antimalarial drug discovery</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2016.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27247245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVCgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=697-707&author=M.+L.+Hovlidauthor=E.+A.+Winzeler&title=Phenotypic+screens+in+antimalarial+drug+discovery&doi=10.1016%2Fj.pt.2016.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic Screens in Antimalarial Drug Discovery</span></div><div class="casAuthors">Hovlid, Marisa L.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phenotypic high-throughput screens are a valuable tool for identifying new chem. compds. with antimalarial activity.  Traditionally, these screens have focused solely on the symptomatic asexual blood stage of the parasite life cycle; however, to discover new medicines for malaria treatment and prevention, robust screening technologies against other parasite life-cycle stages are required.  This review highlights recent advances and progress toward phenotypic screening methodologies over the past several years, with a focus on exoerythrocytic stage screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXuC2T-aeVzrVg90H21EOLACvtfcHk0liSP1ncYuVt0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVCgsbs%253D&md5=591911796d7781522d9a890002426396</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DHovlid%26aufirst%3DM.%2BL.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DPhenotypic%2520screens%2520in%2520antimalarial%2520drug%2520discovery%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D697%26epage%3D707%26doi%3D10.1016%2Fj.pt.2016.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherbuin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanneret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug discovery - the path towards eradication</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1017/s0031182013000826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1017%2FS0031182013000826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23863111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=128-139&author=J.+N.+Burrowsauthor=E.+Burlotauthor=B.+Campoauthor=S.+Cherbuinauthor=S.+Jeanneretauthor=D.+Leroyauthor=T.+Spangenbergauthor=D.+Watersonauthor=T.+N.+Wellsauthor=P.+Willis&title=Antimalarial+drug+discovery+-+the+path+towards+eradication&doi=10.1017%2Fs0031182013000826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - the path towards eradication</span></div><div class="casAuthors">Burrows Jeremy N; Burlot Emilie; Campo Brice; Cherbuin Stephanie; Jeanneret Sarah; Leroy Didier; Spangenberg Thomas; Waterson David; Wells Timothy Nc; Willis Paul</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is a disease that still affects a significant proportion of the global human population.  Whilst advances have been made in lowering the numbers of cases and deaths, it is clear that a strategy based solely on disease control year on year, without reducing transmission and ultimately eradicating the parasite, is unsustainable.  This article highlights the current mainstay treatments alongside a selection of emerging new clinical molecules from the portfolio of Medicines for Malaria Venture (MMV) and our partners.  In each case, the key highlights from each research phase are described to demonstrate how these new potential medicines were discovered.  Given the increased focus of the community on eradicating the disease, the strategy for next generation combination medicines that will provide such potential is explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3YKOgrIcfkIvKgEt20y1XfW6udTcc2ea-ehkGqDm7ebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D&md5=24b1b3b746eb152a54f68c090cad3421</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FS0031182013000826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182013000826%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DBurlot%26aufirst%3DE.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DCherbuin%26aufirst%3DS.%26aulast%3DJeanneret%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DSpangenberg%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3DWillis%26aufirst%3DP.%26atitle%3DAntimalarial%2520drug%2520discovery%2520-%2520the%2520path%2520towards%2520eradication%26jtitle%3DParasitology%26date%3D2014%26volume%3D141%26spage%3D128%26epage%3D139%26doi%3D10.1017%2Fs0031182013000826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharia, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Paez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jegla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">Spiroindolones, a potent compound class for the treatment of malaria</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1126/science.1193225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.1193225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=20813948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=1175-1180&author=M.+Rottmannauthor=C.+McNamaraauthor=B.+K.+S.+Yeungauthor=M.+C.+S.+Leeauthor=B.+Zouauthor=B.+Russellauthor=P.+Seitzauthor=D.+M.+Plouffeauthor=N.+V.+Dhariaauthor=J.+Tanauthor=S.+B.+Cohenauthor=K.+R.+Spencerauthor=G.+E.+Gonzalez-Paezauthor=S.+B.+Lakshminarayanaauthor=A.+Gohauthor=R.+Suwanaruskauthor=T.+Jeglaauthor=E.+K.+Schmittauthor=H.-P.+Beckauthor=R.+Brunauthor=F.+Nostenauthor=L.+Reniaauthor=V.+Dartoisauthor=T.+H.+Kellerauthor=D.+A.+Fidockauthor=E.+A.+Winzelerauthor=T.+T.+Diagana&title=Spiroindolones%2C+a+potent+compound+class+for+the+treatment+of+malaria&doi=10.1126%2Fscience.1193225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Spiroindolones, a Potent Compound Class for the Treatment of Malaria</span></div><div class="casAuthors">Rottmann, Matthias; McNamara, Case; Yeung, Bryan K. S.; Lee, Marcus C. S.; Zou, Bin; Russell, Bruce; Seitz, Patrick; Plouffe, David M.; Dharia, Neekesh V.; Tan, Jocelyn; Cohen, Steven B.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Lakshminarayana, Suresh B.; Goh, Anne; Suwanarusk, Rossarin; Jegla, Timothy; Schmitt, Esther K.; Beck, Hans-Peter; Brun, Reto; Nosten, Francois; Renia, Laurent; Dartois, Veronique; Keller, Thomas H.; Fidock, David A.; Winzeler, Elizabeth A.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">5996</span>),
    <span class="NLM_cas:pages">1175-1180</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Recent reports of increased tolerance to artemisinin derivs.-the most recently adopted class of antimalarials-have prompted a need for new treatments.  The spirotetrahydro-β-carbolines, or spiroindolones, are potent drugs that kill the blood stages of Plasmodium falciparum and Plasmodium vivax clin. isolates at low nanomolar concn.  Spiroindolones rapidly inhibit protein synthesis in P. falciparum, an effect that is ablated in parasites bearing nonsynonymous mutations in the gene encoding the P-type cation-transporter ATPase4 (PfATP4).  The optimized spiroindolone NITD609 shows pharmacokinetic properties compatible with once-daily oral dosing and has single-dose efficacy in a rodent malaria model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6O1WaX-1b7Vg90H21EOLACvtfcHk0lgcDlssjbUZrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ&md5=239bc9babd5cb5f07e2be38741038e2c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1193225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1193225%26sid%3Dliteratum%253Aachs%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DZou%26aufirst%3DB.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSeitz%26aufirst%3DP.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DSpencer%26aufirst%3DK.%2BR.%26aulast%3DGonzalez-Paez%26aufirst%3DG.%2BE.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DJegla%26aufirst%3DT.%26aulast%3DSchmitt%26aufirst%3DE.%2BK.%26aulast%3DBeck%26aufirst%3DH.-P.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DSpiroindolones%252C%2520a%2520potent%2520compound%2520class%2520for%2520the%2520treatment%2520of%2520malaria%26jtitle%3DScience%26date%3D2010%26volume%3D329%26spage%3D1175%26epage%3D1180%26doi%3D10.1126%2Fscience.1193225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spillman, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K.</span></span> <span> </span><span class="NLM_article-title">Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.chom.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23414762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVOhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=227-237&author=N.+J.+Spillmanauthor=R.+J.+W.+Allenauthor=C.+W.+McNamaraauthor=B.+K.+S.+Yeungauthor=E.+A.+Winzelerauthor=T.+T.+Diaganaauthor=K.+Kirk&title=Na%28%2B%29+regulation+in+the+malaria+parasite+Plasmodium+falciparum+involves+the+cation+ATPase+PfATP4+and+is+a+target+of+the+spiroindolone+antimalarials&doi=10.1016%2Fj.chom.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials</span></div><div class="casAuthors">Spillman, Natalie J.; Allen, Richard J. W.; McNamara, Case W.; Yeung, Bryan K. S.; Winzeler, Elizabeth A.; Diagana, Thierry T.; Kirk, Kiaran</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The malaria parasite Plasmodium falciparum establishes in the host erythrocyte plasma membrane new permeability pathways that mediate nutrient uptake into the infected cell.  These pathways simultaneously allow Na+ influx, causing [Na+] in the infected erythrocyte cytosol to increase to high levels.  The intraerythrocytic parasite itself maintains a low cytosolic [Na+] via unknown mechanisms.  Here the authors present evidence that the intraerythrocytic parasite actively extrudes Na+ against an inward gradient via PfATP4, a parasite plasma membrane protein with sequence similarities to Na+-ATPases of lower eukaryotes.  Mutations in PfATP4 confer resistance to a potent class of antimalarials, the spiroindolones.  Consistent with this, the spiroindolones cause a profound disruption in parasite Na+ homeostasis, which is attenuated in parasites bearing resistance-conferring mutations in PfATP4.  The mutant parasites also show some impairment of Na+ regulation.  Taken together, the authors' results are consistent with PfATP4 being a Na+ efflux ATPase and a target of the spiroindolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTK9LqgiWhDLVg90H21EOLACvtfcHk0lgcDlssjbUZrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVOhtL4%253D&md5=415ec48b192ee6ea4681c97695b2b208</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DSpillman%26aufirst%3DN.%2BJ.%26aulast%3DAllen%26aufirst%3DR.%2BJ.%2BW.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DKirk%26aufirst%3DK.%26atitle%3DNa%2528%252B%2529%2520regulation%2520in%2520the%2520malaria%2520parasite%2520Plasmodium%2520falciparum%2520involves%2520the%2520cation%2520ATPase%2520PfATP4%2520and%2520is%2520a%2520target%2520of%2520the%2520spiroindolone%2520antimalarials%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2013%26volume%3D13%26spage%3D227%26epage%3D237%26doi%3D10.1016%2Fj.chom.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: hit to lead optimization of new antimalarial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5116</span>– <span class="NLM_lpage">5130</span>, <span class="refDoi"> DOI: 10.1021/jm2003359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2003359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5116-5130&author=T.+Wuauthor=A.+Nagleauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=A.+Gohauthor=S.+B.+Lakshminarayanaauthor=J.+Wuauthor=H.+Q.+Angauthor=P.+Zengauthor=M.+L.+Kangauthor=W.+Tanauthor=M.+Tanauthor=N.+Yeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=C.+Fischliauthor=R.+Brunauthor=M.+Rottmannauthor=V.+Dartoisauthor=T.+Kellerauthor=T.+Diaganaauthor=E.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+hit+to+lead+optimization+of+new+antimalarial+agents&doi=10.1021%2Fjm2003359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents</span></div><div class="casAuthors">Wu, Tao; Nagle, Advait; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Goh, Anne; Lakshminarayana, Suresh B.; Wu, Jeanette; Ang, Hui Qing; Zeng, Peiting; Kang, Min Low; Tan, William; Tan, Maria; Ye, Nicole; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Fischli, Christoph; Brun, Reto; Rottmann, Matthias; Dartois, Veronique; Keller, Thomas; Diagana, Thierry; Winzeler, Elizabeth; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5116-5130</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from a hit series from a GNF compd. library collection and based on a cell-based proliferation assay of Plasmodium falciparum, a novel imidazolopiperazine scaffold was optimized.  SAR for this series of compds. is discussed, focusing on optimization of cellular potency against wild-type and drug resistant parasites and improvement of physiochem. and pharmacokinetic properties.  The lead compds. in this series showed good potencies in vitro and decent oral exposure levels in vivo.  In a Plasmodium berghei mouse infection model, one lead compd. lowered the parasitemia level by 99.4% after administration of 100 mg/kg single oral dose and prolonged mice survival by an av. of 17.0 days.  The lead compds. were also well-tolerated in the preliminary in vitro toxicity studies and represents an interesting lead for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaD1QipkA-QLVg90H21EOLACvtfcHk0lifHb_IKf1_pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D&md5=eab02c18fda60302ffbcc581256cf149</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2003359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003359%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAng%26aufirst%3DH.%2BQ.%26aulast%3DZeng%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DM.%2BL.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%26aulast%3DWinzeler%26aufirst%3DE.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520hit%2520to%2520lead%2520optimization%2520of%2520new%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5116%26epage%3D5130%26doi%3D10.1021%2Fjm2003359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonamy, G. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharia, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, T.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froissard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattabongkot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1377</span>, <span class="refDoi"> DOI: 10.1126/science.1211936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.1211936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22096101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=1372-1377&author=S.+Meisterauthor=D.+M.+Plouffeauthor=K.+L.+Kuhenauthor=G.+M.+C.+Bonamyauthor=T.+Wuauthor=S.+W.+Barnesauthor=S.+E.+Boppauthor=R.+Borboaauthor=A.+T.+Brightauthor=J.+Cheauthor=S.+Cohenauthor=N.+V.+Dhariaauthor=K.+Gagaringauthor=M.+Gettayacaminauthor=P.+Gordonauthor=T.+Groesslauthor=N.+Katoauthor=M.+C.+S.+Leeauthor=C.+W.+McNamaraauthor=D.+A.+Fidockauthor=A.+Nagleauthor=T.-g.+Namauthor=W.+Richmondauthor=J.+Rolandauthor=M.+Rottmannauthor=B.+Zhouauthor=P.+Froissardauthor=R.+J.+Glynneauthor=D.+Mazierauthor=J.+Sattabongkotauthor=P.+G.+Schultzauthor=T.+Tuntlandauthor=J.+R.+Walkerauthor=Y.+Zhouauthor=A.+Chatterjeeauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Imaging+of+Plasmodium+liver+stages+to+drive+next-generation+antimalarial+drug+discovery&doi=10.1126%2Fscience.1211936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery</span></div><div class="casAuthors">Meister, Stephan; Plouffe, David M.; Kuhen, Kelli L.; Bonamy, Ghislain M. C.; Wu, Tao; Barnes, S. Whitney; Bopp, Selina E.; Borboa, Rachel; Bright, A. Taylor; Che, Jianwei; Cohen, Steve; Dharia, Neekesh V.; Gagaring, Kerstin; Gettayacamin, Montip; Gordon, Perry; Groessl, Todd; Kato, Nobutaka; Lee, Marcus C. S.; McNamara, Case W.; Fidock, David A.; Nagle, Advait; Nam, Tae-gyu; Richmond, Wendy; Roland, Jason; Rottmann, Matthias; Zhou, Bin; Froissard, Patrick; Glynne, Richard J.; Mazier, Dominique; Sattabongkot, Jetsumon; Schultz, Peter G.; Tuntland, Tove; Walker, John R.; Zhou, Yingyao; Chatterjee, Arnab; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6061</span>),
    <span class="NLM_cas:pages">1372-1377</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Most malaria drug development focuses on parasite stages detected in red blood cells, even though, to achieve eradication, next-generation drugs active against both erythrocytic and exo-erythrocytic forms would be preferable.  We applied a multifactorial approach to a set of >4000 com. available compds. with previously demonstrated blood-stage activity (median inhibitory concn. < 1 micromolar) and identified chem. scaffolds with potent activity against both forms.  From this screen, we identified an imidazolopiperazine scaffold series that was highly enriched among compds. active against Plasmodium liver stages.  The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 mg/kg) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity.  The open-source chem. tools resulting from our effort provide starting points for future drug discovery programs, as well as opportunities for researchers to investigate the biol. of exo-erythrocytic forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyO41naZtcdrVg90H21EOLACvtfcHk0lifHb_IKf1_pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOjt7vN&md5=45b2993be36e36eabe1d9280c86c3db2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.1211936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1211936%26sid%3Dliteratum%253Aachs%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DBonamy%26aufirst%3DG.%2BM.%2BC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DBopp%26aufirst%3DS.%2BE.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBright%26aufirst%3DA.%2BT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DNam%26aufirst%3DT.-g.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DFroissard%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DImaging%2520of%2520Plasmodium%2520liver%2520stages%2520to%2520drive%2520next-generation%2520antimalarial%2520drug%2520discovery%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D1372%26epage%3D1377%26doi%3D10.1126%2Fscience.1211936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manary, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, T. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rameh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Targeting Plasmodium PI(4)K to eliminate malaria</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1038/nature12782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnature12782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=24284631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=248-253&author=C.+W.+McNamaraauthor=M.+C.+S.+Leeauthor=C.+S.+Limauthor=S.+H.+Limauthor=J.+Rolandauthor=A.+Nagleauthor=O.+Simonauthor=B.+K.+S.+Yeungauthor=A.+K.+Chatterjeeauthor=S.+L.+McCormackauthor=M.+J.+Manaryauthor=A.-M.+Zeemanauthor=K.+J.+Decheringauthor=T.+R.+S.+Kumarauthor=P.+P.+Henrichauthor=K.+Gagaringauthor=M.+Ibanezauthor=N.+Katoauthor=K.+L.+Kuhenauthor=C.+Fischliauthor=M.+Rottmannauthor=D.+M.+Plouffeauthor=B.+Bursulayaauthor=S.+Meisterauthor=L.+Ramehauthor=J.+Trappeauthor=D.+Haasenauthor=M.+Timmermanauthor=R.+W.+Sauerweinauthor=R.+Suwanaruskauthor=B.+Russellauthor=L.+Reniaauthor=F.+Nostenauthor=D.+C.+Tullyauthor=C.+H.+M.+Kockenauthor=R.+J.+Glynneauthor=C.+Bodenreiderauthor=D.+A.+Fidockauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Targeting+Plasmodium+PI%284%29K+to+eliminate+malaria&doi=10.1038%2Fnature12782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Plasmodium PI(4)K to eliminate malaria</span></div><div class="casAuthors">McNamara, Case W.; Lee, Marcus C. S.; Lim, Chek Shik; Lim, Siau Hoi; Roland, Jason; Nagle, Advait; Simon, Oliver; Yeung, Bryan K. S.; Chatterjee, Arnab K.; McCormack, Susan L.; Manary, Micah J.; Zeeman, Anne-Marie; Dechering, Koen J.; Kumar, T. R. Santha; Henrich, Philipp P.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Fischli, Christoph; Rottmann, Matthias; Plouffe, David M.; Bursulaya, Badry; Meister, Stephan; Rameh, Lucia; Trappe, Joerg; Haasen, Dorothea; Timmerman, Martijn; Sauerwein, Robert W.; Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent; Nosten, Francois; Tully, David C.; Kocken, Clemens H. M.; Glynne, Richard J.; Bodenreider, Christophe; Fidock, David A.; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7479</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Achieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages.  Here the authors identify a lipid kinase, phosphatidylinositol-4-OH kinase (PI(4)K), as the target of imidazopyrazines, a new antimalarial compd. class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host.  Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria models, are active against blood-stage field isolates of the major human pathogens P. falciparum and P. vivax, and inhibit liver-stage hypnozoites in the simian parasite P. cynomolgi.  The authors show that imidazopyrazines exert their effect through inhibitory interaction with the ATP-binding pocket of PI(4)K, altering the intracellular distribution of phosphatidylinositol-4-phosphate.  Collectively, the authors' data define PI(4)K as a key Plasmodium vulnerability, opening up new avenues of target-based discovery to identify drugs with an ideal activity profile for the prevention, treatment and elimination of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTOmMeWluIubVg90H21EOLACvtfcHk0lhgD05vqoPlig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP&md5=9ed8f3e41d257bb4535b4c813abd54cf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature12782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12782%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DO.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DMcCormack%26aufirst%3DS.%2BL.%26aulast%3DManary%26aufirst%3DM.%2BJ.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DKumar%26aufirst%3DT.%2BR.%2BS.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DRameh%26aufirst%3DL.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DTimmerman%26aufirst%3DM.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DTargeting%2520Plasmodium%2520PI%25284%2529K%2520to%2520eliminate%2520malaria%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature12782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Manach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagborough, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakutansky, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanachayangkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witty, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Díaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaad9735</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscitranslmed.aad9735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28446690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaad9735&author=T.+Paquetauthor=C.+Le+Manachauthor=D.+G.+Cabreraauthor=Y.+Younisauthor=P.+P.+Henrichauthor=T.+S.+Abrahamauthor=M.+C.+S.+Leeauthor=R.+Basakauthor=S.+Ghidelli-Disseauthor=M.+J.+Lafuente-Monasterioauthor=M.+Bantscheffauthor=A.+Rueckerauthor=A.+M.+Blagboroughauthor=S.+E.+Zakutanskyauthor=A.-M.+Zeemanauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=J.+Mannilaauthor=J.+Morizziauthor=C.+Scheurerauthor=I.+Angulo-Barturenauthor=M.+S.+Mart%C3%ADnezauthor=S.+Ferrerauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=J.+Readerauthor=M.+Bothaauthor=K.+J.+Decheringauthor=R.+W.+Sauerweinauthor=A.+Tungtaengauthor=P.+Vanachayangkulauthor=C.+S.+Limauthor=J.+Burrowsauthor=M.+J.+Wittyauthor=K.+C.+Marshauthor=C.+Bodenreiderauthor=R.+Rochfordauthor=S.+M.+Solapureauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=C.+Doniniauthor=B.+Campoauthor=L.-M.+Birkholtzauthor=K.+K.+Hansonauthor=G.+Drewesauthor=C.+H.+M.+Kockenauthor=M.+J.+Delvesauthor=D.+Leroyauthor=D.+A.+Fidockauthor=D.+Watersonauthor=L.+J.+Streetauthor=K.+Chibale&title=Antimalarial+efficacy+of+MMV390048%2C+an+inhibitor+of+Plasmodium+phosphatidylinositol+4-kinase&doi=10.1126%2Fscitranslmed.aad9735"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9735%26sid%3Dliteratum%253Aachs%26aulast%3DPaquet%26aufirst%3DT.%26aulast%3DLe%2BManach%26aufirst%3DC.%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DAbraham%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DBasak%26aufirst%3DR.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DBlagborough%26aufirst%3DA.%2BM.%26aulast%3DZakutansky%26aufirst%3DS.%2BE.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DMannila%26aufirst%3DJ.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBotha%26aufirst%3DM.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DVanachayangkul%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DSolapure%26aufirst%3DS.%2BM.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonini%26aufirst%3DC.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26aulast%3DHanson%26aufirst%3DK.%2BK.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAntimalarial%2520efficacy%2520of%2520MMV390048%252C%2520an%2520inhibitor%2520of%2520Plasmodium%2520phosphatidylinositol%25204-kinase%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaad9735%26doi%3D10.1126%2Fscitranslmed.aad9735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godinez-Macias, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribez, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Probing the open global health chemical diversity library for multistage-active starting points for next-generation antimalarials</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjsVOmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=613-628&author=M.+Abrahamauthor=K.+Gagaringauthor=M.+L.+Martinoauthor=M.+Vanaerschotauthor=D.+M.+Plouffeauthor=J.+Callaauthor=K.+P.+Godinez-Maciasauthor=A.+Y.+Duauthor=M.+Wreeauthor=Y.+Antonova-Kochauthor=K.+Eribezauthor=M.+R.+Luthauthor=S.+Ottilieauthor=D.+A.+Fidockauthor=C.+W.+McNamaraauthor=E.+A.+Winzeler&title=Probing+the+open+global+health+chemical+diversity+library+for+multistage-active+starting+points+for+next-generation+antimalarials&doi=10.1021%2Facsinfecdis.9b00482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials</span></div><div class="casAuthors">Abraham, Matthew; Gagaring, Kerstin; Martino, Marisa L.; Vanaerschot, Manu; Plouffe, David M.; Calla, Jaeson; Godinez-Macias, Karla P.; Du, Alan Y.; Wree, Melanie; Antonova-Koch, Yevgeniya; Eribez, Korina; Luth, Madeline R.; Ottilie, Sabine; Fidock, David A.; McNamara, Case W.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-628</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most phenotypic screens aiming to discover new antimalarial chemotypes begin with low cost, high-throughput tests against the asexual blood stage (ABS) of the malaria parasite life cycle.  Compds. active against the ABS are then sequentially tested in more difficult assays that predict whether a compd. has other beneficial attributes.  Although applying this strategy to new chem. libraries may yield new leads, repeated iterations may lead to diminishing returns and the rediscovery of chemotypes hitting well-known targets.  Here, we adopted a different strategy to find starting points, testing ∼70,000 open source small mols. from the Global Health Chem. Diversity Library for activity against the liver stage, mature sexual stage, and asexual blood stage malaria parasites in parallel.  In addn., instead of using an asexual assay that measures accumulated parasite DNA in the presence of compd. (SYBR green), a real time luciferase-dependent parasite viability assay was used that distinguishes slow-acting (delayed death) from fast-acting compds.  Among 382 scaffolds with the activity confirmed by dose response (<10 μM), we discovered 68 novel delayed-death, 84 liver stage, and 68 stage V gametocyte inhibitors as well.  Although 89% of the evaluated compds. had activity in only a single life cycle stage, we discovered six potent (half-maximal inhibitory concn. of <1 μM) multistage scaffolds, including a novel cytochrome bc1 chemotype.  Our data further show the luciferase-based assays have higher sensitivity.  Chemoinformatic anal. of pos. and neg. compds. identified scaffold families with a strong enrichment for activity against specific or multiple stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruhJOTvyVYsLVg90H21EOLACvtfcHk0liN30v2mJJ44w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjsVOmsLY%253D&md5=6ee44448c30e2dff0d6707d8a7ad3d1a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00482%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DMartino%26aufirst%3DM.%2BL.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DCalla%26aufirst%3DJ.%26aulast%3DGodinez-Macias%26aufirst%3DK.%2BP.%26aulast%3DDu%26aufirst%3DA.%2BY.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DEribez%26aufirst%3DK.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DProbing%2520the%2520open%2520global%2520health%2520chemical%2520diversity%2520library%2520for%2520multistage-active%2520starting%2520points%2520for%2520next-generation%2520antimalarials%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D613%26epage%3D628%26doi%3D10.1021%2Facsinfecdis.9b00482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almela, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelièvre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colmenarejo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coterón, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span> <span> </span><span class="NLM_article-title">A New set of chemical starting points with plasmodium falciparum transmission-blocking potential for antimalarial drug discovery</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0135139</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0135139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.pone.0135139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26317851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0135139&author=M.+J.+Almelaauthor=S.+Lozanoauthor=J.+Leli%C3%A8vreauthor=G.+Colmenarejoauthor=J.+M.+Coter%C3%B3nauthor=J.+Rodriguesauthor=C.+Gonzalezauthor=E.+Herreros&title=A+New+set+of+chemical+starting+points+with+plasmodium+falciparum+transmission-blocking+potential+for+antimalarial+drug+discovery&doi=10.1371%2Fjournal.pone.0135139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A new set of chemical starting points with plasmodium falciparum transmission- blocking potential for antimalarial drug discovery</span></div><div class="casAuthors">Almela, Maria Jesus; Lozano, Sonia; Lelievre, Joel; Colmenarejo, Gonzalo; Coteron, Jose Miguel; Rodrigues, Janneth; Gonzalez, Carolina; Herreros, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0135139/1-e0135139/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The discovery of new antimalarials with transmission blocking activity remains a key issue in efforts to control malaria and eventually eradicate the disease.  Recently, high-throughput screening (HTS) assays have been successfully applied to Plasmodium falciparum asexual stages to screen millions of compds., with the identification of thousands of new active mols., some of which are already in clin. phases.  The same approach has now been applied to identify compds. that are active against P. falciparum gametocytes, the parasite stage responsible for transmission.  This study reports screening results for the Tres Cantos Antimalarial Set (TCAMS), of approx. 13,533 mols., against P. falciparum stage V gametocytes.  Secondary confirmation and cytotoxicity assays led to the identification of 98 selective mols. with dual activity against gametocytes and asexual stages.  Hit compds. were chem. clustered and analyzed for appropriate physicochem. properties.  The TCAMS chem. space around the prioritized hits was also studied.  A selection of hit compds. was assessed ex vivo in the std. membrane feeding assay and demonstrated complete block in transmission.  As a result of this effort, new chem. structures not connected to previously described antimalarials have been identified.  This new set of compds. may serve as starting points for future drug discovery programs as well as tool compds. for identifying new modes of action involved in malaria transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZEGJRruPhfrVg90H21EOLACvtfcHk0lg6YNowD3U8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFyrsA%253D%253D&md5=3e90515522f1c9e4261a886445cafe2c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0135139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0135139%26sid%3Dliteratum%253Aachs%26aulast%3DAlmela%26aufirst%3DM.%2BJ.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DCoter%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DHerreros%26aufirst%3DE.%26atitle%3DA%2520New%2520set%2520of%2520chemical%2520starting%2520points%2520with%2520plasmodium%2520falciparum%2520transmission-blocking%2520potential%2520for%2520antimalarial%2520drug%2520discovery%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0135139%26doi%3D10.1371%2Fjournal.pone.0135139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata-Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jado, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaumeau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribez, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taggard, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambachew, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouillier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinás, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Open-source discovery of chemical leads for next-generation chemoprotective antimalarials</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">eaat9446</span>, <span class="refDoi"> DOI: 10.1126/science.aat9446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.aat9446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30523084" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2018&pages=eaat9446&author=Y.+Antonova-Kochauthor=S.+Meisterauthor=M.+Abrahamauthor=M.+R.+Luthauthor=S.+Ottilieauthor=A.+K.+Lukensauthor=T.+Sakata-Katoauthor=M.+Vanaerschotauthor=E.+Owenauthor=J.+C.+Jadoauthor=S.+P.+Maherauthor=J.+Callaauthor=D.+Plouffeauthor=Y.+Zhongauthor=K.+Chenauthor=V.+Chaumeauauthor=A.+J.+Conwayauthor=C.+W.+McNamaraauthor=M.+Ibanezauthor=K.+Gagaringauthor=F.+N.+Serranoauthor=K.+Eribezauthor=C.+M.+Taggardauthor=A.+L.+Cheungauthor=C.+Lincolnauthor=B.+Ambachewauthor=M.+Rouillierauthor=D.+Siegelauthor=F.+Nostenauthor=D.+E.+Kyleauthor=F.-J.+Gamoauthor=Y.+Zhouauthor=M.+Llin%C3%A1sauthor=D.+A.+Fidockauthor=D.+F.+Wirthauthor=J.+Burrowsauthor=B.+Campoauthor=E.+A.+Winzeler&title=Open-source+discovery+of+chemical+leads+for+next-generation+chemoprotective+antimalarials&doi=10.1126%2Fscience.aat9446"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.aat9446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aat9446%26sid%3Dliteratum%253Aachs%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DSakata-Kato%26aufirst%3DT.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DE.%26aulast%3DJado%26aufirst%3DJ.%2BC.%26aulast%3DMaher%26aufirst%3DS.%2BP.%26aulast%3DCalla%26aufirst%3DJ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChaumeau%26aufirst%3DV.%26aulast%3DConway%26aufirst%3DA.%2BJ.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DSerrano%26aufirst%3DF.%2BN.%26aulast%3DEribez%26aufirst%3DK.%26aulast%3DTaggard%26aufirst%3DC.%2BM.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DLincoln%26aufirst%3DC.%26aulast%3DAmbachew%26aufirst%3DB.%26aulast%3DRouillier%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLlin%25C3%25A1s%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DOpen-source%2520discovery%2520of%2520chemical%2520leads%2520for%2520next-generation%2520chemoprotective%2520antimalarials%26jtitle%3DScience%26date%3D2018%26volume%3D362%26spage%3Deaat9446%26doi%3D10.1126%2Fscience.aat9446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carolino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">The antimalarial resistome - finding new drug targets and their modes of action</span>. <i>Curr. Opin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.mib.2020.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.mib.2020.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=32682267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlaju77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2020&pages=49-55&author=K.+Carolinoauthor=E.+A.+Winzeler&title=The+antimalarial+resistome+-+finding+new+drug+targets+and+their+modes+of+action&doi=10.1016%2Fj.mib.2020.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The antimalarial resistome - finding new drug targets and their modes of action</span></div><div class="casAuthors">Carolino, Krypton; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Microbiology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-55</span>CODEN:
                <span class="NLM_cas:coden">COMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1369-5274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  To this day, malaria remains a global burden, affecting millions of people, esp. those in sub-Saharan Africa and Asia.  The rise of drug resistance to current antimalarial treatments, including artemisinin-based combination therapies, has made discovering new small mol. compds. with novel modes of action an urgent matter.  The concerted effort to construct enormous compd. libraries and develop high-throughput phenotypic screening assays to find compds. effective at specifically clearing malaria-causing Plasmodium parasites at any stage of the life cycle has provided many antimalarial prospects, but does not indicate their target or mode of action.  Here, we review recent advances in antimalarial drug discovery efforts, focusing on the following 'omics' approaches in mode of action studies: IVIEWGA, CETSA, metabolomic profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo89BcN2JrkmLVg90H21EOLACvtfcHk0lg6YNowD3U8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlaju77I&md5=66b977eedbf79997dbf956b50101c13e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.mib.2020.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mib.2020.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DCarolino%26aufirst%3DK.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DThe%2520antimalarial%2520resistome%2520-%2520finding%2520new%2520drug%2520targets%2520and%2520their%2520modes%2520of%2520action%26jtitle%3DCurr.%2520Opin.%2520Microbiol.%26date%3D2020%26volume%3D57%26spage%3D49%26epage%3D55%26doi%3D10.1016%2Fj.mib.2020.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Elucidating mechanisms of drug-resistant Plasmodium falciparum</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2019.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.chom.2019.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31295423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=35-47&author=L.+S.+Rossauthor=D.+A.+Fidock&title=Elucidating+mechanisms+of+drug-resistant+Plasmodium+falciparum&doi=10.1016%2Fj.chom.2019.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum</span></div><div class="casAuthors">Ross, Leila S.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-47</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Intensified treatment and control efforts since the early 2000s have dramatically reduced the burden of Plasmodium falciparum malaria.  However, drug resistance threatens to derail this progress.  In this review, we present four antimalarial resistance case studies that differ in timeline, tech. approaches, mechanisms of action, and categories of resistance: chloroquine, sulfadoxine-pyrimethamine, artemisinin, and piperaquine.  Lessons learned from prior losses of treatment efficacy, drug combinations, and control strategies will help advance mechanistic research into how P. falciparum parasites acquire resistance to current first-line artemisinin-based combination therapies.  Understanding resistance in the clinic and lab. is essential to prolong the effectiveness of current antimalarial drugs and to optimize the pipeline of future medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmX21YbTO1LVg90H21EOLACvtfcHk0liiqGbNddU1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FO&md5=801b9192e7b47dc2046a2d03ce9af4f4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2019.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2019.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DL.%2BS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DElucidating%2520mechanisms%2520of%2520drug-resistant%2520Plasmodium%2520falciparum%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2019%26volume%3D26%26spage%3D35%26epage%3D47%26doi%3D10.1016%2Fj.chom.2019.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llanos-Cuentas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casapia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuquiyauri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinojosa, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toovey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arch, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowell, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araeipour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andenmatten, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(18)30309-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2FS1473-3099%2818%2930309-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=29909069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFyqurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=874-883&author=A.+Llanos-Cuentasauthor=M.+Casapiaauthor=R.+Chuquiyauriauthor=J.-C.+Hinojosaauthor=N.+Kerrauthor=M.+Rosarioauthor=S.+Tooveyauthor=R.+H.+Archauthor=M.+A.+Phillipsauthor=F.+D.+Rozenbergauthor=J.+Bathauthor=C.+L.+Ngauthor=A.+N.+Cowellauthor=E.+A.+Winzelerauthor=D.+A.+Fidockauthor=M.+Bakerauthor=J.+J.+M%C3%B6hrleauthor=R.+Hooft+van+Huijsduijnenauthor=N.+Gobeauauthor=N.+Araeipourauthor=N.+Andenmattenauthor=T.+R%C3%BCckleauthor=S.+Duparc&title=Antimalarial+activity+of+single-dose+DSM265%2C+a+novel+plasmodium+dihydroorotate+dehydrogenase+inhibitor%2C+in+patients+with+uncomplicated+Plasmodium+falciparum+or+Plasmodium+vivax+malaria+infection%3A+a+proof-of-concept%2C+open-label%2C+phase+2a+study&doi=10.1016%2Fs1473-3099%2818%2930309-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study</span></div><div class="casAuthors">Llanos-Cuentas, Alejandro; Casapia, Martin; Chuquiyauri, Raul; Hinojosa, Juan-Carlos; Kerr, Nicola; Rosario, Maria; Toovey, Stephen; Arch, Robert H.; Phillips, Margaret A.; Rozenberg, Felix D.; Bath, Jade; Ng, Caroline L.; Cowell, Annie N.; Winzeler, Elizabeth A.; Fidock, David A.; Baker, Mark; Mohrle, Jorg J.; Hooft van Huijsduijnen, Rob; Gobeau, Nathalie; Araeipour, Nada; Andenmatten, Nicole; Ruckle, Thomas; Duparc, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">874-883</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">DSM265 is a novel, long-duration inhibitor of plasmodium dihydroorotate dehydrogenase (DHODH) with excellent selectivity over human DHODH and activity against blood and liver stages of Plasmodium falciparum.  This study aimed to assess the efficacy of DSM265 in patients with P falciparum or Plasmodium vivax malaria infection.  This proof-of-concept, open-label, phase 2a study was conducted at the Asociacio´n Civil Selva Amazo´nica in Iquitos, Peru.  Patients aged 18-70 years, weighing 45-90 kg, who had clin. malaria (P falciparum or P vivax monoinfection) and fever within the previous 24 h were eligible.  Exclusion criteria were clin. or lab. signs of severe malaria, inability to take oral medicine, and use of other antimalarial treatment in the preceding 14 days.  Patients were divided into cohorts of those with P falciparum (cohort a) or P vivax (cohort b) infection.  Two initial cohorts received single oral doses of 400 mg DSM265.  Patients were followed up for efficacy for 28 days and safety for 35 days.  Further cohorts received escalated or de-escalated doses of DSM265, after safety and efficacy assessment of the initial dose.  The primary endpoints were the proportion of patients achieving PCR-adjusted adequate clin. and parasitol. response (ACPR) by day 14 for patients infected with P falciparum and the proportion of patients achieving a crude cure by day 14 for those infected with P vivax.  Cohort success, the criteria for dose escalation, was defined as ACPR (P falciparum) or crude cure (P vivax) in at least 80% of patients in the cohort.  The primary anal. was done in the intention-to-treat population (ITT) and the per-protocol population, and safety analyses were done in all patients who received the study drug.  This study is registered at ClinicalTrials.gov (NCT02123290).  Between Jan 12, 2015, and Dec 2, 2015, 45 Peruvian patients (24 with P falciparum [cohort a] and 21 with P vivax [cohort b] infection) were sequentially enrolled.  For patients with P falciparum malaria in the per-protocol population, all 11 (100%) in the 400 mg group and eight (80%) of ten in the 250 mg group achieved ACPR on day 14.  In the ITT anal., 11 (85%) of 13 in the 400 mg group and eight (73%) of 11 in the 250 mg group achieved ACPR at day 14.  For the patients with P vivax malaria, the primary endpoint was not met.  In the per-protocol anal., none of four patients who had 400 mg, three (50%) of six who had 600 mg, and one (25%) of four who had 800 mg DSM265 achieved crude cure at day 14.  In the ITT anal., none of five in the 400 mg group, three (33%) of nine in the 600 mg group, and one (14%) of seven in the 800 mg group achieved crude cure at day 14.  During the 28-day extended observation of P falciparum patients, a resistance-assocd. mutation in the gene encoding the DSM265 target DHODH was obsd. in two of four recurring patients.  DSM265 was well tolerated.  The most common adverse events were pyrexia (20 [44%] of 45) and headache (18 [40%] of 45), which are both common symptoms of malaria, and no patients had any treatment-related serious adverse events or adverse events leading to study discontinuation.  After a single dose of DSM265, P falciparum parasitemia was rapidly cleared, whereas against P vivax, DSM265 showed less effective clearance kinetics.  Its long duration of action provides the potential to prevent recurrence of P falciparum after treatment with a single dose, which should be further assessed in future combination studies.  The Global Health Innovative Technol. Fund, the Bill & Melinda Gates Foundation, the National Institutes of Health (R01 AI103058), the Wellcome Trust, and the UK Department of International Development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgJbUWoNq8m7Vg90H21EOLACvtfcHk0liiqGbNddU1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFyqurnI&md5=05eacd75b07eee65fca20ec28ea3c1c4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930309-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930309-8%26sid%3Dliteratum%253Aachs%26aulast%3DLlanos-Cuentas%26aufirst%3DA.%26aulast%3DCasapia%26aufirst%3DM.%26aulast%3DChuquiyauri%26aufirst%3DR.%26aulast%3DHinojosa%26aufirst%3DJ.-C.%26aulast%3DKerr%26aufirst%3DN.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DToovey%26aufirst%3DS.%26aulast%3DArch%26aufirst%3DR.%2BH.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DRozenberg%26aufirst%3DF.%2BD.%26aulast%3DBath%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DCowell%26aufirst%3DA.%2BN.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DGobeau%26aufirst%3DN.%26aulast%3DAraeipour%26aufirst%3DN.%26aulast%3DAndenmatten%26aufirst%3DN.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DDuparc%26aufirst%3DS.%26atitle%3DAntimalarial%2520activity%2520of%2520single-dose%2520DSM265%252C%2520a%2520novel%2520plasmodium%2520dihydroorotate%2520dehydrogenase%2520inhibitor%252C%2520in%2520patients%2520with%2520uncomplicated%2520Plasmodium%2520falciparum%2520or%2520Plasmodium%2520vivax%2520malaria%2520infection%253A%2520a%2520proof-of-concept%252C%2520open-label%252C%2520phase%25202a%2520study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2018%26volume%3D18%26spage%3D874%26epage%3D883%26doi%3D10.1016%2Fs1473-3099%2818%2930309-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotharius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito, F. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, L. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazaga, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haselden, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louttit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickham, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gahagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirsalis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathhurst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span> <span> </span><span class="NLM_article-title">A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">296ra111</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaa6645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscitranslmed.aaa6645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26180101" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=296ra111&author=M.+A.+Phillipsauthor=J.+Lothariusauthor=K.+Marshauthor=J.+Whiteauthor=A.+Dayanauthor=K.+L.+Whiteauthor=J.+W.+Njorogeauthor=F.+El+Mazouniauthor=Y.+Laoauthor=S.+Kokkondaauthor=D.+R.+Tomchickauthor=X.+Dengauthor=T.+Lairdauthor=S.+N.+Bhatiaauthor=S.+Marchauthor=C.+L.+Ngauthor=D.+A.+Fidockauthor=S.+Wittlinauthor=M.+Lafuente-Monasterioauthor=F.+J.+G.+Benitoauthor=L.+M.+S.+Alonsoauthor=M.+S.+Martinezauthor=M.+B.+Jimenez-Diazauthor=S.+F.+Bazagaauthor=I.+Angulo-Barturenauthor=J.+N.+Haseldenauthor=J.+Louttitauthor=Y.+Cuiauthor=A.+Sridharauthor=A.-M.+Zeemanauthor=C.+Kockenauthor=R.+Sauerweinauthor=K.+Decheringauthor=V.+M.+Averyauthor=S.+Duffyauthor=M.+Delvesauthor=R.+Sindenauthor=A.+Rueckerauthor=K.+S.+Wickhamauthor=R.+Rochfordauthor=J.+Gahagenauthor=L.+Iyerauthor=E.+Riccioauthor=J.+Mirsalisauthor=I.+Bathhurstauthor=T.+Rueckleauthor=X.+Dingauthor=B.+Campoauthor=D.+Leroyauthor=M.+J.+Rogersauthor=P.+K.+Rathodauthor=J.+N.+Burrowsauthor=S.+A.+Charman&title=A+long-duration+dihydroorotate+dehydrogenase+inhibitor+%28DSM265%29+for+prevention+and+treatment+of+malaria&doi=10.1126%2Fscitranslmed.aaa6645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa6645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa6645%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DLotharius%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DDayan%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DNjoroge%26aufirst%3DJ.%2BW.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DLao%26aufirst%3DY.%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLaird%26aufirst%3DT.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26aulast%3DMarch%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%26aulast%3DBenito%26aufirst%3DF.%2BJ.%2BG.%26aulast%3DAlonso%26aufirst%3DL.%2BM.%2BS.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DBazaga%26aufirst%3DS.%2BF.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DHaselden%26aufirst%3DJ.%2BN.%26aulast%3DLouttit%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DKocken%26aufirst%3DC.%26aulast%3DSauerwein%26aufirst%3DR.%26aulast%3DDechering%26aufirst%3DK.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DDelves%26aufirst%3DM.%26aulast%3DSinden%26aufirst%3DR.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DWickham%26aufirst%3DK.%2BS.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DGahagen%26aufirst%3DJ.%26aulast%3DIyer%26aufirst%3DL.%26aulast%3DRiccio%26aufirst%3DE.%26aulast%3DMirsalis%26aufirst%3DJ.%26aulast%3DBathhurst%26aufirst%3DI.%26aulast%3DRueckle%26aufirst%3DT.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DA%2520long-duration%2520dihydroorotate%2520dehydrogenase%2520inhibitor%2520%2528DSM265%2529%2520for%2520prevention%2520and%2520treatment%2520of%2520malaria%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D296ra111%26doi%3D10.1126%2Fscitranslmed.aaa6645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paguio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gligorijevic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seudieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roepe, P. D.</span></span> <span> </span><span class="NLM_article-title">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1810</span>, <span class="refDoi"> DOI: 10.1128/aac.48.5.1807-1810.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.48.5.1807-1810.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15105139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1807-1810&author=T.+N.+Bennettauthor=M.+Paguioauthor=B.+Gligorijevicauthor=C.+Seudieuauthor=A.+D.+Kosarauthor=E.+Davidsonauthor=P.+D.+Roepe&title=Novel%2C+rapid%2C+and+inexpensive+cell-based+quantification+of+antimalarial+drug+efficacy&doi=10.1128%2Faac.48.5.1807-1810.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy</span></div><div class="casAuthors">Bennett, Tyler N.; Paguio, Michelle; Gligorijevic, Bojana; Seudieu, Clement; Kosar, Andrew D.; Davidson, Eugene; Roepe, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1807-1810</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the development of a new SYBR Green I-based plate assay for analyzing the activities of antimalarial drugs against intraerythrocytic Plasmodium falciparum.  This assay is considerably faster, less labor-intensive, and less expensive than conventional radiotracer (e.g., [3H]hypoxanthine and [3H]ethanolamine)-based assays or P. falciparum lactate dehydrogenase activity-based assays.  The assay significantly improves the pace at which antimalarial drug discovery efforts may proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFhAlJNQSwX7Vg90H21EOLACvtfcHk0lhUH7SkZ_CWSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslCks7o%253D&md5=87ee6c113aefaf11160624c8fe8c8354</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1807-1810.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1807-1810.2004%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DT.%2BN.%26aulast%3DPaguio%26aufirst%3DM.%26aulast%3DGligorijevic%26aufirst%3DB.%26aulast%3DSeudieu%26aufirst%3DC.%26aulast%3DKosar%26aufirst%3DA.%2BD.%26aulast%3DDavidson%26aufirst%3DE.%26aulast%3DRoepe%26aufirst%3DP.%2BD.%26atitle%3DNovel%252C%2520rapid%252C%2520and%2520inexpensive%2520cell-based%2520quantification%2520of%2520antimalarial%2520drug%2520efficacy%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1807%26epage%3D1810%26doi%3D10.1128%2Faac.48.5.1807-1810.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1128/aac.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+inexpensive+fluorescence-based+technique+for+high-throughput+antimalarial+drug+screening&doi=10.1128%2Faac.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0lhhA53KyGKaBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520inexpensive%2520fluorescence-based%2520technique%2520for%2520high-throughput%2520antimalarial%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2Faac.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brideau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikounis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, A.</span></span> <span> </span><span class="NLM_article-title">Improved statistical methods for hit selection in high-throughput screening</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1177/1087057103258285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1177%2F1087057103258285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=14711389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=634-647&author=C.+Brideauauthor=B.+Gunterauthor=B.+Pikounisauthor=A.+Liaw&title=Improved+statistical+methods+for+hit+selection+in+high-throughput+screening&doi=10.1177%2F1087057103258285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Improved statistical methods for hit selection in high-throughput screening</span></div><div class="casAuthors">Brideau Christine; Gunter Bert; Pikounis Bill; Liaw Andy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">634-47</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">High-throughput screening (HTS) plays a central role in modern drug discovery, allowing the rapid screening of large compound collections against a variety of putative drug targets.  HTS is an industrial-scale process, relying on sophisticated automation, control, and state-of-the art detection technologies to organize, test, and measure hundreds of thousands to millions of compounds in nano- to microliter volumes.  Despite this high technology, hit selection for HTS is still typically done using simple data analysis and basic statistical methods.  The authors discuss in this article some shortcomings of these methods and present alternatives based on modern methods of statistical data analysis.  Most important, they describe and show numerous real examples from the biologist-friendly Stat Server HTS application (SHS), a custom-developed software tool built on the commercially available S-PLUS and StatServer statistical analysis and server software.  This system remotely processes HTS data using powerful and sophisticated statistical methodology but insulates users from the technical details by outputting results in a variety of readily interpretable graphs and tables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC1RVHw8Iwb-RS7coPn-RtfW6udTcc2ebn7qrEVO6-H7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D&md5=ddc5921a0776f3372c664d6e91446ba3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F1087057103258285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057103258285%26sid%3Dliteratum%253Aachs%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DGunter%26aufirst%3DB.%26aulast%3DPikounis%26aufirst%3DB.%26aulast%3DLiaw%26aufirst%3DA.%26atitle%3DImproved%2520statistical%2520methods%2520for%2520hit%2520selection%2520in%2520high-throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D634%26epage%3D647%26doi%3D10.1177%2F1087057103258285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Y.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1177/1087057107312628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1177%2F1087057107312628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=18216390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=159-167&author=Z.+Wuauthor=D.+Liuauthor=Y.+Sui&title=Quantitative+assessment+of+hit+detection+and+confirmation+in+single+and+duplicate+high-throughput+screenings&doi=10.1177%2F1087057107312628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings</span></div><div class="casAuthors">Wu, Zhijin; Liu, Dongmei; Sui, Yunxia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-167</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The process of identifying active targets (hits) in high-throughput screening (HTS) usually involves 2 steps: first, removing or adjusting for systematic variation in the measurement process so that extreme values represent strong biol. activity instead of systematic biases such as plate effect or edge effect and, second, choosing a meaningful cutoff on the calcd. statistic to declare pos. compds.  Both false-pos. and false-neg. errors are inevitable in this process.  Common control or estn. of error rates is often based on an assumption of normal distribution of the noise.  The error rates in hit detection, esp. false-neg. rates, are hard to verify because in most assays, only compds. selected in primary screening are followed up in confirmation expts.  In this article, the authors take advantage of a quant. HTS expt. in which all compds. are tested 42 times over a wide range of 14 concns. so true positives can be found through a dose-response curve.  Using the activity status defined by dose curve, the authors analyzed the effect of various data-processing procedures on the sensitivity and specificity of hit detection, the control of error rate, and hit confirmation.  A new summary score is proposed and demonstrated to perform well in hit detection and useful in confirmation rate estn.  In general, adjusting for positional effects is beneficial, but a robust test can prevent overadjustment.  Error rates estd. based on normal assumption do not agree with actual error rates, for the tails of noise distribution deviate from normal distribution.  However, false discovery rate based on empirically estd. null distribution is very close to obsd. false discovery proportion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq0POuJ0JE3bVg90H21EOLACvtfcHk0ljHRHPybkS6jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCitbc%253D&md5=bf394a1b7ebbffe88570942775878f80</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1087057107312628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107312628%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DSui%26aufirst%3DY.%26atitle%3DQuantitative%2520assessment%2520of%2520hit%2520detection%2520and%2520confirmation%2520in%2520single%2520and%2520duplicate%2520high-throughput%2520screenings%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D159%26epage%3D167%26doi%3D10.1177%2F1087057107312628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Seven year itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00903</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=36-44&author=J.+B.+Baellauthor=J.+W.+M.+Nissink&title=Seven+year+itch%3A+pan-assay+interference+compounds+%28PAINS%29+in+2017-utility+and+limitations&doi=10.1021%2Facschembio.7b00903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations</span></div><div class="casAuthors">Baell, Jonathan B.; Nissink, J. Willem M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on all necessary considerations for the appropriate use of PAINs filters formulated to process hundreds and thousands of compds. in seconds, and identify PAINS in order to exclude them from further anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocZ7E_j7zxfbVg90H21EOLACvtfcHk0ljHRHPybkS6jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK&md5=051115704137d6a91b8271702c619682</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00903%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DSeven%2520year%2520itch%253A%2520pan-assay%2520interference%2520compounds%2520%2528PAINS%2529%2520in%25202017-utility%2520and%2520limitations%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D36%26epage%3D44%26doi%3D10.1021%2Facschembio.7b00903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/s1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2Fs1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eYt84_2gwLcXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2Fs1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">New developments in anti-malarial target candidate and product profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>, <span class="refDoi"> DOI: 10.1186/s12936-016-1675-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+Hooft+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+Mohrleauthor=T.+N.+C.+Wells&title=New+developments+in+anti-malarial+target+candidate+and+product+profiles&doi=10.1186%2Fs12936-016-1675-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0ljWOxecrs1Bgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DMohrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DNew%2520developments%2520in%2520anti-malarial%2520target%2520candidate%2520and%2520product%2520profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26doi%3D10.1186%2Fs12936-016-1675-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istvan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magistrado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn-Flynn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata-Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnadig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgof, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lorenzo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cozar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaseichuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">A broad analysis of resistance development in the malaria parasite</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11901</span>, <span class="refDoi"> DOI: 10.1038/ncomms11901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fncomms11901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27301419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaiu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11901&author=V.+C.+Coreyauthor=A.+K.+Lukensauthor=E.+S.+Istvanauthor=M.+C.+S.+Leeauthor=V.+Francoauthor=P.+Magistradoauthor=O.+Coburn-Flynnauthor=T.+Sakata-Katoauthor=O.+Fuchsauthor=N.+F.+Gnadigauthor=G.+Goldgofauthor=M.+Linaresauthor=M.+G.+Gomez-Lorenzoauthor=C.+De+Cozarauthor=M.+J.+Lafuente-Monasterioauthor=S.+Pratsauthor=S.+Meisterauthor=O.+Tanaseichukauthor=M.+Wreeauthor=Y.+Zhouauthor=P.+A.+Willisauthor=F.+J.+Gamoauthor=D.+E.+Goldbergauthor=D.+A.+Fidockauthor=D.+F.+Wirthauthor=E.+A.+Winzeler&title=A+broad+analysis+of+resistance+development+in+the+malaria+parasite&doi=10.1038%2Fncomms11901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A broad analysis of resistance development in the malaria parasite</span></div><div class="casAuthors">Corey, Victoria C.; Lukens, Amanda K.; Istvan, Eva S.; Lee, Marcus C. S.; Franco, Virginia; Magistrado, Pamela; Coburn-Flynn, Olivia; Sakata-Kato, Tomoyo; Fuchs, Olivia; Gnadig, Nina F.; Goldgof, Greg; Linares, Maria; Gomez-Lorenzo, Maria G.; De Cozar, Cristina; Lafuente-Monasterio, Maria Jose; Prats, Sara; Meister, Stephan; Tanaseichuk, Olga; Wree, Melanie; Zhou, Yingyao; Willis, Paul A.; Gamo, Francisco-Javier; Goldberg, Daniel E.; Fidock, David A.; Wirth, Dyann F.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11901</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microbial resistance to chemotherapy has caused countless deaths where malaria is endemic.  Chemotherapy may fail either due to pre-existing resistance or evolution of drug-resistant parasites.  Here we use a diverse set of antimalarial compds. to investigate the acquisition of drug resistance and the degree of cross-resistance against common resistance alleles.  We assess cross-resistance using a set of 15 parasite lines carrying resistance-conferring alleles in pfatp4, cytochrome bc1, pfcarl, pfdhod, pfcrt, pfmdr, pfdhfr, cytoplasmic prolyl tRNA synthetase, or hsp90.  Subsequently, we assess whether resistant parasites can be obtained after several rounds of drug selection.  Twenty-three of the 48 in vitro selections result in resistant parasites, with time to resistance onset ranging 15-300 days.  Our data indicate that pre-existing resistance may not be a major hurdle for novel-target antimalarial candidates, and focusing our attention on fast-killing compds. may result in a slower onset of clin. resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3nnd-3RIUGrVg90H21EOLACvtfcHk0ljWOxecrs1Bgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaiu7nE&md5=e9f026d8d5cd9114b4e0aae909cc09f5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fncomms11901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11901%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DV.%2BC.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DIstvan%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DFranco%26aufirst%3DV.%26aulast%3DMagistrado%26aufirst%3DP.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DSakata-Kato%26aufirst%3DT.%26aulast%3DFuchs%26aufirst%3DO.%26aulast%3DGnadig%26aufirst%3DN.%2BF.%26aulast%3DGoldgof%26aufirst%3DG.%26aulast%3DLinares%26aufirst%3DM.%26aulast%3DGomez-Lorenzo%26aufirst%3DM.%2BG.%26aulast%3DDe%2BCozar%26aufirst%3DC.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DPrats%26aufirst%3DS.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DTanaseichuk%26aufirst%3DO.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DA%2520broad%2520analysis%2520of%2520resistance%2520development%2520in%2520the%2520malaria%2520parasite%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11901%26doi%3D10.1038%2Fncomms11901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Cózar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llergo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.-J.</span></span> <span> </span><span class="NLM_article-title">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e30949</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-C%C3%B3zarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.-J.+Gamo&title=P.+falciparum+in+vitro+killing+rates+allow+to+discriminate+between+different+antimalarial+mode-of-action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0liQeXSLZc0rWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-C%25C3%25B3zar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.-J.%26atitle%3DP.%2520falciparum%2520in%2520vitro%2520killing%2520rates%2520allow%2520to%2520discriminate%2520between%2520different%2520antimalarial%2520mode-of-action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ullah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horrocks, P.</span></span> <span> </span><span class="NLM_article-title">A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1093/jac/dkw449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1093%2Fjac%2Fdkw449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27999014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKju7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2017&pages=717-726&author=I.+Ullahauthor=R.+Sharmaauthor=G.+A.+Biaginiauthor=P.+Horrocks&title=A+validated+bioluminescence-based+assay+for+the+rapid+determination+of+the+initial+rate+of+kill+for+discovery+antimalarials&doi=10.1093%2Fjac%2Fdkw449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials</span></div><div class="casAuthors">Ullah, Imran; Sharma, Raman; Biagini, Giancarlo A.; Horrocks, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">717-726</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">1460-2091</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: A future treatment for uncomplicated malaria will contain at least one component that exerts a rapid rate of kill.  We describe here the validation and application of a simple, robust and rapid bioluminescence-based assay for the detn. of the initial rate of kill in intra-erythrocytic asexual stages of Plasmodium falciparum.  Methods: A modification to the concn.-response bioluminescence [here termed bioluminescence relative rate of kill (BRRoK)] assay, utilizing exposure to fold-IC50 concns. (0.33× to 9×), was used to monitor the immediate cytocidal effect of 372 open-source compds. for antimalarial drug discovery available through the Medicines for Malaria Venture Malaria Box.  Results: Antimalarial drugs that exert a rapid cytocidal effect produce a concn.-dependent loss of bioluminescence signal that correlates with available in vitro and in vivo ests. of parasite clearance time and parasite redn. ratio.  Following the measurement of IC50 for the Malaria Box compds. in Dd2luc, the BRRoK assay was used to identify and rank 372 compds. for their initial cytocidal activity.  Fifty-three compds. in the Malaria Box show an initial relative rate of kill greater than that of chloroquine, with 17 of these having an initial relative rate of kill greater than that of dihydroartemisinin.  Conclusions: The BRRoK assay provides a rapid assay format for the estn. of a key pharmacodynamic property of antimalarial drug action.  The simplicity and robustness of the assay suggests it would be readily scalable for high-throughput screening and a crit. decision-making tool for antimalarial drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0QRFxCJcPLrVg90H21EOLACvtfcHk0liQeXSLZc0rWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKju7nF&md5=1ef989b244532563d5d5398e83a6b3e9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkw449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkw449%26sid%3Dliteratum%253Aachs%26aulast%3DUllah%26aufirst%3DI.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DHorrocks%26aufirst%3DP.%26atitle%3DA%2520validated%2520bioluminescence-based%2520assay%2520for%2520the%2520rapid%2520determination%2520of%2520the%2520initial%2520rate%2520of%2520kill%2520for%2520discovery%2520antimalarials%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2017%26volume%3D72%26spage%3D717%26epage%3D726%26doi%3D10.1093%2Fjac%2Fdkw449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolajczak, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, J. C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H. I.</span></span> <span> </span><span class="NLM_article-title">A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2012.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.molbiopara.2012.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23107927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2012&pages=143-147&author=A.+M.+Vaughanauthor=S.+A.+Mikolajczakauthor=N.+Camargoauthor=V.+Lakshmananauthor=M.+Kennedyauthor=S.+E.+Lindnerauthor=J.+L.+Millerauthor=J.+C.+C.+Humeauthor=S.+H.+I.+Kappe&title=A+transgenic+Plasmodium+falciparum+NF54+strain+that+expresses+GFP-luciferase+throughout+the+parasite+life+cycle&doi=10.1016%2Fj.molbiopara.2012.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle</span></div><div class="casAuthors">Vaughan, Ashley M.; Mikolajczak, Sebastian A.; Camargo, Nelly; Lakshmanan, Viswanathan; Kennedy, Mark; Lindner, Scott E.; Miller, Jessica L.; Hume, Jen C. C.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Plasmodium falciparum is the pathogenic agent of the most lethal of human malarias.  Transgenic P. falciparum parasites expressing luciferase have been created to study drug interventions of both asexual and sexual blood stages but luciferase-expressing mosquito stage and liver stage parasites have not been created which has prevented the easy quantification of mosquito stage development (e.g. for transmission blocking interventions) and liver stage development (for interventions that prevent infection).  To overcome this obstacle, we have created a transgenic P. falciparum NF54 parasite that expresses a GFP-luciferase transgene throughout the life cycle.  Luciferase expression is robust and measurable at all life cycle stages, including midgut oocyst, salivary gland sporozoites and liver stages, where in vivo development is easily measurable using humanized mouse infections in conjunction with an in vivo imaging system.  This parasite reporter strain will accelerate testing of interventions against pre-erythrocytic life cycle stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEiYLv5gv3C7Vg90H21EOLACvtfcHk0lic4X8fG1Or7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmtbvE&md5=44f08828a763df0fb20a3cf8f110478c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2012.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DA.%2BM.%26aulast%3DMikolajczak%26aufirst%3DS.%2BA.%26aulast%3DCamargo%26aufirst%3DN.%26aulast%3DLakshmanan%26aufirst%3DV.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DLindner%26aufirst%3DS.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DHume%26aufirst%3DJ.%2BC.%2BC.%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26atitle%3DA%2520transgenic%2520Plasmodium%2520falciparum%2520NF54%2520strain%2520that%2520expresses%2520GFP-luciferase%2520throughout%2520the%2520parasite%2520life%2520cycle%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2012%26volume%3D186%26spage%3D143%26epage%3D147%26doi%3D10.1016%2Fj.molbiopara.2012.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giustiniano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirali, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massarotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biletta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiglia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">A Practical synthesis of 5-aroyl-1-aryltetrazoles using an Ugi-like 4-component reaction followed by a biomimetic transamination</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_fpage">4107</span>– <span class="NLM_lpage">4118</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1258273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1055%2Fs-0030-1258273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=4107-4118&author=M.+Giustinianoauthor=T.+Piraliauthor=A.+Massarottiauthor=B.+Bilettaauthor=E.+Novellinoauthor=P.+Campigliaauthor=G.+Sorbaauthor=G.+C.+Tron&title=A+Practical+synthesis+of+5-aroyl-1-aryltetrazoles+using+an+Ugi-like+4-component+reaction+followed+by+a+biomimetic+transamination&doi=10.1055%2Fs-0030-1258273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A practical synthesis of 5-aroyl-1-aryltetrazoles using an Ugi-like 4-component reaction followed by a biomimetic transamination</span></div><div class="casAuthors">Giustiniano, Mariateresa; Pirali, Tracey; Massarotti, Alberto; Biletta, Beatrice; Novellino, Ettore; Campiglia, Pietro; Sorba, Giovanni; Tron, Gian Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4107-4118</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Multicomponent reactions, followed by subsequent transformations, are fascinating tools for the rapid and effective synthesis of mol. scaffolds with potential pharmacol. relevance.  The authors became interested in the prepn. of novel 5-aroyl-1-aryltetrazoles as (1) they still represent challenging structures not easily accessible through the methods described in literature, and (2) the α-ketotetrazolic framework may be considered as a potential bioisostere of the enonic linker of chalcones.  In the present work, a novel, simple, effective and general synthesis for this class of compds. is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq56LDvOFXjLVg90H21EOLACvtfcHk0lic4X8fG1Or7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslymtg%253D%253D&md5=4c7bc04af602825b4739ae13fd6cf854</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1258273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1258273%26sid%3Dliteratum%253Aachs%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DBiletta%26aufirst%3DB.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiglia%26aufirst%3DP.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DA%2520Practical%2520synthesis%2520of%25205-aroyl-1-aryltetrazoles%2520using%2520an%2520Ugi-like%25204-component%2520reaction%2520followed%2520by%2520a%2520biomimetic%2520transamination%26jtitle%3DSynthesis%26date%3D2010%26spage%3D4107%26epage%3D4118%26doi%3D10.1055%2Fs-0030-1258273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, B.</span></span> <span> </span><span class="NLM_article-title">Catalytic three-component Ugi reaction</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3622</span>– <span class="NLM_lpage">3625</span>, <span class="refDoi"> DOI: 10.1002/anie.200800494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1002%2Fanie.200800494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=18383491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD1c3ns1OrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=3622-3625&author=S.+C.+Panauthor=B.+List&title=Catalytic+three-component+Ugi+reaction&doi=10.1002%2Fanie.200800494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic three-component Ugi reaction</span></div><div class="casAuthors">Pan Subhas Chandra; List Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3622-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFAZsCYMEUNa__Jf7-eMvJfW6udTcc2eY1sloAEX6OXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3ns1OrtA%253D%253D&md5=22d858a74c1acfa22d61b15a19609e2b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fanie.200800494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200800494%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%2BC.%26aulast%3DList%26aufirst%3DB.%26atitle%3DCatalytic%2520three-component%2520Ugi%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2008%26volume%3D47%26spage%3D3622%26epage%3D3625%26doi%3D10.1002%2Fanie.200800494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferdig, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span> <span> </span><span class="NLM_article-title">Dissecting the loci of low-level quinine resistance in malaria parasites</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04035.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fj.1365-2958.2004.04035.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15130119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlKktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=985-997&author=M.+T.+Ferdigauthor=R.+A.+Cooperauthor=J.+Muauthor=B.+Dengauthor=D.+A.+Joyauthor=X.-z.+Suauthor=T.+E.+Wellems&title=Dissecting+the+loci+of+low-level+quinine+resistance+in+malaria+parasites&doi=10.1111%2Fj.1365-2958.2004.04035.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the loci of low-level quinine resistance in malaria parasites</span></div><div class="casAuthors">Ferdig, Michael T.; Cooper, Roland A.; Mu, Jianbing; Deng, Bingbing; Joy, Deirdre A.; Su, Xin-zhuan; Wellems, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">985-997</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Quinine (QN) remains effective against Plasmodium falciparum, but its decreasing efficacy is documented from different continents.  Multiple genes are likely to contribute to the evolution of QN resistance.  To locate genes contributing to QN response variation, the authors have searched a P. falciparum genetic cross for quant. trait loci (QTL).  Results identify additive QTL in segments of chromosomes (Chrs) 13, 7 and 5, and pair-wise effects from two addnl. loci of Chrs 9 and 6 that interact, resp., with the QTL of Chrs 13 and 7.  The mapped segments of Chrs 7 and 5 contain pfcrt, the determinant of chloroquine resistance (CQR), and pfmdr1, a gene known to affect QN responses.  Assocn. of pfcrt with a QTL of QN resistance supports anecdotal evidence for an evolutionary relation between CQR and reduced QN sensitivity.  The Chr 13 segment contains several candidate genes, one of which (pfnhe-1) encodes a putative Na+/H+ exchanger.  A repeat polymorphism in pfnhe-1 shows significant assocn. with low QN response in a collection of P. falciparum strains from Asia, Africa and Central and South America.  Dissection of the genes and modifiers involved in QN response will require exptl. strategies that can evaluate multiple genes from different chromosomes in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6utR13qyRQ7Vg90H21EOLACvtfcHk0lgjR7tcf3mcpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlKktro%253D&md5=1880310764971a757ec3379cfd38378b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04035.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04035.x%26sid%3Dliteratum%253Aachs%26aulast%3DFerdig%26aufirst%3DM.%2BT.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DJoy%26aufirst%3DD.%2BA.%26aulast%3DSu%26aufirst%3DX.-z.%26aulast%3DWellems%26aufirst%3DT.%2BE.%26atitle%3DDissecting%2520the%2520loci%2520of%2520low-level%2520quinine%2520resistance%2520in%2520malaria%2520parasites%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D52%26spage%3D985%26epage%3D997%26doi%3D10.1111%2Fj.1365-2958.2004.04035.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panton, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluzman, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Rosario, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwadz, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker-Jonah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogstad, D. J.</span></span> <span> </span><span class="NLM_article-title">Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1038/345253a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2F345253a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1970614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADyaK3cXksFGksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=1990&pages=253-255&author=T.+E.+Wellemsauthor=L.+J.+Pantonauthor=I.+Y.+Gluzmanauthor=V.+E.+do+Rosarioauthor=R.+W.+Gwadzauthor=A.+Walker-Jonahauthor=D.+J.+Krogstad&title=Chloroquine+resistance+not+linked+to+mdr-like+genes+in+a+Plasmodium+falciparum+cross&doi=10.1038%2F345253a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross</span></div><div class="casAuthors">Wellems, Thomas E.; Panton, Lindsey J.; Gluzman, Ilya Y.; Do Rosario, Virgilio E.; Gwadz, Robert W.; Walker-Jonah, Annie; Krogstad, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6272</span>),
    <span class="NLM_cas:pages">253-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Chloroquine is thought to act against falciparum malaria by accumulating in the acid vesicles of the parasite and interfering with their function.  Parasites resistant to chloroquine expel the drug rapidly in an unaltered form, thereby reducing levels of accumulation in the vesicles.  The discovery that verapamil partially reverses chloroquinone resistance in vitro led to the proposal that efflux may involve an ATP-driven P-glycoprotein pump similar to that in mammalian multidrug-resistant (mdr) tumor cell lines.  Indeed, P. falciparum contains ≥2 mdr-like genes, 1 of which has been suggested to confer the chloroquine resistant (CQR) phenotype.  To det. if either of these genes is linked to chloroquine resistance, a genetic cross between CQR and chloroquine-susceptible clones of P. falciparum was performed.  Examn. of 16 independent recombinant progeny indicated that the rapid efflux phenotype is controlled by a single gene or a closely linked group of genes.  But there was no linkage between the rapid efflux, CQR phenotype, and either of the mdr-like P. falciparum genes or amplification of those genes.  These data indicate that the genetic locus governing chloroquine efflux and resistance is independent of the known mdr-like genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOs02xXBAdbVg90H21EOLACvtfcHk0lgjR7tcf3mcpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFGksrY%253D&md5=9d48bc57a7f172bf87985167be16529a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2F345253a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F345253a0%26sid%3Dliteratum%253Aachs%26aulast%3DWellems%26aufirst%3DT.%2BE.%26aulast%3DPanton%26aufirst%3DL.%2BJ.%26aulast%3DGluzman%26aufirst%3DI.%2BY.%26aulast%3Ddo%2BRosario%26aufirst%3DV.%2BE.%26aulast%3DGwadz%26aufirst%3DR.%2BW.%26aulast%3DWalker-Jonah%26aufirst%3DA.%26aulast%3DKrogstad%26aufirst%3DD.%2BJ.%26atitle%3DChloroquine%2520resistance%2520not%2520linked%2520to%2520mdr-like%2520genes%2520in%2520a%2520Plasmodium%2520falciparum%2520cross%26jtitle%3DNature%26date%3D1990%26volume%3D345%26spage%3D253%26epage%3D255%26doi%3D10.1038%2F345253a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lorenzo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span> <span> </span><span class="NLM_article-title">Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">441</span>, <span class="refDoi"> DOI: 10.1186/s12936-015-0962-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-015-0962-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26542470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=441&author=M.+Linaresauthor=S.+Vieraauthor=B.+Crespoauthor=V.+Francoauthor=M.+G.+Gomez-Lorenzoauthor=M.+B.+Jimenez-Diazauthor=I.+Angulo-Barturenauthor=L.+M.+Sanzauthor=F.+J.+Gamo&title=Identifying+rapidly+parasiticidal+anti-malarial+drugs+using+a+simple+and+reliable+in+vitro+parasite+viability+fast+assay&doi=10.1186%2Fs12936-015-0962-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay</span></div><div class="casAuthors">Linares, Maria; Viera, Sara; Crespo, Benigno; Franco, Virginia; Gomez-Lorenzo, Maria G.; Jimenez-Diaz, Maria Belen; Angulo-Barturen, Inigo; Sanz, Laura Maria; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">441/1-441/8</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The emergence of Plasmodium falciparum resistance to artemisinins threatens to undermine the effectiveness of artemisinin-based combination anti-malarial therapy.  Developing suitable drugs to replace artemisinins requires the identification of new compds. that display rapid parasite killing kinetics.  However, no current methods fully meet the requirements to screen large compd. libraries for candidates with such properties.  This study describes the development and validation of an in vitro parasite viability fast assay for identifying rapidly parasiticidal anti-malarial drugs.  Methods: Parasite killing kinetics were detd. by first culturing unlabeled erythrocytes with P. falciparum in the presence of anti-malarial drugs for 24 or 48 h.  After removing the drug, samples were added to erythrocytes prelabeled with intracellular dye to allow their subsequent identification.  The ability of viable parasites to re-establish infection in labeled erythrocytes could then be detected by two-color flow cytometry after tagging of parasite DNA.  Thus, double-stained erythrocytes (with the pre-labeled intracellular dye and the parasite DNA dye) result only after establishment of new infections by surviving parasites.  The capacity of the test anti-malarial drugs to eliminate viable parasites within 24 or 48 h could, therefore, be detd.  Results: The parasite viability fast assay could be completed within 48 h following drug treatment and distinguished between rapidly parasiticidal anti-malarial drugs vs. those acting more slowly.  The assay was validated against ten std. anti-malarial agents with known properties and results correlated well with established methods.  An abbreviated assay, suitable for adaptation to medium-high throughput screening, was validated and applied against a set of 20 compds. retrieved from the publically available Medicines for Malaria Venture 'Malaria Box'.  Conclusion: The quantification of new infections to det. parasite viability offers important advantages over existing methods, and is amenable to medium-high throughput screening.  In particular, the parasite viability fast assay allows discrimination of rapidly parasiticidal anti-malarial candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKa5S_QxclMbVg90H21EOLACvtfcHk0ljIokNrpat_AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVamsQ%253D%253D&md5=d40ccaff6ca43c12627fdfe5db7a1d49</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-0962-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-0962-2%26sid%3Dliteratum%253Aachs%26aulast%3DLinares%26aufirst%3DM.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DFranco%26aufirst%3DV.%26aulast%3DGomez-Lorenzo%26aufirst%3DM.%2BG.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26atitle%3DIdentifying%2520rapidly%2520parasiticidal%2520anti-malarial%2520drugs%2520using%2520a%2520simple%2520and%2520reliable%2520in%2520vitro%2520parasite%2520viability%2520fast%2520assay%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26spage%3D441%26doi%3D10.1186%2Fs12936-015-0962-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span> <span> </span><span class="NLM_article-title">The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e1001169</span>, <span class="refDoi"> DOI: 10.1371/journal.pmed.1001169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.pmed.1001169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22363211" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=e1001169&author=M.+Delvesauthor=D.+Plouffeauthor=C.+Scheurerauthor=S.+Meisterauthor=S.+Wittlinauthor=E.+A.+Winzelerauthor=R.+E.+Sindenauthor=D.+Leroy&title=The+activities+of+current+antimalarial+drugs+on+the+life+cycle+stages+of+Plasmodium%3A+a+comparative+study+with+human+and+rodent+parasites&doi=10.1371%2Fjournal.pmed.1001169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.1001169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.1001169%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DLeroy%26aufirst%3DD.%26atitle%3DThe%2520activities%2520of%2520current%2520antimalarial%2520drugs%2520on%2520the%2520life%2520cycle%2520stages%2520of%2520Plasmodium%253A%2520a%2520comparative%2520study%2520with%2520human%2520and%2520rodent%2520parasites%26jtitle%3DPLoS%2520Med.%26date%3D2012%26volume%3D9%26spage%3De1001169%26doi%3D10.1371%2Fjournal.pmed.1001169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehane, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">PfCRT and its role in antimalarial drug resistance</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2012.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.pt.2012.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23020971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCqsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=504-514&author=A.+Eckerauthor=A.+M.+Lehaneauthor=J.+Clainauthor=D.+A.+Fidock&title=PfCRT+and+its+role+in+antimalarial+drug+resistance&doi=10.1016%2Fj.pt.2012.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">PfCRT and its role in antimalarial drug resistance</span></div><div class="casAuthors">Ecker, Andrea; Lehane, Adele M.; Clain, Jerome; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">504-514</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Plasmodium falciparum resistance to chloroquine, the former gold std. antimalarial drug, is mediated primarily by mutant forms of the chloroquine resistance transporter (PfCRT).  These mutations impart upon PfCRT the ability to efflux chloroquine from the intracellular digestive vacuole, the site of drug action.  Recent studies reveal that PfCRT variants can also affect parasite fitness, protect immature gametocytes against chloroquine action, and alter P. falciparum susceptibility to current first-line therapies.  These results highlight the need to be vigilant in screening for the appearance of novel pfcrt alleles that could contribute to new multi-drug resistance phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJYBQpU1odbVg90H21EOLACvtfcHk0ljbAQzg0Q-YGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCqsrnF&md5=c3875a84466125ca660ba11ae38026b3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2012.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2012.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DEcker%26aufirst%3DA.%26aulast%3DLehane%26aufirst%3DA.%2BM.%26aulast%3DClain%26aufirst%3DJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DPfCRT%2520and%2520its%2520role%2520in%2520antimalarial%2520drug%2520resistance%26jtitle%3DTrends%2520Parasitol.%26date%3D2012%26volume%3D28%26spage%3D504%26epage%3D514%26doi%3D10.1016%2Fj.pt.2012.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicht, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erramilli, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okombo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendome, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenah, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacometti, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roepe, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kossiakoff, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancia, F.</span></span> <span> </span><span class="NLM_article-title">Structure and drug resistance of the Plasmodium falciparum transporter PfCRT</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>576</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1795-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fs41586-019-1795-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31776516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1OitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=2019&pages=315-320&author=J.+Kimauthor=Y.+Z.+Tanauthor=K.+J.+Wichtauthor=S.+K.+Erramilliauthor=S.+K.+Dhingraauthor=J.+Okomboauthor=J.+Vendomeauthor=L.+M.+Hagenahauthor=S.+I.+Giacomettiauthor=A.+L.+Warrenauthor=K.+Nosolauthor=P.+D.+Roepeauthor=C.+S.+Potterauthor=B.+Carragherauthor=A.+A.+Kossiakoffauthor=M.+Quickauthor=D.+A.+Fidockauthor=F.+Mancia&title=Structure+and+drug+resistance+of+the+Plasmodium+falciparum+transporter+PfCRT&doi=10.1038%2Fs41586-019-1795-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and drug resistance of the Plasmodium falciparum transporter PfCRT</span></div><div class="casAuthors">Kim, Jonathan; Tan, Yong Zi; Wicht, Kathryn J.; Erramilli, Satchal K.; Dhingra, Satish K.; Okombo, John; Vendome, Jeremie; Hagenah, Laura M.; Giacometti, Sabrina I.; Warren, Audrey L.; Nosol, Kamil; Roepe, Paul D.; Potter, Clinton S.; Carragher, Bridget; Kossiakoff, Anthony A.; Quick, Matthias; Fidock, David A.; Mancia, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">7786</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The emergence and spread of drug-resistant Plasmodium falciparum impedes global efforts to control and eliminate malaria.  For decades, treatment of malaria has relied on chloroquine (CQ), a safe and affordable 4-aminoquinoline that was highly effective against intra-erythrocytic asexual blood-stage parasites, until resistance arose in Southeast Asia and South America and spread worldwide1.  Clin. resistance to the chem. related current first-line combination drug piperaquine (PPQ) has now emerged regionally, reducing its efficacy2.  Resistance to CQ and PPQ has been assocd. with distinct sets of point mutations in the P. falciparum CQ-resistance transporter PfCRT, a 49-kDa member of the drug/metabolite transporter superfamily that traverses the membrane of the acidic digestive vacuole of the parasite3-9.  Here we present the structure, at 3.2 Å resoln., of the PfCRT isoform of CQ-resistant, PPQ-sensitive South American 7G8 parasites, using single-particle cryo-electron microscopy and antigen-binding fragment technol.  Mutations that contribute to CQ and PPQ resistance localize primarily to moderately conserved sites on distinct helixes that line a central neg. charged cavity, indicating that this cavity is the principal site of interaction with the pos. charged CQ and PPQ.  Binding and transport studies reveal that the 7G8 isoform binds both drugs with comparable affinities, and that these drugs are mutually competitive.  The 7G8 isoform transports CQ in a membrane potential- and pH-dependent manner, consistent with an active efflux mechanism that drives CQ resistance5, but does not transport PPQ.  Functional studies on the newly emerging PfCRT F145I and C350R mutations, assocd. with decreased PPQ susceptibility in Asia and South America, resp.6,9, reveal their ability to mediate PPQ transport in 7G8 variant proteins and to confer resistance in gene-edited parasites.  Structural, functional and in silico analyses suggest that distinct mechanistic features mediate the resistance to CQ and PPQ in PfCRT variants.  These data provide at.-level insights into the mol. mechanism of this key mediator of antimalarial treatment failures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu5Qp28Tv1MrVg90H21EOLACvtfcHk0lgsbz2bUQAodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1OitbjJ&md5=2aeb0261d31cbaf435b7ace937f65b5e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1795-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1795-x%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DY.%2BZ.%26aulast%3DWicht%26aufirst%3DK.%2BJ.%26aulast%3DErramilli%26aufirst%3DS.%2BK.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DOkombo%26aufirst%3DJ.%26aulast%3DVendome%26aufirst%3DJ.%26aulast%3DHagenah%26aufirst%3DL.%2BM.%26aulast%3DGiacometti%26aufirst%3DS.%2BI.%26aulast%3DWarren%26aufirst%3DA.%2BL.%26aulast%3DNosol%26aufirst%3DK.%26aulast%3DRoepe%26aufirst%3DP.%2BD.%26aulast%3DPotter%26aufirst%3DC.%2BS.%26aulast%3DCarragher%26aufirst%3DB.%26aulast%3DKossiakoff%26aufirst%3DA.%2BA.%26aulast%3DQuick%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMancia%26aufirst%3DF.%26atitle%3DStructure%2520and%2520drug%2520resistance%2520of%2520the%2520Plasmodium%2520falciparum%2520transporter%2520PfCRT%26jtitle%3DNature%26date%3D2019%26volume%3D576%26spage%3D315%26epage%3D320%26doi%3D10.1038%2Fs41586-019-1795-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small-Saunders, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e00303</span>, <span class="refDoi"> DOI: 10.1128/mbio.02731-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FmBio.02731-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31088920" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=e00303&author=S.+K.+Dhingraauthor=S.+J.+Gabryszewskiauthor=J.+L.+Small-Saundersauthor=T.+Yeoauthor=P.+P.+Henrichauthor=S.+Mokauthor=D.+A.+Fidock&title=Global+spread+of+mutant+PfCRT+and+its+pleiotropic+impact+on+Plasmodium+falciparum+multidrug+resistance+and+fitness&doi=10.1128%2Fmbio.02731-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FmBio.02731-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02731-18%26sid%3Dliteratum%253Aachs%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DSmall-Saunders%26aufirst%3DJ.%2BL.%26aulast%3DYeo%26aufirst%3DT.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DGlobal%2520spread%2520of%2520mutant%2520PfCRT%2520and%2520its%2520pleiotropic%2520impact%2520on%2520Plasmodium%2520falciparum%2520multidrug%2520resistance%2520and%2520fitness%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26spage%3De00303%26doi%3D10.1128%2Fmbio.02731-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modchang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musset, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chookajorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Combinatorial genetic modeling of pfcrt-mediated drug resistance evolution in Plasmodium falciparum</span>. <i>Mol. Biol. Evol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1554</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1093/molbev/msw037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1093%2Fmolbev%2Fmsw037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26908582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGntLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=1554-1570&author=S.+J.+Gabryszewskiauthor=C.+Modchangauthor=L.+Mussetauthor=T.+Chookajornauthor=D.+A.+Fidock&title=Combinatorial+genetic+modeling+of+pfcrt-mediated+drug+resistance+evolution+in+Plasmodium+falciparum&doi=10.1093%2Fmolbev%2Fmsw037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial genetic modeling of pfcrt-mediated drug resistance evolution in Plasmodium falciparum</span></div><div class="casAuthors">Gabryszewski, Stanislaw J.; Modchang, Charin; Musset, Lise; Chookajorn, Thanat; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology and Evolution</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1554-1570</span>CODEN:
                <span class="NLM_cas:coden">MBEVEO</span>;
        ISSN:<span class="NLM_cas:issn">0737-4038</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The emergence of drug resistance continuously threatens global control of infectious diseases, including malaria caused by the protozoan parasite Plasmodium falciparum.  A crit. parasite determinant is the P. falciparum chloroquine resistance transporter (PfCRT), the primary mediator of chloroquine (CQ) resistance (CQR), and a pleiotropic modulator of susceptibility to several first-line artemisinin-based combination therapy partner drugs.  Aside from the validated CQR mol. marker K76T, P. falciparum parasites have acquired at least three addnl. pfcrt mutations, whose contributions to resistance and fitness have been heretofore unclear.  Focusing on the quadruple-mutant Ecuadorian PfCRT haplotype Ecu1110 (K76T/A220S/N326D/I356L), we genetically modified the pfcrt locus of isogenic, asexual blood stage P. falciparum parasites using zinc-finger nucleases, producing all possible combinations of intermediate pfcrt alleles.  Our anal. included the related quintuple-mutant PfCRT haplotype 7G8 (Ecu1110 + C72S) that is widespread throughout South America and the Western Pacific.  Drug susceptibilities and in vitro growth profiles of our combinatorial pfcrt-modified parasites were used to simulate the mutational trajectories accessible to parasites as they evolved CQR.  Our results uncover unique contributions to parasite drug resistance and growth for mutations beyond K76T and predict crit. roles for the CQ metabolite monodesethyl-CQ and the related quinoline-type drug amodiaquine in driving mutant pfcrt evolution.  Modeling outputs further highlight the influence of parasite proliferation rates alongside gains in drug resistance in dictating successful trajectories.  Our findings suggest that P. falciparum parasites have navigated constrained pfcrt adaptive landscapes by means of probabilistically rare mutational bursts that led to the infrequent emergence of pfcrt alleles in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAW3iJo3w18LVg90H21EOLACvtfcHk0lgsbz2bUQAodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGntLvN&md5=464e9739dcc1d77523571041b4b95b2c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fmolbev%2Fmsw037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmolbev%252Fmsw037%26sid%3Dliteratum%253Aachs%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DModchang%26aufirst%3DC.%26aulast%3DMusset%26aufirst%3DL.%26aulast%3DChookajorn%26aufirst%3DT.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DCombinatorial%2520genetic%2520modeling%2520of%2520pfcrt-mediated%2520drug%2520resistance%2520evolution%2520in%2520Plasmodium%2520falciparum%26jtitle%3DMol.%2520Biol.%2520Evol.%26date%3D2016%26volume%3D33%26spage%3D1554%26epage%3D1570%26doi%3D10.1093%2Fmolbev%2Fmsw037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palatulan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn-Flynn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehane, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1111/mmi.13035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fmmi.13035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=25898991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=381-395&author=I.+Petersenauthor=S.+J.+Gabryszewskiauthor=G.+L.+Johnstonauthor=S.+K.+Dhingraauthor=A.+Eckerauthor=R.+E.+Lewisauthor=M.+J.+de+Almeidaauthor=J.+Straimerauthor=P.+P.+Henrichauthor=E.+Palatulanauthor=D.+J.+Johnsonauthor=O.+Coburn-Flynnauthor=C.+Sanchezauthor=A.+M.+Lehaneauthor=M.+Lanzerauthor=D.+A.+Fidock&title=Balancing+drug+resistance+and+growth+rates+via+compensatory+mutations+in+the+Plasmodium+falciparum+chloroquine+resistance+transporter&doi=10.1111%2Fmmi.13035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter</span></div><div class="casAuthors">Petersen, Ines; Gabryszewski, Stanislaw J.; Johnston, Geoffrey L.; Dhingra, Satish K.; Ecker, Andrea; Lewis, Rebecca E.; Justino de Almeida, Mariana; Straimer, Judith; Henrich, Philipp P.; Palatulan, Eugene; Johnson, David J.; Coburn-Flynn, Olivia; Sanchez, Cecilia; Lehane, Adele M.; Lanzer, Michael; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">381-395</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The widespread use of chloroquine to treat Plasmodium falciparum infections has resulted in the selection and dissemination of variant haplotypes of the primary resistance determinant PfCRT.  These haplotypes have encountered drug pressure and within-host competition with wild-type drug-sensitive parasites.  To examine these selective forces in vitro, the authors genetically engineered P. falciparum to express geog. diverse PfCRT haplotypes.  Variant alleles from the Philippines (PH1 and PH2, which differ solely by the C72S mutation) both conferred a moderate gain of chloroquine resistance and a redn. in growth rates in vitro.  Of the two, PH2 showed higher IC50 values, contrasting with reduced growth.  Furthermore, a highly mutated pfcrt allele from Cambodia (Cam734) conferred moderate chloroquine resistance and enhanced growth rates, when tested against wild-type pfcrt in coculture competition assays.  These three alleles mediated cross-resistance to amodiaquine, an antimalarial drug widely used in Africa.  Each allele, along with the globally prevalent Dd2 and 7G8 alleles, rendered parasites more susceptible to lumefantrine, the partner drug used in the leading first-line artemisinin-based combination therapy.  These data reveal ongoing region-specific evolution of PfCRT that impacts drug susceptibility and relative fitness in settings of mixed infections, and raise important considerations about optimal agents to treat chloroquine-resistant malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS7oO_1IwPzbVg90H21EOLACvtfcHk0liPtCTvUvONsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFOgtLg%253D&md5=24e1efdbff8359b7bd8e8bf5876e193a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fmmi.13035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.13035%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DI.%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DJohnston%26aufirst%3DG.%2BL.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DEcker%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DR.%2BE.%26aulast%3Dde%2BAlmeida%26aufirst%3DM.%2BJ.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DPalatulan%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DD.%2BJ.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DLehane%26aufirst%3DA.%2BM.%26aulast%3DLanzer%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DBalancing%2520drug%2520resistance%2520and%2520growth%2520rates%2520via%2520compensatory%2520mutations%2520in%2520the%2520Plasmodium%2520falciparum%2520chloroquine%2520resistance%2520transporter%26jtitle%3DMol.%2520Microbiol.%26date%3D2015%26volume%3D97%26spage%3D381%26epage%3D395%26doi%3D10.1111%2Fmmi.13035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mungthin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.molcel.2004.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15383277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosl2jsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=867-877&author=D.+J.+Johnsonauthor=D.+A.+Fidockauthor=M.+Mungthinauthor=V.+Lakshmananauthor=A.+B.+S.+Sidhuauthor=P.+G.+Brayauthor=S.+A.+Ward&title=Evidence+for+a+central+role+for+PfCRT+in+conferring+Plasmodium+falciparum+resistance+to+diverse+antimalarial+agents&doi=10.1016%2Fj.molcel.2004.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents</span></div><div class="casAuthors">Johnson, David J.; Fidock, David A.; Mungthin, Mathirut; Lakshmanan, Viswanathan; Sidhu, Amar Bir Singh; Bray, Patrick G.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">867-877</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Chloroquine resistance in Plasmodium falciparum is primarily conferred by mutations in pfcrt.  Parasites resistant to chloroquine can display hypersensitivity to other antimalarials; however, the patterns of cross-resistance are complex, and the genetic basis has remained elusive.  The authors show that stepwise selection for resistance to amantadine or halofantrine produced previously unknown pfcrt mutations (including S163R), which were assocd. with a loss of verapamil-reversible chloroquine resistance.  This was accompanied by restoration of efficient chloroquine binding to hematin in these selected lines.  This S163R mutation provides insight into a mechanism by which PfCRT could gate the transport of protonated chloroquine through the digestive vacuole membrane.  Evidence for the presence of this mutation in a Southeast Asian isolate supports the argument for a broad role for PfCRT in detg. levels of susceptibility to structurally diverse antimalarials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_N46vdIaMD7Vg90H21EOLACvtfcHk0liPtCTvUvONsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosl2jsbw%253D&md5=20c0cc8f064d73bdf6543b616ebb4afc</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMungthin%26aufirst%3DM.%26aulast%3DLakshmanan%26aufirst%3DV.%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DBray%26aufirst%3DP.%2BG.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DEvidence%2520for%2520a%2520central%2520role%2520for%2520PfCRT%2520in%2520conferring%2520Plasmodium%2520falciparum%2520resistance%2520to%2520diverse%2520antimalarial%2520agents%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D867%26epage%3D877%26doi%3D10.1016%2Fj.molcel.2004.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicht, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpornsin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takala-Harrison, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3314</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05652-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fs41467-018-05652-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30115924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ovFWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3314&author=L.+S.+Rossauthor=S.+K.+Dhingraauthor=S.+Mokauthor=T.+Yeoauthor=K.+J.+Wichtauthor=K.+Kumpornsinauthor=S.+Takala-Harrisonauthor=B.+Witkowskiauthor=R.+M.+Fairhurstauthor=F.+Arieyauthor=D.+Menardauthor=D.+A.+Fidock&title=Emerging+Southeast+Asian+PfCRT+mutations+confer+Plasmodium+falciparum+resistance+to+the+first-line+antimalarial+piperaquine&doi=10.1038%2Fs41467-018-05652-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine</span></div><div class="casAuthors">Ross Leila S; Dhingra Satish K; Mok Sachel; Yeo Tomas; Wicht Kathryn J; Kumpornsin Krittikorn; Fidock David A; Kumpornsin Krittikorn; Takala-Harrison Shannon; Witkowski Benoit; Menard Didier; Fairhurst Rick M; Fairhurst Rick M; Ariey Frederic; Menard Didier; Fidock David A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3314</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The widely used antimalarial combination therapy dihydroartemisinin + piperaquine (DHA + PPQ) has failed in Cambodia.  Here, we perform a genomic analysis that reveals a rapid increase in the prevalence of novel mutations in the Plasmodium falciparum chloroquine resistance transporter PfCRT following DHA + PPQ implementation.  These mutations occur in parasites harboring the K13 C580Y artemisinin resistance marker.  By introducing PfCRT mutations into sensitive Dd2 parasites or removing them from resistant Cambodian isolates, we show that the H97Y, F145I, M343L, or G353V mutations each confer resistance to PPQ, albeit with fitness costs for all but M343L.  These mutations sensitize Dd2 parasites to chloroquine, amodiaquine, and quinine.  In Dd2 parasites, multicopy plasmepsin 2, a candidate molecular marker, is not necessary for PPQ resistance.  Distended digestive vacuoles were observed in pfcrt-edited Dd2 parasites but not in Cambodian isolates.  Our findings provide compelling evidence that emerging mutations in PfCRT can serve as a molecular marker and mediator of PPQ resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTexkzFIUjqpDUE-swuRqsHfW6udTcc2eb0iQ6uvUXOVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ovFWrug%253D%253D&md5=6a946bc2c1ee06687682ace15c931b6f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05652-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05652-0%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DL.%2BS.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DYeo%26aufirst%3DT.%26aulast%3DWicht%26aufirst%3DK.%2BJ.%26aulast%3DKumpornsin%26aufirst%3DK.%26aulast%3DTakala-Harrison%26aufirst%3DS.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DEmerging%2520Southeast%2520Asian%2520PfCRT%2520mutations%2520confer%2520Plasmodium%2520falciparum%2520resistance%2520to%2520the%2520first-line%2520antimalarial%2520piperaquine%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3314%26doi%3D10.1038%2Fs41467-018-05652-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. W.</span></span> <span> </span><span class="NLM_article-title">Hemozoin and antimalarial drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1450</span>, <span class="refDoi"> DOI: 10.4155/fmc.13.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.4155%2Ffmc.13.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23919553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1437-1450&author=K.+Y.+Fongauthor=D.+W.+Wright&title=Hemozoin+and+antimalarial+drug+discovery&doi=10.4155%2Ffmc.13.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Hemozoin and antimalarial drug discovery</span></div><div class="casAuthors">Fong, Kim Y.; Wright, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1437-1450</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent initiatives to develop more effective and affordable drugs, controlling mosquitoes and development of a preventative vaccine have been launched with the goal of completely eradicating malaria.  To this end, Novartis (Surrey, UK) and GlaxoSmithKline (Middlesex, UK) screened their chem. libraries of approx. two million small mols. for antimalarial properties, which resulted in a set of over 20,000 highly druggable' initial hits.  Efforts in academia are centered on specific pathway targets.  One such high-throughput screening effort has been focused on hemozoin formation, a unique heme detoxification pathway found in the malaria parasite.  This review discusses the current approaches and limitations of high-throughput screening discovery of hemozoin inhibitors.  In the future, new methods must be developed to validate the mechanism of action of these hit compds. within the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMTZ2S5wds7LVg90H21EOLACvtfcHk0li27EUckuOYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amurnN&md5=7a899b8fa8c03df274f99ecd30143d97</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.113%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DK.%2BY.%26aulast%3DWright%26aufirst%3DD.%2BW.%26atitle%3DHemozoin%2520and%2520antimalarial%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1437%26epage%3D1450%26doi%3D10.4155%2Ffmc.13.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, D. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Quinolines block every step of malaria heme crystal growth</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7483</span>– <span class="NLM_lpage">7485</span>, <span class="refDoi"> DOI: 10.1073/pnas.1708153114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1708153114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28696317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFygurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7483-7485&author=D.+J.+Sullivan&title=Quinolines+block+every+step+of+malaria+heme+crystal+growth&doi=10.1073%2Fpnas.1708153114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolines block every step of malaria heme crystal growth</span></div><div class="casAuthors">Sullivan, David J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7483-7485</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In this new work, Olafson et al.(1) use at.-force microscopy to capture the in situ growth of heme crystals to show how step propagation is inhibited by the quinoline class of antimalarials.  The authors also obsd. the effects of artemisin, another important antimalarial that binds heme, but does not inhibit crystn. (1).  Direct observations of how these compds. affect growth lead Olafson et al. to detail three classes of quinoline inhibition mechanisms.  This work opens new opportunities for a lock-and-key approach to targeted drug development that is rooted in the phys. basis for hemozoin crystal growth inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohJ7Ku-JfyZbVg90H21EOLACvtfcHk0li27EUckuOYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFygurbO&md5=f5a42957c470816d88d72de26b4cb135</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1708153114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1708153114%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DD.%2BJ.%26atitle%3DQuinolines%2520block%2520every%2520step%2520of%2520malaria%2520heme%2520crystal%2520growth%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D7483%26epage%3D7485%26doi%3D10.1073%2Fpnas.1708153114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bray, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mungthin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span> <span> </span><span class="NLM_article-title">Access to hematin: the basis of chloroquine resistance</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1124/mol.54.1.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1124%2Fmol.54.1.170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=9658203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=170-179&author=P.+G.+Brayauthor=M.+Mungthinauthor=R.+G.+Ridleyauthor=S.+A.+Ward&title=Access+to+hematin%3A+the+basis+of+chloroquine+resistance&doi=10.1124%2Fmol.54.1.170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Access to hematin: the basis of chloroquine resistance</span></div><div class="casAuthors">Bray, Patrick G.; Mungthin, Mathirut; Ridley, Robert G.; Ward, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-179</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The saturable uptake of chloroquine by parasites of Plasmodium falciparum has been attributed to specific carrier-mediated transport of chloroquine.  It is suggested that chloroquine is transported in exchange for protons by the parasite membrane Na+/H+ exchanger [J Biol Chem 272:2652-2658 (1997)].  Once inside the parasite, it is proposed that chloroquine inhibits the polymn. of hematin, allowing this toxic Hb metabolite to accumulate and kill the cell [Pharmacol Ther 57:203-235 (1993)].  To date, the contribution of these proposed mechanisms to the uptake and antimalarial activity of chloroquine has not been assessed.  Using sodium-free medium, we demonstrate that chloroquine is not directly exchanged for protons by the plasmodial Na+/H+ exchanger.  Furthermore, we show that saturable chloroquine uptake at equil. is due solely to the binding of chloroquine to hematin rather than active uptake: using Ro 40-4388, a potent and specific inhibitor of Hb digestion and, by implication, hematin release, we demonstrate a concn.-dependent redn. in the no. of chloroquine binding sites.  An equal no. of chloroquine binding sites are found in both resistant and susceptible clones, but the apparent affinity of chloroquine binding is found to correlate with drug activity (r2 = 0.93, p < 0.0001).  This completely accounts for both the reduced drug accumulation and activity obsd. in resistant clones and the "reversal" of resistance produced by verapamil.  The data presented here reconcile most of the available biochem. data from studies of the mode of action of chloroquine and the mechanism of chloroquine resistance.  We show that the activity of chloroquine and amodiaquine is directly dependent on the saturable binding of the drugs to hematin and that the inhibition of hematin polymn. may be secondary to this binding.  The chloroquine-resistance mechanism regulates the access of chloroquine to hematin.  Our model is consistent with a resistance mechanism that acts specifically at the food vacuole to alter the binding of chloroquine to hematin rather than changing the active transport of chloroquine across the parasite plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXajT--H2nkrVg90H21EOLACvtfcHk0lhFLNbHgMI5qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKqtb8%253D&md5=ed9524c10245179621baa0614464c719</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fmol.54.1.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.54.1.170%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DP.%2BG.%26aulast%3DMungthin%26aufirst%3DM.%26aulast%3DRidley%26aufirst%3DR.%2BG.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DAccess%2520to%2520hematin%253A%2520the%2520basis%2520of%2520chloroquine%2520resistance%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D170%26epage%3D179%26doi%3D10.1124%2Fmol.54.1.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combrinck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabotha, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ncokazi, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambele, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppe, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">Insights into the role of heme in the mechanism of action of antimalarials</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1021/cb300454t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300454t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKrsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=133-137&author=J.+M.+Combrinckauthor=T.+E.+Mabothaauthor=K.+K.+Ncokaziauthor=M.+A.+Ambeleauthor=D.+Taylorauthor=P.+J.+Smithauthor=H.+C.+Hoppeauthor=T.+J.+Egan&title=Insights+into+the+role+of+heme+in+the+mechanism+of+action+of+antimalarials&doi=10.1021%2Fcb300454t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the Role of Heme in the Mechanism of Action of Antimalarials</span></div><div class="casAuthors">Combrinck, Jill M.; Mabotha, Tebogo E.; Ncokazi, Kanyile K.; Ambele, Melvin A.; Taylor, Dale; Smith, Peter J.; Hoppe, Heinrich C.; Egan, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-137</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using cell fractionation and measurement of Fe(III)heme-pyridine, the antimalarial chloroquine (CQ) has been shown to cause a dose-dependent decrease in hemozoin and concomitant increase in toxic free heme in cultured Plasmodium falciparum that is directly correlated with parasite survival.  Transmission electron microscopy techniques have further shown that heme is redistributed from the parasite digestive vacuole to the cytoplasm and that CQ disrupts hemozoin crystal growth, resulting in mosaic boundaries in the crystals formed in the parasite.  Extension of the cell fractionation study to other drugs has shown that artesunate, amodiaquine, lumefantrine, mefloquine, and quinine, all clin. important antimalarials, also inhibit hemozoin formation in the parasite cell, while the antifolate pyrimethamine and its combination with sulfadoxine do not.  This study finally provides direct evidence in support of the hemozoin inhibition hypothesis for the mechanism of action of CQ and shows that other quinoline and related antimalarials inhibit cellular hemozoin formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnlmATMRqwkbVg90H21EOLACvtfcHk0lhFLNbHgMI5qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKrsLjK&md5=237f5287c6ac189902358fb005b469a8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fcb300454t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300454t%26sid%3Dliteratum%253Aachs%26aulast%3DCombrinck%26aufirst%3DJ.%2BM.%26aulast%3DMabotha%26aufirst%3DT.%2BE.%26aulast%3DNcokazi%26aufirst%3DK.%2BK.%26aulast%3DAmbele%26aufirst%3DM.%2BA.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26aulast%3DHoppe%26aufirst%3DH.%2BC.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DInsights%2520into%2520the%2520role%2520of%2520heme%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520antimalarials%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D133%26epage%3D137%26doi%3D10.1021%2Fcb300454t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrzypek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, R.</span></span> <span> </span><span class="NLM_article-title">The “pushmi-pullyu” of resistance to chloroquine in malaria</span>. <i>Essays Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1042/ebc20160060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1042%2FEBC20160060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28258239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC1czis1yjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=167-175&author=R.+Skrzypekauthor=R.+Callaghan&title=The+%E2%80%9Cpushmi-pullyu%E2%80%9D+of+resistance+to+chloroquine+in+malaria&doi=10.1042%2Febc20160060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The "pushmi-pullyu" of resistance to chloroquine in malaria</span></div><div class="casAuthors">Skrzypek Ruth; Callaghan Richard</div><div class="citationInfo"><span class="NLM_cas:title">Essays in biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">167-175</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malarial infection continues to impart devastating health problems in the developing world.  Treatment of malaria has involved chemotherapy since 168 BC, with the most prevalent and successful forms using plant alkaloids.  Perhaps the greatest treatment success against malaria was by chloroquine, a synthetic derivative of the quinines found in the Cinchona tree bark.  Chloroquine is able to kill parasites by interfering with haem metabolism in the parasite's digestive vacuole.  The widespread use of chloroquine predictably resulted in the development of drug-resistant malaria and the most highly implicated resistance mediators are the transporter proteins P-glycoprotein (P-gp) homologue 1 (P-gh1) and Plasmodium falciparum chloroquine-resistance transporter (PfCRT), which reside on the parasite's digestive vacuole.  The presence of PfCRT and P-gh1 on the vacuole membrane is analogous to the two-headed fictional creature known as the "Pushmi-Pullyu".  P-gh1 (Pushmi) increases influx of chloroquine into the vacuole, while PfCRT (Pullmi) causes efflux of chloroquine from the vacuole.  This review describes how drug-resistant malarial parasites co-ordinate chloroquine distribution through adaptive mutations to promote their survival in the presence of this cytotoxic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9b0lxx8xJh5PlX7E30qdzfW6udTcc2eb6OAwH_XYx6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czis1yjtQ%253D%253D&md5=479cfe4ebf676bda79b55e6260443787</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1042%2FEBC20160060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FEBC20160060%26sid%3Dliteratum%253Aachs%26aulast%3DSkrzypek%26aufirst%3DR.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DThe%2520%25E2%2580%259Cpushmi-pullyu%25E2%2580%259D%2520of%2520resistance%2520to%2520chloroquine%2520in%2520malaria%26jtitle%3DEssays%2520Biochem.%26date%3D2017%26volume%3D61%26spage%3D167%26epage%3D175%26doi%3D10.1042%2Febc20160060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Transporters involved in resistance to antimalarial drugs</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.tips.2006.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16996622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=594-601&author=S.+G.+Valderramosauthor=D.+A.+Fidock&title=Transporters+involved+in+resistance+to+antimalarial+drugs&doi=10.1016%2Fj.tips.2006.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Transporters involved in resistance to antimalarial drugs</span></div><div class="casAuthors">Valderramos, Stephanie G.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">594-601</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ability to treat and control Plasmodium falciparum infection through chemotherapy has been compromised by the advent and spread of resistance to antimalarial drugs.  Research in this area has identified the P. falciparum chloroquine resistance transporter (PfCRT) and the multidrug resistance-1 (PfMDR1) transporter as key determinants of decreased in vitro susceptibility to several principal antimalarial drugs.  Transfection-based in vitro studies are consistent with clin. findings of an assocn. between mutations in the pfcrt gene and failure of chloroquine treatment, and between amplification of the pfmdr1 gene and failure of mefloquine treatment.  Many countries are now switching to artemisinin-based combination therapies.  These incorporate partner drugs of which some have an in vitro efficacy that can be modulated by changes in pfcrt or pfmdr1.  Here, we summarize investigations of these and other recently identified P. falciparum transporters in the context of antimalarial mode of action and mechanisms of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUd4TGzuaQv7Vg90H21EOLACvtfcHk0lgzal0L7lrLyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7nJ&md5=7c139fdb3de3f8625f988e5e5d7bc73a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DValderramos%26aufirst%3DS.%2BG.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DTransporters%2520involved%2520in%2520resistance%2520to%2520antimalarial%2520drugs%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D594%26epage%3D601%26doi%3D10.1016%2Fj.tips.2006.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1086/507115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1086%2F507115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16845638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BD28vit1alug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2006&pages=528-535&author=A.+B.+S.+Sidhuauthor=A.+C.+Uhlemannauthor=S.+G.+Valderramosauthor=J.+C.+Valderramosauthor=S.+Krishnaauthor=D.+A.+Fidock&title=Decreasing+pfmdr1+copy+number+in+Plasmodium+falciparum+malaria+heightens+susceptibility+to+mefloquine%2C+lumefantrine%2C+halofantrine%2C+quinine%2C+and+artemisinin&doi=10.1086%2F507115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin</span></div><div class="casAuthors">Sidhu Amar Bir Singh; Uhlemann Anne-Catrin; Valderramos Stephanie G; Valderramos Juan-Carlos; Krishna Sanjeev; Fidock David A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">528-35</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The global dissemination of drug-resistant Plasmodium falciparum is spurring intense efforts to implement artemisinin (ART)-based combination therapies for malaria, including mefloquine (MFQ)-artesunate and lumefantrine (LUM)-artemether.  Clinical studies have identified an association between an increased risk of MFQ, MFQ-artesunate, and LUM-artemether treatment failures and pfmdr1 gene amplification.  To directly address the contribution that pfmdr1 copy number makes to drug resistance, we genetically disrupted 1 of the 2 pfmdr1 copies in the drug-resistant FCB line, which resulted in reduced pfmdr1 mRNA and protein expression.  These knockdown clones manifested a 3-fold decrease in MFQ IC(50) values, compared with that for the FCB line, verifying the role played by pfmdr1 expression levels in mediating resistance to MFQ.  These clones also showed increased susceptibility to LUM, halofantrine, quinine, and ART.  No change was observed for chloroquine.  These results highlight the importance of pfmdr1 copy number in determining P. falciparum susceptibility to multiple agents currently being used to combat malaria caused by multidrug-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1o6ybd2Dyzo2y4bB4mnvYfW6udTcc2eZx2hhJN8RYk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vit1alug%253D%253D&md5=630ecb75857529bfcbf4e6db1fa3d779</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1086%2F507115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F507115%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DUhlemann%26aufirst%3DA.%2BC.%26aulast%3DValderramos%26aufirst%3DS.%2BG.%26aulast%3DValderramos%26aufirst%3DJ.%2BC.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DDecreasing%2520pfmdr1%2520copy%2520number%2520in%2520Plasmodium%2520falciparum%2520malaria%2520heightens%2520susceptibility%2520to%2520mefloquine%252C%2520lumefantrine%252C%2520halofantrine%252C%2520quinine%252C%2520and%2520artemisinin%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D194%26spage%3D528%26epage%3D535%26doi%3D10.1086%2F507115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preechapornkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pongtavornpinyo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span> <span> </span><span class="NLM_article-title">Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1515</span>, <span class="refDoi"> DOI: 10.1128/aac.00241-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.00241-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=19164150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksFWksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1509-1515&author=P.+Preechapornkulauthor=M.+Imwongauthor=K.+Chotivanichauthor=W.+Pongtavornpinyoauthor=A.+M.+Dondorpauthor=N.+P.+J.+Dayauthor=N.+J.+Whiteauthor=S.+Pukrittayakamee&title=Plasmodium+falciparum+pfmdr1+amplification%2C+mefloquine+resistance%2C+and+parasite+fitness&doi=10.1128%2Faac.00241-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness</span></div><div class="casAuthors">Preechapornkul, Piyanuch; Imwong, Mallika; Chotivanich, Kesinee; Pongtavornpinyo, Wirichada; Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.; Pukrittayakamee, Sasithon</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1509-1515</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mefloquine is widely used in combination with artemisinin derivs. for the treatment of falciparum malaria.  Mefloquine resistance in Plasmodium falciparum has been related to increased copy nos. of multidrug-resistant gene 1 (pfmdr1).  We studied the ex vivo dynamics of pfmdr1 gene amplification in culture-adapted P. falciparum in relation to mefloquine resistance and parasite fitness.  A Thai P. falciparum isolate (isolate TM036) was assessed by the use of multiple genetic markers as a single genotype.  Resistance was selected by exposure to stepwise increasing concns. of mefloquine up to 30 ng/mL in continuous culture.  The pfmdr1 gene copy nos. increased as susceptibility to mefloquine declined (P = 0.03).  No codon mutations at positions 86, 184, 1034, 1042, and 1246 in the pfmdr1 gene were detected.  Two subclones of selected parasites (av. copy nos., 2.3 and 3.1, resp.) showed a fitness disadvantage when they were grown together with the original parasites contg. a single pfmdr1 gene copy in the absence of mefloquine; the multiplication rates were 6.3% and 8.7% lower, resp. (P < 0.01).  Modeling of the dynamics of the pfmdr1 copy nos. over time in relation to the relative fitness of the parasites suggested that net pfmdr1 gene amplification from one to two copies occurs once in every 108 parasites and that amplification from two to three copies occurs once in every 103 parasites.  Pfmdr1 gene amplification in P. flaciparum is a frequent event and confers mefloquine resistance.  Parasites with multiple copies of the pfmdr1 gene have decreased survival fitness in the absence of drug pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovGPZpoua8crVg90H21EOLACvtfcHk0lg1Y6V7n3dfKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksFWksLc%253D&md5=d2d7a241d83a07bc8638132645277a71</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.00241-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00241-08%26sid%3Dliteratum%253Aachs%26aulast%3DPreechapornkul%26aufirst%3DP.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DPongtavornpinyo%26aufirst%3DW.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DDay%26aufirst%3DN.%2BP.%2BJ.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26atitle%3DPlasmodium%2520falciparum%2520pfmdr1%2520amplification%252C%2520mefloquine%2520resistance%252C%2520and%2520parasite%2520fitness%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1509%26epage%3D1515%26doi%3D10.1128%2Faac.00241-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahyong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrapuvich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span> <span> </span><span class="NLM_article-title">Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e1003375</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1003375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1371%2Fjournal.ppat.1003375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23717205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003375&author=J.+L.+Gulerauthor=D.+L.+Freemanauthor=V.+Ahyongauthor=R.+Patrapuvichauthor=J.+Whiteauthor=R.+Gujjarauthor=M.+A.+Phillipsauthor=J.+DeRisiauthor=P.+K.+Rathod&title=Asexual+populations+of+the+human+malaria+parasite%2C+Plasmodium+falciparum%2C+use+a+two-step+genomic+strategy+to+acquire+accurate%2C+beneficial+DNA+amplifications&doi=10.1371%2Fjournal.ppat.1003375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications</span></div><div class="casAuthors">Guler, Jennifer L.; Freeman, Daniel L.; Ahyong, Vida; Patrapuvich, Rapatbhorn; White, John; Gujjar, Ramesh; Phillips, Margaret A.; DeRisi, Joseph; Rathod, Pradipsinh K.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1003375</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Malaria drug resistance contributes to up to a million annual deaths.  Judicious deployment of new antimalarials and vaccines could benefit from an understanding of early mol. events that promote the evolution of parasites.  Continuous in vitro challenge of Plasmodium falciparum parasites with a novel dihydroorotate dehydrogenase (DHODH) inhibitor reproducibly selected for resistant parasites.  Genome-wide anal. of independently-derived resistant clones revealed a two-step strategy to evolutionary success.  Some haploid blood-stage parasites first survive antimalarial pressure through fortuitous DNA duplications that always included the DHODH gene.  Independently-selected parasites had different sized amplification units but they were always flanked by distant A/T tracks.  Higher level amplification and resistance was attained using a second, more efficient and more accurate, mechanism for head-to-tail expansion of the founder unit.  This second homol.-based process could faithfully tune DNA copy nos. in either direction, always retaining the unique DNA amplification sequence from the original A/T-mediated duplication for that parasite line.  Pseudo-polyploidy at relevant genomic loci sets the stage for gaining addnl. mutations at the locus of interest.  Overall, we reveal a population-based genomic strategy for mutagenesis that operates in human stages of P. falciparum to efficiently yield resistance-causing genetic changes at the correct locus in a successful parasite.  Importantly, these founding events arise with precision; no other new amplifications are seen in the resistant haploid blood stage parasite.  This minimizes the need for meiotic genetic cleansing that can only occur in sexual stage development of the parasite in mosquitoes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre-k9Fm0WQKrVg90H21EOLACvtfcHk0lh5QRnCsJi6Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslOhtb8%253D&md5=9b2ad216a436922860c7f29aa5402c52</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003375%26sid%3Dliteratum%253Aachs%26aulast%3DGuler%26aufirst%3DJ.%2BL.%26aulast%3DFreeman%26aufirst%3DD.%2BL.%26aulast%3DAhyong%26aufirst%3DV.%26aulast%3DPatrapuvich%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGujjar%26aufirst%3DR.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DDeRisi%26aufirst%3DJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26atitle%3DAsexual%2520populations%2520of%2520the%2520human%2520malaria%2520parasite%252C%2520Plasmodium%2520falciparum%252C%2520use%2520a%2520two-step%2520genomic%2520strategy%2520to%2520acquire%2520accurate%252C%2520beneficial%2520DNA%2520amplifications%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003375%26doi%3D10.1371%2Fjournal.ppat.1003375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afanador, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification and mechanistic understanding of dihydroorotate dehydrogenase point mutations in Plasmodium falciparum that confer in vitro resistance to the clinical candidate DSM265</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVarurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=90-101&author=J.+Whiteauthor=S.+K.+Dhingraauthor=X.+Dengauthor=F.+El+Mazouniauthor=M.+C.+S.+Leeauthor=G.+A.+Afanadorauthor=A.+Lawongauthor=D.+R.+Tomchickauthor=C.+L.+Ngauthor=J.+Bathauthor=P.+K.+Rathodauthor=D.+A.+Fidockauthor=M.+A.+Phillips&title=Identification+and+mechanistic+understanding+of+dihydroorotate+dehydrogenase+point+mutations+in+Plasmodium+falciparum+that+confer+in+vitro+resistance+to+the+clinical+candidate+DSM265&doi=10.1021%2Facsinfecdis.8b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and mechanistic understanding of dihydroorotate dehydrogenase point mutations in Plasmodium falciparum that confer in vitro resistance to the clinical candidate DSM265</span></div><div class="casAuthors">White, John; Dhingra, Satish K.; Deng, Xiaoyi; El Mazouni, Farah; Lee, Marcus C. S.; Afanador, Gustavo A.; Lawong, Aloysus; Tomchick, Diana R.; Ng, Caroline L.; Bath, Jade; Rathod, Pradipsinh K.; Fidock, David A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-101</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria is one of the most challenging human infectious diseases, and both prevention and control have been hindered by the development of Plasmodium falciparum resistance to existing therapies.  Several new compds. with novel mechanisms are in clin. development for the treatment of malaria, including DSM265, an inhibitor of Plasmodium dihydroorotate dehydrogenase.  To explore the mechanisms by which resistance might develop to DSM265 in the field, we selected for DSM265-resistant P. falciparum parasites in vitro.  Any of five different amino acid changes led to reduced efficacy on the parasite and to decreased DSM265 binding to P. falciparum DHODH.  The DSM265-resistant parasites retained full sensitivity to atovaquone.  All but one of the obsd. mutations were in the DSM265 binding site, and the remaining C276F was in the adjacent flavin cofactor site.  The C276F mutation was previously identified in a recrudescent parasite during a Phase IIa clin. study.  We confirmed that this mutation (and the related C276Y) accounted for the full level of obsd. DSM265 resistance by regenerating the mutation using CRISPR/Cas9 genome editing.  X-ray structure anal. of the C276F mutant enzyme showed that conformational changes of nearby residues were required to accommodate the larger F276 residue, which in turn led to a restriction in the size of the DSM265 binding pocket.  These findings underscore the importance of developing DSM265 as part of a combination therapy with other agents for successful use against malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQMMzkCwd_zrVg90H21EOLACvtfcHk0lh5QRnCsJi6Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVarurzN&md5=6b9001020d2332016c7f189a6dbe9380</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00211%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DAfanador%26aufirst%3DG.%2BA.%26aulast%3DLawong%26aufirst%3DA.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DBath%26aufirst%3DJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520and%2520mechanistic%2520understanding%2520of%2520dihydroorotate%2520dehydrogenase%2520point%2520mutations%2520in%2520Plasmodium%2520falciparum%2520that%2520confer%2520in%2520vitro%2520resistance%2520to%2520the%2520clinical%2520candidate%2520DSM265%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D90%26epage%3D101%26doi%3D10.1021%2Facsinfecdis.8b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calcada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baptista, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Pedrosa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veiga, M. I.</span></span> <span> </span><span class="NLM_article-title">Expansion of a specific Plasmodium falciparum PfMDR1 haplotype in Southeast Asia with increased substrate transport</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e02093</span>, <span class="refDoi"> DOI: 10.1128/mbio.02093-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FmBio.02093-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=33262257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3MXitl2ktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=e02093&author=C.+Calcadaauthor=M.+Silvaauthor=V.+Baptistaauthor=V.+Thathyauthor=R.+Silva-Pedrosaauthor=D.+Granjaauthor=P.+E.+Ferreiraauthor=J.+P.+Gilauthor=D.+A.+Fidockauthor=M.+I.+Veiga&title=Expansion+of+a+specific+Plasmodium+falciparum+PfMDR1+haplotype+in+Southeast+Asia+with+increased+substrate+transport&doi=10.1128%2Fmbio.02093-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Expansion of a specific Plasmodium falciparum PfMDR1 haplotype in southeast asia with increased substrate transport</span></div><div class="casAuthors">Calcada, Carla; Silva, Miguel; Baptista, Vitoria; Thathy, Vandana; Silva-Pedrosa, Rita; Granja, Diana; Ferreira, Pedro Eduardo; Gil, Jose Pedro; Fidock, David A.; Veiga, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e02093-20</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Artemisinin-based combination therapies (ACTs) have been vital in reducing malaria mortality rates since the 2000s.  Their efficacy, however, is threatened by the emergence and spread of artemisinin resistance in Southeast Asia.  The Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) transporter plays a central role in parasite resistance to ACT partner drugs through gene copy no. variations (CNV) and/or single nucleotide polymorphisms (SNPs).  Using genomic epidemiol., we show that multiple pfmdr1 copies encoding the N86 and 184F haplotype are prevalent across Southeast Asia.  Applying genome editing tools on the Southeast Asian Dd2 strain and using a surrogate assay to measure transporter activity in infected red blood cells, we demonstrate that parasites harboring multicopy N86/184F PfMDR1 have a higher Fluo-4 transport capacity compared with those expressing the wild-type N86/Y184 haplotype.  Multicopy N86/184F PfMDR1 is also assocd. with decreased parasite susceptibility to lumefantrine.  These findings provide evidence of the geog. selection and expansion of specific multicopy PfMDR1 haplotypes assocd. with multidrug resistance in Southeast Asia.  IMPORTANCE Global efforts to eliminate malaria depend on the continued success of artemisinin-based combination therapies (ACTs) that target Plasmodium asexual blood-stage parasites.  Resistance to ACTs, however, has emerged, creating the need to define the underlying mechanisms.  Mutations in the P. falciparum multidrug resistance protein 1 (PfMDR1) transporter constitute an important determinant of resistance.  Applying gene editing tools combined with an anal. of a public database contg. thousands of parasite genomes, we show geog. selection and expansion of a pfmdr1 gene amplification encoding the N86/184F haplotype in Southeast Asia.  Parasites expressing this PfMDR1 variant possess a higher transport capacity that modulates their responses to antimalarials.  These data could help tailor and optimize antimalarial drug usage in different regions where malaria is endemic by taking into account the regional prevalence of pfmdr1 polymorphisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIJwTd_yqyL7Vg90H21EOLACvtfcHk0liAPo029Lm17w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitl2ktLg%253D&md5=4e726d0d5d8a353aa495d657249c0a44</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FmBio.02093-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02093-20%26sid%3Dliteratum%253Aachs%26aulast%3DCalcada%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DV.%26aulast%3DThathy%26aufirst%3DV.%26aulast%3DSilva-Pedrosa%26aufirst%3DR.%26aulast%3DGranja%26aufirst%3DD.%26aulast%3DFerreira%26aufirst%3DP.%2BE.%26aulast%3DGil%26aufirst%3DJ.%2BP.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DVeiga%26aufirst%3DM.%2BI.%26atitle%3DExpansion%2520of%2520a%2520specific%2520Plasmodium%2520falciparum%2520PfMDR1%2520haplotype%2520in%2520Southeast%2520Asia%2520with%2520increased%2520substrate%2520transport%26jtitle%3DmBio%26date%3D2020%26volume%3D11%26spage%3De02093%26doi%3D10.1128%2Fmbio.02093-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galatis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culvenor, J. G.</span></span> <span> </span><span class="NLM_article-title">A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1083/jcb.113.5.1033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1083%2Fjcb.113.5.1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1674943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADyaK3MXit1Ggs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=1033-1042&author=A.+F.+Cowmanauthor=S.+Karczauthor=D.+Galatisauthor=J.+G.+Culvenor&title=A+P-glycoprotein+homologue+of+Plasmodium+falciparum+is+localized+on+the+digestive+vacuole&doi=10.1083%2Fjcb.113.5.1033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A P-glycoprotein homolog of Plasmodium falciparum is localized on the digestive vacuole</span></div><div class="casAuthors">Cowman, Alan F.; Karcz, Steve; Galatis, Denise; Culvenor, Janetta G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1033-42</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Resistance to chloroquine in P. falciparum bears a striking similarity to the multi-drug resistance (MDR) phenotype of mammalian tumor cells which is mediated by overexpression of P-glycoprotein.  The P. falciparum homolog of the P-glycoprotein (Pgh1) is shown to be a 160,000-D protein that is expressed throughout the asexual erythrocytic life cycle of the parasite.  Quant. immunoblotting anal. has shown that the protein is expressed at approx. equal levels in chloroquine resistant and sensitive isolates, suggesting that overexpression of Pgh1 is not essential for chloroquine resistance.  The chloroquine-resistant cloned line FAC8 however, does express ∼3-fold more Pgh1 protein than other isolates, probably because of the increased pfmdrl gene copy no. present in this isolate.  Immunofluorescence and immunoelectron microscopy has demonstrated that Pghl is localized on the membrane of the digestive vacuole of mature parasites.  This subcellular localization suggests that Pgh1 may modulate intracellular chloroquine concns. and has important implications for the normal physiol. function of this protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ItQc711SwrVg90H21EOLACvtfcHk0liAPo029Lm17w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1Ggs7Y%253D&md5=7449c0521688a64814b9710425b0bae0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1083%2Fjcb.113.5.1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.113.5.1033%26sid%3Dliteratum%253Aachs%26aulast%3DCowman%26aufirst%3DA.%2BF.%26aulast%3DKarcz%26aufirst%3DS.%26aulast%3DGalatis%26aufirst%3DD.%26aulast%3DCulvenor%26aufirst%3DJ.%2BG.%26atitle%3DA%2520P-glycoprotein%2520homologue%2520of%2520Plasmodium%2520falciparum%2520is%2520localized%2520on%2520the%2520digestive%2520vacuole%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1991%26volume%3D113%26spage%3D1033%26epage%3D1042%26doi%3D10.1083%2Fjcb.113.5.1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdig, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzer, M.</span></span> <span> </span><span class="NLM_article-title">Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3000</span>– <span class="NLM_lpage">3011</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fsj.emboj.7601203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16794577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFaju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3000-3011&author=P.+Rohrbachauthor=C.+P.+Sanchezauthor=K.+Haytonauthor=O.+Friedrichauthor=J.+Patelauthor=A.+B.+S.+Sidhuauthor=M.+T.+Ferdigauthor=D.+A.+Fidockauthor=M.+Lanzer&title=Genetic+linkage+of+pfmdr1+with+food+vacuolar+solute+import+in+Plasmodium+falciparum&doi=10.1038%2Fsj.emboj.7601203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum</span></div><div class="casAuthors">Rohrbach, Petra; Sanchez, Cecilia P.; Hayton, Karen; Friedrich, Oliver; Patel, Jigar; Sidhu, Amar Bir Singh; Ferdig, Michael T.; Fidock, David A.; Lanzer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3000-3011</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The P-glycoprotein homolog of the human malaria parasite Plasmodium falciparum (Pgh-1) has been implicated in decreased susceptibility to several antimalarial drugs, including quinine, mefloquine and artemisinin.  Pgh-1 mainly resides within the parasite's food vacuolar membrane.  Here, the authors describe a surrogate assay for Pgh-1 function based on the subcellular distribution of Fluo-4 acetoxymethylester and its free fluorochrome.  They identified two distinct Fluo-4 staining phenotypes: preferential staining of the food vacuole vs. a more diffuse staining of the entire parasite.  Genetic, positional cloning and pharmacol. data causatively link the food vacuolar Fluo-4 phenotype to those Pgh-1 variants that are assocd. with altered drug responses.  The authors propose that Pgh-1 imports solutes, including certain antimalarial drugs, into the parasite's food vacuole.  The implications of these findings for drug resistance mechanisms and testing are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLKuHOZnsHbVg90H21EOLACvtfcHk0liAPo029Lm17w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFaju78%253D&md5=58b5e18769365c45c76eb5ade1116b34</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601203%26sid%3Dliteratum%253Aachs%26aulast%3DRohrbach%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DC.%2BP.%26aulast%3DHayton%26aufirst%3DK.%26aulast%3DFriedrich%26aufirst%3DO.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DFerdig%26aufirst%3DM.%2BT.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DLanzer%26aufirst%3DM.%26atitle%3DGenetic%2520linkage%2520of%2520pfmdr1%2520with%2520food%2520vacuolar%2520solute%2520import%2520in%2520Plasmodium%2520falciparum%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3000%26epage%3D3011%26doi%3D10.1038%2Fsj.emboj.7601203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A. B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderramos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2005.04729.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1111%2Fj.1365-2958.2005.04729.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=16091034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFCltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=913-926&author=A.+B.+S.+Sidhuauthor=S.+G.+Valderramosauthor=D.+A.+Fidock&title=pfmdr1+mutations+contribute+to+quinine+resistance+and+enhance+mefloquine+and+artemisinin+sensitivity+in+Plasmodium+falciparum&doi=10.1111%2Fj.1365-2958.2005.04729.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum</span></div><div class="casAuthors">Sidhu, Amar Bir Singh; Valderramos, Stephanie Gaw; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">913-926</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The emergence and spread of multidrug resistant Plasmodium falciparum has severely limited the therapeutic options for the treatment of malaria.  With ever-increasing failure rates assocd. with chloroquine or sulfadoxine-pyrimethamine treatment, attention has turned to the few alternatives, which include quinine and mefloquine.  Here, we have investigated the role of pfmdr1 3' coding region point mutations in antimalarial drug susceptibility by allelic exchange in the GC03 and 3BA6 parasite lines.  Results with pfmdr1-recombinant clones indicate a significant role for the N1042D mutation in contributing to resistance to quinine and its diastereomer quinidine.  The triple mutations S1034C/N1042D/D1246Y, highly prevalent in South America, were also found to enhance parasite susceptibility to mefloquine, halofantrine and artemisinin.  Pfmdr1 3' mutations showed minimal effect on P. falciparum resistance to chloroquine or its metabolite mono-desethylchloroquine in these parasite lines, in contrast to previously published results obtained with 7G8 parasites.  This study supports the hypothesis that pfmdr1 3' point mutations can significantly affect parasite susceptibility to a wide range of antimalarials in a strain-specific manner that depends on the parasite genetic background.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79sbmkOdCnrVg90H21EOLACvtfcHk0lj4oTznrTLaRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFCltb4%253D&md5=95a4627c0035fcbd0e0f2cd07aff26b3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2005.04729.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2005.04729.x%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DA.%2BB.%2BS.%26aulast%3DValderramos%26aufirst%3DS.%2BG.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3Dpfmdr1%2520mutations%2520contribute%2520to%2520quinine%2520resistance%2520and%2520enhance%2520mefloquine%2520and%2520artemisinin%2520sensitivity%2520in%2520Plasmodium%2520falciparum%26jtitle%3DMol.%2520Microbiol.%26date%3D2005%26volume%3D57%26spage%3D913%26epage%3D926%26doi%3D10.1111%2Fj.1365-2958.2005.04729.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veiga, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnadig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehane, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11553</span>, <span class="refDoi"> DOI: 10.1038/ncomms11553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fncomms11553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27189525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1GrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11553&author=M.+I.+Veigaauthor=S.+K.+Dhingraauthor=P.+P.+Henrichauthor=J.+Straimerauthor=N.+Gnadigauthor=A.+C.+Uhlemannauthor=R.+E.+Martinauthor=A.+M.+Lehaneauthor=D.+A.+Fidock&title=Globally+prevalent+PfMDR1+mutations+modulate+Plasmodium+falciparum+susceptibility+to+artemisinin-based+combination+therapies&doi=10.1038%2Fncomms11553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies</span></div><div class="casAuthors">Veiga, M. Isabel; Dhingra, Satish K.; Henrich, Philipp P.; Straimer, Judith; Gnadig, Nina; Uhlemann, Anne-Catrin; Martin, Rowena E.; Lehane, Adele M.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11553</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antimalarial chemotherapy, globally reliant on artemisinin-based combination therapies (ACTs), is threatened by the spread of drug resistance in Plasmodium falciparum parasites.  Here we use zinc-finger nucleases to genetically modify the multidrug resistance-1 transporter PfMDR1 at amino acids 86 and 184, and demonstrate that the widely prevalent N86Y mutation augments resistance to the ACT partner drug amodiaquine and the former first-line agent chloroquine.  In contrast, N86Y increases parasite susceptibility to the partner drugs lumefantrine and mefloquine, and the active artemisinin metabolite dihydroartemisinin.  The PfMDR1 N86 plus Y184F isoform moderately reduces piperaquine potency in strains expressing an Asian/African variant of the chloroquine resistance transporter PfCRT.  Mutations in both digestive vacuole-resident transporters are thought to differentially regulate ACT drug interactions with host haem, a product of parasite-mediated Hb degrdn.  Global mapping of these mutations illustrates where the different ACTs could be selectively deployed to optimize treatment based on regional differences in PfMDR1 haplotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1g2E2xblEvbVg90H21EOLACvtfcHk0lj4oTznrTLaRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1GrtLY%253D&md5=f9cf4b37ad7e5956e33de6e792c412ca</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fncomms11553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11553%26sid%3Dliteratum%253Aachs%26aulast%3DVeiga%26aufirst%3DM.%2BI.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGnadig%26aufirst%3DN.%26aulast%3DUhlemann%26aufirst%3DA.%2BC.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DLehane%26aufirst%3DA.%2BM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DGlobally%2520prevalent%2520PfMDR1%2520mutations%2520modulate%2520Plasmodium%2520falciparum%2520susceptibility%2520to%2520artemisinin-based%2520combination%2520therapies%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11553%26doi%3D10.1038%2Fncomms11553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Villiers, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1667</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2008.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.jinorgbio.2008.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=18508124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVylsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2008&pages=1660-1667&author=K.+A.+de%0AVilliersauthor=H.+M.+Marquesauthor=T.+J.+Egan&title=The+crystal+structure+of+halofantrine-ferriprotoporphyrin+IX+and+the+mechanism+of+action+of+arylmethanol+antimalarials&doi=10.1016%2Fj.jinorgbio.2008.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials</span></div><div class="casAuthors">de Villiers, Katherine A.; Marques, Helder M.; Egan, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1660-1667</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The crystal structure of the complex formed between the antimalarial drug halofantrine and ferriprotoporphyrin IX (Fe(III)PPIX) has been detd. by single crystal X-ray diffraction.  The structure shows that halofantrine coordinates to the Fe(III) center through its alc. functionality in addn. to π-stacking of the phenanthrene ring over the porphyrin.  The length of the Fe(III)-O bond is consistent with an alkoxide and not an alc. coordinating group.  The iron porphyrin is five coordinate and monomeric.  Changes in the electronic spectrum of Fe(III)PPIX upon addn. of halofantrine base in acetonitrile soln. are almost identical to those obsd. upon addn. of quinidine free base in the same solvent.  This suggests homologous binding.  Mol. mechanics modeling of Fe(III)PPIX complexes of quinidine, quinine, 9-epiquinine, and 9-epiquinidine based on this homol. suggests that the antimalarially active quinidine and quinine can readily adopt conformations that permit formation of an intramol. salt bridge between the protonated quinuclidine tertiary amino group and unprotonated heme propionate group, while the inactive epimers 9-epiquinidine and 9-epiquinine have to adopt high energy conformations in order to accommodate such salt bridge formation.  We propose that salt bridge formation may interrupt formation of the hemozoin precursor dimer formed during the heme detoxification pathway and so account for the strong activity of the two active isomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP3NeDvvyihLVg90H21EOLACvtfcHk0lhZToZwtAgK_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVylsrw%253D&md5=52eebdf4f26b8eb6e7c01ecc336f12cb</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2008.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2008.04.001%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVilliers%26aufirst%3DK.%2BA.%26aulast%3DMarques%26aufirst%3DH.%2BM.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520crystal%2520structure%2520of%2520halofantrine-ferriprotoporphyrin%2520IX%2520and%2520the%2520mechanism%2520of%2520action%2520of%2520arylmethanol%2520antimalarials%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2008%26volume%3D102%26spage%3D1660%26epage%3D1667%26doi%3D10.1016%2Fj.jinorgbio.2008.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gildenhuys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streltsov, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">le Roex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villiers, K. A.</span></span> <span> </span><span class="NLM_article-title">Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">16767</span>– <span class="NLM_lpage">16777</span>, <span class="refDoi"> DOI: 10.1039/c5dt02671g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1039%2FC5DT02671G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26335948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVahtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=16767-16777&author=J.+Gildenhuysauthor=C.+J.+Sammyauthor=R.+M%C3%BCllerauthor=V.+A.+Streltsovauthor=T.+le+Roexauthor=D.+Kuterauthor=K.+A.+de+Villiers&title=Alkoxide+coordination+of+iron%28III%29+protoporphyrin+IX+by+antimalarial+quinoline+methanols%3A+a+key+interaction+observed+in+the+solid-state+and+solution&doi=10.1039%2Fc5dt02671g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution</span></div><div class="casAuthors">Gildenhuys, Johandie; Sammy, Chandre J.; Muller, Ronel; Streltsov, Victor A.; le Roex, Tanya; Kuter, David; de Villiers, Katherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16767-16777</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The quinoline methanol antimalarial drug mefloquine is a structural analog of the Cinchona alkaloids, quinine and quinidine.  The authors have elucidated the single crystal x-ray diffraction structure of the complexes formed between racemic erythro mefloquine and ferriprotoporphyrin IX (Fe(III)PPIX) and show that alkoxide coordination is a key interaction in the solid-state.  Mass spectrometry confirms the existence of coordination complexes of quinine, quinidine and mefloquine to Fe(III)PPIX in acetonitrile.  The length of the iron(III)-O bond in the quinine and quinidine complexes as detd. by Extended x-ray Absorption Fine Structure (EXAFS) spectroscopy unequivocally confirms that coordination of the quinoline methanol compds. to Fe(III)PPIX occurs in nonaq. aprotic soln. via their benzylic alkoxide functional group.  UV-visible spectrophotometric titrns. of the low-spin bis-pyridyl-Fe(III)PPIX complex with each of the quinoline methanol compds. results in the displacement of a single pyridine mol. and subsequent formation of a six-coordinate pyridine-Fe(III)PPIX-drug complex.  Probably formation of the drug-Fe(III)PPIX coordination complexes is favored in a nonaq. environment, such as that found in lipid bodies or membranes in the malaria parasite, and that their existence may contribute to the mechanism of haemozoin inhibition or other toxicity effects that lead ultimately to parasite death.  In either case, coordination is a key interaction to be considered in the design of novel antimalarial drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS21SeNW7VlbVg90H21EOLACvtfcHk0lhZToZwtAgK_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVahtb%252FF&md5=074842359d592fea07acac50a92bf242</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2FC5DT02671G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5DT02671G%26sid%3Dliteratum%253Aachs%26aulast%3DGildenhuys%26aufirst%3DJ.%26aulast%3DSammy%26aufirst%3DC.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26aulast%3DStreltsov%26aufirst%3DV.%2BA.%26aulast%3Dle%2BRoex%26aufirst%3DT.%26aulast%3DKuter%26aufirst%3DD.%26aulast%3Dde%2BVilliers%26aufirst%3DK.%2BA.%26atitle%3DAlkoxide%2520coordination%2520of%2520iron%2528III%2529%2520protoporphyrin%2520IX%2520by%2520antimalarial%2520quinoline%2520methanols%253A%2520a%2520key%2520interaction%2520observed%2520in%2520the%2520solid-state%2520and%2520solution%26jtitle%3DDalton%2520Trans.%26date%3D2015%26volume%3D44%26spage%3D16767%26epage%3D16777%26doi%3D10.1039%2Fc5dt02671g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaschula, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misplon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walden, J.</span></span> <span> </span><span class="NLM_article-title">Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1021/jm990437l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990437l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=283-291&author=T.+J.+Eganauthor=R.+Hunterauthor=C.+H.+Kaschulaauthor=H.+M.+Marquesauthor=A.+Misplonauthor=J.+Walden&title=Structure-function+relationships+in+aminoquinolines%3A+effect+of+amino+and+chloro+groups+on+quinoline-hematin+complex+formation%2C+inhibition+of+beta-hematin+formation%2C+and+antiplasmodial+activity&doi=10.1021%2Fjm990437l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Function Relationships in Aminoquinolines: Effect of Amino and Chloro Groups on Quinoline-Hematin Complex Formation, Inhibition of β-Hematin Formation, and Antiplasmodial Activity</span></div><div class="casAuthors">Egan, Timothy J.; Hunter, Roger; Kaschula, Catherine H.; Marques, Helder M.; Misplon, Ashley; Walden, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparison of 19 aminoquinolines supports the hypothesis that chloroquine and related antimalarials act by complexing ferriprotoporphyrin IX (Fe(III)PPIX), inhibiting its conversion to β-hematin (hemozoin) and hence its detoxification.  The study suggests that a basic amino side chain is also essential for antiplasmodial activity.  2- And 4-aminoquinolines are unique in their strong affinity for Fe(III)PPIX, and attachment of side chains to the amino group has relatively little influence on the strength of complex formation.  Assocn. with Fe(III)PPIX is necessary, but not sufficient, for inhibiting β-hematin formation.  Presence of a 7-chloro group in the 4-aminoquinoline ring is a requirement for β-hematin inhibitory activity, and this is also unaffected by side chains attached to the amino group.  In turn, β-hematin inhibitory activity is necessary, but not sufficient, for antiplasmodial activity as the presence of an aminoalkyl group attached to the 4-amino-7-chloroquinoline template is essential for strong activity.  We thus propose that the 4-aminoquinoline nucleus of chloroquine and related antimalarials is responsible for complexing Fe(III)PPIX, the 7-chloro group is required for inhibition of β-hematin formation, and the basic amino side chain is required for drug accumulation in the food vacuole of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq7Z8ChnMTWLVg90H21EOLACvtfcHk0lhZToZwtAgK_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVWkug%253D%253D&md5=ebfd428cdc81ed7761c9b79859e9d0ce</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm990437l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990437l%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DKaschula%26aufirst%3DC.%2BH.%26aulast%3DMarques%26aufirst%3DH.%2BM.%26aulast%3DMisplon%26aufirst%3DA.%26aulast%3DWalden%26aufirst%3DJ.%26atitle%3DStructure-function%2520relationships%2520in%2520aminoquinolines%253A%2520effect%2520of%2520amino%2520and%2520chloro%2520groups%2520on%2520quinoline-hematin%2520complex%2520formation%252C%2520inhibition%2520of%2520beta-hematin%2520formation%252C%2520and%2520antiplasmodial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D283%26epage%3D291%26doi%3D10.1021%2Fjm990437l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olafson, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekilov, P. G.</span></span> <span> </span><span class="NLM_article-title">Antimalarials inhibit hematin crystallization by unique drug-surface site interactions</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7536</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700125114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1700125114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=28559329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVSisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7531-7536&author=K.+N.+Olafsonauthor=T.+Q.+Nguyenauthor=J.+D.+Rimerauthor=P.+G.+Vekilov&title=Antimalarials+inhibit+hematin+crystallization+by+unique+drug-surface+site+interactions&doi=10.1073%2Fpnas.1700125114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarials inhibit hematin crystallization by unique drug-surface site interactions</span></div><div class="casAuthors">Olafson, Katy N.; Nguyen, Tam Q.; Rimer, Jeffrey D.; Vekilov, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In malaria pathophysiol., divergent hypotheses on the inhibition of hematin crystn. posit that drugs act either by the sequestration of sol. hematin or their interaction with crystal surfaces.  We use physiol. relevant, time-resolved in situ surface observations and show that quinoline antimalarials inhibit β-hematin crystal surfaces by three distinct modes of action: step pinning, kink blocking, and step bunch induction.  Detailed exptl. evidence of kink blocking validates classical theory and demonstrates that this mechanism is not the most effective inhibition pathway.  Quinolines also form various complexes with sol. hematin, but complexation is insufficient to suppress heme detoxification and is a poor indicator of drug specificity.  Collectively, our findings reveal the significance of drug-crystal interactions and open avenues for rationally designing antimalarial compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozIH1yd-Lw47Vg90H21EOLACvtfcHk0li-6cz3JEHeug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVSisro%253D&md5=71b34aad88ded63bbc23f23618923347</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700125114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700125114%26sid%3Dliteratum%253Aachs%26aulast%3DOlafson%26aufirst%3DK.%2BN.%26aulast%3DNguyen%26aufirst%3DT.%2BQ.%26aulast%3DRimer%26aufirst%3DJ.%2BD.%26aulast%3DVekilov%26aufirst%3DP.%2BG.%26atitle%3DAntimalarials%2520inhibit%2520hematin%2520crystallization%2520by%2520unique%2520drug-surface%2520site%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D7531%26epage%3D7536%26doi%3D10.1073%2Fpnas.1700125114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandlin, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. W.</span></span> <span> </span><span class="NLM_article-title">Identification of beta-hematin inhibitors in the MMV Malaria Box</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2015.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.ijpddr.2015.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26150923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FgvVKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=84-91&author=K.+Y.+Fongauthor=R.+D.+Sandlinauthor=D.+W.+Wright&title=Identification+of+beta-hematin+inhibitors+in+the+MMV+Malaria+Box&doi=10.1016%2Fj.ijpddr.2015.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of β-hematin inhibitors in the MMV Malaria Box</span></div><div class="casAuthors">Fong Kim Y; Sandlin Rebecca D; Wright David W</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">84-91</span>
        ISSN:<span class="NLM_cas:issn">2211-3207</span>.
    </div><div class="casAbstract">The Malaria Box, assembled by the Medicines for Malaria Venture, is a set of 400 structurally diverse, commercially available compounds with demonstrated activity against blood-stage Plasmodium falciparum.  The compounds are a representative subset of the 20,000 in vitro antimalarials identified from the high-throughput screening efforts of St.  Jude Children's Research Hospital (TN, USA), Novartis and GlaxoSmithKline.  In addition, a small set of active compounds from commercially available libraries was added to this group, but it has not previously been published.  Elucidation of the biochemical pathways on which these compounds act is a major challenge; therefore, access to these compounds has been made available free of charge to the investigator community.  Here, the Malaria Box compounds were tested for activity against the formation of β-hematin, a synthetic form of the heme detoxification biomineral, hemozoin.  Further, the mechanism of action of these compounds within the malaria parasite was explored.  Ten of the Malaria Box compounds demonstrated significant inhibition of β-hematin formation.  In this assay, dose-response data revealed IC50 values ranging from 8.7 to 22.7 μM for these hits, each of which is more potent than chloroquine (a known inhibitor of hemozoin formation).  The in vitro antimalarial activity of these ten hits was confirmed in cultures of the chloroquine sensitive D6 strain of the parasite resulting in IC50 values of 135-2165 nM, followed by testing in the multidrug resistant strain, C235.  Cultures of P. falciparum (D6) were then examined for their heme distribution following treatment with nine of the commercially available confirmed compounds, seven of which disrupted the hemozoin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqxCXYj5rt8Rcr74wzj5o5fW6udTcc2eZYUV25Yi8erbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FgvVKiug%253D%253D&md5=7fc760552c08c112ea9fde62e45433f0</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2015.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2015.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DK.%2BY.%26aulast%3DSandlin%26aufirst%3DR.%2BD.%26aulast%3DWright%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520beta-hematin%2520inhibitors%2520in%2520the%2520MMV%2520Malaria%2520Box%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2015%26volume%3D5%26spage%3D84%26epage%3D91%26doi%3D10.1016%2Fj.ijpddr.2015.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okombo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mambwe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Watt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanches-Vaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezuidenhout, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauterbach, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coetzer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudêncio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Multistage antiplasmodium activity of astemizole analogues and inhibition of hemozoin formation as a contributor to their mode of action</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=303-315&author=M.+Kumarauthor=J.+Okomboauthor=D.+Mambweauthor=D.+Taylorauthor=N.+Lawrenceauthor=J.+Readerauthor=M.+van+der%0AWattauthor=D.+Fontinhaauthor=M.+Sanches-Vazauthor=B.+C.+Bezuidenhoutauthor=S.+B.+Lauterbachauthor=D.+Liebenbergauthor=L.-M.+Birkholtzauthor=T.+L.+Coetzerauthor=M.+Prud%C3%AAncioauthor=T.+J.+Eganauthor=S.+Wittlinauthor=K.+Chibale&title=Multistage+antiplasmodium+activity+of+astemizole+analogues+and+inhibition+of+hemozoin+formation+as+a+contributor+to+their+mode+of+action&doi=10.1021%2Facsinfecdis.8b00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action</span></div><div class="casAuthors">Kumar, Malkeet; Okombo, John; Mambwe, Dickson; Taylor, Dale; Lawrence, Nina; Reader, Janette; van der Watt, Mariette; Fontinha, Diana; Sanches-Vaz, Margarida; Bezuidenhout, Belinda C.; Lauterbach, Sonja B.; Liebenberg, Dale; Birkholtz, Lyn-Marie; Coetzer, Theresa L.; Prudencio, Miguel; Egan, Timothy J.; Wittlin, Sergio; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-315</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A drug repositioning approach was leveraged to derivatize astemizole (AST), an antihistamine drug whose antimalarial activity was previously identified in a high-throughput screen.  The multistage activity potential against Plasmodium parasite's life cycle of the subsequent analogs was examd. by evaluating against the parasite asexual blood, liver and gametocyte stages.  In addn., the previously reported contribution of heme detoxification to the compd.'s mode of action was interrogated.  Ten of the seventeen derivs. showed IC50s < 0.1 μM against the chloroquine (CQ)-sensitive Plasmodium falciparum NF54 (PfNF54) strain while maintaining submicromolar potency against the multidrug resistant strain, PfK1, with most showing low likelihood of cross-resistance with CQ.  Selected analogs (PfNF54- IC50 < 0.1 μM) were tested for cytotoxicity on CHO cells and found to be highly selective (selectivity index > 100).  The first ever gametocytes screening of AST and its analogs revealed their moderate activity (IC50: 1-5 μM) against late stage P. falciparum gametocytes, while the evaluation of activity against P. berghei liver stages identified one compd. (3) with three-fold greater activity than the parent AST compd.  Mechanistic studies showed a strong correlation between in vitro inhibition of β-hematin formation by the AST derivs. and their antiplasmodium IC50s.  Analyses of intracellular inhibition of hemozoin formation within the parasite further yielded signatures attributable to a possible perturbation of the heme detoxification machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy4gh2bMFlULVg90H21EOLACvtfcHk0limGtAum6wYMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbjI&md5=84f0b65a7d17715aea48271a7cf1bbeb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00272%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DOkombo%26aufirst%3DJ.%26aulast%3DMambwe%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BWatt%26aufirst%3DM.%26aulast%3DFontinha%26aufirst%3DD.%26aulast%3DSanches-Vaz%26aufirst%3DM.%26aulast%3DBezuidenhout%26aufirst%3DB.%2BC.%26aulast%3DLauterbach%26aufirst%3DS.%2BB.%26aulast%3DLiebenberg%26aufirst%3DD.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26aulast%3DCoetzer%26aufirst%3DT.%2BL.%26aulast%3DPrud%25C3%25AAncio%26aufirst%3DM.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DMultistage%2520antiplasmodium%2520activity%2520of%2520astemizole%2520analogues%2520and%2520inhibition%2520of%2520hemozoin%2520formation%2520as%2520a%2520contributor%2520to%2520their%2520mode%2520of%2520action%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D303%26epage%3D315%26doi%3D10.1021%2Facsinfecdis.8b00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trager, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J.</span></span> <span> </span><span class="NLM_article-title">Human malaria parasites in continuous culture</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1126/science.781840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.781840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=781840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1976&pages=673-675&author=W.+Tragerauthor=J.+Jensen&title=Human+malaria+parasites+in+continuous+culture&doi=10.1126%2Fscience.781840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Human malaria parasites in continuous culture</span></div><div class="casAuthors">Trager W; Jensen J B</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4254</span>),
    <span class="NLM_cas:pages">673-5</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Plasmodium falciparum can now be maintained in continuous culture in human erythrocytes incubated at 38 degrees C in RPMI 1640 medium with human serum under an atmosphere with 7 percent carbon dioxide and low oxygen (1 or 5 percent).  The original parasite material, derived from an infected Aotus trivirgatus monkey, was diluted more than 100 million times by the addition of human erythrocytes at 3- or 4-day intervals.  The parasites continued to reproduce in their normal asexual cycle of approximately 48 hours but were no longer highly synchronous.  The have remained infective to Aotus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPnKdQ--_afmyYR5VtavbzfW6udTcc2eZgsOu-94kRyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D&md5=a7f43c2255b75d9841c36338433c78b8</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.781840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.781840%26sid%3Dliteratum%253Aachs%26aulast%3DTrager%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DJ.%26atitle%3DHuman%2520malaria%2520parasites%2520in%2520continuous%2520culture%26jtitle%3DScience%26date%3D1976%26volume%3D193%26spage%3D673%26epage%3D675%26doi%3D10.1126%2Fscience.781840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santo-Tomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.exppara.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=17087929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=296-300&author=C.+Snyderauthor=J.+Cholletauthor=J.+Santo-Tomasauthor=C.+Scheurerauthor=S.+Wittlin&title=In+vitro+and+in+vivo+interaction+of+synthetic+peroxide+RBx11160+%28OZ277%29+with+piperaquine+in+Plasmodium+models&doi=10.1016%2Fj.exppara.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models</span></div><div class="casAuthors">Snyder, Christopher; Chollet, Jacques; Santo-Tomas, Josefina; Scheurer, Christian; Wittlin, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">296-300</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RBx11160 (OZ277) is a promising antimalarial drug candidate that Ranbaxy Labs. Limited and Medicines for Malaria Venture (MMV) are currently developing as a fixed combination with piperaquine.  Here, we describe the in vitro (Plasmodium falciparum) and in vivo (Plasmodium berghei) activities of piperaquine in combination with RBx11160 and artemether.  In vitro, both combinations demonstrated a slight tendency towards antagonism with mean sums of fractional inhibitory concns. (mean ΣFICs) of 1.5.  In vivo, piperaquine and artemether were borderline antagonistic (mean ΣFIC of 1.4).  However, an additive in vivo interaction of piperaquine and RBx11160 (mean ΣFIC of 1.1) was identified, suggesting that a RBx11160-piperaquine combination therapy in humans should allow each mol. to exert its full antimalarial effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsaEePIfPhrVg90H21EOLACvtfcHk0limGtAum6wYMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ&md5=e1513c45d411887f6e65d7d31a61ad6d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DSanto-Tomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520interaction%2520of%2520synthetic%2520peroxide%2520RBx11160%2520%2528OZ277%2529%2520with%2520piperaquine%2520in%2520Plasmodium%2520models%26jtitle%3DExp.%2520Parasitol.%26date%3D2007%26volume%3D115%26spage%3D296%26epage%3D300%26doi%3D10.1016%2Fj.exppara.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambros, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderberg, J. P.</span></span> <span> </span><span class="NLM_article-title">Synchronization of Plasmodium falciparum erythrocytic stages in culture</span>. <i>J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">418</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.2307/3280287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.2307%2F3280287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=383936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1979&pages=418-420&author=C.+Lambrosauthor=J.+P.+Vanderberg&title=Synchronization+of+Plasmodium+falciparum+erythrocytic+stages+in+culture&doi=10.2307%2F3280287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synchronization of Plasmodium falciparum erythrocytic stages in culture</span></div><div class="casAuthors">Lambros C; Vanderberg J P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">418-20</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Synchronous development of the erythrocytic stages of a human malaria parasite, Plasmodium falciparum, in culture was accomplished by suspending cultured parasites in 5% D-sorbitol and subsequent reintroduction into culture.  Immediately after sorbitol treatment, cultures consisted mainly of single and multiple ring-form infections.  At the same time, varying degrees of lysis of erythrocytes infected with the more mature stages of the parasite was evident.  Approximately 95% of the parasites were in the ring stage of development at 48 and 96 hr after sorbitol treatment-likewise, a high percentage of trophozoite and schizont stages was observed at 24, 72, and 120 hr.  D-Mannitol produced similar, selective, lytic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8OaabOIODNFUIs6wFK5xJfW6udTcc2eaO035oRNgA4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D&md5=b1f79ae8156db4fdef9b290140de2298</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2307%2F3280287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3280287%26sid%3Dliteratum%253Aachs%26aulast%3DLambros%26aufirst%3DC.%26aulast%3DVanderberg%26aufirst%3DJ.%2BP.%26atitle%3DSynchronization%2520of%2520Plasmodium%2520falciparum%2520erythrocytic%2520stages%2520in%2520culture%26jtitle%3DJ.%2520Parasitol.%26date%3D1979%26volume%3D65%26spage%3D418%26epage%3D420%26doi%3D10.2307%2F3280287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel-Blanco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straschil, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda-Zubiaurre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchter, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, J.</span></span> <span> </span><span class="NLM_article-title">A high throughput screen for next-generation leads targeting malaria parasite transmission</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3805</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05777-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fs41467-018-05777-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30228275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BB3czgtFSlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3805&author=M.+J.+Delvesauthor=C.+Miguel-Blancoauthor=H.+Matthewsauthor=I.+Molinaauthor=A.+Rueckerauthor=S.+Yahiyaauthor=U.+Straschilauthor=M.+Abrahamauthor=M.+L.+Leonauthor=O.+J.+Fischerauthor=A.+Rueda-Zubiaurreauthor=J.+R.+Brandtauthor=A.+Cortesauthor=A.+Barnardauthor=M.+J.+Fuchterauthor=F.+Calderonauthor=E.+A.+Winzelerauthor=R.+E.+Sindenauthor=E.+Herrerosauthor=F.+J.+Gamoauthor=J.+Baum&title=A+high+throughput+screen+for+next-generation+leads+targeting+malaria+parasite+transmission&doi=10.1038%2Fs41467-018-05777-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">A high throughput screen for next-generation leads targeting malaria parasite transmission</span></div><div class="casAuthors">Delves Michael J; Miguel-Blanco Celia; Matthews Holly; Ruecker Andrea; Yahiya Sabrina; Straschil Ursula; Sinden Robert E; Baum Jake; Miguel-Blanco Celia; Molina Irene; Leon Maria Luisa; Cortes Alvaro; Calderon Felix; Herreros Esperanza; Gamo Francisco J; Abraham Matthew; Winzeler Elizabeth A; Fischer Oliver J; Rueda-Zubiaurre Ainoa; Brandt Jochen R; Barnard Anna; Fuchter Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3805</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Spread of parasite resistance to artemisinin threatens current frontline antimalarial therapies, highlighting the need for new drugs with alternative modes of action.  Since only 0.2-1% of asexual parasites differentiate into sexual, transmission-competent forms, targeting this natural bottleneck provides a tangible route to interrupt disease transmission and mitigate resistance selection.  Here we present a high-throughput screen of gametogenesis against a ~70,000 compound diversity library, identifying seventeen drug-like molecules that target transmission.  Hit molecules possess varied activity profiles including male-specific, dual acting male-female and dual-asexual-sexual, with one promising N-((4-hydroxychroman-4-yl)methyl)-sulphonamide scaffold found to have sub-micromolar activity in vitro and in vivo efficacy.  Development of leads with modes of action focussed on the sexual stages of malaria parasite development provide a previously unexplored base from which future therapeutics can be developed, capable of preventing parasite transmission through the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm0WpjOO-yVDUE-swuRqsHfW6udTcc2eaO035oRNgA4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czgtFSlsg%253D%253D&md5=d62b545c247a6ef26d1521aea097d629</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05777-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05777-2%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DMiguel-Blanco%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DH.%26aulast%3DMolina%26aufirst%3DI.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DYahiya%26aufirst%3DS.%26aulast%3DStraschil%26aufirst%3DU.%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DLeon%26aufirst%3DM.%2BL.%26aulast%3DFischer%26aufirst%3DO.%2BJ.%26aulast%3DRueda-Zubiaurre%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DJ.%2BR.%26aulast%3DCortes%26aufirst%3DA.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DCalderon%26aufirst%3DF.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DBaum%26aufirst%3DJ.%26atitle%3DA%2520high%2520throughput%2520screen%2520for%2520next-generation%2520leads%2520targeting%2520malaria%2520parasite%2520transmission%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3805%26doi%3D10.1038%2Fs41467-018-05777-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straschil, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelièvre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Barragán, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span> <span> </span><span class="NLM_article-title">Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3268</span>– <span class="NLM_lpage">3274</span>, <span class="refDoi"> DOI: 10.1128/aac.00325-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.00325-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=23629698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVartrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=3268-3274&author=M.+J.+Delvesauthor=A.+Rueckerauthor=U.+Straschilauthor=J.+Leli%C3%A8vreauthor=S.+Marquesauthor=M.+J.+L%C3%B3pez-Barrag%C3%A1nauthor=E.+Herrerosauthor=R.+E.+Sinden&title=Male+and+female+Plasmodium+falciparum+mature+gametocytes+show+different+responses+to+antimalarial+drugs&doi=10.1128%2Faac.00325-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs</span></div><div class="casAuthors">Delves, Michael J.; Ruecker, Andrea; Straschil, Ursula; Lelievre, Joel; Marques, Sara; Lopez-Barragan, Maria Jose; Herreros, Esperanza; Sinden, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3268-3274</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">It is the mature gametocytes of Plasmodium that are solely responsible for parasite transmission from the mammalian host to the mosquito.  They are therefore a logical target for transmission-blocking antimalarial interventions, which aim to break the cycle of reinfection and reduce the prevalence of malaria cases.  Gametocytes, however, are not a homogeneous cell population.  They are sexually dimorphic, and both males and females are required for parasite transmission.  Using two bioassays, we explored the effects of 20 antimalarials on the functional viability of both male and female mature gametocytes of Plasmodium falciparum.  We show that mature male gametocytes (as reported by their ability to produce male gametes, i.e., to exflagellate) are sensitive to antifolates, some endoperoxides, methylene blue, and thiostrepton, with submicromolar 50% inhibitory concns. (IC50s), whereas female gametocytes (as reported by their ability to activate and form gametes expressing the marker Pfs25) are much less sensitive to antimalarial intervention, with only methylene blue and thiostrepton showing any significant activity.  These findings show firstly that the antimalarial responses of male and female gametocytes differ and secondly that the mature male gametocyte should be considered a more vulnerable target than the female gametocyte for transmission-blocking drugs.  Given the female-biased sex ratio of Plasmodium falciparum (∼3 to 5 females:1 male), current gametocyte assays without a sex-specific readout are unlikely to identify male-targeted compds. and prioritize them for further development.  Both assays reported here are being scaled up to at least medium throughput and will permit identification of key transmission-blocking mols. that have been overlooked by other screening campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXL2JCR3jpE7Vg90H21EOLACvtfcHk0ljLgpCl15Prww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVartrfF&md5=7ef11a016fe88572a0d1faea7100ae8f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1128%2FAAC.00325-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00325-13%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DStraschil%26aufirst%3DU.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DMarques%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez-Barrag%25C3%25A1n%26aufirst%3DM.%2BJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26atitle%3DMale%2520and%2520female%2520Plasmodium%2520falciparum%2520mature%2520gametocytes%2520show%2520different%2520responses%2520to%2520antimalarial%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D3268%26epage%3D3274%26doi%3D10.1128%2Faac.00325-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straschil, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel-Blanco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span> <span> </span><span class="NLM_article-title">Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1038/nprot.2016.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnprot.2016.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=27560172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCgsb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1668-1680&author=M.+J.+Delvesauthor=U.+Straschilauthor=A.+Rueckerauthor=C.+Miguel-Blancoauthor=S.+Marquesauthor=A.+C.+Dufourauthor=J.+Baumauthor=R.+E.+Sinden&title=Routine+in+vitro+culture+of+P.+falciparum+gametocytes+to+evaluate+novel+transmission-blocking+interventions&doi=10.1038%2Fnprot.2016.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions</span></div><div class="casAuthors">Delves, Michael J.; Straschil, Ursula; Ruecker, Andrea; Miguel-Blanco, Celia; Marques, Sara; Baum, Jake; Sinden, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1680</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevention of parasite transmission from the human host to the mosquito has been recognized as a vital tool for malaria eradication campaigns.  However, transmission-blocking antimalarial drug and/or vaccine discovery and development is currently hampered by the expense and difficulty of producing mature Plasmodium falciparum gametocytes in vitro-the parasite stage responsible for mosquito infection.  Current protocols for P. falciparum gametocyte culture usually require complex parasite synchronization and addn. of stimulating and/or inhibitory factors, and they may not have demonstrated the essential property of mosquito infectivity.  This protocol details all the steps required for reliable P. falciparum gametocyte prodn. and highlights common factors that influence culture success.  The protocol can be completed in 15 d, and particular emphasis is placed upon operating a gametocyte culture facility on a continuous cycle.  In addn., we show how functionally viable gametocytes can be used to evaluate transmission-blocking drugs both in a field setting and at high throughput (HTP) for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomtyKdEiN1lLVg90H21EOLACvtfcHk0ljLgpCl15Prww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCgsb%252FL&md5=cb055e9f91b4446b238f0a6383abd49b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2016.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2016.096%26sid%3Dliteratum%253Aachs%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DStraschil%26aufirst%3DU.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DMiguel-Blanco%26aufirst%3DC.%26aulast%3DMarques%26aufirst%3DS.%26aulast%3DDufour%26aufirst%3DA.%2BC.%26aulast%3DBaum%26aufirst%3DJ.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26atitle%3DRoutine%2520in%2520vitro%2520culture%2520of%2520P.%2520falciparum%2520gametocytes%2520to%2520evaluate%2520novel%2520transmission-blocking%2520interventions%26jtitle%3DNat.%2520Protoc.%26date%3D2016%26volume%3D11%26spage%3D1668%26epage%3D1680%26doi%3D10.1038%2Fnprot.2016.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ncokazi, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.ab.2004.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=15745752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVaqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=306-319&author=K.+K.+Ncokaziauthor=T.+J.+Egan&title=A+colorimetric+high-throughput+beta-hematin+inhibition+screening+assay+for+use+in+the+search+for+antimalarial+compounds&doi=10.1016%2Fj.ab.2004.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A colorimetric high-throughput β-hematin inhibition screening assay for use in the search for antimalarial compounds</span></div><div class="casAuthors">Ncokazi, Kanyile K.; Egan, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">306-319</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Antimalarial drugs such as chloroquine are believed to act by inhibiting hemozoin formation in the food vacuole of the malaria parasite.  We have developed a new assay for measuring and detecting inhibition of synthetic hemozoin (β-hematin) formation.  Aq. pyridine (5% vol./vol., pH 7.5) forms a low-spin complex with hematin but not with β-hematin.  Its absorbance obeys Beer's law, making it useful for quantitating hematin concn. in hematin/β-hematin mixts., allowing compds. to be investigated for inhibition of β-hematin formation.  The assay is rapid (60 min incubation) and requires no centrifugation.  The β-hematin inhibition data show good agreement with alternative assay methods reported by four labs.  The assay was adapted for high-throughput colorimetric screening, allowing visual identification of β-hematin inhibitors.  In this mode, the assay successfully detected all 18 β-hematin inhibitors in a set of 47 compds. tested, with no false pos. results.  The quant. in vitro antimalarial activities of a set of 13 aminoquinolines and quinoline methanols were found to correlate significantly with β-hematin inhibition values detd. using the assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uXeKrfDEtbVg90H21EOLACvtfcHk0ljLgpCl15Prww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVaqu74%253D&md5=a4475a05f1e33e9465c97f9832bdbfb2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DNcokazi%26aufirst%3DK.%2BK.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DA%2520colorimetric%2520high-throughput%2520beta-hematin%2520inhibition%2520screening%2520assay%2520for%2520use%2520in%2520the%2520search%2520for%2520antimalarial%2520compounds%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D338%26spage%3D306%26epage%3D319%26doi%3D10.1016%2Fj.ab.2004.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combrinck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibhard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">253</span>, <span class="refDoi"> DOI: 10.1186/s12936-015-0729-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-015-0729-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26099266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BC2MblvVOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=253&author=J.+M.+Combrinckauthor=K.+Y.+Fongauthor=L.+Gibhardauthor=P.+J.+Smithauthor=D.+W.+Wrightauthor=T.+J.+Egan&title=Optimization+of+a+multi-well+colorimetric+assay+to+determine+haem+species+in+Plasmodium+falciparum+in+the+presence+of+anti-malarials&doi=10.1186%2Fs12936-015-0729-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials</span></div><div class="casAuthors">Combrinck Jill M; Gibhard Liezl; Smith Peter J; Fong Kim Y; Wright David W; Egan Timothy J</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">253</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The activity of several well-known anti-malarials, including chloroquine (CQ), is attributed to their ability to inhibit the formation of haemozoin (Hz) in the malaria parasite.  The formation of inert Hz, or malaria pigment, from toxic haem acquired from the host red blood cell of the parasite during haemoglobin digestion represents a pathway essential for parasite survival.  Inhibition of this critical pathway therefore remains a desirable target for novel anti-malarials.  A recent publication described the results of a haem fractionation assay used to directly determine haemoglobin, free haem and Hz in Plasmodium falciparum inoculated with CQ.  CQ was shown to cause a dose-dependent increase in cellular-free haem that was correlated with decreased parasite survival.  The method provided valuable information but was limited due to its low throughput and high demand on parasite starting material.  Here, this haem fractionation assay has been successfully adapted to a higher throughput method in 24-well plates, significantly reducing lead times and starting material volumes.  METHODS:  All major haem species in P. falciparum trophozoites, isolated through a series of cellular fractionation steps were determined spectrophotometrically in aqueous pyridine (5 % v/v, pH 7.5) as a low spin complex with haematin.  Cell counts were determined using a haemocytometer and a rapid novel fluorescent flow cytometry method.  RESULTS:  A higher throughput haem fractionation assay in 24-well plates, containing at most ten million trophozoites was validated against the original published method using CQ and its robustness was confirmed.  It provided a minimum six-fold improvement in productivity and 24-fold reduction in starting material volume.  The assay was successfully applied to amodiaquine (AQ), which was shown to inhibit Hz formation, while the antifolate pyrimethamine (PYR) and the mitochondrial electron transporter inhibitor atovaquone (Atov) demonstrated no increase in toxic cellular free haem.  CONCLUSIONS:  This higher throughput cellular haem fractionation assay can easily be applied to novel anti-malarials with a significantly decreased lead time, providing a valuable tool with which to probe the mechanisms of action of both new and established anti-malarials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSkYd91Hqw8CO2kE7krGOBfW6udTcc2eb9RVCxJxnLobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblvVOjsg%253D%253D&md5=69f2d3755b60d8b90d5c354bef46461a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-0729-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-0729-9%26sid%3Dliteratum%253Aachs%26aulast%3DCombrinck%26aufirst%3DJ.%2BM.%26aulast%3DFong%26aufirst%3DK.%2BY.%26aulast%3DGibhard%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DP.%2BJ.%26aulast%3DWright%26aufirst%3DD.%2BW.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26atitle%3DOptimization%2520of%2520a%2520multi-well%2520colorimetric%2520assay%2520to%2520determine%2520haem%2520species%2520in%2520Plasmodium%2520falciparum%2520in%2520the%2520presence%2520of%2520anti-malarials%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26spage%3D253%26doi%3D10.1186%2Fs12936-015-0729-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnadig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadani, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacheux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urnov, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit-Vical, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1126/science.1260867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1126%2Fscience.1260867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=25502314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=428-431&author=J.+Straimerauthor=N.+F.+Gnadigauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=V.+Duruauthor=A.+P.+Ramadaniauthor=M.+Dacheuxauthor=N.+Khimauthor=L.+Zhangauthor=S.+Lamauthor=P.+D.+Gregoryauthor=F.+D.+Urnovauthor=O.+Mercereau-Puijalonauthor=F.+Benoit-Vicalauthor=R.+M.+Fairhurstauthor=D.+Menardauthor=D.+A.+Fidock&title=K13-propeller+mutations+confer+artemisinin+resistance+in+Plasmodium+falciparum+clinical+isolates&doi=10.1126%2Fscience.1260867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span></div><div class="casAuthors">Straimer, Judith; Gnaedig, Nina F.; Witkowski, Benoit; Amaratunga, Chanaki; Duru, Valentine; Ramadani, Arba Pramundita; Dacheux, Melanie; Khim, Nimol; Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.; Mercereau-Puijalon, Odile; Benoit-Vical, Francoise; Fairhurst, Rick M.; Menard, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6220</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden.  We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients.  With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations.  Conversely, survival rates in wild-type parasites increased from ≤0.6% to 2 to 29% after the insertion of K13 mutations.  These mutations conferred elevated resistance to recent Cambodian isolates compared with that of ref. lines, suggesting a contemporary contribution of addnl. genetic factors.  Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ml-eUMKETLVg90H21EOLACvtfcHk0ljhdWp2NgdWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D&md5=5776238fb78428d16bcaed8d16fa73af</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1126%2Fscience.1260867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1260867%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGnadig%26aufirst%3DN.%2BF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DRamadani%26aufirst%3DA.%2BP.%26aulast%3DDacheux%26aufirst%3DM.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DGregory%26aufirst%3DP.%2BD.%26aulast%3DUrnov%26aufirst%3DF.%2BD.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DK13-propeller%2520mutations%2520confer%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520clinical%2520isolates%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D428%26epage%3D431%26doi%3D10.1126%2Fscience.1260867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Plasmodium falciparum In vitro drug resistance selections and gene editing</span>. <i>Methods Mol. Biol</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-9550-9_9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1007%2F978-1-4939-9550-9_9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31267498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1ahs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2019&pages=123-140&author=C.+L.+Ngauthor=D.+A.+Fidock&title=Plasmodium+falciparum+In+vitro+drug+resistance+selections+and+gene+editing&doi=10.1007%2F978-1-4939-9550-9_9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum In Vitro Drug Resistance Selections and Gene Editing</span></div><div class="casAuthors">Ng, Caroline L.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue">Malaria Control and Elimination</span>),
    <span class="NLM_cas:pages">123-140</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Malaria continues to be a global health burden, threatening over 40% of the world's population.  Drug resistance in Plasmodium falciparum , the etiol. agent of the majority of human malaria cases, is compromising elimination efforts.  New approaches to treating drug-resistant malaria benefit from defining resistance liabilities of known antimalarial agents and compds. in development and defining genetic changes that mediate loss of parasite susceptibility.  Here, we present protocols for in vitro selection of drug-resistant parasites and for site-directed gene editing of candidate resistance mediators to test for causality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEsswlUQlg6LVg90H21EOLACvtfcHk0lgFza1GcAWn4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1ahs78%253D&md5=ab48e78ea27ca7e4389071d6bad17e0a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-9550-9_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-9550-9_9%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DPlasmodium%2520falciparum%2520In%2520vitro%2520drug%2520resistance%2520selections%2520and%2520gene%2520editing%26jtitle%3DMethods%2520Mol.%2520Biol%26date%3D2019%26volume%3D2013%26spage%3D123%26epage%3D140%26doi%3D10.1007%2F978-1-4939-9550-9_9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onguka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foe, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieplak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpornsin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linington, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlemann, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weerapana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">The antimalarial natural product salinipostin a identifies essential alpha/beta serine hydrolases involved in lipid metabolism in P. falciparum parasites</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2020.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1016%2Fj.chembiol.2020.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31978322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFyitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&pages=143-157&author=E.+Yooauthor=C.+J.+Schulzeauthor=B.+H.+Stokesauthor=O.+Ongukaauthor=T.+Yeoauthor=S.+Mokauthor=N.+F.+Gn%C3%A4digauthor=Y.+Zhouauthor=K.+Kuritaauthor=I.+T.+Foeauthor=S.+M.+Terrellauthor=M.+J.+Boucherauthor=P.+Cieplakauthor=K.+Kumpornsinauthor=M.+C.+S.+Leeauthor=R.+G.+Liningtonauthor=J.+Z.+Longauthor=A.-C.+Uhlemannauthor=E.+Weerapanaauthor=D.+A.+Fidockauthor=M.+Bogyo&title=The+antimalarial+natural+product+salinipostin+a+identifies+essential+alpha%2Fbeta+serine+hydrolases+involved+in+lipid+metabolism+in+P.+falciparum+parasites&doi=10.1016%2Fj.chembiol.2020.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites</span></div><div class="casAuthors">Yoo, Euna; Schulze, Christopher J.; Stokes, Barbara H.; Onguka, Ouma; Yeo, Tomas; Mok, Sachel; Gnadig, Nina F.; Zhou, Yani; Kurita, Kenji; Foe, Ian T.; Terrell, Stephanie M.; Boucher, Michael J.; Cieplak, Piotr; Kumpornsin, Krittikorn; Lee, Marcus C. S.; Linington, Roger G.; Long, Jonathan Z.; Uhlemann, Anne-Catrin; Weerapana, Eranthie; Fidock, David A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-157.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Salinipostin A (Sal A) is a potent antiplasmodial marine natural product with an undefined mechanism of action. Using a Sal A-derived activity-based probe, we identify its targets in the Plasmodium falciparum parasite. All of the identified proteins contain α/β serine hydrolase domains and several are essential for parasite growth. One of the essential targets displays a high degree of homol. to human monoacylglycerol lipase (MAGL) and is able to process lipid esters including a MAGL acylglyceride substrate. This Sal A target is inhibited by the anti-obesity drug Orlistat, which disrupts lipid metab.  Resistance selections yielded parasites that showed only minor redns. in sensitivity and that acquired mutations in a PRELI domain-contg. protein linked to drug resistance in Toxoplasma gondii. This inability to evolve efficient resistance mechanisms combined with the non-essentiality of human homologs makes the serine hydrolases identified here promising antimalarial targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOgOe9iPSaVbVg90H21EOLACvtfcHk0lgFza1GcAWn4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFyitb0%253D&md5=236485f5855092e9e7e2acde4d3b9ac4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2020.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2020.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DSchulze%26aufirst%3DC.%2BJ.%26aulast%3DStokes%26aufirst%3DB.%2BH.%26aulast%3DOnguka%26aufirst%3DO.%26aulast%3DYeo%26aufirst%3DT.%26aulast%3DMok%26aufirst%3DS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DKurita%26aufirst%3DK.%26aulast%3DFoe%26aufirst%3DI.%2BT.%26aulast%3DTerrell%26aufirst%3DS.%2BM.%26aulast%3DBoucher%26aufirst%3DM.%2BJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKumpornsin%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DLinington%26aufirst%3DR.%2BG.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DUhlemann%26aufirst%3DA.-C.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DThe%2520antimalarial%2520natural%2520product%2520salinipostin%2520a%2520identifies%2520essential%2520alpha%252Fbeta%2520serine%2520hydrolases%2520involved%2520in%2520lipid%2520metabolism%2520in%2520P.%2520falciparum%2520parasites%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2020%26volume%3D27%26spage%3D143%26epage%3D157%26doi%3D10.1016%2Fj.chembiol.2020.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipanayis, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luquette, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. J.</span></span> <span> </span><span class="NLM_article-title">Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">E1128</span>– <span class="NLM_lpage">E1136</span>, <span class="refDoi"> DOI: 10.1073/pnas.1110574108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1110574108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=22065754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Wis7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E1128-E1136&author=R.+Xiauthor=A.+G.+Hadjipanayisauthor=L.+J.+Luquetteauthor=T.-M.+Kimauthor=E.+Leeauthor=J.+Zhangauthor=M.+D.+Johnsonauthor=D.+M.+Muznyauthor=D.+A.+Wheelerauthor=R.+A.+Gibbsauthor=R.+Kucherlapatiauthor=P.+J.+Park&title=Copy+number+variation+detection+in+whole-genome+sequencing+data+using+the+Bayesian+information+criterion&doi=10.1073%2Fpnas.1110574108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion</span></div><div class="casAuthors">Xi, Ruibin; Hadjipanayis, Angela G.; Luquette, Lovelace J.; Kim, Tae-Min; Lee, Eunjung; Zhang, Jianhua; Johnson, Mark D.; Muzny, Donna M.; Wheeler, David A.; Gibbs, Richard A.; Kucherlapati, Raju; Park, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">E1128-E1136, SE1128/1-SE1128/22</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">DNA copy no. variations (CNVs) play an important role in the pathogenesis and progression of cancer and confer susceptibility to a variety of human disorders.  Array comparative genomic hybridization has been used widely to identify CNVs genome wide, but the next-generation sequencing technol. provides an opportunity to characterize CNVs genome wide with unprecedented resoln.  In this study, the authors developed an algorithm to detect CNVs from whole-genome sequencing data and applied it to a newly sequenced glioblastoma genome with a matched control.  This read-depth algorithm, called BIC-seq, can accurately and efficiently identify CNVs via minimizing the Bayesian information criterion.  Using BIC-seq, the authors identified hundreds of CNVs as small as 40 bp in the cancer genome sequenced at 10x coverage, whereas they could only detect large CNVs (> 15 kb) in the array comparative genomic hybridization profiles for the same genome.  Eighty percent (14/16) of the small variants tested (110 bp to 14 kb) were exptl. validated by quant. PCR, demonstrating high sensitivity and true pos. rate of the algorithm.  The authors also extended the algorithm to detect recurrent CNVs in multiple samples as well as deriving error bars for breakpoints using a Gibbs sampling approach.  The authors propose this statistical approach as a principled yet practical and efficient method to est. CNVs in whole-genome sequencing data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKT3hljOFfJbVg90H21EOLACvtfcHk0lgUCmeDSnp--A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Wis7nP&md5=862295af13a43f0a9288a572da10bd86</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1110574108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1110574108%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DR.%26aulast%3DHadjipanayis%26aufirst%3DA.%2BG.%26aulast%3DLuquette%26aufirst%3DL.%2BJ.%26aulast%3DKim%26aufirst%3DT.-M.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DP.%2BJ.%26atitle%3DCopy%2520number%2520variation%2520detection%2520in%2520whole-genome%2520sequencing%2520data%2520using%2520the%2520Bayesian%2520information%2520criterion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3DE1128%26epage%3DE1136%26doi%3D10.1073%2Fpnas.1110574108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crighton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katneni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moehrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abla, N.</span></span> <span> </span><span class="NLM_article-title">An in vitro toolbox to accelerate anti-malarial drug discovery and development</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1186/s12936-019-3075-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-019-3075-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=31898492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&pages=1&author=S.+A.+Charmanauthor=A.+Andreuauthor=H.+Barkerauthor=S.+Blundellauthor=A.+Campbellauthor=M.+Campbellauthor=G.+Chenauthor=F.+C.+K.+Chiuauthor=E.+Crightonauthor=K.+Katneniauthor=J.+Morizziauthor=R.+Patilauthor=T.+Phamauthor=E.+Ryanauthor=J.+Saundersauthor=D.+M.+Shacklefordauthor=K.+L.+Whiteauthor=L.+Almondauthor=M.+Dickinsauthor=D.+A.+Smithauthor=J.+J.+Moehrleauthor=J.+N.+Burrowsauthor=N.+Abla&title=An+in+vitro+toolbox+to+accelerate+anti-malarial+drug+discovery+and+development&doi=10.1186%2Fs12936-019-3075-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro toolbox to accelerate anti-malarial drug discovery and development</span></div><div class="casAuthors">Charman, Susan A.; Andreu, Alice; Barker, Helena; Blundell, Scott; Campbell, Anna; Campbell, Michael; Chen, Gong; Chiu, Francis C. K.; Crighton, Elly; Katneni, Kasiram; Morizzi, Julia; Patil, Rahul; Pham, Thao; Ryan, Eileen; Saunders, Jessica; Shackleford, David M.; White, Karen L.; Almond, Lisa; Dickins, Maurice; Smith, Dennis A.; Moehrle, Joerg J.; Burrows, Jeremy N.; Abla, Nada</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Modeling and simulation are being increasingly utilized to support the discovery and development of new anti-malarial drugs.  These approaches require reliable in vitro data for physicochem. properties, permeability, binding, intrinsic clearance and cytochrome P 450 inhibition.  This work was conducted to generate an in vitro data toolbox using standardized methods for a set of 45 anti-malarial drugs and to assess changes in physicochem. properties in relation to changing target product and candidate profiles.  Methods: Ionization consts. were detd. by potentiometric titrn. and partition coeffs. were measured using a shake-flask method.  Soly. was assessed in biorelevant media and permeability coeffs. and efflux ratios were detd. using Caco-2 cell monolayers.  Binding to plasma and media proteins was measured using either ultracentrifugation or rapid equil. dialysis.  Metabolic stability and cytochrome P 450 inhibition were assessed using human liver microsomes.  Sample anal. was conducted by LC-MS/MS.  Results: Both soly. and fraction unbound decreased, and permeability and unbound intrinsic clearance increased, with increasing Log D7.4.  In general, development compds. were somewhat more lipophilic than legacy drugs.  For many compds., permeability and protein binding were challenging to assess and both required the use of exptl. conditions that minimized the impact of non-specific binding.  Intrinsic clearance in human liver microsomes was varied across the data set and several compds. exhibited no measurable substrate loss under the conditions used.  Inhibition of cytochrome P 450 enzymes was minimal for most compds.  Conclusions: This is the first data set to describe in vitro properties for 45 legacy and development anti-malarial drugs.  The studies identified several practical methodol. issues common to many of the more lipophilic compds. and highlighted areas which require more work to customize exptl. conditions for compds. being designed to meet the new target product profiles.  The dataset will be a valuable tool for malaria researchers aiming to develop PBPK models for the prediction of human PK properties and/or drug-drug interactions.  Furthermore, generation of this comprehensive data set within a single lab. allows direct comparison of properties across a large dataset and evaluation of changing property trends that have occurred over time with changing target product and candidate profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz-G7Yo6U877Vg90H21EOLACvtfcHk0lgUCmeDSnp--A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D&md5=a996cd5a032c9042bc957d0bddecbd3b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-3075-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-3075-5%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DAndreu%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DBlundell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DCrighton%26aufirst%3DE.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DAlmond%26aufirst%3DL.%26aulast%3DDickins%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DMoehrle%26aufirst%3DJ.%2BJ.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DAbla%26aufirst%3DN.%26atitle%3DAn%2520in%2520vitro%2520toolbox%2520to%2520accelerate%2520anti-malarial%2520drug%2520discovery%2520and%2520development%26jtitle%3DMalar.%2520J.%26date%3D2020%26volume%3D19%26spage%3D1%26doi%3D10.1186%2Fs12936-019-3075-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katneni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crighton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas-Valentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittimalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span> <span> </span><span class="NLM_article-title">Lead optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series for the treatment of malaria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4929</span>– <span class="NLM_lpage">4956</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtl2lu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4929-4956&author=S.+Kokkondaauthor=X.+Dengauthor=K.+L.+Whiteauthor=F.+El+Mazouniauthor=J.+Whiteauthor=D.+M.+Shacklefordauthor=K.+Katneniauthor=F.+C.+K.+Chiuauthor=H.+Barkerauthor=J.+McLarenauthor=E.+Crightonauthor=G.+Chenauthor=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=S.+Ferrerauthor=L.+Huertas-Valentinauthor=M.+S.+Martinez-Martinezauthor=M.+J.+Lafuente-Monasterioauthor=R.+Chittimallaauthor=S.+P.+Shahiauthor=S.+Wittlinauthor=D.+Watersonauthor=J.+N.+Burrowsauthor=D.+Matthewsauthor=D.+Tomchickauthor=P.+K.+Rathodauthor=M.+J.+Palmerauthor=S.+A.+Charmanauthor=M.+A.+Phillips&title=Lead+optimization+of+a+pyrrole-based+dihydroorotate+dehydrogenase+inhibitor+series+for+the+treatment+of+malaria&doi=10.1021%2Facs.jmedchem.0c00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria</span></div><div class="casAuthors">Kokkonda, Sreekanth; Deng, Xiaoyi; White, Karen L.; El Mazouni, Farah; White, John; Shackleford, David M.; Katneni, Kasiram; Chiu, Francis C. K.; Barker, Helena; McLaren, Jenna; Crighton, Elly; Chen, Gong; Angulo-Barturen, Inigo; Jimenez-Diaz, Maria Belen; Ferrer, Santiago; Huertas-Valentin, Leticia; Martinez-Martinez, Maria Santos; Lafuente-Monasterio, Maria Jose; Chittimalla, Rajesh; Shahi, Shatrughan P.; Wittlin, Sergio; Waterson, David; Burrows, Jeremy N.; Matthews, Dave; Tomchick, Diana; Rathod, Pradipsinh K.; Palmer, Michael J.; Charman, Susan A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4929-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria puts at risk nearly half the world's population and causes high mortality in sub-Saharan Africa, while drug resistance threatens current therapies.  The pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (DHODH) is a validated target for malaria treatment based on our finding that triazolopyrimidine DSM265 (1) showed efficacy in clin. studies.  Herein, we describe optimization of a pyrrole-based series identified using a target-based DHODH screen.  Compds. with nanomolar potency vs. Plasmodium DHODH and Plasmodium parasites were identified with good pharmacol. properties.  X-ray studies showed that the pyrroles bind an alternative enzyme conformation from 1 leading to improved species selectivity vs. mammalian enzymes and equiv. activity on Plasmodium falciparum and Plasmodium vivax DHODH.  The best lead DSM502 (37)(I) showed in vivo efficacy at similar levels of blood exposure to 1, although metabolic stability was reduced.  Overall, the pyrrole-based DHODH inhibitors provide an attractive alternative scaffold for the development of new antimalarial compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKUG8uEm6XLVg90H21EOLACvtfcHk0lhkgMVbu3Q3ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtl2lu7o%253D&md5=33fcfe54e02132d8fd9a4816d40212b3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00311%26sid%3Dliteratum%253Aachs%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DMcLaren%26aufirst%3DJ.%26aulast%3DCrighton%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DHuertas-Valentin%26aufirst%3DL.%26aulast%3DMartinez-Martinez%26aufirst%3DM.%2BS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DChittimalla%26aufirst%3DR.%26aulast%3DShahi%26aufirst%3DS.%2BP.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DTomchick%26aufirst%3DD.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DLead%2520optimization%2520of%2520a%2520pyrrole-based%2520dihydroorotate%2520dehydrogenase%2520inhibitor%2520series%2520for%2520the%2520treatment%2520of%2520malaria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4929%26epage%3D4956%26doi%3D10.1021%2Facs.jmedchem.0c00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baragaña, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimaldi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proto, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagborough, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porzelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolscher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luksch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakutansky, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Díaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noviyanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Bazaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebrevska, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">A novel multiple-stage antimalarial agent that inhibits protein synthesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>522</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nature14451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1038%2Fnature14451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26085270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeiurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=522&publication_year=2015&pages=315-320&author=B.+Baraga%C3%B1aauthor=I.+Hallyburtonauthor=M.+C.+S.+Leeauthor=N.+R.+Norcrossauthor=R.+Grimaldiauthor=T.+D.+Ottoauthor=W.+R.+Protoauthor=A.+M.+Blagboroughauthor=S.+Meisterauthor=G.+Wirjanataauthor=A.+Rueckerauthor=L.+M.+Uptonauthor=T.+S.+Abrahamauthor=M.+J.+Almeidaauthor=A.+Pradhanauthor=A.+Porzelleauthor=M.+S.+Mart%C3%ADnezauthor=J.+M.+Bolscherauthor=A.+Woodlandauthor=T.+Lukschauthor=S.+Norvalauthor=F.+Zuccottoauthor=J.+Thomasauthor=F.+Simeonsauthor=L.+Stojanovskiauthor=M.+Osuna-Cabelloauthor=P.+M.+Brockauthor=T.+S.+Churcherauthor=K.+A.+Salaauthor=S.+E.+Zakutanskyauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=L.+M.+Sanzauthor=J.+Rileyauthor=R.+Basakauthor=M.+Campbellauthor=V.+M.+Averyauthor=R.+W.+Sauerweinauthor=K.+J.+Decheringauthor=R.+Noviyantiauthor=B.+Campoauthor=J.+A.+Frearsonauthor=I.+Angulo-Barturenauthor=S.+Ferrer-Bazagaauthor=F.+J.+Gamoauthor=P.+G.+Wyattauthor=D.+Leroyauthor=P.+Sieglauthor=M.+J.+Delvesauthor=D.+E.+Kyleauthor=S.+Wittlinauthor=J.+Marfurtauthor=R.+N.+Priceauthor=R.+E.+Sindenauthor=E.+A.+Winzelerauthor=S.+A.+Charmanauthor=L.+Bebrevskaauthor=D.+W.+Grayauthor=S.+Campbellauthor=A.+H.+Fairlambauthor=P.+A.+Willisauthor=J.+C.+Raynerauthor=D.+A.+Fidockauthor=K.+D.+Readauthor=I.+H.+Gilbertauthor=I.+H.+Gilbert&title=A+novel+multiple-stage+antimalarial+agent+that+inhibits+protein+synthesis&doi=10.1038%2Fnature14451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A novel multiple-stage antimalarial agent that inhibits protein synthesis</span></div><div class="casAuthors">Baragana, Beatriz; Hallyburton, Irene; Lee, Marcus C. S.; Norcross, Neil R.; Grimaldi, Raffaella; Otto, Thomas D.; Proto, William R.; Blagborough, Andrew M.; Meister, Stephan; Wirjanata, Grennady; Ruecker, Andrea; Upton, Leanna M.; Abraham, Tara S.; Almeida, Mariana J.; Pradhan, Anupam; Porzelle, Achim; Martinez, Maria Santos; Bolscher, Judith M.; Woodland, Andrew; Luksch, Torsten; Norval, Suzanne; Zuccotto, Fabio; Thomas, John; Simeons, Frederick; Stojanovski, Laste; Osuna-Cabello, Maria; Brock, Paddy M.; Churcher, Tom S.; Sala, Katarzyna A.; Zakutansky, Sara E.; Jimenez-Diaz, Maria Belen; Sanz, Laura Maria; Riley, Jennifer; Basak, Rajshekhar; Campbell, Michael; Avery, Vicky M.; Sauerwein, Robert W.; Dechering, Koen J.; Noviyanti, Rintis; Campo, Brice; Frearson, Julie A.; Angulo-Barturen, Inigo; Ferrer-Bazaga, Santiago; Gamo, Francisco Javier; Wyatt, Paul G.; Leroy, Didier; Siegl, Peter; Delves, Michael J.; Kyle, Dennis E.; Wittlin, Sergio; Marfurt, Jutta; Price, Ric N.; Sinden, Robert E.; Winzeler, Elizabeth A.; Charman, Susan A.; Bebrevska, Lidiya; Gray, David W.; Campbell, Simon; Fairlamb, Alan H.; Willis, Paul A.; Rayner, Julian C.; Fidock, David A.; Read, Kevin D.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">522</span>
        (<span class="NLM_cas:issue">7556</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">There is an urgent need for new drugs to treat malaria, with broad therapeutic potential and novel modes of action, to widen the scope of treatment and to overcome emerging drug resistance.  Here we describe the discovery of DDD107498, a compd. with a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite, with good pharmacokinetic properties and an acceptable safety profile.  DDD107498 demonstrates potential to address a variety of clin. needs, including single-dose treatment, transmission blocking and chemoprotection.  DDD107498 was developed from a screening program against blood-stage malaria parasites; its mol. target has been identified as translation elongation factor 2 (eEF2), which is responsible for the GTP-dependent translocation of the ribosome along mRNA, and is essential for protein synthesis.  This discovery of eEF2 as a viable antimalarial drug target opens up new possibilities for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhDYwtxN92qrVg90H21EOLACvtfcHk0lhkgMVbu3Q3ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeiurzE&md5=bd5f1dd3c4389aa8a6f193df0aa068a1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnature14451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14451%26sid%3Dliteratum%253Aachs%26aulast%3DBaraga%25C3%25B1a%26aufirst%3DB.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DGrimaldi%26aufirst%3DR.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DProto%26aufirst%3DW.%2BR.%26aulast%3DBlagborough%26aufirst%3DA.%2BM.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DUpton%26aufirst%3DL.%2BM.%26aulast%3DAbraham%26aufirst%3DT.%2BS.%26aulast%3DAlmeida%26aufirst%3DM.%2BJ.%26aulast%3DPradhan%26aufirst%3DA.%26aulast%3DPorzelle%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DBolscher%26aufirst%3DJ.%2BM.%26aulast%3DWoodland%26aufirst%3DA.%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DSimeons%26aufirst%3DF.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DBrock%26aufirst%3DP.%2BM.%26aulast%3DChurcher%26aufirst%3DT.%2BS.%26aulast%3DSala%26aufirst%3DK.%2BA.%26aulast%3DZakutansky%26aufirst%3DS.%2BE.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DBasak%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer-Bazaga%26aufirst%3DS.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DBebrevska%26aufirst%3DL.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26aulast%3DRayner%26aufirst%3DJ.%2BC.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DA%2520novel%2520multiple-stage%2520antimalarial%2520agent%2520that%2520inhibits%2520protein%2520synthesis%26jtitle%3DNature%26date%3D2015%26volume%3D522%26spage%3D315%26epage%3D320%26doi%3D10.1038%2Fnature14451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenviaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graumans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Vegte-Bolmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattabongkot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinetz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5060</span>– <span class="NLM_lpage">5067</span>, <span class="refDoi"> DOI: 10.1128/aac.02727-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.02727-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=24913172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5060-5067&author=K.+L.+Kuhenauthor=A.+K.+Chatterjeeauthor=M.+Rottmannauthor=K.+Gagaringauthor=R.+Borboaauthor=J.+Buenviajeauthor=Z.+Chenauthor=C.+Francekauthor=T.+Wuauthor=A.+Nagleauthor=S.+W.+Barnesauthor=D.+Plouffeauthor=M.+C.+S.+Leeauthor=D.+A.+Fidockauthor=W.+Graumansauthor=M.+van+de+Vegte-Bolmerauthor=G.+J.+van+Gemertauthor=G.+Wirjanataauthor=B.+Sebayangauthor=J.+Marfurtauthor=B.+Russellauthor=R.+Suwanaruskauthor=R.+N.+Priceauthor=F.+Nostenauthor=A.+Tungtaengauthor=M.+Gettayacaminauthor=J.+Sattabongkotauthor=J.+Taylorauthor=J.+R.+Walkerauthor=D.+Tullyauthor=K.+P.+Patraauthor=E.+L.+Flanneryauthor=J.+M.+Vinetzauthor=L.+Reniaauthor=R.+W.+Sauerweinauthor=E.+A.+Winzelerauthor=R.+J.+Glynneauthor=T.+T.+Diagana&title=KAF156+is+an+antimalarial+clinical+candidate+with+potential+for+use+in+prophylaxis%2C+treatment%2C+and+prevention+of+disease+transmission&doi=10.1128%2Faac.02727-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">KAf156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission</span></div><div class="casAuthors">Kuhen, Kelli L.; Chatterjee, Arnab K.; Rottmann, Matthias; Gagaring, Kerstin; Borboa, Rachel; Buenviaje, Jennifer; Chen, Zhong; Francek, Carolyn; Wu, Tao; Nagle, Advait; Barnes, S. Whitney; Plouffe, David; Lee, Marcus C. S.; Fidock, David A.; Graumans, Wouter; van de Vegte-Bolmer, Marga; van Gemert, Geert J.; Wirjanata, Grennady; Sebayang, Boni; Marfurt, Jutta; Russell, Bruce; Suwanarusk, Rossarin; Price, Ric N.; Nosten, Francois; Tungtaeng, Anchalee; Gettayacamin, Montip; Sattabongkot, Jetsumon; Taylor, Jennifer; Walker, John R.; Tully, David; Patra, Kailash P.; Flannery, Erika L.; Vinetz, Joseph M.; Renia, Laurent; Sauerwein, Robert W.; Winzeler, Elizabeth A.; Glynne, Richard J.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5060-5067, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Renewed global efforts toward malaria eradication have highlighted the need for novel antimalarial agents with activity against multiple stages of the parasite life cycle.  We have previously reported the discovery of a novel class of antimalarial compds. in the imidazolopiperazine series that have activity in the prevention and treatment of blood stage infection in a mouse model of malaria.  Consistent with the previously reported activity profile of this series, the clin. candidate KAF156 shows blood schizonticidal activity with 50% inhibitory concns. of 6 to 17.4 nM against P. falciparum drug-sensitive and drug-resistant strains, as well as potent therapeutic activity in a mouse models of malaria with 50, 90, and 99 % EDs of 0.6, 0.9, and 1.4 mg/kg, resp.  When administered prophylactically in a sporozoite challenge mouse model, KAF156 is completely protective as a single oral dose of 10 mg/kg.  Finally, KAF156 displays potent Plasmodium transmission blocking activities both in vitro and in vivo.  Collectively, our data suggest that KAF156, currently under evaluation in clin. trials, has the potential to treat, prevent, and block the transmission of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4QluxrWtdq7Vg90H21EOLACvtfcHk0ljJNpUUGEe44w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK&md5=c97e07e4832e871885546880084be5ca</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1128%2FAAC.02727-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02727-13%26sid%3Dliteratum%253Aachs%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBuenviaje%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DGraumans%26aufirst%3DW.%26aulast%3Dvan%2Bde%2BVegte-Bolmer%26aufirst%3DM.%26aulast%3Dvan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DSebayang%26aufirst%3DB.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTully%26aufirst%3DD.%26aulast%3DPatra%26aufirst%3DK.%2BP.%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DVinetz%26aufirst%3DJ.%2BM.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DKAF156%2520is%2520an%2520antimalarial%2520clinical%2520candidate%2520with%2520potential%2520for%2520use%2520in%2520prophylaxis%252C%2520treatment%252C%2520and%2520prevention%2520of%2520disease%2520transmission%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5060%26epage%3D5067%26doi%3D10.1128%2Faac.02727-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miley, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickles, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pershing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakharov, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5555</span>– <span class="NLM_lpage">5560</span>, <span class="refDoi"> DOI: 10.1128/aac.01183-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1128%2FAAC.01183-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26124159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOltLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=5555-5560&author=G.+P.+Mileyauthor=S.+Pouauthor=R.+Winterauthor=A.+Nilsenauthor=Y.+Liauthor=J.+X.+Kellyauthor=A.+M.+Sticklesauthor=M.+W.+Matherauthor=I.+P.+Forquerauthor=A.+M.+Pershingauthor=K.+Whiteauthor=D.+Shacklefordauthor=J.+Saundersauthor=G.+Chenauthor=L.-M.+Tingauthor=K.+Kimauthor=L.+N.+Zakharovauthor=C.+Doniniauthor=J.+N.+Burrowsauthor=A.+B.+Vaidyaauthor=S.+A.+Charmanauthor=M.+K.+Riscoe&title=ELQ-300+prodrugs+for+enhanced+delivery+and+single-dose+cure+of+malaria&doi=10.1128%2Faac.01183-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria</span></div><div class="casAuthors">Miley, Galen P.; Pou, Sovitj; Winter, Rolf; Nilsen, Aaron; Li, Yuexin; Kelly, Jane X.; Stickles, Allison M.; Mather, Michael W.; Forquer, Isaac P.; Pershing, April M.; White, Karen; Shackleford, David; Saunders, Jessica; Chen, Gong; Ting, Li-Min; Kim, Kami; Zakharov, Lev N.; Donini, Cristina; Burrows, Jeremy N.; Vaidya, Akhil B.; Charman, Susan A.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5555-5560</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">ELQ-300 is a preclin. candidate that targets the liver and blood stages of Plasmodium falciparum, as well as the forms that are crucial to transmission of disease: gametocytes, zygotes, and ookinetes.  A significant obstacle to the clin. development of ELQ-300 is related to its physicochem. properties.  Its relatively poor aq. soly. and high crystallinity limit absorption to the degree that only low blood concns. can be achieved following oral dosing.  While these low blood concns. are sufficient for therapy, the levels are too low to establish an acceptable safety margin required by regulatory agencies for clin. development.  One way to address the challenging physicochem. properties of ELQ-300 is through the development of prodrugs.  Here, we profile ELQ-337, a bioreversible O-linked carbonate ester prodrug of the parent mol.  At the molar equivalent dose of 3 mg/kg of body wt., the delivery of ELQ-300 from ELQ-337 is enhanced by 3- to 4-fold, reaching a max. concn. of drug in serum (Cmax) of 5.9 μM by 6 h after oral administration, and unlike ELQ-300 at any dose, ELQ-337 provides single-dose cures of patent malaria infections in mice at low-single-digit milligram per kg doses.  Our findings show that the prodrug strategy represents a viable approach to overcome the physicochem. limitations of ELQ-300 to deliver the active drug to the bloodstream at concns. sufficient for safety and toxicol. studies, as well as achieving single-dose cures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtvlwGjW4RGbVg90H21EOLACvtfcHk0ljeVaYXGJmcfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOltLzF&md5=aaeb38b2f2ddf3e60abc9e453b3ca11b</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1128%2FAAC.01183-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01183-15%26sid%3Dliteratum%253Aachs%26aulast%3DMiley%26aufirst%3DG.%2BP.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DR.%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DStickles%26aufirst%3DA.%2BM.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DPershing%26aufirst%3DA.%2BM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DShackleford%26aufirst%3DD.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTing%26aufirst%3DL.-M.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DZakharov%26aufirst%3DL.%2BN.%26aulast%3DDonini%26aufirst%3DC.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DELQ-300%2520prodrugs%2520for%2520enhanced%2520delivery%2520and%2520single-dose%2520cure%2520of%2520malaria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D5555%26epage%3D5560%26doi%3D10.1128%2Faac.01183-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelleau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casteras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryszewski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkman, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neafsey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musset, L.</span></span> <span> </span><span class="NLM_article-title">Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">11672</span>– <span class="NLM_lpage">11677</span>, <span class="refDoi"> DOI: 10.1073/pnas.1507142112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1073%2Fpnas.1507142112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=26261345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=11672-11677&author=S.+Pelleauauthor=E.+L.+Mossauthor=S.+K.+Dhingraauthor=B.+Volneyauthor=J.+Casterasauthor=S.+J.+Gabryszewskiauthor=S.+K.+Volkmanauthor=D.+F.+Wirthauthor=E.+Legrandauthor=D.+A.+Fidockauthor=D.+E.+Neafseyauthor=L.+Musset&title=Adaptive+evolution+of+malaria+parasites+in+French+Guiana%3A+Reversal+of+chloroquine+resistance+by+acquisition+of+a+mutation+in+pfcrt&doi=10.1073%2Fpnas.1507142112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt</span></div><div class="casAuthors">Pelleau, Stephane; Moss, Eli L.; Dhingra, Satish K.; Volney, Beatrice; Casteras, Jessica; Gabryszewski, Stanislaw J.; Volkman, Sarah K.; Wirth, Dyann F.; Legrand, Eric; Fidock, David A.; Neafsey, Daniel E.; Musset, Lise</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11672-11677</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In regions with high malaria endemicity, the withdrawal of chloroquine (CQ) as first-line treatment of Plasmodium falciparum infections has typically led to the restoration of CQ susceptibility through the reexpansion of the wild-type (WT) allele K76 of the chloroquine resistance transporter gene (pfcrt) at the expense of less fit mutant alleles carrying the CQ resistance (CQR) marker K76T.  In low-transmission settings, such as South America, drug resistance mutations can attain 100% prevalence, thereby precluding the return of WT parasites after the complete removal of drug pressure.  In French Guiana, despite the fixation of the K76T allele, the prevalence of CQR isolates progressively dropped from >90% to <30% during 17 y after CQ withdrawal in 1995.  Using a genome-wide assocn. study with CQ-sensitive (CQS) and CQR isolates, we have identified a single mutation in pfcrt encoding a C350R substitution that is assocd. with the restoration of CQ susceptibility.  Genome editing of the CQR ref. strain 7G8 to incorporate PfCRT C350R caused a complete loss of CQR.  A retrospective mol. survey on 580 isolates collected from 1997 to 2012 identified all C350R mutant parasites as being CQS.  This mutation emerged in 2002 and rapidly spread throughout the P. falciparum population.  The C350R allele is also assocd. with a significant decrease in piperaquine susceptibility in vitro, suggesting that piperaquine pressure in addn. to potential fitness costs assocd. with the 7G8-type CQR pfcrt allele may have selected for this mutation.  These findings have important implications for understanding the evolutionary dynamics of antimalarial drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNflcEeeRkVLVg90H21EOLACvtfcHk0ljeVaYXGJmcfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7rI&md5=0a13742f5aac3842cdf9ce4d516b0b71</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1507142112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1507142112%26sid%3Dliteratum%253Aachs%26aulast%3DPelleau%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DE.%2BL.%26aulast%3DDhingra%26aufirst%3DS.%2BK.%26aulast%3DVolney%26aufirst%3DB.%26aulast%3DCasteras%26aufirst%3DJ.%26aulast%3DGabryszewski%26aufirst%3DS.%2BJ.%26aulast%3DVolkman%26aufirst%3DS.%2BK.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DLegrand%26aufirst%3DE.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DNeafsey%26aufirst%3DD.%2BE.%26aulast%3DMusset%26aufirst%3DL.%26atitle%3DAdaptive%2520evolution%2520of%2520malaria%2520parasites%2520in%2520French%2520Guiana%253A%2520Reversal%2520of%2520chloroquine%2520resistance%2520by%2520acquisition%2520of%2520a%2520mutation%2520in%2520pfcrt%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D11672%26epage%3D11677%26doi%3D10.1073%2Fpnas.1507142112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M. H.</span></span> <span> </span><span class="NLM_article-title">The past, present and future of anti-malarial medicines</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">93</span>, <span class="refDoi"> DOI: 10.1186/s12936-019-2724-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=10.1186%2Fs12936-019-2724-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=30902052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=93&author=E.+G.+Tseauthor=M.+Korsikauthor=M.+H.+Todd&title=The+past%2C+present+and+future+of+anti-malarial+medicines&doi=10.1186%2Fs12936-019-2724-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future of anti-malarial medicines</span></div><div class="casAuthors">Tse Edwin G; Korsik Marat; Todd Matthew H; Todd Matthew H</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide.  Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact.  Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead.  New drugs are needed, particularly those with new mechanisms of action.  Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine.  A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated.  Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAJgQVEudAeqqcneEtCi92fW6udTcc2ebVHbeD8N14b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D&md5=b15a2176b672dff36de8c4ea6cfb6a54</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-2724-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-2724-z%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DE.%2BG.%26aulast%3DKorsik%26aufirst%3DM.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DThe%2520past%252C%2520present%2520and%2520future%2520of%2520anti-malarial%2520medicines%26jtitle%3DMalar.%2520J.%26date%3D2019%26volume%3D18%26spage%3D93%26doi%3D10.1186%2Fs12936-019-2724-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujjar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmquist, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Mazouni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, P. K.</span></span> <span> </span><span class="NLM_article-title">Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3649</span>– <span class="NLM_lpage">3653</span>, <span class="refDoi"> DOI: 10.1021/jm8001026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8001026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3649-3653&author=M.+A.+Phillipsauthor=R.+Gujjarauthor=N.+A.+Malmquistauthor=J.+Whiteauthor=F.+El+Mazouniauthor=J.+Baldwinauthor=P.+K.+Rathod&title=Triazolopyrimidine-based+dihydroorotate+dehydrogenase+inhibitors+with+potent+and+selective+activity+against+the+malaria+parasite+Plasmodium+falciparum&doi=10.1021%2Fjm8001026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitors with Potent and Selective Activity against the Malaria Parasite Plasmodium falciparum</span></div><div class="casAuthors">Phillips, Margaret A.; Gujjar, Ramesh; Malmquist, Nicholas A.; White, John; El Mazouni, Farah; Baldwin, Jeffrey; Rathod, Pradipsinh K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3649-3653</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitor I that is potent (KI = 15 nM) and species-selective (>5000-fold over the human enzyme) was identified by high-throughput screening.  The substituted triazolopyrimidine and its structural analogs were produced by an inexpensive three-step synthesis, and the series showed good assocn. between PfDHODH inhibition and parasite toxicity.  This study has identified the first nanomolar PfDHODH inhibitor with potent antimalarial activity in whole cells (EC50 = 79 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpklJJmj9EM77Vg90H21EOLACvtfcHk0lhxsZd_9xx_lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbs%253D&md5=7bdbdc57d346ef3290623adc4aed89ee</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm8001026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001026%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DGujjar%26aufirst%3DR.%26aulast%3DMalmquist%26aufirst%3DN.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DBaldwin%26aufirst%3DJ.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26atitle%3DTriazolopyrimidine-based%2520dihydroorotate%2520dehydrogenase%2520inhibitors%2520with%2520potent%2520and%2520selective%2520activity%2520against%2520the%2520malaria%2520parasite%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3649%26epage%3D3653%26doi%3D10.1021%2Fjm8001026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i83"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02022">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_74808"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02022?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02022</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">EC<sub>50</sub> values against NF54-luc <i>P. falciparum</i> parasites; EC<sub>50</sub> values associated with cellular heme fractionation; free heme and Hz levels in drug-treated NF54 parasites; whole-genome sequence metrics from Illumina MiSeq (300 bp paired end reads) for the four <b>9</b>-resistant 3D7 clones; CNVs identified in <b>9</b>-resistant 3D7 clones; SNPs observed in <b>9</b>-resistant 3D7 resistant clones; relative rate of kill versus control antimalarials; reduced efficacy of 3-analogues containing 5-Pyr on Dd2 compared to 3D7; snapshots from Integrated Genomics Viewer showing CNVs; and NMR spectra for compounds <b>3–34</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_001.pdf">jm0c02022_si_001.pdf (5.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02022/suppl_file/jm0c02022_si_002.csv">jm0c02022_si_002.csv (5.68 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02022&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02022%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02022" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799d974dd7f1234","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
